{"0166ec00f0e0ac777ad1188dad8442ddb25be8d7": [["| Patient historyyear-old, previously immunocompetent, female student admitted to our emergency department (ED) with the complaint of cough, sputum production for 2 weeks, fever for 1 week.", [["sputum", "ANATOMY", 141, 147], ["cough", "DISEASE", 134, 139], ["fever", "DISEASE", 172, 177], ["Patient", "SPECIES", 2, 9], ["cough", "PROBLEM", 134, 139], ["sputum production", "PROBLEM", 141, 158], ["fever", "PROBLEM", 172, 177], ["cough", "OBSERVATION", 134, 139]]], ["The patient showed no clinical response to therapy with the secondgeneration cephalosporins combined with azithromycin.", [["cephalosporins", "CHEMICAL", 77, 91], ["azithromycin", "CHEMICAL", 106, 118], ["cephalosporins", "CHEMICAL", 77, 91], ["azithromycin", "CHEMICAL", 106, 118], ["patient", "ORGANISM", 4, 11], ["secondgeneration cephalosporins", "SIMPLE_CHEMICAL", 60, 91], ["azithromycin", "SIMPLE_CHEMICAL", 106, 118], ["patient", "SPECIES", 4, 11], ["therapy", "TREATMENT", 43, 50], ["the secondgeneration cephalosporins", "TREATMENT", 56, 91], ["azithromycin", "TREATMENT", 106, 118], ["no", "UNCERTAINTY", 19, 21]]], ["Before admission to ED, she had already suffered from bilateral and progressive pneumonia within past 48 hours ( Figure 1 ).| Findings on admissionThe patient was transferred to RICU for intensified treatment.", [["pneumonia", "DISEASE", 80, 89], ["patient", "ORGANISM", 151, 158], ["patient", "SPECIES", 151, 158], ["bilateral and progressive pneumonia", "PROBLEM", 54, 89], ["intensified treatment", "TREATMENT", 187, 208], ["bilateral", "ANATOMY_MODIFIER", 54, 63], ["progressive", "OBSERVATION_MODIFIER", 68, 79], ["pneumonia", "OBSERVATION", 80, 89]]], ["Under physical examination, she had a high fever (39.7\u00b0C) with tachypnea (20/min) and tachycardia (100/ min) but normal blood pressure (130/80 mm Hg).", [["blood", "ANATOMY", 120, 125], ["fever", "DISEASE", 43, 48], ["tachypnea", "DISEASE", 63, 72], ["tachycardia", "DISEASE", 86, 97], ["Hg", "CHEMICAL", 146, 148], ["blood", "ORGANISM_SUBSTANCE", 120, 125], ["Under physical examination", "TEST", 0, 26], ["a high fever", "PROBLEM", 36, 48], ["tachypnea", "PROBLEM", 63, 72], ["tachycardia", "PROBLEM", 86, 97]]], ["Localised coarse crackles were heard in the bilateral lower lobe.", [["lower lobe", "ANATOMY", 54, 64], ["lower lobe", "MULTI-TISSUE_STRUCTURE", 54, 64], ["Localised coarse crackles", "PROBLEM", 0, 25], ["coarse", "OBSERVATION_MODIFIER", 10, 16], ["crackles", "OBSERVATION", 17, 25], ["bilateral lower lobe", "ANATOMY", 44, 64]]], ["The patient's mucous membranes were dry, without any signs of peripheral oedema.", [["mucous membranes", "ANATOMY", 14, 30], ["peripheral oedema", "DISEASE", 62, 79], ["patient", "ORGANISM", 4, 11], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 14, 30], ["peripheral oedema", "PATHOLOGICAL_FORMATION", 62, 79], ["patient", "SPECIES", 4, 11], ["peripheral oedema", "PROBLEM", 62, 79], ["mucous membranes", "ANATOMY", 14, 30], ["dry", "OBSERVATION", 36, 39], ["peripheral", "ANATOMY_MODIFIER", 62, 72], ["oedema", "OBSERVATION", 73, 79]]], ["There were no signs of bleeding or skin rash.", [["skin", "ANATOMY", 35, 39], ["bleeding", "DISEASE", 23, 31], ["skin rash", "DISEASE", 35, 44], ["skin", "ORGAN", 35, 39], ["bleeding", "PROBLEM", 23, 31], ["skin rash", "PROBLEM", 35, 44], ["no signs of", "UNCERTAINTY", 11, 22], ["bleeding", "OBSERVATION", 23, 31], ["skin", "ANATOMY", 35, 39], ["rash", "OBSERVATION", 40, 44]]], ["Arterial blood gas analysis (ABGA) showed hypoxia (PaO 2 58 mm Hg) on room air under 5 L/min oxygen via a face mask.", [["Arterial blood", "ANATOMY", 0, 14], ["hypoxia", "DISEASE", 42, 49], ["oxygen", "CHEMICAL", 93, 99], ["Hg", "CHEMICAL", 63, 65], ["oxygen", "CHEMICAL", 93, 99], ["Arterial", "ORGANISM_SUBSTANCE", 0, 8], ["blood", "ORGANISM_SUBSTANCE", 9, 14], ["oxygen", "SIMPLE_CHEMICAL", 93, 99], ["Arterial blood gas analysis", "TEST", 0, 27], ["ABGA", "TEST", 29, 33], ["hypoxia", "PROBLEM", 42, 49], ["PaO", "TEST", 51, 54], ["oxygen", "TREATMENT", 93, 99], ["a face mask", "TREATMENT", 104, 115], ["hypoxia", "OBSERVATION", 42, 49]]], ["The ejection fraction seemed to be maintained to roughly 65% in echocardiography.", [["The ejection fraction", "TEST", 0, 21], ["echocardiography", "TEST", 64, 80], ["ejection fraction", "OBSERVATION", 4, 21]]], ["Her leucocyte cell count was 6.07 \u00d7 10 9 per L, presenting 8.6% of lymphocytes and 89.6% of neutrophils.", [["leucocyte cell", "ANATOMY", 4, 18], ["lymphocytes", "ANATOMY", 67, 78], ["neutrophils", "ANATOMY", 92, 103], ["Her leucocyte cell", "CELL", 0, 18], ["lymphocytes", "CELL", 67, 78], ["neutrophils", "CELL", 92, 103], ["lymphocytes", "CELL_TYPE", 67, 78], ["neutrophils", "CELL_TYPE", 92, 103], ["Her leucocyte cell count", "TEST", 0, 24], ["lymphocytes", "TEST", 67, 78], ["neutrophils", "TEST", 92, 103], ["leucocyte cell count", "OBSERVATION", 4, 24]]], ["Platelets were slightly low with 114 \u00d7 10 9 per L. Plasma NT-proBNP was normal (70.28 pg/mL) and albumin concentration was low at 23 g/L (reference 40-55 g/L).", [["Platelets", "ANATOMY", 0, 9], ["NT-proBNP", "CHEMICAL", 58, 67], ["Platelets", "CELL", 0, 9], ["NT-proBNP", "GENE_OR_GENE_PRODUCT", 58, 67], ["albumin", "GENE_OR_GENE_PRODUCT", 97, 104], ["Platelets", "CELL_TYPE", 0, 9], ["albumin", "PROTEIN", 97, 104], ["Platelets", "TEST", 0, 9], ["slightly low", "PROBLEM", 15, 27], ["Plasma NT", "TEST", 51, 60], ["proBNP", "TEST", 61, 67], ["albumin concentration", "TEST", 97, 118], ["slightly", "OBSERVATION_MODIFIER", 15, 23], ["low", "OBSERVATION_MODIFIER", 24, 27]]], ["Elevated lactate dehydrogenase (LDH, 2274 U/L) and creatine kinase (CK, 2510 U/L) was noted.| BronchoscopyBronchoscopy was performed in RICU as soon as possible (Figure 2A-C) .", [["lactate", "CHEMICAL", 9, 16], ["creatine", "CHEMICAL", 51, 59], ["lactate", "CHEMICAL", 9, 16], ["creatine", "CHEMICAL", 51, 59], ["lactate dehydrogenase", "GENE_OR_GENE_PRODUCT", 9, 30], ["LDH", "GENE_OR_GENE_PRODUCT", 32, 35], ["creatine kinase", "GENE_OR_GENE_PRODUCT", 51, 66], ["CK", "GENE_OR_GENE_PRODUCT", 68, 70], ["lactate dehydrogenase", "PROTEIN", 9, 30], ["LDH", "PROTEIN", 32, 35], ["creatine kinase", "PROTEIN", 51, 66], ["CK", "PROTEIN", 68, 70], ["Elevated lactate dehydrogenase", "PROBLEM", 0, 30], ["LDH", "TEST", 32, 35], ["U/L", "TEST", 42, 45], ["creatine kinase", "TEST", 51, 66], ["CK", "TEST", 68, 70], ["U/L)", "TEST", 77, 81], ["BronchoscopyBronchoscopy", "TEST", 94, 118], ["lactate dehydrogenase", "OBSERVATION", 9, 30]]], ["Bronchoscopic examination revealed that some formed mucous plug blocked the opening of segmental bronchial of left lower lobe.", [["mucous plug", "ANATOMY", 52, 63], ["segmental bronchial", "ANATOMY", 87, 106], ["left lower lobe", "ANATOMY", 110, 125], ["mucous plug", "PATHOLOGICAL_FORMATION", 52, 63], ["bronchial", "ORGAN", 97, 106], ["lower lobe", "MULTI-TISSUE_STRUCTURE", 115, 125], ["Bronchoscopic examination", "TEST", 0, 25], ["some formed mucous plug", "PROBLEM", 40, 63], ["some", "OBSERVATION_MODIFIER", 40, 44], ["formed", "OBSERVATION_MODIFIER", 45, 51], ["mucous plug", "OBSERVATION", 52, 63], ["opening", "OBSERVATION_MODIFIER", 76, 83], ["segmental", "ANATOMY_MODIFIER", 87, 96], ["bronchial", "ANATOMY", 97, 106], ["left lower lobe", "ANATOMY", 110, 125]]], ["Convex probe endobronchial ultrasound (CP-EBUS) was used for performing real-time transbronchial needle aspiration (TBNA) of peribronchial lesions, and therefore, was used as a means of tissue culture.", [["peribronchial lesions", "ANATOMY", 125, 146], ["tissue", "ANATOMY", 186, 192], ["transbronchial needle", "MULTI-TISSUE_STRUCTURE", 82, 103], ["peribronchial lesions", "PATHOLOGICAL_FORMATION", 125, 146], ["tissue", "TISSUE", 186, 192], ["Convex probe endobronchial ultrasound", "TEST", 0, 37], ["transbronchial needle aspiration", "TEST", 82, 114], ["TBNA", "TEST", 116, 120], ["peribronchial lesions", "PROBLEM", 125, 146], ["tissue culture", "TEST", 186, 200], ["endobronchial", "ANATOMY", 13, 26], ["peribronchial", "ANATOMY", 125, 138], ["lesions", "OBSERVATION", 139, 146]]], ["Transbronchial lung biopsy (TBLB) and EBUS-TBNA was both reported as inflammatory cell infiltration and necrosis.", [["Transbronchial lung biopsy", "ANATOMY", 0, 26], ["TBLB", "ANATOMY", 28, 32], ["inflammatory cell", "ANATOMY", 69, 86], ["necrosis", "DISEASE", 104, 112], ["lung biopsy", "MULTI-TISSUE_STRUCTURE", 15, 26], ["inflammatory cell", "CELL", 69, 86], ["Transbronchial lung biopsy", "TEST", 0, 26], ["TBLB", "TEST", 28, 32], ["EBUS", "TEST", 38, 42], ["TBNA", "TEST", 43, 47], ["inflammatory cell infiltration", "PROBLEM", 69, 99], ["necrosis", "PROBLEM", 104, 112], ["lung", "ANATOMY", 15, 19], ["biopsy", "OBSERVATION", 20, 26], ["EBUS", "ANATOMY", 38, 42], ["TBNA", "ANATOMY", 43, 47], ["inflammatory cell infiltration", "OBSERVATION", 69, 99], ["necrosis", "OBSERVATION", 104, 112]]], ["Pathologic section of intraluminal secretion demonstrated as fibrous exudation ( Figure 2D -F).", [["intraluminal", "ANATOMY", 22, 34], ["fibrous", "ANATOMY", 61, 68], ["intraluminal", "IMMATERIAL_ANATOMICAL_ENTITY", 22, 34], ["intraluminal secretion", "PROBLEM", 22, 44], ["fibrous exudation", "PROBLEM", 61, 78], ["intraluminal", "ANATOMY_MODIFIER", 22, 34], ["secretion", "OBSERVATION", 35, 44], ["fibrous", "OBSERVATION_MODIFIER", 61, 68], ["exudation", "OBSERVATION_MODIFIER", 69, 78]]], ["The NGS result from bronchoalveolar lavage fluid (BALF) was positive for human adenovirus 7.", [["bronchoalveolar lavage fluid", "ANATOMY", 20, 48], ["BALF", "ANATOMY", 50, 54], ["bronchoalveolar lavage fluid", "ORGANISM_SUBSTANCE", 20, 48], ["BALF", "ORGANISM_SUBSTANCE", 50, 54], ["human", "ORGANISM", 73, 78], ["adenovirus 7", "ORGANISM", 79, 91], ["human", "SPECIES", 73, 78], ["human adenovirus 7", "SPECIES", 73, 91], ["The NGS", "TEST", 0, 7], ["bronchoalveolar lavage fluid (BALF)", "TEST", 20, 55], ["human adenovirus", "PROBLEM", 73, 89], ["bronchoalveolar lavage", "OBSERVATION", 20, 42]]], ["Real-time PCR testing of BALF was also performed to screen for adenovirus with a cycle threshold value of 31 ( Figure 3 ).", [["BALF", "ANATOMY", 25, 29], ["BALF", "ORGANISM_SUBSTANCE", 25, 29], ["adenovirus", "ORGANISM", 63, 73], ["adenovirus", "SPECIES", 63, 73], ["Real-time PCR testing of BALF", "TEST", 0, 29], ["adenovirus", "PROBLEM", 63, 73], ["a cycle threshold value", "TEST", 79, 102]]], ["Culture of sputum and BALF did not show any evidence of bacterial or fungal infection.", [["sputum", "ANATOMY", 11, 17], ["BALF", "ANATOMY", 22, 26], ["fungal infection", "DISEASE", 69, 85], ["sputum", "ORGANISM_SUBSTANCE", 11, 17], ["BALF", "ORGANISM_SUBSTANCE", 22, 26], ["Culture of sputum and BALF", "TEST", 0, 26], ["bacterial or fungal infection", "PROBLEM", 56, 85], ["bacterial", "OBSERVATION_MODIFIER", 56, 65], ["fungal", "OBSERVATION_MODIFIER", 69, 75], ["infection", "OBSERVATION", 76, 85]]], ["Acid-fast stain of sputum found no evidence of tuberculosis.", [["sputum", "ANATOMY", 19, 25], ["tuberculosis", "DISEASE", 47, 59], ["Acid", "SIMPLE_CHEMICAL", 0, 4], ["sputum", "ORGANISM_SUBSTANCE", 19, 25], ["Acid-fast stain", "TEST", 0, 15], ["sputum", "TEST", 19, 25], ["tuberculosis", "PROBLEM", 47, 59], ["no evidence of", "UNCERTAINTY", 32, 46], ["tuberculosis", "OBSERVATION", 47, 59]]], ["Interesting, culture of EBUS-TBNA biopsied tissue showed candida growth.| BronchoscopyBronchoscopy was also used for airway management in further intensive care.", [["tissue", "ANATOMY", 43, 49], ["airway", "ANATOMY", 117, 123], ["candida", "DISEASE", 57, 64], ["EBUS-TBNA biopsied tissue", "TISSUE", 24, 49], ["airway", "MULTI-TISSUE_STRUCTURE", 117, 123], ["EBUS", "TEST", 24, 28], ["TBNA biopsied tissue", "TEST", 29, 49], ["candida growth", "PROBLEM", 57, 71], ["BronchoscopyBronchoscopy", "TREATMENT", 74, 98], ["airway management", "TREATMENT", 117, 134], ["further intensive care", "TREATMENT", 138, 160], ["candida growth", "OBSERVATION", 57, 71]]], ["Bronchoscopy with BAL in the patient was well tolerated, primarily related to better drainage of secretions and pathogenic investigation ( Figure 2G -I).| Treatment of ARDS with prone ventilation and V-V ECMOOn admission (HD 1-2, day 1-2), the patient needed 5 L/min oxygen via a face mask, which resulted in an arterial PaO 2 of 45-58 mm Hg and O 2 saturation of 92%-98%.", [["BAL", "ANATOMY", 18, 21], ["secretions", "ANATOMY", 97, 107], ["face", "ANATOMY", 280, 284], ["arterial", "ANATOMY", 312, 320], ["ARDS", "DISEASE", 168, 172], ["oxygen", "CHEMICAL", 267, 273], ["oxygen", "CHEMICAL", 267, 273], ["Hg", "CHEMICAL", 339, 341], ["O 2", "CHEMICAL", 346, 349], ["BAL", "ORGANISM_SUBSTANCE", 18, 21], ["patient", "ORGANISM", 29, 36], ["patient", "ORGANISM", 244, 251], ["oxygen", "SIMPLE_CHEMICAL", 267, 273], ["patient", "SPECIES", 29, 36], ["patient", "SPECIES", 244, 251], ["Bronchoscopy", "TEST", 0, 12], ["BAL", "TREATMENT", 18, 21], ["secretions", "PROBLEM", 97, 107], ["pathogenic investigation", "TEST", 112, 136], ["ARDS", "PROBLEM", 168, 172], ["prone ventilation", "TREATMENT", 178, 195], ["HD", "TEST", 222, 224], ["5 L/min oxygen", "TREATMENT", 259, 273], ["a face mask", "TREATMENT", 278, 289], ["an arterial PaO", "TEST", 309, 324], ["O 2 saturation", "TEST", 346, 360], ["secretions", "OBSERVATION", 97, 107], ["ARDS", "OBSERVATION", 168, 172], ["arterial", "ANATOMY", 312, 320]]], ["There was no progress of the pericardial effusion and no further decrease of the ejection fraction.", [["pericardial", "ANATOMY", 29, 40], ["pericardial effusion", "DISEASE", 29, 49], ["pericardial", "ORGAN", 29, 40], ["the pericardial effusion", "PROBLEM", 25, 49], ["further decrease of the ejection fraction", "PROBLEM", 57, 98], ["no", "UNCERTAINTY", 10, 12], ["pericardial", "ANATOMY", 29, 40], ["effusion", "OBSERVATION", 41, 49], ["no", "UNCERTAINTY", 54, 56], ["decrease", "OBSERVATION_MODIFIER", 65, 73], ["ejection fraction", "OBSERVATION", 81, 98]]], ["The left pleural effusions progressed to 3 and 3.5 cm.", [["left pleural effusions", "ANATOMY", 4, 26], ["left pleural effusions", "DISEASE", 4, 26], ["left pleural effusions", "CANCER", 4, 26], ["The left pleural effusions", "PROBLEM", 0, 26], ["left", "ANATOMY_MODIFIER", 4, 8], ["pleural", "ANATOMY", 9, 16], ["effusions", "OBSERVATION", 17, 26], ["3 and 3.5 cm", "OBSERVATION_MODIFIER", 41, 53]]], ["Then, diagnostic ultrasound-guided thoracentesis was carried out, which yielded yellow fluid.", [["yellow fluid", "ANATOMY", 80, 92], ["diagnostic ultrasound", "TEST", 6, 27], ["thoracentesis", "TREATMENT", 35, 48], ["yellow fluid", "PROBLEM", 80, 92], ["thoracentesis", "OBSERVATION", 35, 48], ["yellow fluid", "OBSERVATION", 80, 92]]], ["Analysis of the pleural fluid revealed exudates with 7.47 mmol/L of glucose, 2561.8 U/L of LDH, 34.9 U/L of ADA and 42.4 U/L of amylase.", [["pleural fluid", "ANATOMY", 16, 29], ["exudates", "ANATOMY", 39, 47], ["glucose", "CHEMICAL", 68, 75], ["glucose", "CHEMICAL", 68, 75], ["pleural fluid", "ORGANISM_SUBSTANCE", 16, 29], ["glucose", "SIMPLE_CHEMICAL", 68, 75], ["LDH", "GENE_OR_GENE_PRODUCT", 91, 94], ["ADA", "SIMPLE_CHEMICAL", 108, 111], ["amylase", "GENE_OR_GENE_PRODUCT", 128, 135], ["LDH", "PROTEIN", 91, 94], ["ADA", "PROTEIN", 108, 111], ["amylase", "PROTEIN", 128, 135], ["Analysis of the pleural fluid", "TEST", 0, 29], ["exudates", "PROBLEM", 39, 47], ["glucose", "TEST", 68, 75], ["U", "TEST", 84, 85], ["LDH", "TEST", 91, 94], ["U", "TEST", 101, 102], ["ADA", "TEST", 108, 111], ["U", "TEST", 121, 122], ["amylase", "TEST", 128, 135], ["pleural", "ANATOMY", 16, 23], ["fluid", "OBSERVATION", 24, 29], ["exudates", "OBSERVATION", 39, 47], ["LDH", "ANATOMY", 91, 94], ["amylase", "ANATOMY", 128, 135]]], ["A cell fractionation of pleural effusion revealed 5% of neutrophils and 28% of lymphocytes.", [["cell", "ANATOMY", 2, 6], ["pleural effusion", "ANATOMY", 24, 40], ["neutrophils", "ANATOMY", 56, 67], ["lymphocytes", "ANATOMY", 79, 90], ["pleural effusion", "DISEASE", 24, 40], ["cell", "CELL", 2, 6], ["pleural effusion", "CANCER", 24, 40], ["neutrophils", "CELL", 56, 67], ["lymphocytes", "CELL", 79, 90], ["neutrophils", "CELL_TYPE", 56, 67], ["lymphocytes", "CELL_TYPE", 79, 90], ["A cell fractionation", "TEST", 0, 20], ["pleural effusion", "PROBLEM", 24, 40], ["neutrophils", "TEST", 56, 67], ["lymphocytes", "TEST", 79, 90], ["cell fractionation", "OBSERVATION", 2, 20], ["pleural", "ANATOMY", 24, 31], ["effusion", "OBSERVATION", 32, 40]]], ["On HD 3, her respiratory condition deteriorated.", [["respiratory", "ANATOMY", 13, 24], ["HD", "TREATMENT", 3, 5], ["her respiratory condition", "PROBLEM", 9, 34], ["respiratory", "ANATOMY", 13, 24], ["deteriorated", "OBSERVATION", 35, 47]]], ["Although we introduced high-flow nasal cannula at FiO 2 60%, the patient had dyspnoea associated with hyperventilation (>30 breaths per min), O 2 saturation fluctuated between 86% and 92%.", [["nasal", "ANATOMY", 33, 38], ["dyspnoea", "DISEASE", 77, 85], ["hyperventilation", "DISEASE", 102, 118], ["O 2", "CHEMICAL", 142, 145], ["nasal cannula", "MULTI-TISSUE_STRUCTURE", 33, 46], ["patient", "ORGANISM", 65, 72], ["patient", "SPECIES", 65, 72], ["high-flow nasal cannula at FiO", "TREATMENT", 23, 53], ["dyspnoea", "PROBLEM", 77, 85], ["hyperventilation", "PROBLEM", 102, 118], ["O 2 saturation", "TEST", 142, 156], ["high", "OBSERVATION_MODIFIER", 23, 27]]], ["Chest radiographs on HD 2 and HD 3 showed increasing signs of a pulmonary infiltration.| Treatment of ARDS with prone ventilation and V-V ECMOEarly in the morning of HD 4, sufficient oxygen uptake was no longer possible, resulting in the need for oral intubation and mechanical ventilation (MV).", [["pulmonary", "ANATOMY", 64, 73], ["oral", "ANATOMY", 247, 251], ["pulmonary infiltration", "DISEASE", 64, 86], ["ARDS", "DISEASE", 102, 106], ["oxygen", "CHEMICAL", 183, 189], ["oxygen", "CHEMICAL", 183, 189], ["pulmonary", "ORGAN", 64, 73], ["V-V", "GENE_OR_GENE_PRODUCT", 134, 137], ["oxygen", "SIMPLE_CHEMICAL", 183, 189], ["oral", "ORGANISM_SUBDIVISION", 247, 251], ["MV", "SPECIES", 291, 293], ["Chest radiographs", "TEST", 0, 17], ["HD", "TEST", 21, 23], ["HD", "TEST", 30, 32], ["a pulmonary infiltration", "PROBLEM", 62, 86], ["ARDS", "PROBLEM", 102, 106], ["prone ventilation", "TREATMENT", 112, 129], ["HD", "TREATMENT", 166, 168], ["sufficient oxygen uptake", "PROBLEM", 172, 196], ["oral intubation", "TREATMENT", 247, 262], ["mechanical ventilation", "TREATMENT", 267, 289], ["increasing", "OBSERVATION_MODIFIER", 42, 52], ["pulmonary", "ANATOMY", 64, 73], ["infiltration", "OBSERVATION", 74, 86], ["ARDS", "OBSERVATION", 102, 106], ["no longer", "UNCERTAINTY", 201, 210]]], ["Mechanical respiratory support with smaller tidal volume ventilation (300 mL, ideal body weight = 50 kg) and high positive end-expiratory pressure F I G U R E 1 Initial chest CT findings in the patient.", [["respiratory", "ANATOMY", 11, 22], ["body", "ANATOMY", 84, 88], ["body", "ORGANISM_SUBDIVISION", 84, 88], ["patient", "ORGANISM", 194, 201], ["patient", "SPECIES", 194, 201], ["Mechanical respiratory support", "TREATMENT", 0, 30], ["smaller tidal volume ventilation", "TREATMENT", 36, 68], ["ideal body weight", "TEST", 78, 95], ["Initial chest CT findings", "TEST", 161, 186], ["respiratory support", "OBSERVATION", 11, 30], ["smaller", "OBSERVATION_MODIFIER", 36, 43], ["tidal volume", "OBSERVATION", 44, 56], ["chest", "ANATOMY", 169, 174]]], ["It was showed that bilateral consolidation and patchy infiltration were aggravated within 48 hours before admission (PEEP, 14 cmH 2 O) was started due to the development of ARDS.", [["cmH 2 O", "CHEMICAL", 126, 133], ["ARDS", "DISEASE", 173, 177], ["bilateral consolidation", "PROBLEM", 19, 42], ["patchy infiltration", "PROBLEM", 47, 66], ["PEEP", "TREATMENT", 117, 121], ["ARDS", "PROBLEM", 173, 177], ["bilateral", "ANATOMY_MODIFIER", 19, 28], ["consolidation", "OBSERVATION", 29, 42], ["patchy", "OBSERVATION_MODIFIER", 47, 53], ["infiltration", "OBSERVATION", 54, 66], ["ARDS", "OBSERVATION", 173, 177]]], ["The patient received strategies of sedative analgesics and neuromuscular blockade with midazolam and vecuronium.", [["neuromuscular", "ANATOMY", 59, 72], ["midazolam", "CHEMICAL", 87, 96], ["vecuronium", "CHEMICAL", 101, 111], ["midazolam", "CHEMICAL", 87, 96], ["vecuronium", "CHEMICAL", 101, 111], ["patient", "ORGANISM", 4, 11], ["midazolam", "SIMPLE_CHEMICAL", 87, 96], ["vecuronium", "SIMPLE_CHEMICAL", 101, 111], ["patient", "SPECIES", 4, 11], ["sedative analgesics", "TREATMENT", 35, 54], ["neuromuscular blockade", "TREATMENT", 59, 81], ["midazolam", "TREATMENT", 87, 96], ["vecuronium", "TREATMENT", 101, 111]]], ["The patient did not need norepinephrine immediately after intubation.", [["norepinephrine", "CHEMICAL", 25, 39], ["norepinephrine", "CHEMICAL", 25, 39], ["patient", "ORGANISM", 4, 11], ["norepinephrine", "SIMPLE_CHEMICAL", 25, 39], ["patient", "SPECIES", 4, 11], ["norepinephrine", "TREATMENT", 25, 39], ["intubation", "TREATMENT", 58, 68]]], ["The hypoxia further worsened (ABGA: pH 7.7.448, PaCO 2 32.8 mm Hg, PaO 2 40.9 mm Hg, O 2 saturation 75%, with ventilator settings at FiO 2 100%).", [["hypoxia", "DISEASE", 4, 11], ["Hg", "CHEMICAL", 63, 65], ["PaO 2", "CHEMICAL", 67, 72], ["Hg", "CHEMICAL", 81, 83], ["O 2", "CHEMICAL", 85, 88], ["The hypoxia", "PROBLEM", 0, 11], ["ABGA", "TEST", 30, 34], ["pH", "TEST", 36, 38], ["PaCO", "TEST", 48, 52], ["Hg", "TEST", 63, 65], ["PaO", "TEST", 67, 70], ["mm Hg", "TEST", 78, 83], ["O 2 saturation", "TEST", 85, 99], ["ventilator settings", "TREATMENT", 110, 129], ["FiO", "TEST", 133, 136], ["hypoxia", "OBSERVATION", 4, 11], ["worsened", "OBSERVATION_MODIFIER", 20, 28]]], ["After applying with prone ventilation, O 2 saturation fluctuated between 80% and 88%.", [["O 2", "CHEMICAL", 39, 42], ["prone ventilation", "TREATMENT", 20, 37], ["O 2 saturation", "TEST", 39, 53]]], ["To overcome intractable hypoxia, venovenous ECMO (V-V ECMO) was started (6 hours after prone ventilation).", [["hypoxia", "DISEASE", 24, 31], ["intractable hypoxia", "PROBLEM", 12, 31], ["venovenous ECMO", "TREATMENT", 33, 48], ["V-V ECMO", "TREATMENT", 50, 58], ["prone ventilation", "TREATMENT", 87, 104], ["intractable", "OBSERVATION_MODIFIER", 12, 23], ["hypoxia", "OBSERVATION", 24, 31], ["venovenous ECMO", "OBSERVATION", 33, 48]]], ["ECMO device parameters including rotate speed, blood flow and sweep gas are reported in Table 1 , where changes over time were shown.| Treatment of ARDS with prone ventilation and V-V ECMOFrom HD 5 to 11, prone ventilation was done every night for 12-14 hours to reduce in intrapulmonary ventilation perfusion mismatch and ventilator induced lung injury, and to obtain better drainage of secretions.| Treatment of ARDS with prone ventilation and V-V ECMOUntil HD 10, the patient began to improve gradually in ventilator parameters (Table 2) .", [["blood", "ANATOMY", 47, 52], ["intrapulmonary", "ANATOMY", 273, 287], ["lung", "ANATOMY", 342, 346], ["secretions", "ANATOMY", 388, 398], ["ARDS", "DISEASE", 148, 152], ["lung injury", "DISEASE", 342, 353], ["ARDS", "DISEASE", 414, 418], ["blood", "ORGANISM_SUBSTANCE", 47, 52], ["intrapulmonary", "MULTI-TISSUE_STRUCTURE", 273, 287], ["lung", "ORGAN", 342, 346], ["patient", "ORGANISM", 471, 478], ["patient", "SPECIES", 471, 478], ["ECMO device", "TREATMENT", 0, 11], ["rotate speed", "TEST", 33, 45], ["blood flow", "TEST", 47, 57], ["sweep gas", "TEST", 62, 71], ["ARDS", "PROBLEM", 148, 152], ["prone ventilation", "TREATMENT", 158, 175], ["V-V ECMOFrom HD", "TREATMENT", 180, 195], ["prone ventilation", "TREATMENT", 205, 222], ["intrapulmonary ventilation perfusion mismatch", "TREATMENT", 273, 318], ["ventilator induced lung injury", "PROBLEM", 323, 353], ["secretions", "PROBLEM", 388, 398], ["ARDS", "PROBLEM", 414, 418], ["prone ventilation", "TREATMENT", 424, 441], ["V-V ECMOUntil HD", "TREATMENT", 446, 462], ["ARDS", "OBSERVATION", 148, 152], ["intrapulmonary", "ANATOMY", 273, 287], ["ventilation", "OBSERVATION", 288, 299], ["perfusion mismatch", "OBSERVATION", 300, 318], ["lung", "ANATOMY", 342, 346], ["injury", "OBSERVATION", 347, 353], ["secretions", "OBSERVATION", 388, 398], ["ARDS", "OBSERVATION", 414, 418]]], ["Notably, the deterioration of C dyn peaked on HD 5 with an index value of 7.5 mL/ cmH 2 O, and improvement of the C dyn was noticed on HD 10.", [["C dyn", "SIMPLE_CHEMICAL", 30, 35], ["C dyn", "SIMPLE_CHEMICAL", 114, 119], ["the deterioration of C dyn", "PROBLEM", 9, 35], ["HD", "TREATMENT", 46, 48], ["an index value", "TEST", 56, 70], ["the C dyn", "PROBLEM", 110, 119], ["HD", "TREATMENT", 135, 137], ["deterioration", "OBSERVATION_MODIFIER", 13, 26], ["C dyn", "OBSERVATION_MODIFIER", 30, 35], ["C dyn", "OBSERVATION_MODIFIER", 114, 119]]], ["Then, spontaneous breathing with oral intubation was attempted with V-V ECMO with settings at FiO 2 21% (ECMO circuit).", [["oral", "ANATOMY", 33, 37], ["oral", "ORGANISM_SUBDIVISION", 33, 37], ["oral intubation", "TREATMENT", 33, 48], ["V-V ECMO", "TREATMENT", 68, 76], ["settings", "TREATMENT", 82, 90], ["FiO", "TREATMENT", 94, 97], ["ECMO circuit", "TREATMENT", 105, 117]]], ["At that time, the patient maintained haemodynamic and oxygen saturation with MV settings at Vt 280 mL, PEEP 10 cmH 2 O, RR 20/min, FiO 2 50%, which resulted in an arterial PaO 2 of 84.6 mm Hg, PaCO 2 of 42.3 mm Hg, and pH 7.471.", [["arterial", "ANATOMY", 163, 171], ["oxygen", "CHEMICAL", 54, 60], ["oxygen", "CHEMICAL", 54, 60], ["Hg", "CHEMICAL", 189, 191], ["PaCO 2", "CHEMICAL", 193, 199], ["Hg", "CHEMICAL", 211, 213], ["patient", "ORGANISM", 18, 25], ["oxygen", "SIMPLE_CHEMICAL", 54, 60], ["patient", "SPECIES", 18, 25], ["MV", "SPECIES", 77, 79], ["oxygen saturation", "TEST", 54, 71], ["MV settings", "TEST", 77, 88], ["Vt", "TEST", 92, 94], ["PEEP", "TEST", 103, 107], ["RR", "TEST", 120, 122], ["FiO", "TEST", 131, 134], ["an arterial PaO", "TEST", 160, 175], ["PaCO", "TEST", 193, 197], ["mm Hg", "TEST", 208, 213], ["pH", "TEST", 219, 221], ["oxygen saturation", "OBSERVATION", 54, 71], ["arterial", "ANATOMY", 163, 171]]], ["We noted no signs of disseminated bleeding, and only the nasal cavity bleeding was noticed on HD 9-11.", [["nasal cavity", "ANATOMY", 57, 69], ["bleeding", "DISEASE", 34, 42], ["bleeding", "DISEASE", 70, 78], ["nasal cavity", "PATHOLOGICAL_FORMATION", 57, 69], ["disseminated bleeding", "PROBLEM", 21, 42], ["the nasal cavity bleeding", "PROBLEM", 53, 78], ["HD", "TEST", 94, 96], ["no signs of", "UNCERTAINTY", 9, 20], ["disseminated", "OBSERVATION_MODIFIER", 21, 33], ["bleeding", "OBSERVATION", 34, 42], ["nasal cavity", "ANATOMY", 57, 69], ["bleeding", "OBSERVATION", 70, 78]]], ["On HD 11, V-V ECMO was weaned.", [["V-V", "GENE_OR_GENE_PRODUCT", 10, 13], ["HD", "TREATMENT", 3, 5], ["V-V ECMO", "TREATMENT", 10, 18]]], ["The patient received 6 units of red blood cell concentrates on HD 11 in response to decreasing hemoglobin concentrations after V-V ECMO removal.| Treatment of ARDS with prone ventilation and V-V ECMOAfter V-V ECMO was weaned, she maintained good saturation in supine position with PEEP 6-10 cmH 2 O and FiO 2 between 40% and 50%.", [["red blood cell", "ANATOMY", 32, 46], ["ARDS", "DISEASE", 159, 163], ["patient", "ORGANISM", 4, 11], ["red blood cell", "CELL", 32, 46], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 95, 105], ["V-V", "GENE_OR_GENE_PRODUCT", 127, 130], ["V-V", "GENE_OR_GENE_PRODUCT", 205, 208], ["red blood cell", "CELL_TYPE", 32, 46], ["hemoglobin", "PROTEIN", 95, 105], ["patient", "SPECIES", 4, 11], ["red blood cell concentrates", "TREATMENT", 32, 59], ["HD", "TREATMENT", 63, 65], ["decreasing hemoglobin concentrations", "PROBLEM", 84, 120], ["V-V ECMO removal", "TREATMENT", 127, 143], ["ARDS", "PROBLEM", 159, 163], ["prone ventilation", "TREATMENT", 169, 186], ["V", "TEST", 191, 192], ["V ECMO", "TREATMENT", 207, 213], ["PEEP", "TEST", 281, 285], ["FiO", "TEST", 303, 306], ["ARDS", "OBSERVATION", 159, 163]]], ["The strategies of sedative analgesics and neuromuscular blockade were weaned.", [["neuromuscular", "ANATOMY", 42, 55], ["neuromuscular blockade", "DISEASE", 42, 64], ["sedative analgesics", "TREATMENT", 18, 37], ["neuromuscular blockade", "TREATMENT", 42, 64]]], ["Over the next 2 days, the P/F ratio stayed between 220 and 300.", [["the P/F ratio", "TEST", 22, 35]]], ["On HD 15,| Diagnostic thoracic ultrasoundThe point of care ultrasound of chest was used to assess cardiac function, lung B lines, fluid responsiveness and inferior vena cava diameter (IVCD), suggested evidence of fluid overload (Figure 4 ).", [["thoracic", "ANATOMY", 22, 30], ["chest", "ANATOMY", 73, 78], ["cardiac", "ANATOMY", 98, 105], ["lung B lines", "ANATOMY", 116, 128], ["fluid", "ANATOMY", 130, 135], ["inferior vena cava", "ANATOMY", 155, 173], ["fluid", "ANATOMY", 213, 218], ["fluid overload", "DISEASE", 213, 227], ["chest", "ORGANISM_SUBDIVISION", 73, 78], ["cardiac", "ORGAN", 98, 105], ["lung B lines", "CELL", 116, 128], ["fluid", "ORGANISM_SUBSTANCE", 130, 135], ["inferior vena cava", "MULTI-TISSUE_STRUCTURE", 155, 173], ["fluid", "ORGANISM_SUBSTANCE", 213, 218], ["lung B lines", "CELL_LINE", 116, 128], ["HD", "TREATMENT", 3, 5], ["Diagnostic thoracic ultrasound", "TEST", 11, 41], ["care ultrasound of chest", "TEST", 54, 78], ["cardiac function", "TEST", 98, 114], ["lung B lines", "TREATMENT", 116, 128], ["fluid responsiveness", "TEST", 130, 150], ["fluid overload", "PROBLEM", 213, 227], ["thoracic", "ANATOMY", 22, 30], ["chest", "ANATOMY", 73, 78], ["lung", "ANATOMY", 116, 120], ["B lines", "OBSERVATION", 121, 128], ["fluid responsiveness", "OBSERVATION", 130, 150], ["inferior vena cava", "ANATOMY", 155, 173], ["diameter", "OBSERVATION_MODIFIER", 174, 182], ["suggested evidence of", "UNCERTAINTY", 191, 212], ["fluid overload", "OBSERVATION", 213, 227]]], ["The patient did not need norepinephrine after intubation and ECMO.", [["norepinephrine", "CHEMICAL", 25, 39], ["norepinephrine", "CHEMICAL", 25, 39], ["patient", "ORGANISM", 4, 11], ["norepinephrine", "SIMPLE_CHEMICAL", 25, 39], ["patient", "SPECIES", 4, 11], ["norepinephrine", "TREATMENT", 25, 39], ["intubation", "TREATMENT", 46, 56], ["ECMO", "TREATMENT", 61, 65]]], ["The anteroposterior IVCD was kept at 1.5 cm below the diaphragm in the hepatic segment in supine position during normal inspiration and expiration.", [["diaphragm", "ANATOMY", 54, 63], ["hepatic segment", "ANATOMY", 71, 86], ["diaphragm", "ORGAN", 54, 63], ["hepatic segment", "MULTI-TISSUE_STRUCTURE", 71, 86], ["The anteroposterior IVCD", "TREATMENT", 0, 24], ["anteroposterior", "OBSERVATION_MODIFIER", 4, 19], ["IVCD", "OBSERVATION", 20, 24], ["1.5 cm", "OBSERVATION_MODIFIER", 37, 43], ["diaphragm", "ANATOMY", 54, 63], ["hepatic", "ANATOMY", 71, 78], ["segment", "ANATOMY_MODIFIER", 79, 86], ["supine position", "ANATOMY_MODIFIER", 90, 105], ["normal inspiration", "OBSERVATION", 113, 131]]], ["It also presented the extravascular lung water by lung ultrasonography.", [["extravascular lung", "ANATOMY", 22, 40], ["lung", "ANATOMY", 50, 54], ["extravascular lung water", "ORGANISM_SUBSTANCE", 22, 46], ["lung", "ORGAN", 50, 54], ["lung ultrasonography", "TEST", 50, 70], ["extravascular", "ANATOMY_MODIFIER", 22, 35], ["lung", "ANATOMY", 36, 40], ["lung", "ANATOMY", 50, 54]]], ["Comparison of the chest ultrasound from HD 7, HD 8, and HD 10 showed improvement of lung consolidation, coincided with improvement of CXR ( Figure 5 ).| Intermittent use of CidofovirBased on the report of the NGS result in HD 4, Cidofovir was started as soon as possible (HD 7).", [["chest", "ANATOMY", 18, 23], ["lung", "ANATOMY", 84, 88], ["CidofovirBased", "CHEMICAL", 173, 187], ["Cidofovir", "CHEMICAL", 229, 238], ["Cidofovir", "CHEMICAL", 229, 238], ["lung", "ORGAN", 84, 88], ["Cidofovir", "SIMPLE_CHEMICAL", 229, 238], ["CXR", "PROTEIN", 134, 137], ["the chest ultrasound", "TEST", 14, 34], ["HD", "TEST", 46, 48], ["HD", "TEST", 56, 58], ["lung consolidation", "PROBLEM", 84, 102], ["CXR", "TEST", 134, 137], ["CidofovirBased", "TREATMENT", 173, 187], ["the NGS", "TEST", 205, 212], ["HD", "TREATMENT", 223, 225], ["Cidofovir", "TREATMENT", 229, 238], ["chest", "ANATOMY", 18, 23], ["lung", "ANATOMY", 84, 88], ["consolidation", "OBSERVATION", 89, 102], ["improvement", "OBSERVATION_MODIFIER", 119, 130]]], ["Briefly, Cidofovir was administrated at a dose of 5 mg/kg in the first week, followed by the same dose in the next week.", [["Cidofovir", "CHEMICAL", 9, 18], ["Cidofovir", "CHEMICAL", 9, 18], ["Cidofovir", "SIMPLE_CHEMICAL", 9, 18], ["Cidofovir", "TREATMENT", 9, 18]]], ["Hydration with normal saline before and after Cidofovir was used with probenecid (1.25 g/m 2 ) to prevent renal toxicity.", [["renal", "ANATOMY", 106, 111], ["Cidofovir", "CHEMICAL", 46, 55], ["probenecid", "CHEMICAL", 70, 80], ["renal toxicity", "DISEASE", 106, 120], ["Cidofovir", "CHEMICAL", 46, 55], ["probenecid", "CHEMICAL", 70, 80], ["saline", "SIMPLE_CHEMICAL", 22, 28], ["Cidofovir", "SIMPLE_CHEMICAL", 46, 55], ["probenecid", "SIMPLE_CHEMICAL", 70, 80], ["renal", "ORGAN", 106, 111], ["Hydration", "TREATMENT", 0, 9], ["normal saline", "TREATMENT", 15, 28], ["Cidofovir", "TREATMENT", 46, 55], ["probenecid", "TREATMENT", 70, 80], ["renal toxicity", "PROBLEM", 106, 120], ["renal", "ANATOMY", 106, 111], ["toxicity", "OBSERVATION", 112, 120]]], ["The concentrations of HAdV DNA in BALF had not dropped after the first dose of Cidofovir ( Figure 3B) .", [["BALF", "ANATOMY", 34, 38], ["Cidofovir", "CHEMICAL", 79, 88], ["Cidofovir", "CHEMICAL", 79, 88], ["HAdV", "ORGANISM", 22, 26], ["DNA", "CELLULAR_COMPONENT", 27, 30], ["BALF", "ORGANISM_SUBSTANCE", 34, 38], ["Cidofovir", "SIMPLE_CHEMICAL", 79, 88], ["BALF", "CELL_TYPE", 34, 38], ["HAdV", "SPECIES", 22, 26], ["HAdV DNA in BALF", "TEST", 22, 38], ["Cidofovir ( Figure 3B", "TREATMENT", 79, 100], ["concentrations", "OBSERVATION_MODIFIER", 4, 18], ["HAdV DNA", "OBSERVATION", 22, 30]]], ["Then, the second dose of Cidofovir was given on HD 14.", [["Cidofovir", "CHEMICAL", 25, 34], ["Cidofovir", "CHEMICAL", 25, 34], ["Cidofovir", "SIMPLE_CHEMICAL", 25, 34], ["Cidofovir", "TREATMENT", 25, 34], ["HD", "TREATMENT", 48, 50]]], ["On HD 15, the oral intubation was removed and sequenced with high-flow nasal cannula at FiO 2 40%.", [["oral", "ANATOMY", 14, 18], ["nasal", "ANATOMY", 71, 76], ["oral", "ORGANISM_SUBDIVISION", 14, 18], ["HD", "TREATMENT", 3, 5], ["the oral intubation", "TREATMENT", 10, 29], ["high-flow nasal cannula", "TREATMENT", 61, 84]]], ["Then, virus loads of HAdV were only analysed based on oropharyngeal swabs samples.", [["oropharyngeal swabs samples", "ANATOMY", 54, 81], ["HAdV", "ORGANISM", 21, 25], ["oropharyngeal swabs samples", "ORGANISM_SUBSTANCE", 54, 81], ["virus loads of HAdV", "TREATMENT", 6, 25], ["oropharyngeal swabs samples", "TEST", 54, 81]]], ["It became undetectable in oropharyngeal swabs sample after the using of the second dose of Cidofovir ( Figure 3B -D).| Antimicrobial therapyInitially, no particular exposure was known and the source of infection remains unclear.", [["oropharyngeal swabs sample", "ANATOMY", 26, 52], ["Cidofovir", "CHEMICAL", 91, 100], ["infection", "DISEASE", 202, 211], ["Cidofovir", "CHEMICAL", 91, 100], ["oropharyngeal swabs", "ORGANISM_SUBSTANCE", 26, 45], ["Cidofovir", "SIMPLE_CHEMICAL", 91, 100], ["oropharyngeal swabs sample", "TEST", 26, 52], ["Cidofovir ( Figure 3B", "TREATMENT", 91, 112], ["Antimicrobial therapyInitially", "TREATMENT", 119, 149], ["infection", "PROBLEM", 202, 211], ["undetectable", "OBSERVATION_MODIFIER", 10, 22], ["infection", "OBSERVATION", 202, 211]]], ["Hence, based on the clinical and laboratory findings suggesting sever CAP, we started treatment with Peramivir, Sulbactam/Cefoperazone,| Further course of the diseaseThe course of the clinical parameters is shown in Figures 5-7 .", [["CAP", "DISEASE", 70, 73], ["Peramivir", "CHEMICAL", 101, 110], ["Sulbactam", "CHEMICAL", 112, 121], ["Cefoperazone", "CHEMICAL", 122, 134], ["Peramivir", "CHEMICAL", 101, 110], ["Sulbactam", "CHEMICAL", 112, 121], ["Cefoperazone", "CHEMICAL", 122, 134], ["Peramivir", "SIMPLE_CHEMICAL", 101, 110], ["Sulbactam", "SIMPLE_CHEMICAL", 112, 121], ["Cefoperazone", "SIMPLE_CHEMICAL", 122, 134], ["sever CAP", "PROBLEM", 64, 73], ["treatment", "TREATMENT", 86, 95], ["Peramivir", "TREATMENT", 101, 110], ["Sulbactam", "TREATMENT", 112, 121], ["Cefoperazone", "TREATMENT", 122, 134], ["the disease", "PROBLEM", 155, 166], ["the clinical parameters", "TEST", 180, 203], ["disease", "OBSERVATION", 159, 166]]], ["Comparison of the chest radiographs from H 9 and H 10 showed improvement of infiltration, subsequently improvement noticed by chest CT on HD 13.", [["chest", "ANATOMY", 18, 23], ["the chest radiographs", "TEST", 14, 35], ["infiltration", "PROBLEM", 76, 88], ["chest CT", "TEST", 126, 134], ["HD", "TREATMENT", 138, 140], ["chest", "ANATOMY", 18, 23], ["infiltration", "OBSERVATION", 76, 88], ["improvement", "OBSERVATION_MODIFIER", 103, 114], ["chest", "ANATOMY", 126, 131]]], ["Despite an initial lymphocytopenia, lymphocytes count rose until HD 13, and subsequently normalised.", [["lymphocytes", "ANATOMY", 36, 47], ["lymphocytopenia", "DISEASE", 19, 34], ["lymphocytes", "CELL", 36, 47], ["lymphocytes", "CELL_TYPE", 36, 47], ["an initial lymphocytopenia", "PROBLEM", 8, 34], ["lymphocytes count", "TEST", 36, 53], ["HD", "TEST", 65, 67], ["lymphocytopenia", "OBSERVATION", 19, 34], ["lymphocytes count", "OBSERVATION", 36, 53]]], ["It was suggested that the observed clinical improvement coincided with normalisation of lymphocytopenia.", [["lymphocytopenia", "DISEASE", 88, 103], ["lymphocytopenia", "PROBLEM", 88, 103], ["lymphocytopenia", "OBSERVATION", 88, 103]]], ["Almost simultaneously, plasma LDH and CK level fell continuously.", [["plasma", "ANATOMY", 23, 29], ["plasma", "ORGANISM_SUBSTANCE", 23, 29], ["LDH", "GENE_OR_GENE_PRODUCT", 30, 33], ["CK", "GENE_OR_GENE_PRODUCT", 38, 40], ["CK", "PROTEIN", 38, 40], ["plasma LDH", "TEST", 23, 33], ["CK level", "TEST", 38, 46]]], ["The inflammatory parameters interleukin-6 (IL-6) and C-reactive protein (CRP) had also dropped.", [["interleukin-6", "GENE_OR_GENE_PRODUCT", 28, 41], ["IL-6", "GENE_OR_GENE_PRODUCT", 43, 47], ["C-reactive protein", "GENE_OR_GENE_PRODUCT", 53, 71], ["CRP", "GENE_OR_GENE_PRODUCT", 73, 76], ["interleukin-6 (IL-6", "PROTEIN", 28, 47], ["C-reactive protein", "PROTEIN", 53, 71], ["CRP", "PROTEIN", 73, 76], ["The inflammatory parameters interleukin", "TEST", 0, 39], ["IL", "TEST", 43, 45], ["C-reactive protein", "TEST", 53, 71], ["CRP", "TEST", 73, 76], ["inflammatory", "OBSERVATION_MODIFIER", 4, 16], ["reactive protein", "OBSERVATION", 55, 71]]], ["Albumin concentrations were decreased to levels as low as 23 g/L, then, the patient received albumin substitution until HD 23.", [["Albumin", "CHEMICAL", 0, 7], ["Albumin", "GENE_OR_GENE_PRODUCT", 0, 7], ["patient", "ORGANISM", 76, 83], ["albumin", "GENE_OR_GENE_PRODUCT", 93, 100], ["patient", "SPECIES", 76, 83], ["Albumin concentrations", "TEST", 0, 22], ["levels", "TEST", 41, 47], ["albumin substitution", "TREATMENT", 93, 113], ["HD", "TREATMENT", 120, 122]]], ["Of note, thrombocythemia developed later, with a peak at HD 20, and a late restore.", [["thrombocythemia", "DISEASE", 9, 24], ["thrombocythemia", "PROBLEM", 9, 24], ["thrombocythemia", "OBSERVATION", 9, 24]]], ["After the removal of ECMO, we continued to give anticoagulation treatment for the patient .The patient improved continuously and discharged on HD 30 without any further sever complications.| DISCUSSIONHere, we reported a case of critical ARDS caused by a highly virulent strain of adenovirus.", [["ARDS", "DISEASE", 238, 242], ["patient", "ORGANISM", 82, 89], ["patient", "ORGANISM", 95, 102], ["adenovirus", "ORGANISM", 281, 291], ["patient", "SPECIES", 82, 89], ["patient", "SPECIES", 95, 102], ["adenovirus", "SPECIES", 281, 291], ["the removal of ECMO", "TREATMENT", 6, 25], ["anticoagulation treatment", "TREATMENT", 48, 73], ["HD", "TREATMENT", 143, 145], ["any further sever complications", "PROBLEM", 157, 188], ["critical ARDS", "PROBLEM", 229, 242], ["a highly virulent strain of adenovirus", "PROBLEM", 253, 291], ["improved", "OBSERVATION_MODIFIER", 103, 111], ["ARDS", "OBSERVATION", 238, 242], ["adenovirus", "OBSERVATION", 281, 291]]], ["Management including antiviral agents, extracorporeal membrane oxygenation (ECMO) and prone ventilation was the focus of interest.", [["extracorporeal membrane", "ANATOMY", 39, 62], ["extracorporeal membrane", "MULTI-TISSUE_STRUCTURE", 39, 62], ["Management", "TREATMENT", 0, 10], ["antiviral agents", "TREATMENT", 21, 37], ["extracorporeal membrane oxygenation", "TREATMENT", 39, 74], ["ECMO", "TREATMENT", 76, 80], ["prone ventilation", "TREATMENT", 86, 103]]], ["Several antiviral agents, including Cidofovir, ribavirin and ganciclovir, have shown in vivo and in vitro anti-adenoviral F I G U R E 5 Serial changes of chest X-ray (CXR) study.", [["Cidofovir", "CHEMICAL", 36, 45], ["ribavirin", "CHEMICAL", 47, 56], ["ganciclovir", "CHEMICAL", 61, 72], ["Cidofovir", "CHEMICAL", 36, 45], ["ribavirin", "CHEMICAL", 47, 56], ["ganciclovir", "CHEMICAL", 61, 72], ["Cidofovir", "SIMPLE_CHEMICAL", 36, 45], ["ribavirin", "SIMPLE_CHEMICAL", 47, 56], ["ganciclovir", "SIMPLE_CHEMICAL", 61, 72], ["Several antiviral agents", "TREATMENT", 0, 24], ["Cidofovir", "TREATMENT", 36, 45], ["ribavirin", "TREATMENT", 47, 56], ["ganciclovir", "TREATMENT", 61, 72], ["chest X-ray", "TEST", 154, 165], ["CXR) study", "TEST", 167, 177], ["antiviral agents", "OBSERVATION", 8, 24], ["chest", "ANATOMY", 154, 159]]], ["Initial CXR showed progressive and bilateral pneumonic consolidation in whole lung (HD 3 and HD 4).", [["whole lung", "ANATOMY", 72, 82], ["pneumonic", "DISEASE", 45, 54], ["lung", "ORGAN", 78, 82], ["CXR", "PROTEIN", 8, 11], ["Initial CXR", "TEST", 0, 11], ["progressive and bilateral pneumonic consolidation in whole lung", "PROBLEM", 19, 82], ["HD", "TREATMENT", 84, 86], ["HD", "TREATMENT", 93, 95], ["progressive", "OBSERVATION_MODIFIER", 19, 30], ["bilateral", "ANATOMY_MODIFIER", 35, 44], ["pneumonic", "OBSERVATION_MODIFIER", 45, 54], ["consolidation", "OBSERVATION", 55, 68], ["whole", "ANATOMY_MODIFIER", 72, 77], ["lung", "ANATOMY", 78, 82]]], ["From HD 7, pneumonic consolidation in right side began disappear.", [["right side", "ANATOMY", 38, 48], ["pneumonic", "DISEASE", 11, 20], ["pneumonic consolidation in right side", "PROBLEM", 11, 48], ["pneumonic", "OBSERVATION_MODIFIER", 11, 20], ["consolidation", "OBSERVATION", 21, 34], ["right", "ANATOMY_MODIFIER", 38, 43]]], ["From HD 10, the image study showed evidence of obvious improvement of bilateral pneumonic consolidation, subsequently further improvement noticed by CXR on HD 14 and HD 20 efficacy.", [["pneumonic", "DISEASE", 80, 89], ["CXR", "PROTEIN", 149, 152], ["the image study", "TEST", 12, 27], ["bilateral pneumonic consolidation", "PROBLEM", 70, 103], ["CXR", "TEST", 149, 152], ["HD", "TREATMENT", 156, 158], ["HD", "TREATMENT", 166, 168], ["evidence of", "UNCERTAINTY", 35, 46], ["obvious", "OBSERVATION_MODIFIER", 47, 54], ["improvement", "OBSERVATION_MODIFIER", 55, 66], ["bilateral", "ANATOMY_MODIFIER", 70, 79], ["pneumonic", "OBSERVATION_MODIFIER", 80, 89], ["consolidation", "OBSERVATION", 90, 103], ["improvement", "OBSERVATION_MODIFIER", 126, 137]]], ["Cidofovir is a nucleotide analogue and shows in vitro and in vivo antiviral activity.", [["Cidofovir", "CHEMICAL", 0, 9], ["nucleotide", "CHEMICAL", 15, 25], ["Cidofovir", "CHEMICAL", 0, 9], ["nucleotide", "CHEMICAL", 15, 25], ["Cidofovir", "SIMPLE_CHEMICAL", 0, 9], ["Cidofovir", "TREATMENT", 0, 9], ["a nucleotide analogue", "TREATMENT", 13, 34], ["vitro", "TREATMENT", 48, 53], ["antiviral activity", "OBSERVATION", 66, 84]]], ["This agent is used mainly in critical adenoviral infection and immunocompromised patients, including children and stem cell and solid organ transplantation recipients.", [["stem cell", "ANATOMY", 114, 123], ["solid organ", "ANATOMY", 128, 139], ["adenoviral infection", "DISEASE", 38, 58], ["adenoviral", "ORGANISM", 38, 48], ["patients", "ORGANISM", 81, 89], ["children", "ORGANISM", 101, 109], ["stem cell", "CELL", 114, 123], ["solid", "CANCER", 128, 133], ["organ", "ORGAN", 134, 139], ["recipients", "ORGANISM", 156, 166], ["patients", "SPECIES", 81, 89], ["children", "SPECIES", 101, 109], ["adenoviral", "SPECIES", 38, 48], ["This agent", "TREATMENT", 0, 10], ["critical adenoviral infection", "PROBLEM", 29, 58], ["stem cell", "TREATMENT", 114, 123], ["solid organ transplantation recipients", "TREATMENT", 128, 166], ["adenoviral", "ANATOMY", 38, 48], ["infection", "OBSERVATION", 49, 58], ["stem cell", "OBSERVATION", 114, 123], ["organ", "ANATOMY", 134, 139], ["transplantation", "OBSERVATION", 140, 155]]], ["Despite several reports of treatment failure and the absence of randomised controlled trials, most studies showed that Cidofovir is clinically effective against adenoviral infection in immunocompromised patients.", [["Cidofovir", "CHEMICAL", 119, 128], ["adenoviral infection", "DISEASE", 161, 181], ["Cidofovir", "CHEMICAL", 119, 128], ["Cidofovir", "SIMPLE_CHEMICAL", 119, 128], ["adenoviral", "ORGANISM", 161, 171], ["patients", "ORGANISM", 203, 211], ["patients", "SPECIES", 203, 211], ["adenoviral", "SPECIES", 161, 171], ["treatment failure", "PROBLEM", 27, 44], ["randomised controlled trials", "TREATMENT", 64, 92], ["most studies", "TEST", 94, 106], ["Cidofovir", "TREATMENT", 119, 128], ["adenoviral infection", "PROBLEM", 161, 181], ["infection", "OBSERVATION", 172, 181]]], ["7, 8 Although the efficacy of Cidofovir in adenoviral infection is not established in immunocompetent patients, it showed clinical benefit and improvement in oxygenation in several clinical trials in immunocompetent military trainees.", [["Cidofovir", "CHEMICAL", 30, 39], ["adenoviral infection", "DISEASE", 43, 63], ["Cidofovir", "CHEMICAL", 30, 39], ["Cidofovir", "SIMPLE_CHEMICAL", 30, 39], ["adenoviral", "ORGANISM", 43, 53], ["patients", "ORGANISM", 102, 110], ["patients", "SPECIES", 102, 110], ["adenoviral", "SPECIES", 43, 53], ["Cidofovir", "TREATMENT", 30, 39], ["adenoviral infection", "PROBLEM", 43, 63], ["infection", "OBSERVATION", 54, 63], ["improvement", "OBSERVATION_MODIFIER", 143, 154], ["oxygenation", "OBSERVATION_MODIFIER", 158, 169]]], ["9 In fact, most immunocompetent patients overcame adenovirus pneumonia without antiviral agents, even in case reports, some patients overcame adenovirus pneumonia complicated by ARDS without the use of antiviral agents.", [["pneumonia", "DISEASE", 61, 70], ["pneumonia", "DISEASE", 153, 162], ["ARDS", "DISEASE", 178, 182], ["patients", "ORGANISM", 32, 40], ["adenovirus", "ORGANISM", 50, 60], ["patients", "ORGANISM", 124, 132], ["adenovirus", "ORGANISM", 142, 152], ["patients", "SPECIES", 32, 40], ["patients", "SPECIES", 124, 132], ["adenovirus", "SPECIES", 50, 60], ["adenovirus pneumonia", "PROBLEM", 50, 70], ["antiviral agents", "TREATMENT", 79, 95], ["adenovirus pneumonia", "PROBLEM", 142, 162], ["ARDS", "PROBLEM", 178, 182], ["antiviral agents", "TREATMENT", 202, 218], ["most immunocompetent", "OBSERVATION_MODIFIER", 11, 31], ["pneumonia", "OBSERVATION", 61, 70], ["pneumonia", "OBSERVATION", 153, 162], ["ARDS", "OBSERVATION", 178, 182]]], ["Clinical, in some cases of critical pneumonia caused by adenovirus serotype 55, the disease course is more aggressive, and antiviral agents are used more frequently.", [["pneumonia", "DISEASE", 36, 45], ["adenovirus serotype 55", "ORGANISM", 56, 78], ["critical pneumonia", "PROBLEM", 27, 45], ["adenovirus serotype", "PROBLEM", 56, 75], ["antiviral agents", "TREATMENT", 123, 139], ["critical", "OBSERVATION_MODIFIER", 27, 35], ["pneumonia", "OBSERVATION", 36, 45], ["aggressive", "OBSERVATION_MODIFIER", 107, 117]]], ["10 In this report, as the clinical response to ribavirin was not good, Cidofovir was added to ribavirin, with subsequent virological improvement.| DISCUSSIONECMO has been used for salvage therapy in intractable hypoxia in patients with ARDS.", [["ribavirin", "CHEMICAL", 47, 56], ["Cidofovir", "CHEMICAL", 71, 80], ["ribavirin", "CHEMICAL", 94, 103], ["hypoxia", "DISEASE", 211, 218], ["ARDS", "DISEASE", 236, 240], ["ribavirin", "CHEMICAL", 47, 56], ["Cidofovir", "CHEMICAL", 71, 80], ["ribavirin", "CHEMICAL", 94, 103], ["ribavirin", "SIMPLE_CHEMICAL", 47, 56], ["Cidofovir", "SIMPLE_CHEMICAL", 71, 80], ["ribavirin", "SIMPLE_CHEMICAL", 94, 103], ["patients", "ORGANISM", 222, 230], ["patients", "SPECIES", 222, 230], ["ribavirin", "TREATMENT", 47, 56], ["Cidofovir", "TREATMENT", 71, 80], ["ribavirin", "TREATMENT", 94, 103], ["salvage therapy", "TREATMENT", 180, 195], ["intractable hypoxia", "PROBLEM", 199, 218], ["ARDS", "PROBLEM", 236, 240], ["intractable", "OBSERVATION_MODIFIER", 199, 210], ["hypoxia", "OBSERVATION", 211, 218], ["ARDS", "OBSERVATION", 236, 240]]], ["11, 12 With ECMO, the ventilator settings are changed to permit lung rest and to minimise ventilator-induced lung injury.", [["lung", "ANATOMY", 64, 68], ["lung", "ANATOMY", 109, 113], ["lung injury", "DISEASE", 109, 120], ["lung", "ORGAN", 64, 68], ["lung", "ORGAN", 109, 113], ["ECMO", "TREATMENT", 12, 16], ["the ventilator settings", "TREATMENT", 18, 41], ["lung rest", "TREATMENT", 64, 73], ["ventilator", "TREATMENT", 90, 100], ["lung injury", "PROBLEM", 109, 120], ["lung", "ANATOMY", 64, 68], ["lung", "ANATOMY", 109, 113], ["injury", "OBSERVATION", 114, 120]]], ["There have been reported cases of adenovirus pneumonia complicated by ARDS using ECMO, some used ECMO therapy to overcome intractable hypoxia.", [["pneumonia", "DISEASE", 45, 54], ["ARDS", "DISEASE", 70, 74], ["hypoxia", "DISEASE", 134, 141], ["adenovirus", "ORGANISM", 34, 44], ["adenovirus pneumonia", "PROBLEM", 34, 54], ["ARDS", "PROBLEM", 70, 74], ["ECMO", "TREATMENT", 81, 85], ["ECMO therapy", "TREATMENT", 97, 109], ["intractable hypoxia", "PROBLEM", 122, 141], ["adenovirus", "OBSERVATION_MODIFIER", 34, 44], ["pneumonia", "OBSERVATION", 45, 54], ["ARDS", "OBSERVATION", 70, 74]]], ["13 Sun et al reported five cases of adenoviral ARDS.", [["ARDS", "DISEASE", 47, 51], ["adenoviral", "ORGANISM", 36, 46], ["adenoviral", "SPECIES", 36, 46], ["adenoviral ARDS", "PROBLEM", 36, 51], ["adenoviral", "ANATOMY", 36, 46], ["ARDS", "OBSERVATION", 47, 51]]], ["Despite ECMO therapy in one patients, only one survived.", [["patients", "ORGANISM", 28, 36], ["patients", "SPECIES", 28, 36], ["ECMO therapy", "TREATMENT", 8, 20]]], ["14 In survivors, the time lag between invasive MV and ECMO therapy was shorter than in nonsurvivors.", [["MV", "SPECIES", 47, 49], ["invasive MV", "TREATMENT", 38, 49], ["ECMO therapy", "TREATMENT", 54, 66]]], ["Here, the time lag between invasive MV and ECMO was less than 1 day in our case.", [["MV", "SPECIES", 36, 38], ["invasive MV", "TREATMENT", 27, 38], ["ECMO", "TREATMENT", 43, 47]]], ["In conclusion, early ECMO therapy is a potential option for the treatment of intractable hypoxia and can avoid ventilator associated lung injury.", [["lung", "ANATOMY", 133, 137], ["hypoxia", "DISEASE", 89, 96], ["lung injury", "DISEASE", 133, 144], ["lung", "ORGAN", 133, 137], ["early ECMO therapy", "TREATMENT", 15, 33], ["the treatment", "TREATMENT", 60, 73], ["intractable hypoxia", "PROBLEM", 77, 96], ["ventilator associated lung injury", "PROBLEM", 111, 144], ["intractable", "OBSERVATION_MODIFIER", 77, 88], ["hypoxia", "OBSERVATION", 89, 96], ["lung", "ANATOMY", 133, 137], ["injury", "OBSERVATION", 138, 144]]], ["Improvement in oxygenation in the prone position is thought to result from a reduction in intrapulmonary ventilation perfusion mismatch, ventilator-induced lung injury and better drainage of secretions.", [["intrapulmonary", "ANATOMY", 90, 104], ["lung", "ANATOMY", 156, 160], ["secretions", "ANATOMY", 191, 201], ["lung injury", "DISEASE", 156, 167], ["lung", "ORGAN", 156, 160], ["secretions", "ORGANISM_SUBSTANCE", 191, 201], ["a reduction", "PROBLEM", 75, 86], ["intrapulmonary ventilation perfusion mismatch", "TREATMENT", 90, 135], ["ventilator", "TREATMENT", 137, 147], ["lung injury", "PROBLEM", 156, 167], ["better drainage of secretions", "PROBLEM", 172, 201], ["oxygenation", "OBSERVATION_MODIFIER", 15, 26], ["reduction", "OBSERVATION_MODIFIER", 77, 86], ["intrapulmonary", "ANATOMY", 90, 104], ["ventilation perfusion mismatch", "OBSERVATION", 105, 135], ["lung", "ANATOMY", 156, 160], ["injury", "OBSERVATION", 161, 167], ["secretions", "OBSERVATION", 191, 201]]], ["[15] [16] [17] [18] In our case, we found improvement in haemodynamic and oxygenation was possibly attributed to synergy.", [["[15] [16] [17] [18]", "SIMPLE_CHEMICAL", 0, 19], ["synergy", "PROBLEM", 113, 120], ["improvement", "OBSERVATION_MODIFIER", 42, 53], ["possibly attributed to", "UNCERTAINTY", 90, 112]]], ["The patient showed gradual improvement in oxygenation and haemodynamic with prone ventilation for 16 hours.| DISCUSSIONThere are several limitations in this report.", [["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["prone ventilation", "TREATMENT", 76, 93], ["gradual", "OBSERVATION_MODIFIER", 19, 26], ["improvement", "OBSERVATION_MODIFIER", 27, 38], ["oxygenation", "OBSERVATION_MODIFIER", 42, 53]]], ["We did not use PiCCO system to determine pulmonary vascular leak, which was an instant and objective method of quantification of pulmonary vascular leak by the extravascular lung water index (EVLWI).", [["pulmonary vascular", "ANATOMY", 41, 59], ["pulmonary vascular", "ANATOMY", 129, 147], ["extravascular lung", "ANATOMY", 160, 178], ["pulmonary vascular", "MULTI-TISSUE_STRUCTURE", 41, 59], ["pulmonary vascular", "MULTI-TISSUE_STRUCTURE", 129, 147], ["lung", "ORGAN", 174, 178], ["PiCCO system", "TREATMENT", 15, 27], ["pulmonary vascular leak", "PROBLEM", 41, 64], ["pulmonary vascular leak", "PROBLEM", 129, 152], ["the extravascular lung water index", "TEST", 156, 190], ["pulmonary", "ANATOMY", 41, 50], ["vascular", "ANATOMY", 51, 59], ["leak", "OBSERVATION", 60, 64], ["pulmonary", "ANATOMY_MODIFIER", 129, 138], ["vascular", "ANATOMY", 139, 147], ["leak", "OBSERVATION", 148, 152], ["extravascular", "ANATOMY_MODIFIER", 160, 173], ["lung", "ANATOMY", 174, 178], ["water index", "OBSERVATION", 179, 190]]], ["And efficacy was presumed based on the clinical course, including Lac level, HCT, urine output and superior vena cava diameter.| DISCUSSIONTaken together, this report emphasised the complexity and specific challenges of intensive care treatment of patients with F I G U R E 6 Serial changes of chest CT scan study.", [["urine", "ANATOMY", 82, 87], ["superior vena cava", "ANATOMY", 99, 117], ["urine", "ORGANISM_SUBSTANCE", 82, 87], ["superior vena cava", "MULTI-TISSUE_STRUCTURE", 99, 117], ["patients", "ORGANISM", 248, 256], ["chest", "ORGAN", 294, 299], ["patients", "SPECIES", 248, 256], ["Lac level", "TEST", 66, 75], ["HCT", "TEST", 77, 80], ["urine output", "TEST", 82, 94], ["intensive care treatment", "TREATMENT", 220, 244], ["chest CT scan study", "TEST", 294, 313], ["superior vena cava", "ANATOMY", 99, 117], ["diameter", "OBSERVATION_MODIFIER", 118, 126], ["chest", "ANATOMY", 294, 299]]], ["On HD 11, V-V ECMO was weaned.", [["V-V", "GENE_OR_GENE_PRODUCT", 10, 13], ["HD", "TREATMENT", 3, 5], ["V-V ECMO", "TREATMENT", 10, 18]]], ["Chest CT scan showed bilateral consolidation and multiple patchy infiltrations with right pleural effusion.", [["right pleural effusion", "ANATOMY", 84, 106], ["right pleural effusion", "DISEASE", 84, 106], ["pleural", "ORGAN", 90, 97], ["Chest CT scan", "TEST", 0, 13], ["bilateral consolidation", "PROBLEM", 21, 44], ["multiple patchy infiltrations", "PROBLEM", 49, 78], ["right pleural effusion", "PROBLEM", 84, 106], ["bilateral", "ANATOMY_MODIFIER", 21, 30], ["consolidation", "OBSERVATION", 31, 44], ["multiple", "OBSERVATION_MODIFIER", 49, 57], ["patchy", "OBSERVATION_MODIFIER", 58, 64], ["infiltrations", "OBSERVATION", 65, 78], ["right", "ANATOMY_MODIFIER", 84, 89], ["pleural", "ANATOMY", 90, 97], ["effusion", "OBSERVATION", 98, 106]]], ["In HD 22, bilateral lobe pneumonic infiltrations and right pleural effusion were improved, follow-up CT scan (HD 30) shows continual improvement of lung abnormality critical adenovirus pneumonia.", [["right pleural effusion", "ANATOMY", 53, 75], ["lung", "ANATOMY", 148, 152], ["pleural effusion", "DISEASE", 59, 75], ["lung abnormality", "DISEASE", 148, 164], ["pneumonia", "DISEASE", 185, 194], ["bilateral lobe pneumonic", "CANCER", 10, 34], ["pleural", "ORGAN", 59, 66], ["lung", "ORGAN", 148, 152], ["adenovirus", "ORGANISM", 174, 184], ["HD", "TREATMENT", 3, 5], ["bilateral lobe pneumonic infiltrations", "PROBLEM", 10, 48], ["right pleural effusion", "PROBLEM", 53, 75], ["follow-up CT scan", "TEST", 91, 108], ["HD", "TEST", 110, 112], ["lung abnormality critical adenovirus pneumonia", "PROBLEM", 148, 194], ["bilateral lobe", "ANATOMY", 10, 24], ["pneumonic", "OBSERVATION_MODIFIER", 25, 34], ["infiltrations", "OBSERVATION", 35, 48], ["right", "ANATOMY_MODIFIER", 53, 58], ["pleural", "ANATOMY", 59, 66], ["effusion", "OBSERVATION", 67, 75], ["improved", "OBSERVATION_MODIFIER", 81, 89], ["improvement", "OBSERVATION_MODIFIER", 133, 144], ["lung", "ANATOMY", 148, 152], ["abnormality", "OBSERVATION", 153, 164], ["critical", "OBSERVATION_MODIFIER", 165, 173], ["adenovirus", "OBSERVATION_MODIFIER", 174, 184], ["pneumonia", "OBSERVATION", 185, 194]]], ["The efficacy of Cidofovir in more critical adenovirus pneumonia complicated by ARDS is promising, but more study is needed.", [["Cidofovir", "CHEMICAL", 16, 25], ["pneumonia", "DISEASE", 54, 63], ["ARDS", "DISEASE", 79, 83], ["Cidofovir", "CHEMICAL", 16, 25], ["Cidofovir", "SIMPLE_CHEMICAL", 16, 25], ["adenovirus", "ORGANISM", 43, 53], ["Cidofovir", "TREATMENT", 16, 25], ["critical adenovirus pneumonia", "PROBLEM", 34, 63], ["ARDS", "PROBLEM", 79, 83], ["adenovirus", "OBSERVATION_MODIFIER", 43, 53], ["pneumonia", "OBSERVATION", 54, 63], ["ARDS", "OBSERVATION", 79, 83]]], ["Early ECMO therapy and prone ventilation is also a promising therapeutic option in adenoviral ARDS complicated by ARDS.ACKNOWLEDGMENTSWe thank our patient for informed consent and the many nurses, doctors and technical and supporting staff, without whose assistance the outcome in this critical case would likely have been fatal.", [["ARDS", "DISEASE", 94, 98], ["adenoviral", "ORGANISM", 83, 93], ["patient", "ORGANISM", 147, 154], ["patient", "SPECIES", 147, 154], ["adenoviral", "SPECIES", 83, 93], ["Early ECMO therapy", "TREATMENT", 0, 18], ["prone ventilation", "TREATMENT", 23, 40], ["adenoviral ARDS", "PROBLEM", 83, 98], ["ECMO", "OBSERVATION", 6, 10]]], ["We also thank the following physicians, namely Qiang Guo, Wei Lei, Jiajia Wang, Xiaohui Zhang, Nan Su and Hua Xu for medical service.", [["Hua", "ANATOMY", 106, 109]]]], "760b4e53667d84ac664ca9044a2ba889c724d345": [["IntroductionPrior to the 21st century, coronaviruses (CoVs) were considered pathogens of great relevance in veterinary medicine but with a reduced impact on human health [1] [2] [3] [4] .", [["coronaviruses", "ORGANISM", 39, 52], ["CoVs", "ORGANISM", 54, 58], ["human", "ORGANISM", 157, 162], ["[1] [2] [3] [4]", "SIMPLE_CHEMICAL", 170, 185], ["human", "SPECIES", 157, 162], ["human", "SPECIES", 157, 162], ["coronaviruses (CoVs", "PROBLEM", 39, 58], ["a reduced impact on human health", "TREATMENT", 137, 169]]], ["However, a greater global concern for CoVs in human health began with the epidemic of severe acute respiratory syndrome (SARS) in 2002-2003 and Middle East respiratory syndrome (MERS) in 2012 [5] [6] [7] [8] .", [["CoVs", "CHEMICAL", 38, 42], ["acute respiratory syndrome", "DISEASE", 93, 119], ["SARS", "DISEASE", 121, 125], ["Middle East respiratory syndrome", "DISEASE", 144, 176], ["CoVs", "GENE_OR_GENE_PRODUCT", 38, 42], ["human", "ORGANISM", 46, 51], ["human", "SPECIES", 46, 51], ["human", "SPECIES", 46, 51], ["CoVs in human health", "PROBLEM", 38, 58], ["severe acute respiratory syndrome", "PROBLEM", 86, 119], ["SARS", "PROBLEM", 121, 125], ["Middle East respiratory syndrome", "PROBLEM", 144, 176], ["greater", "OBSERVATION_MODIFIER", 11, 18], ["severe", "OBSERVATION_MODIFIER", 86, 92], ["acute", "OBSERVATION_MODIFIER", 93, 98], ["respiratory syndrome", "OBSERVATION", 99, 119], ["Middle", "ANATOMY_MODIFIER", 144, 150], ["respiratory syndrome", "OBSERVATION", 156, 176]]], ["In addition, at the end of December 2019, another CoV outbreak emerged, again causing global concern in human public health [9] [10] [11] [12] [13] .IntroductionThe family Coronaviridae includes enveloped viruses with a positive-sense, single-stranded RNA genome of approximately 30 kb in size.", [["human", "ORGANISM", 104, 109], ["[9] [10] [11] [12] [13]", "SIMPLE_CHEMICAL", 124, 147], ["positive-sense, single-stranded RNA genome", "DNA", 220, 262], ["human", "SPECIES", 104, 109], ["human", "SPECIES", 104, 109], ["viruses", "OBSERVATION", 205, 212], ["RNA genome", "OBSERVATION", 252, 262], ["30 kb", "OBSERVATION_MODIFIER", 280, 285], ["size", "OBSERVATION_MODIFIER", 289, 293]]], ["Consequently, they have the largest genomes of RNA viruses.", [["RNA viruses", "PROBLEM", 47, 58], ["largest", "OBSERVATION_MODIFIER", 28, 35], ["RNA viruses", "OBSERVATION", 47, 58]]], ["Based on their antigenic and genetic properties, CoVs are organized into four genera: Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus.", [["CoVs", "GENE_OR_GENE_PRODUCT", 49, 53], ["Alphacoronavirus", "GENE_OR_GENE_PRODUCT", 86, 102], ["Betacoronavirus", "GENE_OR_GENE_PRODUCT", 104, 119], ["Gammacoronavirus", "GENE_OR_GENE_PRODUCT", 121, 137], ["Deltacoronavirus", "GENE_OR_GENE_PRODUCT", 143, 159], ["CoVs", "PROTEIN", 49, 53], ["CoVs", "PROBLEM", 49, 53], ["Alphacoronavirus", "TREATMENT", 86, 102], ["Betacoronavirus", "TREATMENT", 104, 119], ["Gammacoronavirus", "TREATMENT", 121, 137], ["Deltacoronavirus", "TREATMENT", 143, 159]]], ["SARS-CoV and MERS-CoV belong to the genus Betacoronavirus [14, 15] .", [["SARS", "DISEASE", 0, 4], ["SARS-CoV", "ORGANISM", 0, 8], ["MERS-CoV", "ORGANISM", 13, 21], ["SARS-CoV and MERS-CoV", "DNA", 0, 21], ["SARS-CoV", "SPECIES", 0, 8], ["MERS-CoV", "SPECIES", 13, 21], ["SARS", "PROBLEM", 0, 4], ["genus", "ANATOMY", 36, 41]]], ["Recently, fullgenome sequencing and phylogenetic analysis of the novel SARS-CoV-2 (previously known as 2019-nCoV) grouped it in the same genus [16, 17] .IntroductionFour main proteins are encoded by the coronaviral genome: spike (S), envelope (E), membrane (M) and nucleocapsid (N).", [["membrane", "ANATOMY", 248, 256], ["SARS", "DISEASE", 71, 75], ["SARS-CoV-2", "ORGANISM", 71, 81], ["spike (S), envelope (E)", "GENE_OR_GENE_PRODUCT", 223, 246], ["membrane", "CELLULAR_COMPONENT", 248, 256], ["nucleocapsid", "CELLULAR_COMPONENT", 265, 277], ["SARS-CoV-2", "DNA", 71, 81], ["2019-nCoV", "DNA", 103, 112], ["coronaviral genome", "DNA", 203, 221], ["spike (S), envelope (E), membrane (M) and nucleocapsid (N)", "PROTEIN", 223, 281], ["SARS-CoV-2", "SPECIES", 71, 81], ["fullgenome sequencing", "TEST", 10, 31], ["phylogenetic analysis", "TEST", 36, 57], ["the novel SARS", "TEST", 61, 75], ["CoV", "TEST", 76, 79]]], ["Each protein plays an individual role in the structure of the viral particle, but they are also involved in other functions of the replication cycle [14, 15] .", [["individual", "OBSERVATION_MODIFIER", 22, 32], ["viral particle", "OBSERVATION", 62, 76]]], ["For more details, see Fig. 1 and the supplementary file.IntroductionCoVs infect birds (\u03b3-and \u03b4-CoVs) and several species of mammals (mainly \u03b1-and \u03b2-CoVs), including humans [14, 15, 18] .", [["IntroductionCoVs", "GENE_OR_GENE_PRODUCT", 56, 72], ["birds", "ORGANISM", 80, 85], ["\u03b3-and \u03b4-CoVs", "GENE_OR_GENE_PRODUCT", 87, 99], ["\u03b1-", "GENE_OR_GENE_PRODUCT", 140, 142], ["\u03b2-CoVs", "GENE_OR_GENE_PRODUCT", 146, 152], ["humans", "ORGANISM", 165, 171], ["humans", "SPECIES", 165, 171], ["humans", "SPECIES", 165, 171], ["IntroductionCoVs infect birds (\u03b3-and \u03b4-CoVs", "PROBLEM", 56, 99], ["several species of mammals", "PROBLEM", 105, 131]]], ["A review of recent sequences in databases has shown that all human CoVs are of animal origin [19] [20] [21] [22] [23] .", [["human", "ORGANISM", 61, 66], ["CoVs", "GENE_OR_GENE_PRODUCT", 67, 71], ["[19] [20] [21] [22] [23]", "SIMPLE_CHEMICAL", 93, 117], ["human CoVs", "PROTEIN", 61, 71], ["human", "SPECIES", 61, 66], ["human", "SPECIES", 61, 66], ["recent sequences in databases", "TEST", 12, 41], ["all human CoVs", "TEST", 57, 71]]], ["SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-229E and HCoV-NL63 probably originated from bats, whereas HCoV-OC43 and HKU1 probably originated from rodents [23, 24] .", [["SARS-CoV-2", "ORGANISM", 0, 10], ["SARS-CoV", "ORGANISM", 12, 20], ["MERS-CoV", "ORGANISM", 22, 30], ["HCoV-229E", "ORGANISM", 32, 41], ["HCoV", "GENE_OR_GENE_PRODUCT", 46, 50], ["NL63", "GENE_OR_GENE_PRODUCT", 51, 55], ["HCoV-OC43", "GENE_OR_GENE_PRODUCT", 95, 104], ["HKU1", "GENE_OR_GENE_PRODUCT", 109, 113], ["SARS-CoV, MERS-CoV, HCoV-229E", "DNA", 12, 41], ["HCoV", "DNA", 46, 50], ["NL63", "DNA", 51, 55], ["HCoV", "DNA", 95, 99], ["OC43", "DNA", 100, 104], ["HKU1", "DNA", 109, 113], ["SARS-CoV", "SPECIES", 12, 20], ["MERS-CoV", "SPECIES", 22, 30], ["HCoV-229E", "SPECIES", 32, 41], ["SARS", "TEST", 0, 4], ["CoV", "TEST", 5, 8], ["SARS", "PROBLEM", 12, 16], ["HCoV", "TEST", 32, 36], ["HCoV", "TEST", 46, 50], ["HCoV", "TEST", 95, 99]]], ["It is important to highlight that bats, which are considered the primordial hosts, can have different viral populations in the same species, facilitating recombination and the emergence of new variants [22, 25] .", [["different viral populations", "PROBLEM", 92, 119], ["viral populations", "OBSERVATION", 102, 119]]], ["These new variants are capable of infecting intermediate hosts, and the combination of deletion DPP4 for MERS-CoV), and fusion of the virion and cell membrane occurs on the cell surface or from within endosomes, depending on the virus.", [["virion", "ANATOMY", 134, 140], ["cell membrane", "ANATOMY", 145, 158], ["cell surface", "ANATOMY", 173, 185], ["endosomes", "ANATOMY", 201, 210], ["DPP4", "GENE_OR_GENE_PRODUCT", 96, 100], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 105, 113], ["virion", "CELLULAR_COMPONENT", 134, 140], ["cell membrane", "CELLULAR_COMPONENT", 145, 158], ["cell surface", "CELLULAR_COMPONENT", 173, 185], ["endosomes", "CELLULAR_COMPONENT", 201, 210], ["DPP4", "PROTEIN", 96, 100], ["MERS", "PROTEIN", 105, 109], ["MERS-CoV", "SPECIES", 105, 113], ["infecting intermediate hosts", "PROBLEM", 34, 62], ["deletion DPP4", "TREATMENT", 87, 100], ["MERS", "PROBLEM", 105, 109], ["fusion of the virion", "TREATMENT", 120, 140], ["cell membrane", "PROBLEM", 145, 158], ["the virus", "PROBLEM", 225, 234], ["virion", "ANATOMY", 134, 140], ["cell membrane", "OBSERVATION", 145, 158]]], ["The fusion is triggered by low pH, leading to the release of the nucleocapsid into the cytoplasm.", [["cytoplasm", "ANATOMY", 87, 96], ["nucleocapsid", "CELLULAR_COMPONENT", 65, 77], ["cytoplasm", "ORGANISM_SUBSTANCE", 87, 96], ["The fusion", "TREATMENT", 0, 10], ["low pH", "PROBLEM", 27, 33], ["fusion", "OBSERVATION", 4, 10], ["low pH", "OBSERVATION_MODIFIER", 27, 33], ["nucleocapsid", "OBSERVATION", 65, 77], ["cytoplasm", "OBSERVATION", 87, 96]]], ["The viral genome is translated to produce proteins 1a and 1ab (the latter by recoding ribosomal translation or ribosomal frameshift).", [["ribosomal", "ANATOMY", 86, 95], ["ribosomal", "ANATOMY", 111, 120], ["1a", "GENE_OR_GENE_PRODUCT", 51, 53], ["1", "GENE_OR_GENE_PRODUCT", 58, 59], ["ribosomal", "CELLULAR_COMPONENT", 86, 95], ["ribosomal", "CELLULAR_COMPONENT", 111, 120], ["viral genome", "DNA", 4, 16], ["1a", "PROTEIN", 51, 53], ["ribosomal frameshift", "PROBLEM", 111, 131], ["viral genome", "OBSERVATION", 4, 16], ["ribosomal frameshift", "OBSERVATION", 111, 131]]], ["These 1a and 1ab proteins are processed by viral proteases to produce a variety of viral proteins, including RNA-dependent RNA polymerase (RdRp), proteins that remodel cell membranes to form structures that are used as viral RNA synthesis sites, enzymes that catalyze several steps in the synthesis of the 5'-terminal cap structure of the mRNA, and an exonuclease involved in proofreading during genome replication.", [["cell membranes", "ANATOMY", 168, 182], ["1ab proteins", "GENE_OR_GENE_PRODUCT", 13, 25], ["RNA-dependent RNA polymerase", "GENE_OR_GENE_PRODUCT", 109, 137], ["RdRp", "GENE_OR_GENE_PRODUCT", 139, 143], ["cell membranes", "CELLULAR_COMPONENT", 168, 182], ["genome", "CELLULAR_COMPONENT", 396, 402], ["1a and 1ab proteins", "PROTEIN", 6, 25], ["viral proteases", "PROTEIN", 43, 58], ["viral proteins", "PROTEIN", 83, 97], ["RNA-dependent RNA polymerase", "PROTEIN", 109, 137], ["RdRp", "PROTEIN", 139, 143], ["viral RNA synthesis sites", "DNA", 219, 244], ["5'-terminal cap structure", "RNA", 306, 331], ["mRNA", "RNA", 339, 343], ["exonuclease", "PROTEIN", 352, 363], ["1ab proteins", "TEST", 13, 25], ["viral proteases", "PROBLEM", 43, 58], ["viral proteins", "PROBLEM", 83, 97], ["RNA-dependent RNA polymerase", "PROBLEM", 109, 137], ["viral RNA synthesis sites", "PROBLEM", 219, 244], ["enzymes", "TEST", 246, 253], ["an exonuclease", "TREATMENT", 349, 363], ["genome replication", "TREATMENT", 396, 414], ["viral proteases", "OBSERVATION", 43, 58], ["viral proteins", "OBSERVATION", 83, 97], ["remodel cell membranes", "OBSERVATION", 160, 182], ["terminal cap", "ANATOMY_MODIFIER", 309, 321], ["genome replication", "OBSERVATION", 396, 414]]], ["The other viral proteins are encoded by a nested set of mRNAs that share a common leader sequence (5' UTR) at the 5' end.", [["viral proteins", "PROTEIN", 10, 24], ["mRNAs", "RNA", 56, 61], ["common leader sequence", "DNA", 75, 97], ["5' UTR", "DNA", 99, 105], ["5' end", "DNA", 114, 120], ["The other viral proteins", "PROBLEM", 0, 24], ["a common leader sequence", "PROBLEM", 73, 97], ["viral proteins", "OBSERVATION", 10, 24]]], ["Discontinuous RNA synthe-sis occurs during synthesis of the negative RNA strand.", [["negative RNA strand", "RNA", 60, 79], ["RNA strand", "OBSERVATION", 69, 79]]], ["Most of the positive strand is not copied, probably because it loosens when the polymerase completes synthesis up to the 5' UTR.", [["5' UTR", "DNA", 121, 127], ["the polymerase", "PROBLEM", 76, 90], ["positive strand", "OBSERVATION", 12, 27]]], ["The resulting negative-strand RNAs, with 3' UTR sequences at the ends, are then copied to form mRNAs.", [["negative-strand RNAs", "RNA", 14, 34], ["3' UTR sequences", "DNA", 41, 57], ["mRNAs", "RNA", 95, 100], ["strand RNAs", "PROBLEM", 23, 34], ["3' UTR sequences", "TEST", 41, 57], ["negative", "OBSERVATION", 14, 22], ["strand RNAs", "OBSERVATION_MODIFIER", 23, 34]]], ["These mRNAs are translated to form the structural and non-structural proteins.", [["mRNAs", "RNA", 6, 11], ["structural and non-structural proteins", "PROTEIN", 39, 77], ["the structural and non-structural proteins", "PROBLEM", 35, 77], ["non-structural proteins", "OBSERVATION", 54, 77]]], ["M, S and E proteins attached to the membrane are inserted into the lumen of the endoplasmic reticulum and then move to the site of viral assembly, the intermediate compartment of the endoplasmic reticulum-Golgi (ERGIC).", [["membrane", "ANATOMY", 36, 44], ["lumen", "ANATOMY", 67, 72], ["endoplasmic reticulum", "ANATOMY", 80, 101], ["endoplasmic reticulum", "ANATOMY", 183, 204], ["Golgi", "ANATOMY", 205, 210], ["ERGIC", "ANATOMY", 212, 217], ["E proteins", "GENE_OR_GENE_PRODUCT", 9, 19], ["membrane", "CELLULAR_COMPONENT", 36, 44], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 67, 72], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 80, 101], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 183, 204], ["Golgi", "CELLULAR_COMPONENT", 205, 210], ["M, S and E proteins", "PROTEIN", 0, 19], ["ERGIC", "PROTEIN", 212, 217], ["membrane", "ANATOMY_MODIFIER", 36, 44], ["lumen", "ANATOMY_MODIFIER", 67, 72], ["endoplasmic reticulum", "OBSERVATION", 80, 101], ["viral", "OBSERVATION", 131, 136], ["endoplasmic reticulum", "OBSERVATION", 183, 204]]], ["Full-length negative-strand RNAs are produced, and these serve as templates for the synthesis of full-length positive-strand RNAs, which are then encapsulated by protein N. The nucleocapsid buds into the ERGIC, acquiring a membrane that contains the proteins S, E and M. Viral particles are transported to the plasma membrane in smooth-walled vesicles and released from the cell by exocytosis when the carrier vesicle fuses with the plasma membrane [26, 28] and recombination of genes results in drastic changes, such as changes in the tissue tropism of the virus, which tends to cause general changes in the pattern of disease.", [["buds", "ANATOMY", 190, 194], ["membrane", "ANATOMY", 223, 231], ["plasma membrane", "ANATOMY", 310, 325], ["smooth-walled vesicles", "ANATOMY", 329, 351], ["cell", "ANATOMY", 374, 378], ["vesicle", "ANATOMY", 410, 417], ["plasma membrane", "ANATOMY", 433, 448], ["tissue", "ANATOMY", 536, 542], ["ERGIC", "GENE_OR_GENE_PRODUCT", 204, 209], ["membrane", "CELLULAR_COMPONENT", 223, 231], ["E", "GENE_OR_GENE_PRODUCT", 262, 263], ["plasma membrane", "CELLULAR_COMPONENT", 310, 325], ["smooth-walled vesicles", "CELLULAR_COMPONENT", 329, 351], ["cell", "CELL", 374, 378], ["vesicle", "CELLULAR_COMPONENT", 410, 417], ["plasma membrane", "CELLULAR_COMPONENT", 433, 448], ["tissue", "TISSUE", 536, 542], ["-length negative-strand RNAs", "RNA", 4, 32], ["positive-strand RNAs", "RNA", 109, 129], ["ERGIC", "PROTEIN", 204, 209], ["S", "PROTEIN", 259, 260], ["E", "PROTEIN", 262, 263], ["the synthesis", "TEST", 80, 93], ["strand RNAs", "PROBLEM", 118, 129], ["a membrane", "TREATMENT", 221, 231], ["the proteins S, E and M. Viral particles", "TEST", 246, 286], ["the plasma membrane", "TEST", 306, 325], ["the plasma membrane", "TEST", 429, 448], ["drastic changes", "PROBLEM", 496, 511], ["the tissue tropism of the virus", "PROBLEM", 532, 563], ["general changes", "PROBLEM", 586, 601], ["disease", "PROBLEM", 620, 627], ["strand RNAs", "OBSERVATION", 21, 32], ["strand RNAs", "OBSERVATION", 118, 129], ["Viral particles", "OBSERVATION", 271, 286], ["walled vesicles", "OBSERVATION", 336, 351], ["cell", "OBSERVATION", 374, 378], ["drastic changes", "OBSERVATION", 496, 511], ["virus", "OBSERVATION", 558, 563], ["disease", "OBSERVATION", 620, 627]]], ["Examples of this include SARS-CoV and MERS-CoV, which were possibly transmitted directly to humans from market civets and dromedaries, respectively ( Fig. 2A) [23, 26] .", [["SARS-CoV", "ORGANISM", 25, 33], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 38, 46], ["humans", "ORGANISM", 92, 98], ["humans", "SPECIES", 92, 98], ["SARS-CoV", "SPECIES", 25, 33], ["MERS-CoV", "SPECIES", 38, 46], ["humans", "SPECIES", 92, 98], ["SARS", "PROBLEM", 25, 29], ["SARS", "OBSERVATION", 25, 29]]], ["SARS-CoV: the first highly pathogenic human CoV outbreak of the 21st century As mentioned above, in 2002, an outbreak of a new disease (SARS) was described for which a novel CoV, known as SARS-CoV, was identified as the etiologic agent [27, 28] .", [["SARS", "DISEASE", 0, 4], ["SARS", "DISEASE", 136, 140], ["SARS-CoV", "ORGANISM", 0, 8], ["human", "ORGANISM", 38, 43], ["CoV", "ORGANISM", 44, 47], ["CoV", "ORGANISM", 174, 177], ["SARS-CoV", "ORGANISM", 188, 196], ["human", "SPECIES", 38, 43], ["SARS-CoV", "SPECIES", 0, 8], ["human CoV", "SPECIES", 38, 47], ["SARS-CoV", "SPECIES", 188, 196], ["a new disease (SARS", "PROBLEM", 121, 140], ["a novel CoV", "PROBLEM", 166, 177], ["SARS-CoV", "PROBLEM", 188, 196], ["new", "OBSERVATION_MODIFIER", 123, 126], ["disease", "OBSERVATION", 127, 134]]], ["The disease reached pandemic proportions, as it spread to 29 countries on five continents, causing a total of 8096 laboratory-confirmed cases of SARS with 774 deaths by August 2003, when aggressive public health intervention measures managed to contain a potential pandemic (Fig. 3A) .IntroductionThe first known case of SARS, caused by the novel CoV, was represented by a 45-year-old man in November 2002 in the city of Foshan, Guangdong Province, China [29, 30] .", [["SARS", "DISEASE", 145, 149], ["deaths", "DISEASE", 159, 165], ["SARS", "DISEASE", 321, 325], ["CoV", "ORGANISM", 347, 350], ["man", "ORGANISM", 385, 388], ["man", "SPECIES", 385, 388], ["The disease", "PROBLEM", 0, 11], ["SARS", "PROBLEM", 145, 149], ["aggressive public health intervention measures", "TREATMENT", 187, 233], ["SARS", "PROBLEM", 321, 325], ["disease", "OBSERVATION", 4, 11], ["SARS", "OBSERVATION", 321, 325]]], ["The mysterious respiratory disease, which in the future would be called SARS, had high fever (>38\u00b0C), followed by dry cough and rapid progression to respiratory failure as clinical manifestations (Fig. 2B) [31, 32] .", [["respiratory", "ANATOMY", 15, 26], ["respiratory", "ANATOMY", 149, 160], ["respiratory disease", "DISEASE", 15, 34], ["SARS", "DISEASE", 72, 76], ["fever", "DISEASE", 87, 92], ["dry cough", "DISEASE", 114, 123], ["respiratory failure", "DISEASE", 149, 168], ["The mysterious respiratory disease", "PROBLEM", 0, 34], ["SARS", "PROBLEM", 72, 76], ["high fever", "PROBLEM", 82, 92], ["dry cough", "PROBLEM", 114, 123], ["respiratory failure", "PROBLEM", 149, 168], ["mysterious", "OBSERVATION_MODIFIER", 4, 14], ["respiratory disease", "OBSERVATION", 15, 34], ["cough", "OBSERVATION", 118, 123], ["respiratory failure", "OBSERVATION", 149, 168]]], ["Consequently, a clinical picture of atypical pneumonia was noted; however, the detection of the new infectious agent, which was being transmitted from human to human, did not occur until several months later.", [["pneumonia", "DISEASE", 45, 54], ["human", "ORGANISM", 151, 156], ["human", "ORGANISM", 160, 165], ["human", "SPECIES", 151, 156], ["human", "SPECIES", 160, 165], ["human", "SPECIES", 151, 156], ["human", "SPECIES", 160, 165], ["atypical pneumonia", "PROBLEM", 36, 54], ["the new infectious agent", "PROBLEM", 92, 116], ["atypical", "OBSERVATION_MODIFIER", 36, 44], ["pneumonia", "OBSERVATION", 45, 54], ["new", "OBSERVATION_MODIFIER", 96, 99], ["infectious", "OBSERVATION", 100, 110]]], ["Thus, it was only in April 2003 that the World Health Organization (WHO) announced that the SARS epidemic was caused by a new pathogen, a member of the CoV family never seen before in humans [33, 34] . are not yet known.", [["SARS", "DISEASE", 92, 96], ["CoV", "ORGANISM", 152, 155], ["humans", "ORGANISM", 184, 190], ["humans", "SPECIES", 184, 190], ["humans", "SPECIES", 184, 190], ["the SARS epidemic", "PROBLEM", 88, 105], ["a new pathogen", "PROBLEM", 120, 134]]], ["B. Infections by different CoVs cause signs and symptoms that overlap regardless of the type of virus that causes the disease.", [["Infections", "DISEASE", 3, 13], ["B.", "ORGANISM", 0, 2], ["CoVs", "GENE_OR_GENE_PRODUCT", 27, 31], ["B. Infections", "PROBLEM", 0, 13], ["different CoVs", "PROBLEM", 17, 31], ["signs and symptoms", "PROBLEM", 38, 56], ["the type of virus", "PROBLEM", 84, 101], ["the disease", "PROBLEM", 114, 125], ["Infections", "OBSERVATION", 3, 13], ["virus", "OBSERVATION", 96, 101], ["disease", "OBSERVATION", 118, 125]]], ["The signs and symptoms can affect different systems and organs, varying from mild symptoms in most cases (fever, cough, myalgia, headache, and runny nose, among other symptoms), which can progress to complications with a worse prognosis (pneumonia, kidney failure, breathing problems, acute cardiac injury, sepsis and death).", [["organs", "ANATOMY", 56, 62], ["kidney", "ANATOMY", 249, 255], ["cardiac", "ANATOMY", 291, 298], ["fever", "DISEASE", 106, 111], ["cough", "DISEASE", 113, 118], ["myalgia", "DISEASE", 120, 127], ["headache", "DISEASE", 129, 137], ["runny nose", "DISEASE", 143, 153], ["pneumonia", "DISEASE", 238, 247], ["kidney failure", "DISEASE", 249, 263], ["acute cardiac injury", "DISEASE", 285, 305], ["sepsis", "DISEASE", 307, 313], ["death", "DISEASE", 318, 323], ["organs", "ORGAN", 56, 62], ["nose", "ORGANISM_SUBDIVISION", 149, 153], ["kidney", "ORGAN", 249, 255], ["cardiac", "ORGAN", 291, 298], ["The signs and symptoms", "PROBLEM", 0, 22], ["mild symptoms", "PROBLEM", 77, 90], ["fever", "PROBLEM", 106, 111], ["cough", "PROBLEM", 113, 118], ["myalgia", "PROBLEM", 120, 127], ["headache", "PROBLEM", 129, 137], ["runny nose", "PROBLEM", 143, 153], ["among other symptoms", "PROBLEM", 155, 175], ["a worse prognosis", "PROBLEM", 219, 236], ["pneumonia", "PROBLEM", 238, 247], ["kidney failure", "PROBLEM", 249, 263], ["breathing problems", "PROBLEM", 265, 283], ["acute cardiac injury", "PROBLEM", 285, 305], ["sepsis", "PROBLEM", 307, 313], ["death", "PROBLEM", 318, 323], ["mild", "OBSERVATION_MODIFIER", 77, 81], ["pneumonia", "OBSERVATION", 238, 247], ["kidney", "ANATOMY", 249, 255], ["failure", "OBSERVATION", 256, 263], ["acute", "OBSERVATION_MODIFIER", 285, 290], ["cardiac", "ANATOMY", 291, 298], ["injury", "OBSERVATION", 299, 305], ["sepsis", "OBSERVATION", 307, 313]]], ["The incubation period differs between CoVs, generally ranging from 2 to 14 days [25, [65] [66] [67] [68] [69] Initial SARS cases were restricted to China until February 21, 2003, when an elderly doctor who was treating patients with \"atypical pneumonia\" in Guangdong traveled to Hong Kong and stayed at a hotel in the Kowloon district.", [["SARS", "DISEASE", 118, 122], ["pneumonia", "DISEASE", 243, 252], ["CoVs", "SIMPLE_CHEMICAL", 38, 42], ["patients", "ORGANISM", 219, 227], ["patients", "SPECIES", 219, 227], ["Initial SARS cases", "PROBLEM", 110, 128], ["atypical pneumonia", "PROBLEM", 234, 252], ["pneumonia", "OBSERVATION", 243, 252]]], ["It was at this hotel that some guests were infected and, as a result of the movement of these infected individuals, SARS-CoV spread to a considerable part of the world [27] .", [["SARS", "DISEASE", 116, 120], ["SARS-CoV", "ORGANISM", 116, 124], ["SARS-CoV", "SPECIES", 116, 124], ["these infected individuals", "PROBLEM", 88, 114], ["SARS", "PROBLEM", 116, 120], ["infected", "OBSERVATION", 43, 51], ["infected", "OBSERVATION", 94, 102]]], ["The doctor was admitted to a local hospital with symptoms of acute respiratory disease and later died of the disease.", [["respiratory", "ANATOMY", 67, 78], ["acute respiratory disease", "DISEASE", 61, 86], ["symptoms", "PROBLEM", 49, 57], ["acute respiratory disease", "PROBLEM", 61, 86], ["the disease", "PROBLEM", 105, 116], ["acute", "OBSERVATION_MODIFIER", 61, 66], ["respiratory disease", "OBSERVATION", 67, 86], ["disease", "OBSERVATION", 109, 116]]], ["It is recognized that from this index case, seven other people who were on the same floor in the hotel were directly affected by SARS.", [["SARS", "DISEASE", 129, 133], ["people", "ORGANISM", 56, 62], ["people", "SPECIES", 56, 62]]], ["Practically all of these people were foreign visitors, including three visitors from Singapore, one visitor from Vietnam, and two visitors from Canada.", [["people", "ORGANISM", 25, 31], ["people", "SPECIES", 25, 31]]], ["Soon after returning to their countries, these infected visitors triggered outbreaks in their places of origin.", [["infected", "OBSERVATION", 47, 55], ["origin", "ANATOMY_MODIFIER", 104, 110]]], ["However, the high speed of the scientific response in understanding this new viral disease was unmatched and contributed to the success of SARS containment.IntroductionWith the discovery of a novel CoV responsible for the SARS epidemic, new questions need to be clarified as to which animal is the definitive host of this virus.", [["viral disease", "DISEASE", 77, 90], ["SARS", "DISEASE", 139, 143], ["SARS", "DISEASE", 222, 226], ["CoV", "ORGANISM", 198, 201], ["this new viral disease", "PROBLEM", 68, 90], ["SARS containment", "TREATMENT", 139, 155], ["a novel CoV", "PROBLEM", 190, 201], ["the SARS epidemic", "PROBLEM", 218, 235], ["this virus", "PROBLEM", 317, 327]]], ["Could any animal have acted as an intermediate host involving the transmission of the virus to humans?", [["humans", "ORGANISM", 95, 101], ["humans", "SPECIES", 95, 101], ["humans", "SPECIES", 95, 101]]], ["To solve this puzzle, it was necessary to return to the initial cases of SARS.", [["SARS", "DISEASE", 73, 77], ["SARS", "PROBLEM", 73, 77]]], ["However, in the first retrospectively identified case of SARS in the city of Foshan, it was unclear where and how the man had contracted the disease, but it was known that he had not traveled for weeks but had been exposed to different animals and had prepared chicken, domestic cat, and snake for family consumption [29] .", [["SARS", "DISEASE", 57, 61], ["man", "ORGANISM", 118, 121], ["chicken", "ORGANISM", 261, 268], ["cat", "ORGANISM", 279, 282], ["man", "SPECIES", 118, 121], ["chicken", "SPECIES", 261, 268], ["cat", "SPECIES", 279, 282], ["chicken", "SPECIES", 261, 268], ["SARS", "PROBLEM", 57, 61], ["the disease", "PROBLEM", 137, 148], ["disease", "OBSERVATION", 141, 148]]], ["Additionally, at the beginning of the SARS epidemic, similar to the first case, the disease afflicted restaurant workers who handled wild mammals as exotic foods [28, 35] .", [["SARS", "DISEASE", 38, 42], ["the SARS epidemic", "PROBLEM", 34, 51]]], ["Subsequently, SARS-CoV and/or anti-SARS-CoV antibodies were found in masked palm civets (Paguma larvata) and in animals that were being handled in a market [26, 36] .", [["SARS-CoV", "GENE_OR_GENE_PRODUCT", 14, 22], ["anti-SARS-CoV", "GENE_OR_GENE_PRODUCT", 30, 43], ["palm", "ORGANISM_SUBDIVISION", 76, 80], ["Paguma larvata", "ORGANISM", 89, 103], ["SARS-CoV and/or anti-SARS-CoV antibodies", "PROTEIN", 14, 54], ["Paguma larvata", "SPECIES", 89, 103], ["SARS-CoV", "SPECIES", 14, 22], ["anti-SARS-CoV", "SPECIES", 30, 43], ["palm civets", "SPECIES", 76, 87], ["Paguma larvata", "SPECIES", 89, 103], ["SARS", "PROBLEM", 14, 18], ["anti-SARS", "TEST", 30, 39], ["CoV antibodies", "TEST", 40, 54]]], ["However, it was only later that studies showed that populations of palm civets on farms were negative for SARS-CoV, while those in markets populations showed positive results (i.e., had a higher SARS-CoV antibody prevalence), suggesting that market animals were probably intermediate hosts and were possibly infected from another source in the markets [26, 37, 38] .", [["SARS", "DISEASE", 106, 110], ["palm", "ORGANISM_SUBDIVISION", 67, 71], ["SARS-CoV", "ORGANISM", 106, 114], ["SARS-CoV", "SPECIES", 106, 114], ["SARS-CoV", "SPECIES", 195, 203], ["palm civets", "TEST", 67, 78], ["SARS", "PROBLEM", 106, 110], ["CoV", "PROBLEM", 111, 114], ["a higher SARS", "PROBLEM", 186, 199], ["CoV antibody prevalence", "TEST", 200, 223], ["intermediate hosts", "OBSERVATION", 271, 289], ["possibly", "UNCERTAINTY", 299, 307], ["infected", "OBSERVATION", 308, 316]]], ["Subsequent studies showed that several CoVs were endemic in bats, including a CoV closely related to SARS-CoV.", [["SARS", "DISEASE", 101, 105], ["CoVs", "GENE_OR_GENE_PRODUCT", 39, 43], ["CoV", "ORGANISM", 78, 81], ["SARS-CoV", "ORGANISM", 101, 109], ["SARS-CoV", "SPECIES", 101, 109], ["Subsequent studies", "TEST", 0, 18], ["several CoVs", "PROBLEM", 31, 43], ["a CoV", "PROBLEM", 76, 81], ["SARS", "PROBLEM", 101, 105], ["several", "OBSERVATION_MODIFIER", 31, 38], ["CoVs", "OBSERVATION_MODIFIER", 39, 43], ["endemic", "OBSERVATION_MODIFIER", 49, 56]]], ["These findings suggest that bats are the natural host of all strains of CoV [19, 22, [39] [40] [41] .MERS-CoV: another worrying outbreak of CoV respiratory infectionMERS-CoV is a human CoV that causes SARS-like disease in the Middle East.", [["CoV respiratory infectionMERS-CoV", "DISEASE", 140, 173], ["SARS-like disease", "DISEASE", 201, 218], ["bats", "ORGANISM", 28, 32], ["CoV", "ORGANISM", 72, 75], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 101, 109], ["CoV", "ORGANISM", 140, 143], ["human", "ORGANISM", 179, 184], ["CoV", "ORGANISM", 185, 188], ["human", "SPECIES", 179, 184], ["MERS-CoV", "SPECIES", 101, 109], ["CoV respiratory infectionMERS-CoV", "SPECIES", 140, 173], ["human CoV", "SPECIES", 179, 188], ["CoV", "TEST", 72, 75], ["CoV respiratory infectionMERS", "PROBLEM", 140, 169], ["a human CoV", "PROBLEM", 177, 188], ["SARS", "PROBLEM", 201, 205], ["disease", "PROBLEM", 211, 218], ["CoV", "OBSERVATION_MODIFIER", 140, 143], ["respiratory infectionMERS", "OBSERVATION", 144, 169], ["SARS", "OBSERVATION", 201, 205], ["Middle", "ANATOMY_MODIFIER", 226, 232]]], ["The first reported case of the virus was in a 60-year-old Saudi man who had a 7-day history of fever, cough, sputum, and shortness of breath and was admitted to a private hospital in Jeddah, Saudi Arabia, on June 13, 2012, and died 11 days after admission to the hospital [42] .", [["sputum", "ANATOMY", 109, 115], ["fever", "DISEASE", 95, 100], ["cough", "DISEASE", 102, 107], ["shortness of breath", "DISEASE", 121, 140], ["man", "ORGANISM", 64, 67], ["man", "SPECIES", 64, 67], ["the virus", "PROBLEM", 27, 36], ["fever", "PROBLEM", 95, 100], ["cough", "PROBLEM", 102, 107], ["sputum", "PROBLEM", 109, 115], ["shortness of breath", "PROBLEM", 121, 140], ["fever", "OBSERVATION", 95, 100], ["cough", "OBSERVATION", 102, 107]]], ["A few months later, on September 12 of the same year, a 49-yearold man was transferred from Qatar with acute renal failure and bilateral pneumonia.", [["renal", "ANATOMY", 109, 114], ["acute renal failure", "DISEASE", 103, 122], ["pneumonia", "DISEASE", 137, 146], ["man", "ORGANISM", 67, 70], ["renal", "ORGAN", 109, 114], ["man", "SPECIES", 67, 70], ["acute renal failure", "PROBLEM", 103, 122], ["bilateral pneumonia", "PROBLEM", 127, 146], ["few", "OBSERVATION_MODIFIER", 2, 5], ["acute", "OBSERVATION_MODIFIER", 103, 108], ["renal", "ANATOMY", 109, 114], ["failure", "OBSERVATION", 115, 122], ["bilateral", "ANATOMY_MODIFIER", 127, 136], ["pneumonia", "OBSERVATION", 137, 146]]], ["Molecular tests of patient samples performed in the same month detected a viral genome highly similar to that described in the case of the Saudi Arabian patient [43] .", [["samples", "ANATOMY", 27, 34], ["patient", "ORGANISM", 19, 26], ["patient", "ORGANISM", 153, 160], ["viral genome", "DNA", 74, 86], ["patient", "SPECIES", 19, 26], ["patient", "SPECIES", 153, 160], ["Molecular tests of patient samples", "TEST", 0, 34], ["a viral genome", "PROBLEM", 72, 86], ["viral genome", "OBSERVATION", 74, 86]]], ["The people who had had close contact with the patient, including health professionals, family and friends, were followed up until ten days after the last contact with the patient in an attempt to better understand the form of dissemination and viral contagion.", [["viral contagion", "DISEASE", 244, 259], ["people", "ORGANISM", 4, 10], ["patient", "ORGANISM", 46, 53], ["patient", "ORGANISM", 171, 178], ["people", "SPECIES", 4, 10], ["patient", "SPECIES", 46, 53], ["patient", "SPECIES", 171, 178], ["dissemination and viral contagion", "PROBLEM", 226, 259], ["viral contagion", "OBSERVATION", 244, 259]]], ["Thus, 64 people were followed for ten days after their last contact with the hospitalized patient, and there was no confirmed evidence of continuous person-to-person transmission, despite active extensive contact tracking [43, 44] .MERS-CoV: another worrying outbreak of CoV respiratory infectionHealth authorities were alerted to the circulation of the novel CoV, classified in November 2012 as a new \u03b2-CoV closely related to the CoVs HKU4 and HKU5 present in bats [42] .", [["CoV respiratory infection", "DISEASE", 271, 296], ["people", "ORGANISM", 9, 15], ["patient", "ORGANISM", 90, 97], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 232, 240], ["CoV", "ORGANISM", 271, 274], ["CoV", "ORGANISM", 360, 363], ["\u03b2-CoV", "ORGANISM", 402, 407], ["CoVs", "GENE_OR_GENE_PRODUCT", 431, 435], ["HKU4", "GENE_OR_GENE_PRODUCT", 436, 440], ["HKU5", "GENE_OR_GENE_PRODUCT", 445, 449], ["CoVs HKU4", "DNA", 431, 440], ["HKU5", "DNA", 445, 449], ["people", "SPECIES", 9, 15], ["patient", "SPECIES", 90, 97], ["person", "SPECIES", 149, 155], ["MERS-CoV", "SPECIES", 232, 240], ["\u03b2-CoV", "SPECIES", 402, 407], ["CoV respiratory infection", "PROBLEM", 271, 296], ["the CoVs HKU4", "PROBLEM", 427, 440]]], ["In December 2012, the European Center for Disease Prevention and Control (ECDC) established a list of countries at risk that included Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Palestine, Oman, Qatar, Saudi Arabia, Syria, the United Arab Emirates, and Yemen [45] .", [["Disease Prevention", "TREATMENT", 42, 60]]], ["Subsequently, in May 2013, viral infection was identified in a French patient who had a severe respiratory disease.", [["respiratory", "ANATOMY", 95, 106], ["viral infection", "DISEASE", 27, 42], ["respiratory disease", "DISEASE", 95, 114], ["patient", "ORGANISM", 70, 77], ["patient", "SPECIES", 70, 77], ["viral infection", "PROBLEM", 27, 42], ["a severe respiratory disease", "PROBLEM", 86, 114], ["viral", "OBSERVATION_MODIFIER", 27, 32], ["infection", "OBSERVATION", 33, 42], ["severe", "OBSERVATION_MODIFIER", 88, 94], ["respiratory disease", "OBSERVATION", 95, 114]]], ["The male patient had been in the United Arab Emirates and had recently returned to France.", [["patient", "ORGANISM", 9, 16], ["patient", "SPECIES", 9, 16]]], ["A protocol for monitoring contacts close to the patient was adopted, as well as for tracking individuals who had traveled together to the United Arab Emirates, to detect possible other cases and to prevent human-to-human transmission.", [["patient", "ORGANISM", 48, 55], ["human", "ORGANISM", 206, 211], ["human", "ORGANISM", 215, 220], ["patient", "SPECIES", 48, 55], ["human", "SPECIES", 206, 211], ["human", "SPECIES", 215, 220], ["human", "SPECIES", 206, 211], ["human", "SPECIES", 215, 220], ["A protocol", "TREATMENT", 0, 10]]], ["The contact screening identified a secondary case in a patient admitted to the same hospital room, thereby confirming the person-to-person transmission of the disease [46] .MERS-CoV: another worrying outbreak of CoV respiratory infectionCases of the disease continued to be identified, and as of June 2013, 55 confirmed cases had been reported, with a mortality rate of 56% due to the 31 deaths caused by the virus.", [["CoV respiratory infectionCases", "DISEASE", 212, 242], ["deaths", "DISEASE", 388, 394], ["patient", "ORGANISM", 55, 62], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 173, 181], ["CoV", "ORGANISM", 212, 215], ["patient", "SPECIES", 55, 62], ["person", "SPECIES", 122, 128], ["MERS-CoV", "SPECIES", 173, 181], ["The contact screening", "TEST", 0, 21], ["CoV respiratory infectionCases", "PROBLEM", 212, 242], ["the disease", "PROBLEM", 246, 257], ["a mortality rate", "TEST", 350, 366], ["the virus", "PROBLEM", 405, 414], ["CoV", "OBSERVATION_MODIFIER", 212, 215], ["respiratory infectionCases", "OBSERVATION", 216, 242], ["disease", "OBSERVATION", 250, 257]]], ["The reported cases occurred in different regions: 45 cases were in countries in the Middle East (Saudi Arabia, Jordan, Qatar, and the United Arab Emirates), eight were in Europe (France, Italy, and the United Kingdom) and two were in Africa (Tunisia) [47] .", [["Middle", "ANATOMY_MODIFIER", 84, 90]]], ["Viral infection was the topic at the Sixty-Sixth World Health Assembly in Geneva, Switzerland, with the statement that \"the novel coronavirus is a threat to the whole world\", mainly because of a lack of information related to the virus [48].MERS-CoV: another worrying outbreak of CoV respiratory infectionIn early 2014, there was an abrupt increase in the number of MERS-CoV infections in the Jeddah region of Saudi Arabia, the location of the first reported case of the disease.", [["Viral infection", "DISEASE", 0, 15], ["coronavirus", "DISEASE", 130, 141], ["CoV respiratory infection", "DISEASE", 280, 305], ["MERS-CoV infections", "DISEASE", 366, 385], ["coronavirus", "ORGANISM", 130, 141], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 241, 249], ["CoV", "ORGANISM", 280, 283], ["MERS-CoV", "ORGANISM", 366, 374], ["MERS-CoV", "SPECIES", 241, 249], ["MERS-CoV", "SPECIES", 366, 374], ["Viral infection", "PROBLEM", 0, 15], ["the virus", "PROBLEM", 226, 235], ["CoV respiratory infection", "PROBLEM", 280, 305], ["an abrupt increase", "PROBLEM", 330, 348], ["MERS", "PROBLEM", 366, 370], ["CoV infections", "PROBLEM", 371, 385], ["the disease", "PROBLEM", 467, 478], ["infection", "OBSERVATION", 6, 15], ["respiratory", "ANATOMY", 284, 295], ["infection", "OBSERVATION", 296, 305], ["abrupt", "OBSERVATION_MODIFIER", 333, 339], ["increase", "OBSERVATION_MODIFIER", 340, 348], ["number", "OBSERVATION_MODIFIER", 356, 362], ["CoV infections", "OBSERVATION", 371, 385], ["Jeddah", "ANATOMY_MODIFIER", 393, 399], ["disease", "OBSERVATION", 471, 478]]], ["A total of 255 cases were identified from January 1 to January 16, with an average age of 45 years among patients, with person-to-person transmission identified mainly in people who had contact with a health unit in the region [49] .", [["patients", "ORGANISM", 105, 113], ["people", "ORGANISM", 171, 177], ["patients", "SPECIES", 105, 113], ["person", "SPECIES", 120, 126], ["person", "SPECIES", 130, 136], ["people", "SPECIES", 171, 177]]], ["Two cases of the infection were identified in the Netherlands after two individuals from the same family returned from a pilgrimage to Medina and Mecca (Saudi Arabia), both aged 70 and over [50] .", [["infection", "DISEASE", 17, 26], ["the infection", "PROBLEM", 13, 26], ["infection", "OBSERVATION", 17, 26]]], ["In April 2014, the first case of infection in Malaysia was identified in a male patient over the age of 50.", [["infection", "DISEASE", 33, 42], ["patient", "ORGANISM", 80, 87], ["patient", "SPECIES", 80, 87], ["infection", "PROBLEM", 33, 42], ["infection", "OBSERVATION", 33, 42]]], ["The patient had traveled to Saudi Arabia days before to make a pilgrimage.", [["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["a pilgrimage", "TREATMENT", 61, 73]]], ["There were no positive cases in their close contacts [51] .", [["no", "UNCERTAINTY", 11, 13], ["positive", "OBSERVATION_MODIFIER", 14, 22]]], ["The first reported case of MERS-CoV infection in the USA was from an individual who had traveled to Saudi Arabia.", [["MERS-CoV infection", "DISEASE", 27, 45], ["MERS-CoV", "ORGANISM", 27, 35], ["MERS-CoV", "SPECIES", 27, 35], ["MERS", "PROBLEM", 27, 31], ["CoV infection", "PROBLEM", 32, 45], ["infection", "OBSERVATION", 36, 45]]], ["The number of cases of the disease continued to rise.", [["the disease", "PROBLEM", 23, 34], ["disease", "OBSERVATION", 27, 34]]], ["As of May 2014, more than 570 cases had been reported to WHO, with at least 173 deaths [53] .MERS-CoV: another worrying outbreak of CoV respiratory infectionMERS-CoV continued to spread across countries, and the first case of the virus in South Korea was reported on May 20, 2015.", [["deaths", "DISEASE", 80, 86], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 93, 101], ["CoV respiratory infectionMERS-CoV", "ORGANISM", 132, 165], ["CoV respiratory infectionMERS-CoV", "SPECIES", 132, 165], ["MERS-CoV", "SPECIES", 93, 101], ["CoV respiratory infectionMERS-CoV", "SPECIES", 132, 165], ["CoV respiratory infectionMERS", "PROBLEM", 132, 161], ["CoV", "PROBLEM", 162, 165], ["the virus", "PROBLEM", 226, 235], ["CoV", "OBSERVATION_MODIFIER", 132, 135], ["respiratory infectionMERS", "OBSERVATION", 136, 161]]], ["On May 28, a 44-year-old traveler from South Korea was admitted to a hospital in China.", [["traveler", "ORGANISM", 25, 33]]], ["MERS-CoV infection was confirmed on May 29, marking the first case confirmed in the laboratory in China.", [["MERS-CoV infection", "DISEASE", 0, 18], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 0, 8], ["MERS-CoV", "SPECIES", 0, 8], ["CoV infection", "PROBLEM", 5, 18], ["CoV", "OBSERVATION_MODIFIER", 5, 8], ["infection", "OBSERVATION", 9, 18]]], ["Fear of a new pandemic grew [55] .MERS-CoV: another worrying outbreak of CoV respiratory infectionAccording to WHO, since April 2012, 2519 laboratoryconfirmed cases of MERS-CoV infection had been reported by January 2020.", [["CoV respiratory infectionAccording", "DISEASE", 73, 107], ["MERS-CoV infection", "DISEASE", 168, 186], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 34, 42], ["CoV", "ORGANISM", 73, 76], ["MERS-CoV", "ORGANISM", 168, 176], ["MERS-CoV", "SPECIES", 34, 42], ["MERS-CoV", "SPECIES", 168, 176], ["CoV respiratory infectionAccording", "PROBLEM", 73, 107], ["MERS", "PROBLEM", 168, 172], ["CoV infection", "PROBLEM", 173, 186], ["new", "OBSERVATION_MODIFIER", 10, 13], ["respiratory", "ANATOMY", 77, 88], ["infection", "OBSERVATION", 177, 186]]], ["The lethality rate is 34.3%, with 866 confirmed deaths, the majority occurring in Saudi Arabia (2121 cases, including 788 deaths, with a lethality rate of 37.1%) (Fig. 3B ) [56] .SARS-CoV-2: again a novel virus and now the CoV pandemicSurprisingly, at the end of December 2019, an outbreak of mysterious pneumonia occurred in Wuhan City, Hubei Province, China [57, 58] .", [["deaths", "DISEASE", 48, 54], ["deaths", "DISEASE", 122, 128], ["SARS", "DISEASE", 179, 183], ["pneumonia", "DISEASE", 304, 313], ["SARS-CoV-2", "ORGANISM", 179, 189], ["CoV", "ORGANISM", 223, 226], ["The lethality rate", "TEST", 0, 18], ["a lethality rate", "TEST", 135, 151], ["a novel virus", "PROBLEM", 197, 210], ["mysterious pneumonia", "PROBLEM", 293, 313], ["mysterious", "OBSERVATION_MODIFIER", 293, 303], ["pneumonia", "OBSERVATION", 304, 313]]], ["It was observed that the etiologic agent of the disease was a novel CoV, previously designated 2019-nCoV by WHO and, more recently, SARS-CoV-2 by the International Committee for Taxonomy of Viruses [59, 60] .", [["CoV", "ORGANISM", 68, 71], ["the disease", "PROBLEM", 44, 55], ["SARS", "TEST", 132, 136], ["CoV", "TEST", 137, 140], ["disease", "OBSERVATION", 48, 55]]], ["Consequently, China has been the epicenter of the emergence of the disease called COVID-19 (Coronavirus disease 2019), which WHO characterized the COVID-19 on March 11, 2020 as a pandemic [61, 62] .SARS-CoV-2: again a novel virus and now the CoV pandemicFor the initial cases of COVID-19, it was observed that many patients, before falling ill, were exposed to wild animals at a wholesale seafood market in Huanan (Wuhan, China), a place where birds, bats, snakes, and other farm animals were traded [57, 63] .", [["Coronavirus disease", "DISEASE", 92, 111], ["SARS", "DISEASE", 198, 202], ["SARS-CoV-2", "ORGANISM", 198, 208], ["CoV", "ORGANISM", 242, 245], ["patients", "ORGANISM", 315, 323], ["birds", "ORGANISM", 444, 449], ["snakes", "ORGANISM_SUBDIVISION", 457, 463], ["patients", "SPECIES", 315, 323], ["COVID", "TEST", 82, 87], ["Coronavirus disease", "PROBLEM", 92, 111], ["the COVID", "TEST", 143, 152], ["a novel virus", "PROBLEM", 216, 229], ["COVID", "TEST", 279, 284]]], ["In this scenario, a zoonotic origin of these initial cases was suggested; however, the transmission from person to person was soon recognized due to the various cases of COVID-19 within families and among people who did not go to the Huanan market.", [["people", "ORGANISM", 205, 211], ["person", "SPECIES", 105, 111], ["person", "SPECIES", 115, 121], ["people", "SPECIES", 205, 211]]], ["Already in January 2020, the disease spread rapidly inside and outside Hubei Province, and even other countries.", [["the disease spread", "PROBLEM", 25, 43], ["disease", "OBSERVATION", 29, 36], ["spread", "OBSERVATION_MODIFIER", 37, 43], ["rapidly", "OBSERVATION_MODIFIER", 44, 51]]], ["As of April 17, 2020, a total of 2,114,269 cases of COVID-19 were confirmed worldwide.", [["COVID", "TEST", 52, 57]]], ["Internationally, cases have been reported in 203 countries, areas or territories on five continents (Fig. 4) [64].SARS-CoV-2: again a novel virus and now the CoV pandemicIn case series studies, the clinical characteristics of patients diagnosed with COVID-19 were observed (Fig. 2B) .", [["SARS", "DISEASE", 114, 118], ["patients", "ORGANISM", 226, 234], ["patients", "SPECIES", 226, 234], ["a novel virus", "PROBLEM", 132, 145], ["COVID", "TEST", 250, 255]]], ["Initially, Huang et al. reported that 66% (27/41) of patients admitted to Jinyintan Hospital (Wuhan, China) had a history of exposure to the wholesale seafood market in Huanan [65] .", [["patients", "ORGANISM", 53, 61], ["patients", "SPECIES", 53, 61]]], ["Later, Chen et al. found that 49% (49/99) of the patients admitted to Jinyintan Hospital had a history of exposure to the same market [66] .", [["patients", "ORGANISM", 49, 57], ["patients", "SPECIES", 49, 57]]], ["Subsequently, with the addition of the studies by Wang et al. [67] , Yang et al. [68] , and Tian et al. [69] , the following clinical characteristics of a total of 689 patients were observed: fever (85%, 587/689), cough (58%, 401/689), myalgia or fatigue (29%, 199/689), sputum production (29%, 96/328), dyspnea (17%, 116/689), pharyngitis (13%, 50/386), dizziness (9%, 13/138), headache (7%, 50/689), hemoptysis (5%, 2/41), diarrhea (7%, 28/427), nausea and vomiting (4.4%, 17/386), rhinorrhea (4%, 9/248), and abdominal pain (2%; 3/138) [65] [66] [67] [68] [69] .SARS-CoV-2: again a novel virus and now the CoV pandemicIn the clinical characteristics of patients infected with SARS-CoV-2, it is noted that most patients have relatively moderate symptoms and a good prognosis.", [["sputum", "ANATOMY", 271, 277], ["abdominal", "ANATOMY", 512, 521], ["fever", "DISEASE", 192, 197], ["cough", "DISEASE", 214, 219], ["myalgia", "DISEASE", 236, 243], ["fatigue", "DISEASE", 247, 254], ["sputum production", "DISEASE", 271, 288], ["dyspnea", "DISEASE", 304, 311], ["pharyngitis", "DISEASE", 328, 339], ["dizziness", "DISEASE", 355, 364], ["headache", "DISEASE", 379, 387], ["hemoptysis", "DISEASE", 402, 412], ["diarrhea", "DISEASE", 425, 433], ["nausea and vomiting", "DISEASE", 448, 467], ["rhinorrhea", "DISEASE", 484, 494], ["abdominal pain", "DISEASE", 512, 526], ["SARS", "DISEASE", 565, 569], ["SARS", "DISEASE", 679, 683], ["patients", "ORGANISM", 168, 176], ["abdominal", "ORGANISM_SUBDIVISION", 512, 521], ["[65] [66] [67] [68", "SIMPLE_CHEMICAL", 539, 557], ["SARS-CoV-2", "ORGANISM", 565, 575], ["CoV", "ORGANISM", 609, 612], ["patients", "ORGANISM", 656, 664], ["SARS-CoV-2", "ORGANISM", 679, 689], ["patients", "ORGANISM", 713, 721], ["patients", "SPECIES", 168, 176], ["patients", "SPECIES", 656, 664], ["patients", "SPECIES", 713, 721], ["SARS-CoV", "SPECIES", 679, 687], ["the studies", "TEST", 35, 46], ["fever", "PROBLEM", 192, 197], ["cough", "PROBLEM", 214, 219], ["myalgia", "PROBLEM", 236, 243], ["fatigue", "PROBLEM", 247, 254], ["sputum production", "TEST", 271, 288], ["dyspnea", "PROBLEM", 304, 311], ["pharyngitis", "PROBLEM", 328, 339], ["dizziness", "PROBLEM", 355, 364], ["headache", "PROBLEM", 379, 387], ["hemoptysis", "PROBLEM", 402, 412], ["diarrhea", "PROBLEM", 425, 433], ["nausea", "PROBLEM", 448, 454], ["vomiting", "PROBLEM", 459, 467], ["rhinorrhea", "PROBLEM", 484, 494], ["abdominal pain", "PROBLEM", 512, 526], ["a novel virus", "PROBLEM", 583, 596], ["relatively moderate symptoms", "PROBLEM", 727, 755], ["pharyngitis", "OBSERVATION", 328, 339], ["hemoptysis", "OBSERVATION", 402, 412], ["rhinorrhea", "OBSERVATION", 484, 494], ["abdominal", "ANATOMY", 512, 521], ["moderate", "OBSERVATION_MODIFIER", 738, 746], ["symptoms", "OBSERVATION", 747, 755]]], ["However, individuals with moderate clinical status can progress to severe cases, including organ dysfunction (shock, SARS, acute cardiac injury, and acute kidney injury), and many deaths have been reported [67] .", [["organ", "ANATOMY", 91, 96], ["cardiac", "ANATOMY", 129, 136], ["kidney", "ANATOMY", 155, 161], ["organ dysfunction", "DISEASE", 91, 108], ["shock", "DISEASE", 110, 115], ["SARS", "DISEASE", 117, 121], ["acute cardiac injury", "DISEASE", 123, 143], ["acute kidney injury", "DISEASE", 149, 168], ["deaths", "DISEASE", 180, 186], ["organ", "ORGAN", 91, 96], ["cardiac", "ORGAN", 129, 136], ["kidney", "ORGAN", 155, 161], ["moderate clinical status", "PROBLEM", 26, 50], ["severe cases", "PROBLEM", 67, 79], ["organ dysfunction", "PROBLEM", 91, 108], ["shock", "PROBLEM", 110, 115], ["SARS", "PROBLEM", 117, 121], ["acute cardiac injury", "PROBLEM", 123, 143], ["acute kidney injury", "PROBLEM", 149, 168], ["moderate", "OBSERVATION_MODIFIER", 26, 34], ["acute", "OBSERVATION_MODIFIER", 123, 128], ["cardiac", "ANATOMY", 129, 136], ["injury", "OBSERVATION", 137, 143], ["acute", "OBSERVATION_MODIFIER", 149, 154], ["kidney", "ANATOMY", 155, 161], ["injury", "OBSERVATION", 162, 168]]], ["Recent European Centre for Disease Prevention and Control situation reports show that in total, there were 145,144 deaths, with most deaths confirmed in USA (33, 284) Italy (22, 172) , Spain (19, 130) , France (17, 920) and United Kingdon (13, 729) .", [["deaths", "DISEASE", 115, 121], ["deaths", "DISEASE", 133, 139], ["Disease", "PROBLEM", 27, 34]]], ["Thus, the current COVID-19 pandemic had already exceeded the number of cases and deaths from SARS and MERS combined [64] .SARS-CoV-2: again a novel virus and now the CoV pandemicAt the time, the pathophysiology of severe cases of SARS-CoV-2 infection, as well as SARS-CoV and MERS-CoV, were not fully understood.", [["deaths", "DISEASE", 81, 87], ["SARS", "DISEASE", 93, 97], ["SARS", "DISEASE", 122, 126], ["SARS-CoV-2 infection", "DISEASE", 230, 250], ["SARS-CoV-2", "ORGANISM", 122, 132], ["CoV", "ORGANISM", 166, 169], ["SARS-CoV-2", "ORGANISM", 230, 240], ["SARS-CoV", "ORGANISM", 263, 271], ["MERS-CoV", "ORGANISM", 276, 284], ["CoV-2", "SPECIES", 235, 240], ["SARS-CoV-2", "SPECIES", 230, 240], ["SARS-CoV", "SPECIES", 263, 271], ["MERS-CoV", "SPECIES", 276, 284], ["SARS", "PROBLEM", 93, 97], ["a novel virus", "PROBLEM", 140, 153], ["SARS", "PROBLEM", 230, 234], ["CoV", "PROBLEM", 235, 238], ["2 infection", "PROBLEM", 239, 250], ["SARS", "PROBLEM", 263, 267], ["severe", "OBSERVATION_MODIFIER", 214, 220], ["infection", "OBSERVATION", 241, 250]]], ["However, the first studies have shown that the 'cytokine storm' factor was associated with a greater severity of COVID-19, which was also seen in infections by SARS and MERS CoVs.", [["infections", "DISEASE", 146, 156], ["SARS", "DISEASE", 160, 164], ["COVID-19", "GENE_OR_GENE_PRODUCT", 113, 121], ["cytokine", "PROTEIN", 48, 56], ["the first studies", "TEST", 9, 26], ["the 'cytokine storm' factor", "PROBLEM", 43, 70], ["COVID", "TEST", 113, 118], ["infections", "PROBLEM", 146, 156], ["SARS", "PROBLEM", 160, 164], ["MERS CoVs", "PROBLEM", 169, 178], ["greater", "OBSERVATION_MODIFIER", 93, 100], ["infections", "OBSERVATION", 146, 156]]], ["Increased amounts of proinflammatory cytokines (e.g., IL1B, IFN\u03b3, IP10 and MCP1) were observed in the serum.", [["serum", "ANATOMY", 102, 107], ["IL1B", "GENE_OR_GENE_PRODUCT", 54, 58], ["IFN\u03b3", "GENE_OR_GENE_PRODUCT", 60, 64], ["IP10", "GENE_OR_GENE_PRODUCT", 66, 70], ["MCP1", "GENE_OR_GENE_PRODUCT", 75, 79], ["serum", "ORGANISM_SUBSTANCE", 102, 107], ["proinflammatory cytokines", "PROTEIN", 21, 46], ["IL1B", "PROTEIN", 54, 58], ["IFN\u03b3", "PROTEIN", 60, 64], ["IP10", "PROTEIN", 66, 70], ["MCP1", "PROTEIN", 75, 79], ["proinflammatory cytokines", "PROBLEM", 21, 46], ["IL1B", "TEST", 54, 58], ["IFN\u03b3", "TEST", 60, 64], ["IP10", "TEST", 66, 70], ["MCP1", "TEST", 75, 79], ["amounts", "OBSERVATION_MODIFIER", 10, 17], ["proinflammatory cytokines", "OBSERVATION", 21, 46]]], ["Additionally, the involvement of the cytokine storm factor in the severity of the disease was corroborated by the observation that patients who needed to be admitted to the intensive care unit (ICU) had higher concentrations of cytokines (GCSF, IP10, MCP1, MIP1A and TNF\u03b1) than patients who did not require ICU admission.", [["patients", "ORGANISM", 131, 139], ["GCSF", "GENE_OR_GENE_PRODUCT", 239, 243], ["IP10", "GENE_OR_GENE_PRODUCT", 245, 249], ["MCP1", "GENE_OR_GENE_PRODUCT", 251, 255], ["MIP1A", "GENE_OR_GENE_PRODUCT", 257, 262], ["TNF\u03b1", "GENE_OR_GENE_PRODUCT", 267, 271], ["patients", "ORGANISM", 278, 286], ["cytokine storm factor", "PROTEIN", 37, 58], ["cytokines", "PROTEIN", 228, 237], ["GCSF", "PROTEIN", 239, 243], ["IP10", "PROTEIN", 245, 249], ["MCP1", "PROTEIN", 251, 255], ["MIP1A", "PROTEIN", 257, 262], ["TNF\u03b1", "PROTEIN", 267, 271], ["patients", "SPECIES", 131, 139], ["patients", "SPECIES", 278, 286], ["the cytokine storm factor", "PROBLEM", 33, 58], ["the disease", "PROBLEM", 78, 89], ["cytokines (GCSF", "TREATMENT", 228, 243], ["IP10", "TEST", 245, 249], ["MCP1", "TEST", 251, 255], ["cytokine storm", "OBSERVATION", 37, 51], ["disease", "OBSERVATION", 82, 89]]], ["Presently, in addition to increased secretion of T helper-1 cytokines, increases in secretion of T helper-2 cytokines (e.g., IL4 and IL10) were observed [65] .", [["T helper-1", "GENE_OR_GENE_PRODUCT", 49, 59], ["T helper-2", "GENE_OR_GENE_PRODUCT", 97, 107], ["IL4", "GENE_OR_GENE_PRODUCT", 125, 128], ["IL10", "GENE_OR_GENE_PRODUCT", 133, 137], ["T helper-1 cytokines", "PROTEIN", 49, 69], ["T helper-2 cytokines", "PROTEIN", 97, 117], ["IL4", "PROTEIN", 125, 128], ["IL10", "PROTEIN", 133, 137], ["increased secretion of T helper", "PROBLEM", 26, 57], ["IL4 and IL10)", "TREATMENT", 125, 138], ["increased", "OBSERVATION_MODIFIER", 26, 35], ["increases", "OBSERVATION_MODIFIER", 71, 80]]], ["Based on this background, further studies are needed to characterize the response profiles of the immune system in SARS-CoV-2 infection and to better elucidate the mechanism of pathogenesis.SARS-CoV-2: again a novel virus and now the CoV pandemicAlthough the general population is susceptible to SARS-CoV-2, a higher incidence has been observed in elderly males, especially those with chronic diseases, including diabetes, hypertension, and cardiovascular diseases [65] [66] [67] .", [["cardiovascular", "ANATOMY", 441, 455], ["SARS-CoV-2 infection", "DISEASE", 115, 135], ["SARS", "DISEASE", 190, 194], ["SARS", "DISEASE", 296, 300], ["chronic diseases", "DISEASE", 385, 401], ["diabetes", "DISEASE", 413, 421], ["hypertension", "DISEASE", 423, 435], ["cardiovascular diseases", "DISEASE", 441, 464], ["SARS-CoV-2", "ORGANISM", 115, 125], ["SARS-CoV-2", "ORGANISM", 190, 200], ["CoV", "ORGANISM", 234, 237], ["SARS-CoV-2", "ORGANISM", 296, 306], ["SARS-CoV-2", "SPECIES", 115, 125], ["SARS-CoV", "SPECIES", 296, 304], ["further studies", "TEST", 26, 41], ["the immune system", "TEST", 94, 111], ["SARS", "PROBLEM", 115, 119], ["CoV-2 infection", "PROBLEM", 120, 135], ["pathogenesis", "PROBLEM", 177, 189], ["a novel virus", "PROBLEM", 208, 221], ["chronic diseases", "PROBLEM", 385, 401], ["diabetes", "PROBLEM", 413, 421], ["hypertension", "PROBLEM", 423, 435], ["cardiovascular diseases", "PROBLEM", 441, 464], ["pathogenesis", "OBSERVATION", 177, 189], ["chronic", "OBSERVATION_MODIFIER", 385, 392], ["diseases", "OBSERVATION", 393, 401], ["hypertension", "OBSERVATION", 423, 435], ["cardiovascular", "ANATOMY", 441, 455]]], ["In this context, the most recent case series study involving 138 patients with COVID-19 found an average age of 56 years in this group.", [["patients", "ORGANISM", 65, 73], ["patients", "SPECIES", 65, 73], ["COVID", "TEST", 79, 84]]], ["The researchers also noted that patients referred to the ICU were older than patients without the need for referral to the ICU (average age, 66 years vs. 51 years) [67] .", [["patients", "ORGANISM", 32, 40], ["patients", "ORGANISM", 77, 85], ["patients", "SPECIES", 32, 40], ["patients", "SPECIES", 77, 85]]], ["An additional study by Chen et al. gave similar results, showing that viral infection is more likely to affect elderly men with comorbidities [66] .SARS-CoV-2: again a novel virus and now the CoV pandemicApproximately 120 days after the beginning of the COVID-19 epidemic in China, in the emerging COVID-19 pandemic in Italy, France, Iran, Spain, Germany, USA, and the United Kingdom, a large number of cases (2, 114, 269) and a low mortality rate (~6%) compared to SARS (~10%) and MERS (34.3%) were observed [64] .", [["viral infection", "DISEASE", 70, 85], ["SARS", "DISEASE", 148, 152], ["SARS", "DISEASE", 466, 470], ["men", "ORGANISM", 119, 122], ["SARS-CoV-2", "ORGANISM", 148, 158], ["CoV", "ORGANISM", 192, 195], ["COVID-19", "ORGANISM", 298, 306], ["men", "SPECIES", 119, 122], ["An additional study", "TEST", 0, 19], ["viral infection", "PROBLEM", 70, 85], ["comorbidities", "PROBLEM", 128, 141], ["a novel virus", "PROBLEM", 166, 179], ["the COVID", "TEST", 250, 259], ["a low mortality rate", "PROBLEM", 427, 447], ["SARS", "TEST", 466, 470], ["MERS", "TEST", 482, 486], ["viral", "OBSERVATION_MODIFIER", 70, 75], ["infection", "OBSERVATION", 76, 85], ["large", "OBSERVATION_MODIFIER", 387, 392]]], ["Faced with this scenario, there is a concern that individuals with mild symptoms may spread the virus more easily due to not seeking medical attention [70] .", [["mild symptoms", "PROBLEM", 67, 80], ["the virus", "PROBLEM", 92, 101]]], ["In addition, another factor of concern regarding the high rate of spread of the virus is related to the recent transmission of the virus in asymptomatic individuals in Germany [71] .", [["the virus", "PROBLEM", 76, 85], ["the virus", "PROBLEM", 127, 136]]], ["Additionally, the large number of SARS-CoV-2 cases suggests that this virus may have acquired the ability to undergo efficient human-tohuman transmission, including the ability to bind to human cells.", [["cells", "ANATOMY", 194, 199], ["SARS", "DISEASE", 34, 38], ["SARS-CoV-2", "ORGANISM", 34, 44], ["human", "ORGANISM", 127, 132], ["tohuman", "GENE_OR_GENE_PRODUCT", 133, 140], ["human", "ORGANISM", 188, 193], ["cells", "CELL", 194, 199], ["human cells", "CELL_TYPE", 188, 199], ["human", "SPECIES", 127, 132], ["human", "SPECIES", 188, 193], ["SARS-CoV", "SPECIES", 34, 42], ["human", "SPECIES", 127, 132], ["human", "SPECIES", 188, 193], ["this virus", "PROBLEM", 65, 75], ["large", "OBSERVATION_MODIFIER", 18, 23], ["number", "OBSERVATION_MODIFIER", 24, 30]]], ["It also suggests that the route of transmission of the virus is via saliva, directly or indirectly, even among patients without a cough or other respiratory symptoms, and shows how contagious SARS-CoV-2 is [10, 70, 72] .SARS-CoV-2: again a novel virus and now the CoV pandemicIn sum, with the efforts of scientists, professionals, and health authorities and the urgency to contain the COVID-19 pandemic, impressive results have been achieved in a short time.", [["respiratory", "ANATOMY", 145, 156], ["cough", "DISEASE", 130, 135], ["respiratory symptoms", "DISEASE", 145, 165], ["SARS", "DISEASE", 192, 196], ["SARS", "DISEASE", 220, 224], ["saliva", "ORGANISM_SUBSTANCE", 68, 74], ["patients", "ORGANISM", 111, 119], ["CoV", "ORGANISM", 264, 267], ["patients", "SPECIES", 111, 119], ["the virus", "PROBLEM", 51, 60], ["a cough", "PROBLEM", 128, 135], ["other respiratory symptoms", "PROBLEM", 139, 165], ["CoV", "TEST", 197, 200], ["a novel virus", "PROBLEM", 238, 251], ["the urgency", "PROBLEM", 358, 369], ["the COVID", "TEST", 381, 390], ["virus", "OBSERVATION", 55, 60]]], ["Among these results, the following stand out: the determination and availability to the public of several full-genome sequences of SARS-CoV-2 isolates from clinical specimens, and the efforts by the CDC of China and other institutions that are conducting drug screening for viral pneumonia and developing a vaccine for SARS-CoV-2 [73] [74] [75] [76] [77] .", [["specimens", "ANATOMY", 165, 174], ["viral pneumonia", "DISEASE", 274, 289], ["SARS", "DISEASE", 319, 323], ["SARS-CoV-2", "ORGANISM", 131, 141], ["[73] [74] [75] [76", "SIMPLE_CHEMICAL", 330, 348], ["SARS-CoV", "SPECIES", 131, 139], ["SARS-CoV", "SPECIES", 319, 327], ["SARS", "TEST", 131, 135], ["CoV", "TEST", 136, 139], ["clinical specimens", "TEST", 156, 174], ["drug screening", "TEST", 255, 269], ["viral pneumonia", "PROBLEM", 274, 289], ["a vaccine", "TREATMENT", 305, 314], ["CoV", "TEST", 324, 327], ["pneumonia", "OBSERVATION", 280, 289]]], ["Another factor that has given rise to hope of preventing, or containment, of the COVID-19 epidemic in China and South Korea concerns the rapid isolation of symptomatic individuals and those suspected of having the disease, including self-isolation of those with mild symptoms, in addition to the constant surveillance of people closest to suspected cases.", [["people", "ORGANISM", 321, 327], ["people", "SPECIES", 321, 327], ["the COVID", "TEST", 77, 86], ["symptomatic individuals", "PROBLEM", 156, 179], ["the disease", "PROBLEM", 210, 221], ["mild symptoms", "PROBLEM", 262, 275], ["disease", "OBSERVATION", 214, 221]]], ["In this context, South Korea has been a model in combating the spread of the dissemination SARS-CoV-2 infection because the country quickly stabilized its COVID-19 outbreak at the beginning of the spread of virus through widespread rigorous quarantine measures and the opening of drive-through up testing centers.", [["SARS-CoV-2 infection", "DISEASE", 91, 111], ["SARS-CoV-2", "ORGANISM", 91, 101], ["CoV-2", "SPECIES", 96, 101], ["SARS-CoV-2", "SPECIES", 91, 101], ["the dissemination SARS", "PROBLEM", 73, 95], ["CoV-2 infection", "PROBLEM", 96, 111], ["its COVID", "PROBLEM", 151, 160], ["virus", "PROBLEM", 207, 212], ["rigorous quarantine measures", "TREATMENT", 232, 260]]], ["The great challenge of containing the spread of SARS-CoV-2 requires the joint effort of people throughout the world and will involve the immediate application of WHO recommendations for basic preventive measures against the novel CoV and rapid and accurate diagnosis for containment and clinical management.", [["SARS", "DISEASE", 48, 52], ["SARS-CoV-2", "ORGANISM", 48, 58], ["people", "ORGANISM", 88, 94], ["CoV", "ORGANISM", 230, 233], ["people", "SPECIES", 88, 94], ["SARS-CoV", "SPECIES", 48, 56], ["CoV", "SPECIES", 230, 233], ["SARS", "PROBLEM", 48, 52], ["basic preventive measures", "TREATMENT", 186, 211], ["clinical management", "TREATMENT", 287, 306], ["great", "OBSERVATION_MODIFIER", 4, 9], ["joint", "ANATOMY", 72, 77]]], ["In addition, new advances in applied research involving the disease will be necessary to contain the acceleration of the COVID-19 pandemic.SARS-CoV-2: again a novel virus and now the CoV pandemicAuthor contributions Vivaldo G da Costa designed study.", [["SARS", "DISEASE", 139, 143], ["CoV", "ORGANISM", 183, 186], ["the disease", "PROBLEM", 56, 67], ["the COVID", "TEST", 117, 126], ["pandemic", "PROBLEM", 130, 138], ["a novel virus", "PROBLEM", 157, 170], ["new", "OBSERVATION_MODIFIER", 13, 16], ["disease", "OBSERVATION", 60, 67]]], ["All authors reviewed and approved the final version of the manuscript.SARS-CoV-2: again a novel virus and now the CoV pandemicFunding VGC was supported by scholarships from Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal (FAPDF) and Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior-Brasil (CAPES).", [["SARS", "DISEASE", 70, 74], ["CoV", "ORGANISM", 114, 117], ["CoV pandemicFunding VGC", "SPECIES", 114, 137], ["a novel virus", "PROBLEM", 88, 101]]], ["The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Compliance with ethical standardsConflict of interest All authors declare that they have no conflict of interest.Compliance with ethical standardsEthical approval This article does not contain any studies with research involving human participants and/or animals performed by any of the authors.Compliance with ethical standardsInformed consent None.", [["human", "ORGANISM", 354, 359], ["human", "SPECIES", 354, 359], ["participants", "SPECIES", 360, 372], ["human", "SPECIES", 354, 359], ["data collection", "TEST", 41, 56], ["analysis", "TEST", 61, 69], ["ethical standards", "TREATMENT", 141, 158], ["ethical standards", "TREATMENT", 254, 271], ["Ethical approval", "TREATMENT", 271, 287], ["ethical standards", "TREATMENT", 436, 453], ["no", "UNCERTAINTY", 16, 18]]]], "c9fd14bb30e75a26b15c72e67ec881d2200a95e5": [["INTRODUCTIONIn April 2009 a new strain of influenza virus, A/H1N1, commonly referred to as \"swine flu,\" began to spread in several countries around the world.", [["influenza virus", "DISEASE", 42, 57], ["swine flu", "DISEASE", 92, 101], ["influenza virus", "ORGANISM", 42, 57], ["A/H1N1", "ORGANISM", 59, 65], ["influenza virus", "SPECIES", 42, 57], ["swine flu", "SPECIES", 92, 101], ["influenza virus", "SPECIES", 42, 57], ["A/H1N1", "SPECIES", 59, 65], ["swine flu", "SPECIES", 92, 101], ["influenza virus", "PROBLEM", 42, 57], ["H1N1", "PROBLEM", 61, 65], ["influenza virus", "OBSERVATION", 42, 57]]], ["Evidence that this new strain could pass from human to human led the World Health Organization to quickly raise its pandemic alert level to phase 5, representing \"a strong signal that a pandemic is imminent and that the time to finalise the organisation, communication and implementation of the planned mitigation measures is short.\" 1 This was subsequently raised to phase 6, indicating that a full global pandemic was under way.", [["human", "ORGANISM", 46, 51], ["human", "ORGANISM", 55, 60], ["human", "SPECIES", 46, 51], ["human", "SPECIES", 55, 60], ["human", "SPECIES", 46, 51], ["human", "SPECIES", 55, 60], ["this new strain", "PROBLEM", 14, 29], ["the planned mitigation measures", "TREATMENT", 291, 322], ["a full global pandemic", "PROBLEM", 393, 415], ["pandemic", "OBSERVATION", 407, 415]]], ["Given the lack of any specific vaccine against swine flu, mitigation measures in the United Kingdom have so far focused on identifying, treating, and isolating people who have the disease and educating the public about the steps that individuals can take to reduce the risk of transmission.", [["swine flu", "DISEASE", 47, 56], ["people", "ORGANISM", 160, 166], ["individuals", "ORGANISM", 234, 245], ["swine", "SPECIES", 47, 52], ["people", "SPECIES", 160, 166], ["swine", "SPECIES", 47, 52], ["the disease", "PROBLEM", 176, 187]]], ["These recommendations include using tissues when sneezing, washing hands regularly with soap and water, and setting up a network of \"flu friends\" to provide mutual assistance should someone become ill.", [["tissues", "ANATOMY", 36, 43], ["tissues", "TISSUE", 36, 43], ["sneezing", "PROBLEM", 49, 57]]], ["2 3 Encouraging the public to undertake specific behaviours related to hygiene has proved useful in containing previous outbreaks of infectious disease.", [["infectious disease", "DISEASE", 133, 151], ["infectious disease", "PROBLEM", 133, 151], ["infectious", "OBSERVATION", 133, 143]]], ["Studies of how people responded to the outbreak of severe acute respiratory syndrome in 2002 suggest that perceptions or beliefs about an outbreak may be important in determining compliance with official advice.", [["acute respiratory syndrome", "DISEASE", 58, 84], ["people", "ORGANISM", 15, 21], ["people", "SPECIES", 15, 21], ["severe acute respiratory syndrome", "PROBLEM", 51, 84], ["severe", "OBSERVATION_MODIFIER", 51, 57], ["acute", "OBSERVATION_MODIFIER", 58, 63], ["respiratory syndrome", "OBSERVATION", 64, 84]]], ["In particular the literature on severe acute respiratory syndrome suggests that people may be more likely to comply with health related recommendations if they believe that the recommended behaviours are effective, 5 6 they perceive a high likelihood that they may be affected by the outbreak, [6] [7] [8] they perceive that the illness has severe consequences, 6 they believe that the illness is difficult to treat, 9 and they believe that the government is providing clear and sufficient information about the outbreak and can be trusted to control the spread of infection.", [["acute respiratory syndrome", "DISEASE", 39, 65], ["illness", "DISEASE", 329, 336], ["illness", "DISEASE", 386, 393], ["infection", "DISEASE", 565, 574], ["people", "ORGANISM", 80, 86], ["people", "SPECIES", 80, 86], ["severe acute respiratory syndrome", "PROBLEM", 32, 65], ["the illness", "PROBLEM", 382, 393], ["infection", "PROBLEM", 565, 574], ["severe", "OBSERVATION_MODIFIER", 32, 38], ["acute", "OBSERVATION_MODIFIER", 39, 44], ["respiratory syndrome", "OBSERVATION", 45, 65], ["infection", "OBSERVATION", 565, 574]]], ["7 In addition, higher levels of anxiety or worry may be associated with an increase in behaviour changes.", [["anxiety", "DISEASE", 32, 39], ["worry", "DISEASE", 43, 48], ["anxiety", "PROBLEM", 32, 39], ["an increase in behaviour changes", "PROBLEM", 72, 104], ["increase", "OBSERVATION_MODIFIER", 75, 83]]], ["5 10 In addition to these factors, two others may be relevant in determining whether people adopt precautionary behaviour in response to an outbreak.", [["people", "ORGANISM", 85, 91], ["people", "SPECIES", 85, 91]]], ["11 People may fail to heed official advice conveyed through the media if they believe that this is \"just another health scare.\"", [["People", "ORGANISM", 3, 9], ["People", "SPECIES", 3, 9]]], ["Secondly, many scientific uncertainties surround swine flu.", [["swine", "ORGANISM", 49, 54], ["swine", "SPECIES", 49, 54], ["swine flu", "SPECIES", 49, 58], ["swine", "OBSERVATION_MODIFIER", 49, 54], ["flu", "OBSERVATION", 55, 58]]], ["12 Such uncertainty may influence whether people undertake precautionary behaviours.", [["people", "ORGANISM", 42, 48], ["people", "SPECIES", 42, 48]]], ["13 Understanding the role of specific perceptions in motivating people to engage in precautionary behaviour may help health communicators to improve their messages about outbreaks of new infectious disease generally and swine flu specifically.INTRODUCTIONTo assess the associations between perceptions and anxiety about swine flu and behaviour change relating to swine flu we carried out a cross sectional telephone survey of a large, demographically representative sample of the population of England, Scotland, and Wales.", [["infectious disease", "DISEASE", 187, 205], ["anxiety", "DISEASE", 306, 313], ["people", "ORGANISM", 64, 70], ["swine", "ORGANISM", 363, 368], ["people", "SPECIES", 64, 70], ["swine", "SPECIES", 220, 225], ["swine", "SPECIES", 320, 325], ["swine", "SPECIES", 363, 368], ["swine flu", "SPECIES", 220, 229], ["swine", "SPECIES", 320, 325], ["swine flu", "SPECIES", 363, 372], ["new infectious disease", "PROBLEM", 183, 205], ["anxiety", "PROBLEM", 306, 313], ["swine flu", "PROBLEM", 320, 329], ["behaviour change", "PROBLEM", 334, 350], ["new", "OBSERVATION_MODIFIER", 183, 186], ["infectious", "OBSERVATION", 187, 197], ["large", "OBSERVATION_MODIFIER", 428, 433]]], ["This survey provided a snapshot of public concerns and behaviours at the start of the swine flu outbreak, during a period of scientific uncertainty about the risks posed by the virus.UK involvement in the swine flu outbreakIntense media reporting in the UK about the swine flu outbreak began on 25 April 2009 and peaked on 30 April after WHO raised its pandemic alert status to 5.", [["flu", "DISEASE", 273, 276], ["UK", "GENE_OR_GENE_PRODUCT", 183, 185], ["swine", "SPECIES", 205, 210], ["swine", "SPECIES", 267, 272], ["swine flu", "SPECIES", 86, 95], ["swine flu outbreak", "SPECIES", 205, 223], ["swine flu", "SPECIES", 267, 276], ["the swine flu outbreak", "PROBLEM", 82, 104], ["the virus", "PROBLEM", 173, 182]]], ["The first two cases of swine flu in the UK were confirmed on 27 April.", [["swine flu", "DISEASE", 23, 32], ["UK", "GENE_OR_GENE_PRODUCT", 40, 42], ["swine", "SPECIES", 23, 28], ["swine flu", "SPECIES", 23, 32]]], ["By 12 May, the date on which our data collection finished, 65 people in the UK had been confirmed as having swine flu and several schools had been closed as a precautionary measure.", [["people", "ORGANISM", 62, 68], ["people", "SPECIES", 62, 68], ["swine", "SPECIES", 108, 113], ["swine flu", "SPECIES", 108, 117]]], ["This included an information leaflet sent to every home in the country, which discussed, among other things, the nature of swine flu, what the government had done to prepare for a pandemic, and what individuals could do to protect themselves and others.", [["swine", "SPECIES", 123, 128], ["swine flu", "SPECIES", 123, 132], ["swine flu", "PROBLEM", 123, 132]]], ["3 On 11 June, after we had completed our data collection, WHO raised its pandemic alert status to phase 6.UK involvement in the swine flu outbreakCross sectional telephone survey Between 8 and 12 May Ipsos MORI carried out a telephone survey of 1000 residents of England, Scotland, and Wales, using random digit dialling.", [["UK", "GENE_OR_GENE_PRODUCT", 106, 108], ["swine", "SPECIES", 128, 133], ["swine flu outbreak", "SPECIES", 128, 146], ["our data collection", "TEST", 37, 56]]], ["This sample size provided us with a sample error of about plus or minus 3%.", [["sample", "ANATOMY", 5, 11], ["size", "OBSERVATION_MODIFIER", 12, 16]]], ["Proportional quota sampling was used to ensure that respondents were demographically representative of the general population, with quotas based on age, sex, work status, region, and social grade.", [["Proportional quota sampling", "TEST", 0, 27]]], ["To reduce selection bias, participants were initially informed that the survey related to \"issues currently facing the UK\" and were only informed that the real issue was swine flu after we had obtained verbal consent to proceed.", [["participants", "SPECIES", 26, 38], ["swine flu", "SPECIES", 170, 179]]], ["Respondents were required to be 18 years or older, to speak English, and to have heard of swine flu.BehavioursParticipants were asked nine questions about recent behaviours.", [["flu", "DISEASE", 96, 99], ["swine", "ORGANISM", 90, 95], ["swine", "SPECIES", 90, 95], ["swine flu", "SPECIES", 90, 99], ["swine flu", "PROBLEM", 90, 99]]], ["Three related to activities that had been recommended-namely, increased cleaning or disinfecting of surfaces, washing hands with soap and water more often than usual, and discussing with a friend or family member what to do if either person caught swine flu.", [["person", "SPECIES", 234, 240], ["swine", "SPECIES", 248, 253]]], ["Eight of the questions were phrased as \"Over the past four days, I have . . . because of swine flu.\"", [["swine flu", "DISEASE", 89, 98], ["swine", "SPECIES", 89, 94], ["swine flu", "SPECIES", 89, 98], ["swine flu", "PROBLEM", 89, 98], ["flu", "OBSERVATION", 95, 98]]], ["That does not include having a shower, a bath, or doing the washing up.\"BehavioursPerceived efficacy of behaviours Six items assessed whether participants believed that a specific action reduced their risk of catching swine flu, with possible response options being strongly agree (scored as 5), tend to agree (4), neither agree nor disagree (3), tend to disagree (2), or strongly disagree (1).", [["swine", "ORGANISM", 218, 223], ["participants", "SPECIES", 142, 154], ["swine", "SPECIES", 218, 223], ["swine flu", "SPECIES", 218, 227], ["catching swine flu", "PROBLEM", 209, 227]]], ["Table 2 gives the wording for these questions.AnxietyAnxiety was assessed using the six item version of the validated state trait anxiety inventory.", [["Anxiety", "DISEASE", 46, 53], ["anxiety", "DISEASE", 130, 137], ["AnxietyAnxiety", "PROBLEM", 46, 60], ["anxiety inventory", "PROBLEM", 130, 147]]], ["14 The preamble specified that respondents should answer with respect to how they had been feeling over the past four days in relation to swine flu.", [["swine", "ORGANISM", 138, 143], ["swine", "SPECIES", 138, 143], ["swine flu", "SPECIES", 138, 147]]], ["This scale provided scores of between 6 (least anxiety) and 24 (most anxiety).", [["anxiety", "DISEASE", 47, 54], ["anxiety", "DISEASE", 69, 76], ["This scale", "TEST", 0, 10]]], ["We categorised people who scored 12 or more as having anxiety about swine flu, and those who scored 18 or more as having high anxiety about swine flu.", [["anxiety", "DISEASE", 54, 61], ["swine flu", "DISEASE", 68, 77], ["anxiety", "DISEASE", 126, 133], ["swine flu", "DISEASE", 140, 149], ["people", "ORGANISM", 15, 21], ["people", "SPECIES", 15, 21], ["swine", "SPECIES", 68, 73], ["swine", "SPECIES", 140, 145], ["swine flu", "SPECIES", 68, 77], ["swine flu", "SPECIES", 140, 149], ["anxiety", "PROBLEM", 54, 61], ["high anxiety", "PROBLEM", 121, 133]]], ["15PerceptionsThirty nine items were used to assess key themes of how people perceived the swine flu outbreak.", [["flu", "DISEASE", 96, 99], ["people", "ORGANISM", 69, 75], ["swine", "ORGANISM", 90, 95], ["people", "SPECIES", 69, 75], ["swine", "SPECIES", 90, 95], ["swine flu", "SPECIES", 90, 99], ["the swine flu outbreak", "PROBLEM", 86, 108]]], ["Exploratory factor analysis using principal axis factoring and varimax rotation suggested that nine factors were present in the data.", [["Exploratory factor analysis", "TEST", 0, 27], ["varimax rotation", "TEST", 63, 79]]], ["Scores on these scales were calculated as the mean of the relevant items.", [["these scales", "TEST", 10, 22]]], ["Cronbach's \u03b1 scores of less than 0.6 for the remaining three factors prevented us from forming scales.", [["Cronbach's \u03b1 scores", "TEST", 0, 19]]], ["Instead we used the single item that we thought best summarised the factor in the analysis.", [["the analysis", "TEST", 78, 90]]], ["These related to uncertainty (\"I do not understand what is happening with this swine flu outbreak\"), control (\"I think that if I am careful, I can reduce my risk of catching swine flu\"), and lack of treatments (\"I think there is nothing that can be done to treat people with swine flu\").Personal and other variablesPersonal variables consisted of sex, age, working status, household income, children aged 0 to 4 in the household, educational level, ethnicity, and the presence of any chronic illness or disability diagnosed by a doctor.", [["swine flu", "DISEASE", 275, 284], ["chronic illness", "DISEASE", 484, 499], ["disability", "DISEASE", 503, 513], ["children", "ORGANISM", 391, 399], ["swine", "SPECIES", 174, 179], ["people", "SPECIES", 263, 269], ["swine", "SPECIES", 275, 280], ["children", "SPECIES", 391, 399]]], ["We also asked whether respondents had received the government's leaflet on swine flu and, if so, whether they had read it.", [["swine", "SPECIES", 75, 80], ["swine flu", "SPECIES", 75, 84]]], ["Analyses We calculated two primary outcomes; whether the participant had engaged in any of the six avoidance behaviours (table 1) and whether the participant had engaged in any of the three recommended behaviours (table 1) .", [["participant", "SPECIES", 57, 68], ["participant", "SPECIES", 146, 157]]], ["Binary logistic regressions were used to calculate the univariate associations between personal characteristics and the primary outcomes.", [["Binary logistic regressions", "PROBLEM", 0, 27]]], ["We used t tests to investigate the association between anxiety levels and the primary outcomes.", [["anxiety", "DISEASE", 55, 62], ["t tests", "TEST", 8, 15], ["anxiety levels", "PROBLEM", 55, 69]]], ["Two sets of binary logistic regressions were used to assess the univariate associations between perception variables and primary outcomes, and also the multivariate associations adjusting for significant personal variables and anxiety.", [["anxiety", "DISEASE", 227, 234], ["binary logistic regressions", "TREATMENT", 12, 39], ["significant personal variables", "PROBLEM", 192, 222], ["anxiety", "PROBLEM", 227, 234]]], ["We calculated t tests and odds ratios to assess whether receiving or reading the government's swine flu leaflet was associated with behaviour outcomes or anxiety.Personal and other variablesWeighting the data by age, sex, working status, region, and social grade did not alter the prevalence of any behaviour outcome by more than 1%.", [["anxiety", "DISEASE", 154, 161], ["swine", "ORGANISM", 94, 99], ["swine", "SPECIES", 94, 99], ["t tests", "TEST", 14, 21], ["odds ratios", "TEST", 26, 37], ["behaviour outcomes", "PROBLEM", 132, 150], ["anxiety", "PROBLEM", 154, 161]]], ["We therefore carried out analyses using unweighted data.RESULTSOverall, 14 297 potential respondents were contacted.", [["unweighted data", "TEST", 40, 55]]], ["Of the remainder, 93 were ineligible to participate (including 37 who reported that they had not heard of swine flu) and 55 were out of quota, leaving 1000 eligible people who were interviewed.", [["people", "ORGANISM", 165, 171], ["swine", "SPECIES", 106, 111], ["people", "SPECIES", 165, 171], ["swine flu", "SPECIES", 106, 115]]], ["Of these, three reported that they or a family member had been advised to take antiviral drugs because of exposure to swine flu and were therefore excluded from analyses.RESULTSBehaviour outcomes, anxiety, and perceived efficacy of behaviours Table 1 lists the behaviour changes reported in response to the swine flu outbreak.", [["anxiety", "DISEASE", 197, 204], ["swine", "ORGANISM", 118, 123], ["swine", "SPECIES", 118, 123], ["swine", "SPECIES", 307, 312], ["swine flu", "SPECIES", 118, 127], ["swine flu", "SPECIES", 307, 316], ["antiviral drugs", "TREATMENT", 79, 94], ["swine flu", "PROBLEM", 118, 127], ["anxiety", "PROBLEM", 197, 204], ["the behaviour changes", "PROBLEM", 257, 278], ["the swine flu outbreak", "PROBLEM", 303, 325]]], ["Forty nine people (4.9%) reported engaging in one or other form of avoidance behaviour, whereas 377 (37.8%) said that they had carried out one or more of the three recommended behaviours.", [["people", "ORGANISM", 11, 17], ["people", "SPECIES", 11, 17]]], ["In total, 237 (23.8%) scored 12 or more on the six item state trait anxiety inventory, suggesting anxiety about swine flu.", [["anxiety", "DISEASE", 68, 75], ["anxiety", "DISEASE", 98, 105], ["swine flu", "DISEASE", 112, 121], ["swine", "SPECIES", 112, 117], ["swine flu", "SPECIES", 112, 121], ["trait anxiety inventory", "PROBLEM", 62, 85], ["anxiety", "PROBLEM", 98, 105], ["swine flu", "PROBLEM", 112, 121]]], ["Of these, 21 (2.1%) scored 18 or more, suggesting high anxiety.", [["anxiety", "DISEASE", 55, 62], ["high anxiety", "PROBLEM", 50, 62], ["high", "OBSERVATION_MODIFIER", 50, 54], ["anxiety", "OBSERVATION", 55, 62]]], ["Women, people aged 18 to 24, and parents of young children were significantly more likely to follow recommended behaviours.", [["Women", "ORGANISM", 0, 5], ["people", "ORGANISM", 7, 13], ["children", "ORGANISM", 50, 58], ["Women", "SPECIES", 0, 5], ["people", "SPECIES", 7, 13], ["children", "SPECIES", 50, 58]]], ["Participants who were not employed, were poor, had an annual household income of less than \u00a330 000, or had no educational qualifications were significantly more likely to adopt avoidance behaviours.", [["Participants", "SPECIES", 0, 12]]], ["The largest effects were for participants from non-white ethnic backgrounds, who were significantly more likely than white participants to adopt both recommended behaviours (odds ratio 3.2, 95% confidence interval 2.0 to 5.3) and avoidance behaviours (4.1, 2.0 to 8.4).", [["participants", "SPECIES", 29, 41], ["participants", "SPECIES", 123, 135], ["ratio", "TEST", 179, 184], ["avoidance behaviours", "TEST", 230, 250], ["largest", "OBSERVATION_MODIFIER", 4, 11]]], ["Further analyses showed that ethnicity remained a significant predictor for recommended behaviours (2.6, 1.4 to 4.7) and avoidance behaviours (4.9, 1.8 to 13.1) even after adjusting for age, sex, education, young children in the household, income, and working status.Association between anxiety and behaviourParticipants who had carried out one or more recommended behaviours had significantly higher levels of anxiety than participants who had not (mean difference 1.7, 95% confidence interval 1.3 to 2.1, t=8.5, df=995, P<0.001).", [["anxiety", "DISEASE", 287, 294], ["anxiety", "DISEASE", 411, 418], ["children", "ORGANISM", 213, 221], ["children", "SPECIES", 213, 221], ["participants", "SPECIES", 424, 436], ["Further analyses", "TEST", 0, 16], ["avoidance behaviours", "TEST", 121, 141], ["anxiety", "PROBLEM", 287, 294], ["anxiety", "PROBLEM", 411, 418], ["interval", "TEST", 486, 494], ["t", "TEST", 507, 508]]], ["Similarly, participants who had carried out one or more avoidance behaviours had significantly higher levels of anxiety than those who had not (2.6, 1.7 to 3.5, t=5.8, df=995, P<0.001).", [["anxiety", "DISEASE", 112, 119], ["participants", "SPECIES", 11, 23], ["anxiety", "PROBLEM", 112, 119], ["t", "TEST", 161, 162]]], ["Table 4 shows the mean scores for the perception factors and the univariate and multivariate associations between perceptions and behaviour change.", [["the perception factors", "PROBLEM", 34, 56], ["behaviour change", "PROBLEM", 130, 146]]], ["Adjusting for all significant personal variables in table 3 and for anxiety, all perceptions apart from those relating to the availability of treatments for swine flu were associated with carrying out one or more recommended behaviours.", [["anxiety", "DISEASE", 68, 75], ["swine flu", "DISEASE", 157, 166], ["swine", "ORGANISM", 157, 162], ["swine", "SPECIES", 157, 162], ["swine flu", "SPECIES", 157, 166], ["anxiety", "PROBLEM", 68, 75], ["treatments", "TREATMENT", 142, 152], ["swine flu", "PROBLEM", 157, 166]]], ["Although perceptions relating to likelihood, severity, exaggeration, timeline, and uncertainty also showed significant univariate associations with carrying out one or more avoidance behaviours, only likelihood and severity remained significant after adjusting for personal variables and anxiety.Association between perceptions and behaviourPerceived efficacy of specific behaviours as a predictor of behaviour change Binary logistic regressions showed significant univariate associations between perceived efficacy of reducing the number of people met in a day and adopting one or more avoidance behaviours (odds ratio 1.8, 95% confidence interval:1.4 to 2.3), perceived efficacy of avoiding public transport and reducing the amount of public transport used (2.2, 1.4 to 3.5), perceived efficacy of cleaning or disinfecting things that might be touched and increasing the amount of cleaning or disinfection of things (2.2, 1.7 to 2.8), and perceived efficacy of washing hands regularly with soap and water and actually washing hands more regularly (1.8, 1.5 to 2.2).Association between perceptions and behaviourAlthough the strength of these associations was reduced by adjusting for age, sex, working status, household income, educational level, ethnicity, young children in the house, and anxiety, all four remained significant.Effects of the leaflet on behaviours and anxietyAt the time of the survey, 392 participants said that they had received the government's leaflet about swine flu (39.3%), and 255 (25.6%) said they had read it.", [["anxiety", "DISEASE", 288, 295], ["anxiety", "DISEASE", 1292, 1299], ["anxiety", "DISEASE", 1372, 1379], ["people", "ORGANISM", 542, 548], ["children", "ORGANISM", 1265, 1273], ["participants", "ORGANISM", 1410, 1422], ["people", "SPECIES", 542, 548], ["children", "SPECIES", 1265, 1273], ["participants", "SPECIES", 1410, 1422], ["swine", "SPECIES", 1482, 1487], ["swine flu", "SPECIES", 1482, 1491], ["severity", "PROBLEM", 45, 53], ["exaggeration", "PROBLEM", 55, 67], ["anxiety", "PROBLEM", 288, 295], ["public transport", "TREATMENT", 693, 709], ["public transport", "TREATMENT", 737, 753], ["cleaning", "TREATMENT", 800, 808], ["disinfecting things", "TREATMENT", 812, 831], ["anxiety", "PROBLEM", 1292, 1299], ["anxiety", "PROBLEM", 1372, 1379], ["swine flu", "TEST", 1482, 1491], ["amount", "OBSERVATION_MODIFIER", 873, 879], ["leaflet", "OBSERVATION_MODIFIER", 1346, 1353]]], ["No significant differences were found between participants who had or had not received the leaflet in terms of anxiety (mean difference \u22120.3, 95% confidence interval \u22120.7 to 0.08, t=1.6, df=995, P=0.12), whether they had adopted one or more of the recommended behaviours (odds ratio 0.9, 95% confidence interval 0.7 to 1.2), or whether they had adopted one or more of the avoidance behaviours (0.5, 0.3 to 1.0).", [["anxiety", "DISEASE", 111, 118], ["participants", "SPECIES", 46, 58], ["anxiety", "PROBLEM", 111, 118], ["t", "TEST", 180, 181], ["df", "TEST", 187, 189], ["P", "TEST", 195, 196], ["odds ratio", "TEST", 272, 282], ["significant", "OBSERVATION_MODIFIER", 3, 14]]], ["Comparing participants who had read the leaflet with those who had not did not alter the results for the behaviour outcomes.", [["participants", "SPECIES", 10, 22]]], ["Participants who had read the leaflet were, however, significantly less anxious than the combined group who had either not read the leaflet or not received it (mean difference \u22120.5, 95% confidence interval \u22120.9 to \u22120.05, t=2.2, df=995, P=0.03).DISCUSSIONOur results suggest that less than two weeks after WHO responded to the swine flu outbreak by raising its pandemic alert status to 5 and in the face of intense media coverage and a major government advertising campaign, public responses to swine flu were muted.", [["flu", "DISEASE", 332, 335], ["swine", "ORGANISM", 494, 499], ["Participants", "SPECIES", 0, 12], ["swine", "SPECIES", 326, 331], ["swine", "SPECIES", 494, 499], ["swine flu", "SPECIES", 326, 335], ["swine flu", "SPECIES", 494, 503], ["significantly less anxious", "PROBLEM", 53, 79], ["interval", "TEST", 197, 205], ["t", "TEST", 221, 222], ["df", "TEST", 228, 230], ["P", "TEST", 236, 237], ["the swine flu outbreak", "PROBLEM", 322, 344], ["intense media coverage", "TREATMENT", 406, 428]]], ["Anxiety about the outbreak was low, with only 24% of participants reporting any anxiety and only 2% reporting high anxiety.", [["Anxiety", "DISEASE", 0, 7], ["anxiety", "DISEASE", 80, 87], ["anxiety", "DISEASE", 115, 122], ["participants", "SPECIES", 53, 65], ["Anxiety", "PROBLEM", 0, 7], ["any anxiety", "PROBLEM", 76, 87], ["high anxiety", "PROBLEM", 110, 122]]], ["Behaviour changes were also limited.", [["Behaviour changes", "PROBLEM", 0, 17]]], ["Most people reported that they had not changed the frequency of their hand washing (72%), increased the amount that they cleaned or disinfected things (83%), or discussed plans with a \"flu friend\" (85%).", [["hand", "ANATOMY", 70, 74], ["people", "ORGANISM", 5, 11], ["hand", "ORGANISM_SUBDIVISION", 70, 74], ["people", "SPECIES", 5, 11]]], ["In fact most people (62%) had done none of these things.", [["people", "ORGANISM", 13, 19], ["people", "SPECIES", 13, 19]]], ["There was also little evidence that people were using behaviours with potentially damaging social or economic implications, 16 with fewer than 5% reporting that they had avoided people or places as a result of the outbreak.", [["people", "ORGANISM", 36, 42], ["people", "ORGANISM", 178, 184], ["people", "SPECIES", 36, 42], ["people", "SPECIES", 178, 184]]], ["These results add to an extensive body of work that rebuts any suggestion that the public's first response when faced with a novel threat is to over-react or panic.", [["panic", "DISEASE", 158, 163], ["panic", "PROBLEM", 158, 163]]], ["As might be expected, 6-8 18 believing that there is currently a high risk of catching swine flu and that catching it will have severe consequences were both associated with behaviour change.", [["swine", "SPECIES", 87, 92], ["swine flu", "SPECIES", 87, 96], ["catching swine flu", "PROBLEM", 78, 96], ["severe consequences", "PROBLEM", 128, 147]]], ["The importance of reducing uncertainty and providing clear information has been suggested before 11 19 and although most accounts have focused on this as a way of reducing anxiety, these factors can also affect behavioural responses during major incidents.", [["anxiety", "DISEASE", 172, 179], ["reducing anxiety", "PROBLEM", 163, 179]]], ["20 In this study the mean scores of scales for \"good information\" and \"uncertainty\" suggested that public health communicators had some success in preventing confusion and in conveying a consistent set of comprehensible messages, which in turn seem to have increased rates of recommended behaviour change.The role of perceptionsInforming the public about a potential health risk is never free of context.", [["confusion", "DISEASE", 158, 167], ["this study", "TEST", 6, 16], ["confusion", "PROBLEM", 158, 167]]], ["Previous warnings or alerts that have seemingly come to nothing may determine how people perceive the present situation.", [["people", "ORGANISM", 82, 88], ["people", "SPECIES", 82, 88]]], ["11 17 The high mean score on our exaggeration scale suggests that this may have been the case in the early stages of the swine flu outbreak.", [["flu", "DISEASE", 127, 130], ["swine", "ORGANISM", 121, 126], ["swine", "SPECIES", 121, 126], ["swine flu", "SPECIES", 121, 130], ["The high mean score", "PROBLEM", 6, 25], ["our exaggeration scale", "TEST", 29, 51], ["the swine flu outbreak", "PROBLEM", 117, 139], ["high", "OBSERVATION_MODIFIER", 10, 14], ["mean", "OBSERVATION_MODIFIER", 15, 19], ["swine", "OBSERVATION_MODIFIER", 121, 126], ["flu", "OBSERVATION", 127, 130]]], ["As might be expected, the perception that the incident had been hyped up was associated with a lower likelihood of behaviour change.", [["behaviour change", "PROBLEM", 115, 131], ["behaviour", "OBSERVATION", 115, 124]]], ["21 It is therefore unsurprising that 68% of our respondents agreed with one item in our exaggeration scale, \"I think that the media have over-exaggerated the risks of catching swine flu.\"", [["flu", "DISEASE", 182, 185], ["swine", "SPECIES", 176, 181]]], ["A more encouraging finding was that the authorities still received a relatively high score for trust (mean score 3.9 of 5).", [["mean score", "TEST", 102, 112]]], ["Our finding that participants with higher trust in the government and the responding agencies were more likely to follow their recommendations seems logical and corresponds with evidence of a similar relation during the severe acute respiratory syndrome outbreak.", [["acute respiratory syndrome", "DISEASE", 227, 253], ["participants", "SPECIES", 17, 29], ["the severe acute respiratory syndrome outbreak", "PROBLEM", 216, 262], ["severe", "OBSERVATION_MODIFIER", 220, 226], ["acute", "OBSERVATION_MODIFIER", 227, 232], ["respiratory syndrome", "OBSERVATION", 233, 253]]], ["7 Finally, most of our sample agreed that if they were careful they could reduce their risk of catching swine flu.", [["swine", "SPECIES", 104, 109], ["swine flu", "SPECIES", 104, 113], ["catching swine flu", "PROBLEM", 95, 113]]], ["This perception was associated with an increased probability of taking action.", [["increased", "OBSERVATION_MODIFIER", 39, 48]]], ["Fatalistic assumptions that \"there is nothing you can do\" have been observed in some people during previous incidents 22 but did not pose a major problem in this instance.", [["people", "ORGANISM", 85, 91], ["people", "SPECIES", 85, 91]]], ["More specific perceptions as to which particular actions are effective in reducing the risk revealed an interesting pattern.", [["interesting pattern", "OBSERVATION", 104, 123]]], ["Whereas over 80% of participants believed that the hygiene measures recommended by the government were effective, around half of respondents also believed the same about avoiding other people or public transport.", [["participants", "ORGANISM", 20, 32], ["people", "ORGANISM", 185, 191], ["participants", "SPECIES", 20, 32], ["people", "SPECIES", 185, 191], ["the hygiene measures", "TREATMENT", 47, 67]]], ["Similar effects to those reported here have been observed for sex, 5 6 10 parental status, 20 and low socioeconomic status, 23 although the effect of age, with younger adults being more likely to take action, is contrary to the effect observed in several studies on severe acute respiratory syndrome.", [["acute respiratory syndrome", "DISEASE", 273, 299], ["severe acute respiratory syndrome", "PROBLEM", 266, 299], ["severe", "OBSERVATION_MODIFIER", 266, 272], ["acute", "OBSERVATION_MODIFIER", 273, 278], ["respiratory syndrome", "OBSERVATION", 279, 299]]], ["5-7 10 Of most interest was the association between ethnicity and behaviour change, an association that was apparent even after adjusting for socioeconomic variables.", [["behaviour change", "PROBLEM", 66, 82], ["socioeconomic variables", "PROBLEM", 142, 165]]], ["We did not have enough participants from ethnic minorities to carry out subgroup analyses and to identify which, if any, ethnic groups were reacting most to the outbreak.", [["participants", "SPECIES", 23, 35], ["subgroup analyses", "TEST", 72, 89]]], ["Previous research has found that worry and avoidance behaviours relating to terrorism are more common among minority groups in general than in white respondents, suggesting that this effect may be due to shared perceptions of vulnerability or low levels of control.", [["worry and avoidance behaviours", "DISEASE", 33, 63], ["terrorism", "PROBLEM", 76, 85], ["vulnerability", "PROBLEM", 226, 239], ["low levels of control", "PROBLEM", 243, 264], ["low levels", "OBSERVATION_MODIFIER", 243, 253]]], ["24 More research on the causes of this phenomenon is required.The role of perceptionsThe impact of the swine flu leaflet Our results suggest that the government's swine flu leaflet had limited if any impact on behaviour change, although reading the leaflet was associated with lower anxiety.", [["anxiety", "DISEASE", 283, 290], ["swine", "SPECIES", 103, 108], ["swine", "SPECIES", 163, 168], ["swine flu", "SPECIES", 103, 112], ["this phenomenon", "PROBLEM", 34, 49], ["the swine flu leaflet", "TREATMENT", 99, 120], ["the government's swine flu leaflet", "TREATMENT", 146, 180], ["lower anxiety", "PROBLEM", 277, 290]]], ["These analyses do not imply that the information in the leaflet was ineffective: it might be that the widespread media campaign that preceded delivery of the leaflet meant that the public was already well informed about swine flu by the time of our survey.", [["swine", "SPECIES", 220, 225], ["swine flu", "SPECIES", 220, 229], ["These analyses", "TEST", 0, 14]]], ["At the same time the effects of the leaflet on the use of tissues or on health behaviours among people with flulike symptoms was not assessed in this study.", [["tissues", "ANATOMY", 58, 65], ["tissues", "TISSUE", 58, 65], ["people", "ORGANISM", 96, 102], ["people", "SPECIES", 96, 102], ["flulike symptoms", "PROBLEM", 108, 124], ["this study", "TEST", 145, 155], ["leaflet", "OBSERVATION_MODIFIER", 36, 43]]], ["Finally, we were only able to assess the effects of the leaflet during a period of relatively low swine flu transmission in the UK.Methodological issuesInvestigating public perceptions in the immediate aftermath of a major incident presents several challenges.", [["flu", "DISEASE", 104, 107], ["swine flu", "SPECIES", 98, 107], ["Methodological issues", "PROBLEM", 131, 152]]], ["25 Ideally, a randomly selected sample of the public should be interviewed, with efforts made to ensure a good response rate and comparisons made with the known distribution of key variables in the population to assess the presence of non-response bias.", [["non-response bias", "PROBLEM", 235, 252], ["non-response bias", "OBSERVATION", 235, 252]]], ["25 Because speed was important, we elected to use random digit dialling with quota sampling so that the demographic distribution of our sample matched that of the population of England, Scotland, and Wales.", [["random digit dialling", "TEST", 50, 71], ["quota sampling", "TEST", 77, 91]]], ["The low response rate (7%) may be of more concern, although as participants were not informed of the survey topic until consent had been obtained, any non-response bias on the basis of interest in the topic should have been minimal.", [["participants", "SPECIES", 63, 75], ["The low response rate", "TEST", 0, 21], ["low response", "OBSERVATION_MODIFIER", 4, 16], ["minimal", "OBSERVATION_MODIFIER", 224, 231]]], ["Aside from design issues, another issue with our study was the choice of primary outcome measure.", [["design issues", "PROBLEM", 11, 24], ["our study", "TEST", 45, 54]]], ["Behaviour change is not the same as compliance with official advice.", [["Behaviour change", "PROBLEM", 0, 16]]], ["For example, some people who reported not increasing their hand washing none the less may have complied with advice to wash hands \"often,\" 3 whereas others who did increase their hand washing may still have fallen short of the optimal frequency.", [["hand", "ANATOMY", 59, 63], ["hand", "ANATOMY", 179, 183], ["people", "ORGANISM", 18, 24], ["hand", "ORGANISM_SUBDIVISION", 59, 63], ["hand", "ORGANISM_SUBDIVISION", 179, 183], ["people", "SPECIES", 18, 24]]], ["However, while such data are of importance to disease modellers and policy makers, from the perspective of assessing public responses to an incident, behaviour change is the key indicator to consider.", [["behaviour change", "PROBLEM", 150, 166]]], ["Compliance by default among people who frequently wash their hands is of lesser interest.Methodological issuesOur selection of behaviour outcome measures deliberately avoided two of the key factors communicated to the public during the outbreak: the use of tissues when sneezing and what to do if flu-like symptoms develop.", [["tissues", "ANATOMY", 257, 264], ["flu", "DISEASE", 297, 300], ["people", "ORGANISM", 28, 34], ["tissues", "TISSUE", 257, 264], ["people", "SPECIES", 28, 34], ["behaviour outcome measures", "TREATMENT", 127, 153], ["sneezing", "PROBLEM", 270, 278], ["flu", "PROBLEM", 297, 300], ["symptoms", "PROBLEM", 306, 314]]], ["Given our sample size and the prevalence of flu at the time of the survey, we were unable to assess the set of behaviours regarding flu-like symptoms.", [["flu", "DISEASE", 132, 135], ["flu", "PROBLEM", 44, 47], ["flu-like symptoms", "PROBLEM", 132, 149], ["size", "OBSERVATION_MODIFIER", 17, 21], ["flu", "OBSERVATION", 44, 47]]], ["Use of tissues was not included as this is important for the protection of others rather than oneself and hence may be qualitatively different in terms of its relation with predictor variables.Methodological issuesA caveat is also required about the perception scales that we used.", [["tissues", "ANATOMY", 7, 14], ["tissues", "TISSUE", 7, 14]]], ["Although the items incorporated in these scales had face validity, clustered appropriately during factor analysis, and produced adequate internal reliability their psychometric properties have yet to be determined fully.", [["face validity", "PROBLEM", 52, 65], ["factor analysis", "TEST", 98, 113]]], ["Further studies to expand and refine these scales and to test their properties in different situations are ongoing.Methodological issuesFinally, the cross sectional nature of our data means that we may have underestimated the strength of the associations between some risk factors and behaviour change.", [["Further studies", "TEST", 0, 15], ["these scales", "TEST", 37, 49], ["Methodological issuesFinally", "PROBLEM", 115, 143], ["some risk factors", "PROBLEM", 263, 280], ["behaviour change", "PROBLEM", 285, 301]]], ["For example, engaging in precautionary behaviours may serve to reduce anxiety or reduce someone's perceived risk of catching swine flu.", [["anxiety", "DISEASE", 70, 77], ["swine", "ORGANISM", 125, 130], ["swine", "SPECIES", 125, 130], ["swine flu", "SPECIES", 125, 134], ["anxiety", "PROBLEM", 70, 77], ["catching swine flu", "PROBLEM", 116, 134]]], ["For other analyses we may have overestimated the strength of associations.", [["other analyses", "TEST", 4, 18]]], ["For example, successful behaviour change may increase someone's belief that they have control over the risk, artificially inflating our estimate of this effect.ConclusionsEarly epidemiological assessments suggest that the transmissibility of swine flu is at the lower end of estimates obtained for previous pandemics, whereas its case fatality ratio is comparable to that reported in the 1958 pandemic.", [["swine flu", "DISEASE", 242, 251], ["swine", "ORGANISM", 242, 247], ["swine", "SPECIES", 242, 247], ["swine flu", "SPECIES", 242, 251], ["successful behaviour change", "PROBLEM", 13, 40], ["Early epidemiological assessments", "TEST", 171, 204], ["swine flu", "PROBLEM", 242, 251], ["previous pandemics", "PROBLEM", 298, 316]]], ["12 However, it remains possible that evolution of the virus or seasonal effects might alter both its transmissibility and its severity in the coming months.", [["the virus", "PROBLEM", 50, 59], ["seasonal effects", "PROBLEM", 63, 79], ["virus", "OBSERVATION", 54, 59]]], ["12 Should swine flu develop into a more serious public health problem, then understanding what factors are associated with adaptive behaviour changes among the general public may help communicators to devise more effective public health messages.", [["swine", "SPECIES", 10, 15]]], ["Equally, understanding how the public responds to reports of a potential pandemic may also be useful in identifying ways of encouraging behaviour change during the early stages of any future outbreak of infectious disease.ConclusionsOur results largely endorse the current policy of providing the public with clear, consistent information, which focuses on the practical things that people can do to reduce their risk and which maintains trust by explicitly discussing the current level of knowledge, preparation, and resources available to tackle the outbreak.", [["infectious disease", "DISEASE", 203, 221], ["people", "ORGANISM", 383, 389], ["people", "SPECIES", 383, 389], ["infectious disease", "PROBLEM", 203, 221], ["infectious", "OBSERVATION", 203, 213]]], ["If the present swine flu outbreak does not result in high levels of morbidity, however, it is likely that the current response will be seen by some as yet another example of scientists and media \"crying wolf.\"", [["swine", "ORGANISM", 15, 20], ["swine", "SPECIES", 15, 20], ["swine flu", "SPECIES", 15, 24], ["the present swine flu outbreak", "PROBLEM", 3, 33], ["high levels of morbidity", "PROBLEM", 53, 77]]], ["Finally, the large differences between ethnic groups in terms of behaviour change were of interest.", [["large", "OBSERVATION_MODIFIER", 13, 18], ["differences", "OBSERVATION_MODIFIER", 19, 30]]], ["Further research to confirm and explore these differences is required.WHAT IS ALREADY KNOWN ON THIS TOPICEncouraging people to adopt specific behaviours such as hand washing may help to reduce any effects of an influenza pandemic During the outbreak of severe acute respiratory syndrome, evidence suggested that specific perceptions of the outbreak were associated with people's willingness to make these changes to their behaviourWHAT THIS STUDY ADDSIn the early stages of the swine flu outbreak, relatively few people made recommended changes to their behaviour, despite widespread advertising and media coverage Factors associated with an increased likelihood of making these changes included perceptions that swine flu is severe, the risk of catching it is high, the outbreak will continue for a long time, the authorities can be trusted, and people can control their risk Being uncertain about the outbreak and believing that it had been exaggerated were associated with a lower likelihood of change", [["hand", "ANATOMY", 161, 165], ["influenza pandemic", "DISEASE", 211, 229], ["acute respiratory syndrome", "DISEASE", 260, 286], ["swine flu", "DISEASE", 478, 487], ["swine flu", "DISEASE", 713, 722], ["people", "ORGANISM", 117, 123], ["hand", "ORGANISM_SUBDIVISION", 161, 165], ["people", "ORGANISM", 370, 376], ["swine", "ORGANISM", 478, 483], ["people", "ORGANISM", 513, 519], ["swine", "ORGANISM", 713, 718], ["people", "ORGANISM", 847, 853], ["people", "SPECIES", 117, 123], ["people", "SPECIES", 370, 376], ["swine", "SPECIES", 478, 483], ["people", "SPECIES", 513, 519], ["swine", "SPECIES", 713, 718], ["people", "SPECIES", 847, 853], ["swine flu", "SPECIES", 478, 487], ["swine flu", "SPECIES", 713, 722], ["Further research", "TEST", 0, 16], ["THIS TOPICEncouraging people", "TREATMENT", 95, 123], ["hand washing", "TREATMENT", 161, 173], ["an influenza pandemic", "PROBLEM", 208, 229], ["severe acute respiratory syndrome", "PROBLEM", 253, 286], ["the swine flu outbreak", "PROBLEM", 474, 496], ["media coverage", "TREATMENT", 600, 614], ["severe", "OBSERVATION_MODIFIER", 253, 259], ["acute", "OBSERVATION_MODIFIER", 260, 265], ["respiratory syndrome", "OBSERVATION", 266, 286], ["increased", "OBSERVATION_MODIFIER", 642, 651]]]], "7f4c577cd33f6a4481619564c8c5c82bf9d5d52d": [["1 that a new model of public health reasoning must draw on epistemic and logical concepts that are more typically discussed in philosophy.", [["new", "OBSERVATION_MODIFIER", 9, 12]]], ["These features, which include defeasibility and context sensitivity, are integral to the use of this concept in contexts of uncertainty.", [["defeasibility and context sensitivity", "PROBLEM", 30, 67]]], ["One such context is public health where deliberations are typically conducted under sub-optimal epistemic conditions.", [["epistemic conditions", "OBSERVATION", 96, 116]]], ["The largely negative characterizations of these arguments that have dominated the logical literature to date belie the demonstrable gains that accrue from their use in certain epistemic contexts.", [["negative", "OBSERVATION", 12, 20]]], ["The logical and epistemic features of several of the major informal fallacies will be considered and illustrated in the context of specific public health problems.The Concept of PresumptionPresumption has often been treated as the poor cousin of knowledge in epistemological discussion.", [["epistemic", "OBSERVATION_MODIFIER", 16, 25], ["several", "OBSERVATION_MODIFIER", 38, 45]]], ["Notwithstanding the limited treatment of presumption to date, it seems clear that little progress can be made on a new model of public health reasoning in the absence of a comprehensive analysis of this concept.", [["a comprehensive analysis", "TEST", 170, 194]]], ["These features of presumption include its defeasibility, rational justification, context sensitivity, epistemic status and orientation to action.", [["its defeasibility", "PROBLEM", 38, 55], ["context sensitivity", "TEST", 81, 100]]], ["However, even in public health, presumptions can be shielded from contrary evidence, often with disastrous consequences for human health.Presumptions Are DefeasibleJust such a scenario occurred during the BSE epidemic in the UK.", [["human", "ORGANISM", 124, 129], ["UK", "GENE_OR_GENE_PRODUCT", 225, 227], ["human", "SPECIES", 124, 129], ["human", "SPECIES", 124, 129]]], ["During this epidemic, an analogy between BSE in cattle and scrapie in sheep was used extensively by scientists in their risk assessments of this new bovine disease.", [["BSE", "DISEASE", 41, 44], ["bovine disease", "DISEASE", 149, 163], ["cattle", "ORGANISM", 48, 54], ["sheep", "ORGANISM", 70, 75], ["bovine", "ORGANISM", 149, 155], ["cattle", "SPECIES", 48, 54], ["sheep", "SPECIES", 70, 75], ["bovine", "SPECIES", 149, 155], ["cattle", "SPECIES", 48, 54], ["scrapie", "SPECIES", 59, 66], ["sheep", "SPECIES", 70, 75], ["bovine", "SPECIES", 149, 155], ["this new bovine disease", "PROBLEM", 140, 163], ["new", "OBSERVATION_MODIFIER", 145, 148], ["bovine disease", "OBSERVATION", 149, 163]]], ["However, this analogy was based on some rather tenuous evidence which emerged from early epidemiological investigations and molecular and histopathological studies (Cummings 2010).", [["early epidemiological investigations", "TEST", 83, 119], ["histopathological studies", "TEST", 138, 163]]], ["In the event, scientists and others continued to uphold this analogy even when it was clear that BSE differed from scrapie in significant respects (e.g. host range and pathogenesis).", [["scrapie", "DISEASE", 115, 122], ["scrapie", "SPECIES", 115, 122], ["scrapie", "PROBLEM", 115, 122], ["pathogenesis", "PROBLEM", 168, 180]]], ["A once productive analogy between BSE and scrapie led scientists to draw false conclusions about this new disease long before the first cases of transmission to humans were confirmed.", [["humans", "ORGANISM", 161, 167], ["humans", "SPECIES", 161, 167], ["scrapie", "SPECIES", 42, 49], ["humans", "SPECIES", 161, 167], ["this new disease", "PROBLEM", 97, 113]]], ["This significant failure in the public health of the UK could have been avoided had the analogy between BSE and scrapie remained a defeasible presumption in the thinking of scientists.Presumptions Are DefeasibleAlthough presumption is an epistemic concept, its defeasibility serves an important cognitive function.", [["BSE", "DISEASE", 104, 107], ["scrapie", "DISEASE", 112, 119], ["UK", "GENE_OR_GENE_PRODUCT", 53, 55], ["scrapie", "SPECIES", 112, 119], ["This significant failure", "PROBLEM", 0, 24], ["scrapie", "PROBLEM", 112, 119], ["significant", "OBSERVATION_MODIFIER", 5, 16], ["failure", "OBSERVATION", 17, 24]]], ["In terms of survival, it is in the interests of cognitive agents to have an accurate mental representation of their environment.", [["cognitive agents", "TREATMENT", 48, 64], ["survival", "OBSERVATION", 12, 20]]], ["In order for this to be achieved, agents must be able to overturn false claims or theses in favour of propositions which are a true representation of states of affairs in the world.", [["agents", "TREATMENT", 34, 40]]], ["The defeasibility of presumption enables cognitive agents to undertake this important function.", [["cognitive agents", "TREATMENT", 41, 57]]], ["In public health, scientists and lay people must continually revise their mental representations to accord with an environment which changes rapidly as new threats to human health emerge.", [["people", "ORGANISM", 37, 43], ["human", "ORGANISM", 167, 172], ["people", "SPECIES", 37, 43], ["human", "SPECIES", 167, 172], ["human", "SPECIES", 167, 172]]], ["Cognitive agents, which are well adapted to their environment, have developed rational strategies to address these threats.", [["Cognitive agents", "TREATMENT", 0, 16], ["rational strategies", "TREATMENT", 78, 97]]], ["Defeasible presumptions are one such strategy.", [["Defeasible presumptions", "PROBLEM", 0, 23]]], ["By facilitating the revision of mental representations, defeasible presumptions enable cognitive agents to respond to changing environmental conditions.", [["mental representations", "PROBLEM", 32, 54], ["defeasible presumptions", "PROBLEM", 56, 79], ["cognitive agents", "TREATMENT", 87, 103]]], ["Viewed this way, the defeasibility of presumptions is an important adaptation of the rational resources of cognitive agents to their environment.Presumptions Are Rationally JustifiedAlthough we only ever have a tentative commitment to presumption, that commitment must be rationally warranted.", [["cognitive agents", "TREATMENT", 107, 123]]], ["Moral and ethical considerations relating to the protection of human health warrant a presumption against the safety of new drugs and other medical interventions.", [["human", "ORGANISM", 63, 68], ["human", "SPECIES", 63, 68], ["human", "SPECIES", 63, 68], ["new drugs", "TREATMENT", 120, 129], ["other medical interventions", "TREATMENT", 134, 161]]], ["In terms of public health, presumptions may emerge from epidemiological investigations, experimental studies and systematic reviews.", [["epidemiological investigations", "TEST", 56, 86], ["experimental studies", "TEST", 88, 108], ["systematic reviews", "TEST", 113, 131]]], ["From wherever they hail, presumptions must exhibit the level of warrant that befits a particular domain, discipline or study.", [["discipline or study", "TEST", 105, 124]]], ["When Brown et al. (1987) concluded that there was no evidence that scrapie is transmissible to humans on the basis of a 15-year epidemiological study of scrapie and CJD in humans, and a review of world literature, the level of rational warrant attending that presumption was consonant with the robustness of the investigations that had produced it.Presumptions Are Rationally JustifiedHowever, difficulties arise in public health when a presumption is called upon to have a level of rational warrant that exceeds its evidential base.", [["scrapie", "DISEASE", 67, 74], ["scrapie", "DISEASE", 153, 160], ["CJD", "DISEASE", 165, 168], ["humans", "ORGANISM", 95, 101], ["humans", "ORGANISM", 172, 178], ["humans", "SPECIES", 95, 101], ["humans", "SPECIES", 172, 178], ["scrapie", "SPECIES", 67, 74], ["humans", "SPECIES", 95, 101], ["scrapie", "SPECIES", 153, 160], ["humans", "SPECIES", 172, 178], ["scrapie", "PROBLEM", 67, 74], ["scrapie", "PROBLEM", 153, 160], ["CJD", "PROBLEM", 165, 168], ["the investigations", "TEST", 308, 326], ["no evidence that", "UNCERTAINTY", 50, 66], ["scrapie", "OBSERVATION", 67, 74]]], ["The widespread view among scientists that BSE was bovine scrapie was based on a number of indirect lines of evidence, specifically an early epidemiological investigation conducted by the Central Veterinary Laboratory, and histopathological and molecular studies (Cummings 2010).", [["bovine", "ORGANISM", 50, 56], ["bovine", "SPECIES", 50, 56], ["scrapie", "SPECIES", 57, 64], ["bovine scrapie", "PROBLEM", 50, 64], ["molecular studies", "TEST", 244, 261], ["widespread", "OBSERVATION_MODIFIER", 4, 14], ["Central", "ANATOMY_MODIFIER", 187, 194]]], ["Direct evidence from strain-typing studies was not available to scientists when BSE first emerged in British cattle.", [["cattle", "ORGANISM", 109, 115], ["cattle", "SPECIES", 109, 115], ["BSE", "SPECIES", 80, 83], ["cattle", "SPECIES", 109, 115], ["strain-typing studies", "TEST", 21, 42]]], ["The lack of direct evidence in support of the claim that BSE is bovine scrapie required that scientists treat this claim as a weakly warranted presumption.", [["BSE", "DISEASE", 57, 60], ["bovine", "ORGANISM", 64, 70], ["bovine", "SPECIES", 64, 70], ["bovine scrapie", "PROBLEM", 64, 78], ["bovine scrapie", "OBSERVATION", 64, 78]]], ["Having exceeded the rational warrant of this claim, scientists began to use it extensively during risk assessments of this new bovine disease.", [["bovine disease", "DISEASE", 127, 141], ["bovine", "ORGANISM", 127, 133], ["bovine", "SPECIES", 127, 133], ["bovine", "SPECIES", 127, 133], ["risk assessments", "TEST", 98, 114], ["this new bovine disease", "PROBLEM", 118, 141], ["bovine disease", "OBSERVATION", 127, 141]]], ["That many of these risk assessments were subsequently shown to be erroneous can be directly attributed to a distortion of the rational warrant of this bovine scrapie thesis.Presumptions Are Rationally JustifiedThat presumptions are rationally warranted, and are not just accepted on a whim, has adaptive value for cognitive agents.", [["bovine", "ORGANISM", 151, 157], ["bovine", "SPECIES", 151, 157], ["scrapie", "SPECIES", 158, 165], ["these risk assessments", "TEST", 13, 35], ["this bovine scrapie thesis", "TREATMENT", 146, 172], ["cognitive agents", "TREATMENT", 314, 330]]], ["In order to respond to environmental challenges, agents must resort to using those cognitive procedures which have been most successful in addressing earlier challenges.", [["environmental challenges", "TREATMENT", 23, 47], ["agents", "TREATMENT", 49, 55], ["those cognitive procedures", "TREATMENT", 77, 103]]], ["Rational methods such as deduction and induction have fared well in this regard.", [["Rational methods", "TREATMENT", 0, 16]]], ["The same cannot be said of telepathy and astrology which have lost out to rational procedures in the evolution of our cognitive resources.", [["rational procedures", "TREATMENT", 74, 93], ["our cognitive resources", "TREATMENT", 114, 137]]], ["It is the exercise of rationality across a range of such procedures that leaves cognitive agents best placed to respond to an environment that can be at once predictable and uncertain.", [["such procedures", "TREATMENT", 52, 67], ["cognitive agents", "TREATMENT", 80, 96]]], ["The rational warrant of presumption thus serves as a type of hallmark that we are using a procedure which is most likely to achieve success for us in our cognitive deliberations.Presumptions Are Context SensitivePresumptions display context sensitivity.", [["a procedure", "TREATMENT", 88, 99], ["most likely", "UNCERTAINTY", 109, 120]]], ["This context sensitivity is played out through the rational justification and defeasibility of presumptions.", [["defeasibility of presumptions", "PROBLEM", 78, 107]]], ["An individual may suffer from memory loss or experience a visual disturbance, in which case one or more theses may lack any claim to rational justification.", [["memory loss", "DISEASE", 30, 41], ["visual disturbance", "DISEASE", 58, 76], ["memory loss", "PROBLEM", 30, 41], ["a visual disturbance", "PROBLEM", 56, 76], ["memory loss", "OBSERVATION", 30, 41]]], ["The quantity and type of evidence that is required to overturn a presumption also varies from context to context.", [["quantity", "OBSERVATION_MODIFIER", 4, 12]]], ["A presumption that is supported by several lines of evidence (e.g. expert testimony, experimental results) will be less easily overturned than a presumption with only one type of supporting evidence.", [["several", "OBSERVATION_MODIFIER", 35, 42], ["lines", "OBSERVATION", 43, 48]]], ["It is more difficult to displace a presumption when that presumption is licensing urgent actions in the practical sphere (e.g. the implementation of disease containment measures) than when the implications of a presumption are purely theoretical.Presumptions Are Context SensitiveThe context sensitivity of presumption has important implications for public health.", [["disease containment measures", "TREATMENT", 149, 177]]], ["It requires scientists and others to examine closely the contextual factors that obtain in particular cases, and to draw on those factors as they pertain to the rational warrant and defeasibility of presumptions.", [["defeasibility of presumptions", "PROBLEM", 182, 211]]], ["The presumption against the safety of a new drug may be overturned in the case where an individual is gravely ill and the drug in question represents the only means of saving the patient's life.", [["patient", "ORGANISM", 179, 186], ["patient", "SPECIES", 179, 186]]], ["When scientists during the BSE epidemic continued to uphold the analogy between BSE and scrapie in the face of countervailing considerations (e.g. the emergence of evidence that these two diseases have different host ranges), it was clear that presumptions based on this analogy had lost their context-sensitive status.", [["scrapie", "DISEASE", 88, 95], ["scrapie", "SPECIES", 88, 95], ["these two diseases", "PROBLEM", 178, 196]]], ["Unable to respond to shifting epistemic conditions, presumption assumed the role of dogma in the thinking of scientists.", [["shifting epistemic conditions", "PROBLEM", 21, 50]]], ["The effect was an unshakeable confidence that BSE would act like scrapie which led to mistaken assessments of the risk of this bovine disease for human health.Presumptions Are Context SensitiveThe context sensitivity of our epistemic concepts has an important adaptive function.", [["scrapie", "DISEASE", 65, 72], ["bovine", "ORGANISM", 127, 133], ["human", "ORGANISM", 146, 151], ["bovine", "SPECIES", 127, 133], ["human", "SPECIES", 146, 151], ["scrapie", "SPECIES", 65, 72], ["bovine", "SPECIES", 127, 133], ["human", "SPECIES", 146, 151], ["scrapie", "PROBLEM", 65, 72], ["this bovine disease", "PROBLEM", 122, 141]]], ["Cognitive agents must be aware of, and capable of responding to, rapidly changing conditions in their environment.", [["Cognitive agents", "TREATMENT", 0, 16]]], ["Some of these conditions might present beneficial opportunities for those agents who stand ready to exploit them.", [["those agents", "TREATMENT", 68, 80]]], ["Other conditions pose significant threats to cognitive agents who must take action to minimize them or avert them altogether.", [["cognitive agents", "TREATMENT", 45, 61]]], ["Neither of these responses is possible for cognitive agents whose concepts are insensitive to features of context.", [["cognitive agents", "TREATMENT", 43, 59]]], ["A presumption against the safety of a new drug is not a prudent rational strategy, but a downright dangerous one, when there is a reasonable possibility that the life of a critically ill individual may be saved by the use of this drug.", [["critically ill", "DISEASE", 172, 186], ["this drug", "TREATMENT", 225, 234]]], ["The low epistemic standing of presumption sets it apart from concepts such as knowledge which has a much elevated epistemic status.", [["a much elevated epistemic status", "PROBLEM", 98, 130], ["low", "OBSERVATION_MODIFIER", 4, 7], ["epistemic", "OBSERVATION_MODIFIER", 8, 17], ["elevated", "OBSERVATION_MODIFIER", 105, 113], ["epistemic status", "OBSERVATION", 114, 130]]], ["On one prominent theoretical account, that improvement is achieved through a process of retrospective revalidation, in which the results of inquiry are used to validate presumptions.", [["retrospective revalidation", "TEST", 88, 114], ["one prominent", "OBSERVATION_MODIFIER", 3, 16], ["improvement", "OBSERVATION_MODIFIER", 43, 54]]], ["2 Although the lowly epistemic status of presumption may seem like a weakness of this concept, it is actually a substantial strength during cognitive inquiry.", [["a weakness", "PROBLEM", 67, 77], ["lowly", "OBSERVATION_MODIFIER", 15, 20], ["epistemic", "OBSERVATION", 21, 30], ["weakness", "OBSERVATION", 69, 77]]], ["A requirement for knowledge at the outset of an inquiry serves only to foreclose investigation as claims of that epistemic standing are largely not available to cognitive agents.", [["cognitive agents", "TREATMENT", 161, 177]]], ["Also, the low epistemic standing of presumptions means that we are disinclined to base other claims upon them.", [["low", "OBSERVATION_MODIFIER", 10, 13], ["epistemic", "OBSERVATION_MODIFIER", 14, 23]]], ["This has the advantage that when our commitment to a presumption has to be relinquished, a body of other claims does not also have to be revised or rejected.Presumptions Have a Lowly Epistemic StatusThe capacity of presumptions to improve their epistemic standing during an inquiry can be illustrated in a public health context.", [["capacity", "OBSERVATION_MODIFIER", 203, 211]]], ["Prior to the identification of HIV as the causal agent of AIDS, investigators presumed that early cases of AIDS were the result of a blood-borne virus.", [["blood", "ANATOMY", 133, 138], ["AIDS", "DISEASE", 58, 62], ["AIDS", "DISEASE", 107, 111], ["blood-borne virus", "DISEASE", 133, 150], ["HIV", "ORGANISM", 31, 34], ["blood-borne virus", "ORGANISM", 133, 150], ["HIV", "SPECIES", 31, 34], ["HIV", "PROBLEM", 31, 34], ["AIDS", "PROBLEM", 58, 62], ["AIDS", "PROBLEM", 107, 111], ["a blood-borne virus", "PROBLEM", 131, 150]]], ["This presumption was based on epidemiological evidence, namely, the finding that groups which appeared to be most susceptible to AIDS (i.e. homosexual males and intravenous drug users) were also susceptible to another blood-borne viral infection called hepatitis B. When HIV was eventually confirmed to be the viral agent that is responsible for AIDS, the presumption which had launched the inquiry into this new infectious disease grew in epistemic stature.", [["blood", "ANATOMY", 218, 223], ["AIDS", "DISEASE", 129, 133], ["viral infection", "DISEASE", 230, 245], ["hepatitis B.", "DISEASE", 253, 265], ["AIDS", "DISEASE", 346, 350], ["infectious disease", "DISEASE", 413, 431], ["blood", "ORGANISM_SUBSTANCE", 218, 223], ["hepatitis B.", "ORGANISM", 253, 265], ["HIV", "ORGANISM", 271, 274], ["HIV", "SPECIES", 271, 274], ["HIV", "SPECIES", 271, 274], ["AIDS", "PROBLEM", 129, 133], ["another blood-borne viral infection", "PROBLEM", 210, 245], ["hepatitis B.", "PROBLEM", 253, 265], ["HIV", "PROBLEM", 271, 274], ["the viral agent", "PROBLEM", 306, 321], ["AIDS", "PROBLEM", 346, 350], ["this new infectious disease", "PROBLEM", 404, 431], ["new", "OBSERVATION_MODIFIER", 409, 412], ["infectious", "OBSERVATION_MODIFIER", 413, 423], ["epistemic stature", "OBSERVATION", 440, 457]]], ["This presumption, which was the basis of early health advice from the Centers of Disease Control to the public, was subsequently validated by means of biomedical investigations.", [["Disease Control", "TREATMENT", 81, 96], ["biomedical investigations", "TEST", 151, 176]]], ["The validation provided by these investigations enabled a once low-grade presumption to ascend to the status of knowledge.", [["these investigations", "TEST", 27, 47]]], ["At the same time, presumptions which described other purported causes of early AIDS cases and which were not validated by inquiry were relinquished by investigators.Presumptions Have a Lowly Epistemic StatusAs with the other features of presumption that we have considered in this section, the low-grade status of presumption has adaptive value for cognitive agents.", [["AIDS", "DISEASE", 79, 83], ["early AIDS cases", "PROBLEM", 73, 89], ["cognitive agents", "TREATMENT", 349, 365], ["Lowly", "OBSERVATION_MODIFIER", 185, 190], ["Epistemic", "OBSERVATION", 191, 200]]], ["This feature of presumption embodies a type of cognitive economy for agents.", [["agents", "TREATMENT", 69, 75]]], ["By only making a minimal, initial investment in presumption, agents can conserve valuable cognitive resources.", [["minimal", "OBSERVATION_MODIFIER", 17, 24]]], ["The low-grade status of presumption ensures that even if a presumption delivers little or no return for cognitive agents, there has at least been no substantial expenditure of our cognitive resources on it.", [["cognitive agents", "TREATMENT", 104, 120], ["low-grade", "OBSERVATION_MODIFIER", 4, 13]]], ["Also, because cognitive agents are disinclined to rest any significant commitments or claims on a concept with a low-grade status, there is little cognitive expenditure incurred if a presumption has to be overturned.", [["little cognitive expenditure", "PROBLEM", 140, 168]]], ["This is not true of a better established epistemic concept such as knowledge where rejection of known theses incurs substantial expenditure for agents in the form of wider revision of theses.", [["agents", "TREATMENT", 144, 150], ["wider revision", "TREATMENT", 166, 180], ["not true", "UNCERTAINTY", 8, 16], ["epistemic", "OBSERVATION", 41, 50], ["wider", "OBSERVATION_MODIFIER", 166, 171], ["revision", "OBSERVATION", 172, 180]]], ["The lowgrade nature of presumption thus delivers the maximum cognitive return for agents in terms of validated theses for a minimal, initial outlay of our cognitive resources.Presumptions Are Action OrientedPresumptions can be used in cognitive inquiries that address theoretical questions in a range of domains.", [["agents", "TREATMENT", 82, 88]]], ["Delays in these inquiries as we take time to conduct investigations and gather evidence can have serious consequences.", [["conduct investigations", "TEST", 45, 67], ["serious consequences", "PROBLEM", 97, 117]]], ["Presumption marks a juncture in these inquiries where we can put deliberation on hold, at least on a temporary basis, and implement actions in the practical sphere.", [["a temporary basis", "TREATMENT", 99, 116]]], ["For example, an inquiry into an emerging infectious disease will need to consider the nature and origin of the pathogen, its incubation period, routes of transmission, and much else besides.", [["infectious disease", "DISEASE", 41, 59], ["an emerging infectious disease", "PROBLEM", 29, 59], ["the pathogen", "PROBLEM", 107, 119], ["infectious", "OBSERVATION", 41, 51], ["pathogen", "OBSERVATION", 111, 119]]], ["But alongside or even before these important questions have been answered is the need to put into place disease containment measures.", [["disease containment measures", "TREATMENT", 104, 132]]], ["These measures may include quarantine of infected individuals, the use of prophylactic drugs, and bans on public gatherings and other activities.", [["infected individuals", "PROBLEM", 41, 61], ["prophylactic drugs", "TREATMENT", 74, 92], ["infected", "OBSERVATION", 41, 49]]], ["These types of action were implemented as part of the global response to outbreaks of SARS and avian influenza H5N1, when these diseases first emerged in 2002 and 1997, respectively.", [["SARS", "DISEASE", 86, 90], ["avian influenza H5N1", "DISEASE", 95, 115], ["avian influenza H5N1", "ORGANISM", 95, 115], ["avian influenza H5N1", "SPECIES", 95, 115], ["SARS", "PROBLEM", 86, 90], ["avian influenza H5N1", "PROBLEM", 95, 115], ["these diseases", "PROBLEM", 122, 136]]], ["The point is not that theoretical knowledge of these emerging infectious diseases is not importantit certainly is.", [["infectious diseases", "DISEASE", 62, 81], ["these emerging infectious diseases", "PROBLEM", 47, 81], ["infectious", "OBSERVATION", 62, 72]]], ["Rather, it is that public health officials cannot await the outcome of the scientific investigations that would have produced that knowledge in order to introduce disease containment measures.", [["disease containment measures", "TREATMENT", 163, 191]]], ["A cognitive agent whose rationality privileges the completion of deliberation over the need to take urgent, self-protective actions is unlikely to survive for long enough to discover the limitations of such rationality.Presumptions Are Action OrientedThe cognitive inquiries through which we obtain knowledge of the world and an accurate mental representation of our environment should never be ends in themselves.", [["A cognitive agent", "TREATMENT", 0, 17], ["self-protective actions", "TREATMENT", 108, 131]]], ["Presumption is the bridge between agents' cognitive goals and the need for those goals to remain in the service of addressing challenges in the practical sphere.", [["agents' cognitive goals", "TREATMENT", 34, 57]]], ["This action-oriented concept reminds us that deliberation which cannot be suspended in order to respond to practical concerns is a particularly limiting cognitive resource.Major Informal FallaciesIt emerges that presumption is a particularly versatile epistemic concept which holds considerable promise for a theory of public health reasoning.", [["Fallacies", "OBSERVATION", 187, 196]]], ["Presumption must find a logical home if it is to gain any purchase in the reasoning of cognitive agents.", [["cognitive agents", "TREATMENT", 87, 103]]], ["Although these arguments have occupied a rather inauspicious position in the history of logic, it will be argued that their logical properties assume new significance in the context of public health reasoning.", [["inauspicious", "OBSERVATION_MODIFIER", 48, 60], ["position", "OBSERVATION_MODIFIER", 61, 69]]], ["In this section, we begin to examine those logical properties in a number of prominent informal fallacies.", [["prominent", "OBSERVATION_MODIFIER", 77, 86], ["informal fallacies", "OBSERVATION", 87, 105]]], ["We will also illustrate the use of these arguments in a public health context.Major Informal FallaciesThe section will unfold as follows.", [["Fallacies", "OBSERVATION", 93, 102]]], ["The transformation in the status of these arguments reflects wider logical developments which have enabled logicians and philosophers to develop nondeductive frameworks for the analysis of the fallacies.", [["The transformation", "PROBLEM", 0, 18], ["the analysis", "TEST", 173, 185], ["transformation", "OBSERVATION_MODIFIER", 4, 18], ["fallacies", "OBSERVATION", 193, 202]]], ["Among these frameworks are presumptive and pragmatic analyses of the fallacies.", [["fallacies", "OBSERVATION", 69, 78]]], ["Assessed against presumptive and pragmatic criteria, many of the so-called informal fallacies appear to be not so fallacious after all.", [["fallacies", "CANCER", 84, 93]]], ["These frameworks will be considered as will the very different analysis of the fallacies that they make possible.From Historical Antecedents : : :Philosophical interest in the fallacies can be traced back to Aristotle (384 BC-322 BC) in his Sophistical Refutations.", [["fallacies", "CANCER", 176, 185], ["Philosophical interest in the fallacies", "PROBLEM", 146, 185], ["BC", "TEST", 223, 225], ["BC", "TEST", 230, 232], ["his Sophistical Refutations", "PROBLEM", 237, 264]]], ["In illustration of amphiboly, Aristotle presents this example in which there is play on the 'double meaning' of the expression sight of: 'There must be sight of what one sees: one sees the pillar: ergo the pillar has sight'.", [["pillar", "ANATOMY", 189, 195], ["pillar", "ANATOMY", 206, 212]]], ["5 In illustration of (4), a refutation that depends upon the consequent, Aristotle states that 'since after rain the ground is wet in consequence, we suppose that if the ground is wet, it has been raining; whereas that does not necessarily follow' (section 1, part 5).", [["wet", "OBSERVATION", 180, 183]]], ["For Aristotle, these refutations are little more than fallacies employed by sophists whose aim is 'the semblance of wisdom without the reality':From Historical Antecedents : : :[I]t is the business of one who knows a thing, himself to avoid fallacies in the subjects which he knows and to be able to show up the man who makes them [ : : : ] Those, then, who would be sophists are bound to study the class of arguments aforesaid: for it is worth their while: for a faculty of this kind will make a man seem to be wise, and this is the purpose they happen to have in view. (section 1, part 1) Many Aristotelian fallacies were to be examined again in the seventeenth century by Antoine Arnauld (1612-1694) and Pierre Nicole (1625-1695) in the Port-Royal Logic.", [["man", "ORGANISM", 312, 315], ["man", "ORGANISM", 497, 500], ["man", "SPECIES", 312, 315], ["man", "SPECIES", 497, 500]]], ["Instead, they classified fallacies according to the different ways of reasoning ill (so-called sophisms) and bad reasonings which are common in civil life and ordinary discourse.", [["ill", "DISEASE", 80, 83], ["fallacies", "OBSERVATION", 25, 34]]], ["Fallacies in the former category include ignoratio elenchi, begging the question, non causa pro causa, 7 incomplete enumeration, 8 secundum quid, 9 fallacia accidentis, fallacia compositionis, fallacia divisionis (Aristotle's fallacies of accident, composition and division of words, respectively), and abusing the ambiguity of words.", [["secundum quid", "DISEASE", 131, 144], ["fallacia accidentis", "DISEASE", 148, 167], ["fallacia compositionis", "DISEASE", 169, 191], ["fallacia divisionis", "DISEASE", 193, 212], ["fallacia compositionis", "ORGANISM", 169, 191], ["fallacia accidentis", "SPECIES", 148, 167], ["fallacia compositionis", "SPECIES", 169, 191], ["fallacia divisionis", "SPECIES", 193, 212], ["non causa pro causa", "PROBLEM", 82, 101], ["7 incomplete enumeration", "PROBLEM", 103, 127], ["9 fallacia accidentis", "PROBLEM", 146, 167], ["fallacia compositionis", "PROBLEM", 169, 191], ["fallacia divisionis", "PROBLEM", 193, 212], ["ignoratio elenchi", "OBSERVATION", 41, 58], ["9 fallacia", "OBSERVATION_MODIFIER", 146, 156], ["fallacia compositionis", "OBSERVATION", 169, 191], ["fallacia divisionis", "OBSERVATION", 193, 212]]], ["The Port-Royal Logic continues the Aristotelian treatment of these forms as sophisms.", [["the Aristotelian treatment", "TREATMENT", 31, 57]]], ["XIX, Part II, p.", [["Part II", "GENE_OR_GENE_PRODUCT", 5, 12], ["Part II", "PROTEIN", 5, 12]]], ["Fallacies in the category of bad reasonings which are common in civil life and ordinary discourse include appeals to grounds other than reasons in argument.", [["Fallacies", "DISEASE", 0, 9]]], ["These grounds include a range of interests, emotions and desires 10 :From Historical Antecedents : : :If we examine with care what commonly attaches men rather to one opinion than to another, we shall find that it is not a conviction of the truth, and the force of the reasons, but some bond of self-love, of interest, or of passion (Third Part, Chap.", [["men", "ORGANISM", 149, 152], ["men", "SPECIES", 149, 152]]], ["Clearly, there is little of logical merit in either sophisms or 'bad reasonings' as far as these seventeenth century thinkers are concerned.From Historical Antecedents : : :In Book IV of An Essay Concerning Human Understanding, John Locke (1632-1704) introduces four arguments which are recognizable to present-day readers as 'ad fallacies', although Locke does not describe them as such.", [["Human", "ORGANISM", 207, 212], ["Human", "SPECIES", 207, 212], ["little", "OBSERVATION_MODIFIER", 18, 24]]], ["An argumentum ad verecundiam is the appeal to the authority of men during argument: 'The first is, to allege the opinions of men, whose parts, learning, eminency, power, or some other cause has gained a name, and settled their reputation in the common esteem with some kind of authority'.", [["men", "ORGANISM", 63, 66], ["men", "ORGANISM", 125, 128], ["men", "SPECIES", 63, 66], ["men", "SPECIES", 125, 128]]], ["In an argumentum ad ignorantiam, one's adversary in argument is forced to accept a thesis or prove the opposite of it: 'Another way that men ordinarily use to drive others and force them to submit to their judgments, and receive their opinion in debate, is to require the adversary to admit what they allege as a proof, or to assign a better'.", [["men", "ORGANISM", 137, 140], ["men", "SPECIES", 137, 140]]], ["In an argumentum ad hominem, some aspect of a man's character, principles or practice is used to defeat his thesis: 'a third way is to press a man with consequences drawn from his own principles or concessions'.", [["man", "ORGANISM", 46, 49], ["man", "SPECIES", 46, 49], ["man", "SPECIES", 143, 146]]], ["An argumentum ad judicium is 'the using of proofs drawn from any of the foundations of knowledge or probability'.", [["An argumentum ad judicium", "TREATMENT", 0, 25]]], ["The ad verecundiam, the ad ignorantiam and the ad hominem may dispose us for the reception of truth without helping us attain it: I may be modest, and therefore not oppose another man's persuasion: I may be ignorant, and not be able to produce a better: I may be in error, and another man may show me that I am so.", [["man", "ORGANISM", 180, 183], ["man", "ORGANISM", 285, 288], ["man", "SPECIES", 180, 183], ["man", "SPECIES", 285, 288]]], ["This may dispose me, perhaps, for the reception of truth, but helps me not to it: that must come from proofs and arguments, and light arising from the nature of things themselves, and not from my shamefacedness, ignorance, or error (Book IV, Chapter XVII: Of Reason).", [["shamefacedness", "DISEASE", 196, 210]]], ["Isaac Watts (1674-1748) describes the same four arguments as Locke in his Logic: or The Right Use of Reason.", [["Right", "ANATOMY_MODIFIER", 88, 93]]], ["These sophisms include Aristotelian sophistical refutations and later additions to the class of fallacies: ignorantia elenchi; petitio principii; non causa pro causa; fallacia accidentis; secundum quid; composition and division; ambiguity and imperfect enumeration.", [["fallacies", "DISEASE", 96, 105], ["secundum quid", "DISEASE", 188, 201], ["ignorantia elenchi", "ORGANISM", 107, 125], ["petitio principii", "ORGANISM", 127, 144], ["non causa pro causa", "ORGANISM", 146, 165], ["fallacia accidentis", "ORGANISM", 167, 186], ["ignorantia elenchi", "SPECIES", 107, 125], ["petitio principii", "SPECIES", 127, 144], ["causa", "SPECIES", 150, 155], ["pro causa", "SPECIES", 156, 165], ["fallacia accidentis", "SPECIES", 167, 186], ["Aristotelian sophistical refutations", "PROBLEM", 23, 59], ["ignorantia elenchi", "PROBLEM", 107, 125], ["petitio principii", "PROBLEM", 127, 144], ["fallacia accidentis", "PROBLEM", 167, 186], ["secundum quid", "PROBLEM", 188, 201], ["imperfect enumeration", "PROBLEM", 243, 264]]], ["Watts adopts the now standard treatment of these arguments as types of flawed or 'false argumentation'.", [["standard treatment", "TREATMENT", 21, 39], ["false argumentation", "OBSERVATION", 82, 101]]], ["In his introduction to the sophisms, he states:From Historical Antecedents : : :As the rules of right judgment and of good ratiocination often coincide with each other, so the doctrine of prejudice [ : : : ] has anticipated a great deal of what might be said on the subject of sophisms: yet I shall mention the most remarkable springs of false argumentation, which are reduced by logicians to some of the following heads (Part III, Chap.", [["right", "ANATOMY_MODIFIER", 96, 101], ["false argumentation", "OBSERVATION", 338, 357]]], ["We recognize this to be a type of straw man fallacy and, indeed, Watts uses the expression 'images of straw' in his account of this argument.", [["man", "SPECIES", 40, 43]]], ["Moreover, his discussion foreshadows a concern of John Stuart Mill in A System of Logic when he describes the circle or petitio principii which inheres within the syllogism.", [["syllogism", "DISEASE", 163, 172], ["syllogism", "CANCER", 163, 172], ["petitio principii", "SPECIES", 120, 137], ["the circle or petitio principii", "PROBLEM", 106, 137]]], ["In place of these accounts, which 'have recourse to a loose, vague, and popular kind of language', Whately proposes a logical view of the fallacies.", [["a loose, vague", "PROBLEM", 52, 66], ["fallacies", "OBSERVATION", 138, 147]]], ["The emphasis of this view of the fallacies is 'a scientific analysis of the procedure which takes place in each' (Book III: Introduction, pp. 168-169).", [["the procedure", "TREATMENT", 72, 85]]], ["Fallacies in the former category can be purely logical or semi-logical, depending on whether the fallaciousness arises from 'the bare form of the expression' or 'the ambiguity of the middle term', respectively.", [["fallaciousness", "DISEASE", 97, 111], ["middle", "ANATOMY_MODIFIER", 183, 189]]], ["Fallacies in the latter categorymaterial or non-logical fallacies -are of two kinds: premises are such that they should not have been assumed (non causa pro causa and petitio principii 15 ) and the conclusion is not the required conclusion but an irrelevant one (ignoratio elenchi).", [["pro causa", "SPECIES", 153, 162], ["petitio principii", "SPECIES", 167, 184], ["non-logical fallacies", "OBSERVATION", 44, 65]]], ["An important fallacy which has not been discussed previously is based on analogy.", [["fallacy", "OBSERVATION", 13, 20]]], ["Whately states that there are two kinds of very common error which 'lead to confusion of thought in our use of analogical words'.", [["confusion", "DISEASE", 76, 85], ["confusion", "PROBLEM", 76, 85]]], ["He writes:From Historical Antecedents : : :There are certain kinds of argument recounted and named by Logical writers, which we should by no means universally call Fallacies; but which when unfairly used, and so far as they are fallacious, may very well be referred to the present head; such as \"argumentum ad hominem,\" [or \"personal argument,\"] \"argumentum ad verecundiam,\" \"argumentum ad populum,\" &c.", [["head", "ANATOMY", 281, 285], ["head", "ORGANISM_SUBDIVISION", 281, 285], ["head", "ANATOMY", 281, 285]]], ["15, pp. 236-237; italics in original).From Historical Antecedents : : :Whately makes the point in relation to the argumentum ad hominem but he intends it to apply to the other arguments in this category.", [["the argumentum ad hominem", "TREATMENT", 110, 135]]], ["17 Essentially, he argues that there are occasions in which a man should be prepared to admit a conclusion which is 'in conformity to his principles of Reasoning, or in consistency with his own conduct, situation, &c.' (pp. 237-238).", [["man", "ORGANISM", 62, 65], ["man", "SPECIES", 62, 65]]], ["A conclusion so admitted is not fallacious but is 'allowable and necessary': Such a conclusion is often both allowable and necessary to establish, in order to silence those who will not yield to fair general argument; or to convince those whose weakness and prejudices would not allow them to assign to it its due weight (Book III, Sect.", [["those whose weakness", "PROBLEM", 233, 253]]], ["However, his discussion nevertheless marks an important break with the hitherto dominant view of these arguments as invariably weak or fallacious forms of argument or reasoning.From Historical Antecedents : : :John Stuart Mill (1806-1873) devotes the whole of Book V of A System of Logic to a discussion of the fallacies.", [["fallacies", "OBSERVATION", 311, 320]]], ["Bad reasoning involves our being seduced into not observing the 'true principles of induction': It is, however, not unimportant to consider what are the most common modes of bad reasoning; by what appearances the mind is most likely to be seduced from the observance of true principles of induction (Book V, Chapter I, Sect.", [["most likely", "UNCERTAINTY", 221, 232]]], ["1).From Historical Antecedents : : :Given this emphasis on induction, it is unsurprising that inductive fallacies are the focus of Mill's classification system.", [["inductive fallacies", "PROBLEM", 94, 113], ["Mill's classification system", "PROBLEM", 131, 159]]], ["Mill begins by recognizing a distinction between Fallacies of Inference and Fallacies of Simple Inspection.", [["Simple Inspection", "TEST", 89, 106]]], ["In the former category he includes erroneous conclusions from supposed evidence.", [["erroneous conclusions", "PROBLEM", 35, 56]]], ["This category also includes cases in which simple inspection creates a presumption in favour of a proposition.", [["simple inspection", "TEST", 43, 60]]], ["Within Fallacies of Confusion are included those fallacies which have their source in language, 'whether arising from the vagueness or ambiguity of our terms, or from casual associations with them' (Book V, Chapter II, Sect.", [["Confusion", "DISEASE", 20, 29], ["Confusion", "PROBLEM", 20, 29], ["the vagueness", "PROBLEM", 118, 131]]], ["The category Fallacies of Induction includes those cases in which the facts on which an induction proceeds are false (Fallacies of Observation) or they are true but do not bear out a conclusion founded on them (Fallacies of Generalization).From Historical Antecedents : : :Finally, the category Fallacies of Deduction includes 'those modes of incorrect argumentation in which the premises, or some of them, are general propositions, and the argument a ratiocination' (Book V, Chapter II, Sect.", [["an induction proceeds", "TREATMENT", 85, 106], ["category Fallacies", "OBSERVATION", 4, 22]]], ["This includes argumentation which proceeds from false premises or from premises which are true but which do not support the conclusion.", [["false premises", "OBSERVATION", 48, 62]]], ["However, the first of these errors, Mill argues, can be included in one of the aforementioned categories.", [["Mill", "OBSERVATION_MODIFIER", 36, 40]]], ["These cases are 'provided against by the rules of the syllogism' and are called Fallacies of Ratiocination.From Historical Antecedents : : :As Mill expands his classification system, we see the names of a number of familiar fallacies beginning to appear.", [["syllogism", "DISEASE", 54, 63], ["fallacies", "CANCER", 224, 233]]], ["Under Fallacies of Confusion, Mill discusses the fallacy of ambiguity, petitio principii and ignoratio elenchi.", [["Confusion", "DISEASE", 19, 28], ["petitio principii", "ORGANISM", 71, 88], ["petitio principii", "SPECIES", 71, 88], ["Confusion", "PROBLEM", 19, 28]]], ["The 'confusion' in these fallacies consists in misconceiving the import of the premises, in forgetting what the premises are, and in mistaking the conclusion which is to be proved, respectively.", [["confusion", "DISEASE", 5, 14], ["fallacies", "DISEASE", 25, 34], ["The 'confusion", "PROBLEM", 0, 14]]], ["Under Fallacies of Ratiocination, Mill addresses \u00e0 dicto secundum quid ad dictum simpliciter.", [["Ratiocination", "TREATMENT", 19, 32]]], ["One fallacy in particular is worthy of consideration for what it reveals of Mill's attitude towards modes of reasoning which do not attain the standards of induction.", [["fallacy", "OBSERVATION", 4, 11]]], ["That fallacy is false analogy.", [["false analogy", "OBSERVATION", 16, 29]]], ["6).From Historical Antecedents : : :It is clear that Mill has low regard for reasoning based on presumption on account of its failure to 'even simulate a complete and conclusive induction'.", [["its failure", "PROBLEM", 122, 133], ["clear", "OBSERVATION", 42, 47]]], ["This dismissal of presumption is even more remarkable given Mill's defence of induction, a form of reasoning which has also been maligned, in this case for its failure to attain deductive standards of reasoning and argument.", [["its failure", "PROBLEM", 156, 167]]], ["Indeed, it is the privileging of these latter standards which is responsible for the largely negative characterizations of the fallacies in each of the historical contributions that we have examined in this section.", [["fallacies", "OBSERVATION", 127, 136]]], ["We will see in the next section that more favourable conceptions of the fallacies would eventually emerge, but only among those philosophers who were not prepared to uphold the dominance of deduction in logic and reasoning.: : : to the Present DayThe modern day study of the fallacies is widely held to have commenced with the publication in 1970 of Charles Hamblin's book Fallacies.", [["fallacies", "DISEASE", 72, 81]]], ["In this groundbreaking text, Hamblin rails against the shortcomings of what he terms the 'standard treatment' of the fallacies in most logic textbooks.", [["Hamblin rails", "TREATMENT", 29, 42]]], ["His frustration with this treatment is clearly evident in the following introductory remarks:: : : to the Present DayAnd what we find in most cases, I think it should be admitted, is as debased, worn-out and dogmatic a treatment as could be imagined -incredibly tradition-bound, yet lacking in logic and historical sense alike, and almost without connection to anything else in modern logic at all.", [["this treatment", "TREATMENT", 21, 35], ["a treatment", "TREATMENT", 217, 228]]], ["This is the part of his book in which a writer throws away logic and keeps his reader's attention, if at all, only by retailing traditional puns, anecdotes, and witless examples of his forbears (Hamblin 1970: 12) .: : : to the Present DayBy way of illustration of the textbook treatment of the fallacies, Hamblin considers an example of amphiboly discussed by Irving Copi (1953) in his Introduction to Logic: 'Save soap and waste paper'.", [["fallacies", "DISEASE", 294, 303], ["the textbook treatment", "TREATMENT", 264, 286], ["Hamblin", "TREATMENT", 305, 312]]], ["However, Hamblin laments that '[n]one of the examples so far quoted is of this character; and I regret to report that, in the books I have consulted, I have found no example that is any better' (1970: 18).: : : to the Present DayHamblin's response to the weaknesses of the standard treatment of the fallacies is to develop a formal dialectic.", [["fallacies", "OBSERVATION", 299, 308], ["dialectic", "OBSERVATION", 332, 341]]], ["A formal analysis of rules of dialogue, he contends, offers a unifying framework within which the dialectical flaws of various fallacies may be captured.", [["A formal analysis", "TEST", 0, 17], ["various fallacies", "OBSERVATION", 119, 136]]], ["These rules can prescribe, prohibit or permit dialogue moves by arguers:: : : to the Present DayA formal approach [ : : : ] consists in the setting up of simple systems of precise but not necessarily realistic rules, and the plotting of the properties of the dialogues that might be played out in accordance with them [ : : : ] Rules may prescribe, prohibit, or permit; may be directed to particular people, who play roles in a dialogue; and may be conditional on any feature of the previous history of the dialogue (Hamblin 1970 : 256-257).: : : to the Present DayHamblin's account is undoubtedly a more systematic analysis of the fallacies than that which is offered by the standard treatment.", [["people", "ORGANISM", 400, 406], ["people", "SPECIES", 400, 406], ["the standard treatment", "TREATMENT", 672, 694]]], ["However, it still remains wedded to a central assumption of that treatment, that the fallacies are weak or flawed forms of argument which logicians must succeed in outlawing.", [["that treatment", "TREATMENT", 60, 74], ["weak", "PROBLEM", 99, 103]]], ["This can be seen, for example, in Hamblin's treatment of petitio principii.", [["Hamblin", "CHEMICAL", 34, 41], ["petitio principii", "ORGANISM", 57, 74], ["petitio principii", "SPECIES", 57, 74], ["petitio principii", "SPECIES", 57, 74], ["Hamblin's treatment", "TREATMENT", 34, 53], ["petitio principii", "TREATMENT", 57, 74]]], ["Statement S', the second of these rules guarantees that where statement T is offered as a justification of S, both T and T S must already be among the commitments of the speaker and the hearer of the dialogue.", [["T S", "GENE_OR_GENE_PRODUCT", 121, 124]]], ["For Hamblin, it is clear that circular argument of the type found in petitio principii should not be tolerated in an improved treatment of the fallacies and that it is the purpose of formal dialectic to prohibit such argument, amongst other things.: : : to the Present DayHamblin's treatment of the fallacies achieved a much needed resurgence of interest in these arguments and spawned the development of new frameworks for their analysis.", [["petitio principii", "ORGANISM", 69, 86], ["Hamblin", "TREATMENT", 4, 11], ["petitio principii", "TREATMENT", 69, 86], ["their analysis", "TEST", 424, 438], ["circular", "OBSERVATION_MODIFIER", 30, 38], ["fallacies", "OBSERVATION", 143, 152]]], ["18 Yet, it remained committed to the largely pejorative characterization of these arguments that had dominated historical accounts of the fallacies.", [["arguments", "OBSERVATION", 82, 91], ["fallacies", "OBSERVATION", 138, 147]]], ["Hamblin's continuation of this characterization, despite his vehement criticism of the tradition that produced it, can be traced to his adherence to deductivism in logic.", [["Hamblin", "TREATMENT", 0, 7], ["this characterization", "TEST", 26, 47]]], ["Deductivism is the widely held, though often implicit, view that the only way to do logical analysis is to resort to deductive techniques and norms (Johnson 2011) .", [["logical analysis", "TEST", 84, 100], ["widely", "OBSERVATION_MODIFIER", 19, 25]]], ["19 Although this is not the context in which to undertake a detailed discussion of deductivismthe reader can do no better than Johnson's paper for this discussion -some account of deductivism and its impact on fallacy analysis is still warranted.", [["deductivism", "PROBLEM", 180, 191], ["fallacy analysis", "TEST", 210, 226]]], ["For it is not an exaggeration to say that it was dissatisfaction with deductivism and a desire to do logical analysis differently which brought informal logic into existence and with it an innovative approach to the study of fallacies.: : : to the Present DayThe norms implicit in the deductivist attitude to the study of logic are captured by the soundness doctrine, the idea that a good argument is one that is deductively valid and has true premises.", [["deductivism", "PROBLEM", 70, 81], ["logical analysis", "TEST", 101, 117], ["the study", "TEST", 309, 318]]], ["Certain aspects of Hamblin's treatment appear to challenge this doctrine.", [["Hamblin", "CHEMICAL", 19, 26], ["Hamblin's treatment", "TREATMENT", 19, 38]]], ["In the present context, we are concerned with the effect of deductivism on one corner of logic, the corner that examines weak or fallacious argument.", [["deductivism", "PROBLEM", 60, 71], ["weak or fallacious argument", "PROBLEM", 121, 148]]], ["For it is here that one of the most pernicious consequences of deductivism is to be found.", [["deductivism", "PROBLEM", 63, 74]]], ["That consequence can be formulated in the following terms: if the soundness doctrine is the standard of a good argument, then most of the arguments that people use in their daily affairs (indeed, in philosophy itself) are fallacies.", [["people", "ORGANISM", 153, 159], ["people", "SPECIES", 153, 159]]], ["20 And because we are prejudiced from the outset to find these arguments weak, it is unsurprising that we should describe so many of them as fallacies when, in fact, all we have done is apply an incorrect (that is, deductive) standard to their evaluation.", [["their evaluation", "TEST", 238, 254]]], ["This has been the fate of many of the arguments which we now routinely identify as fallacies.: : : to the Present DayAt the same time as most philosophers and logicians were blind to their own deductivism, a new wave of logicians was not prepared to acquiesce in the deductive ideals of their predecessors.", [["a new wave of logicians", "PROBLEM", 206, 229]]], ["He wanted what most students today want, a course relevant to everyday reasoning, a course relevant to the arguments they hear and read about race, pollution, poverty, sex, atomic warfare, the population explosion, and all the other problems faced by the human race in the second half of the twentieth century.: : : to the Present DayIn the end, developments in the classroom were to prove instrumental in dislodging formal, deductive logic from its position of dominance in logic and in ushering in a new kind of logical study.", [["poverty", "DISEASE", 159, 166], ["human", "ORGANISM", 255, 260], ["human", "SPECIES", 255, 260], ["human", "SPECIES", 255, 260], ["logical study", "TEST", 514, 527]]], ["That study was concerned to examine the use of arguments in context over formal relations between propositions, the latter the object of analysis of formal, deductive logic.", [["That study", "TEST", 0, 10]]], ["This quite different emphasis of informal logic, as it became known, had significant implications for the study of fallacies.", [["the study", "TEST", 102, 111], ["fallacies", "OBSERVATION", 115, 124]]], ["Historical certainties about the arguments that constituted the fallacies soon began to unravel, with analyses of non-fallacious variants of the informal fallacies appearing in journals that bore the name of this new area of logical study.", [["fallacies", "DISEASE", 154, 163], ["non-fallacious variants", "PROBLEM", 114, 137], ["logical study", "TEST", 225, 238]]], ["21 Spearheading this more positive characterization of the fallacies were John Woods and Douglas Walton, two logicians who have gone on to analyse non-fallacious variants of most of the informal fallacies.", [["fallacies", "OBSERVATION", 195, 204]]], ["22 These analyses emphasized presumptive reasoning and plausible argument (Walton 1996a).", [["These analyses", "TEST", 3, 17]]], ["At the same time, the evaluation of argument no longer privileged deductive and inductive criteria and was just as likely (or more likely) to consider pragmatic factors relating to the context of argument (Walton 1995a, 1996b) .", [["the evaluation", "TEST", 18, 32], ["pragmatic factors", "PROBLEM", 151, 168]]], ["However, arguments from ignorance are not always fallacious.", [["ignorance", "OBSERVATION", 24, 33]]], ["Having demonstrated the positive epistemic attributes of informal fallacies in certain contexts, it was not long before theorists began to conceive of them as facilitative heuristics during reasoning.", [["fallacies", "DISEASE", 66, 75], ["positive", "OBSERVATION_MODIFIER", 24, 32], ["epistemic", "OBSERVATION_MODIFIER", 33, 42]]], ["This most recent development in fallacy theory is evident in Walton (2010), although it is in the work of Cummings (2012c, 2013a, b, 2014a, b, c, d, e) that the idea of fallacies-as-heuristics has been experimentally tested for the first time.", [["fallacies", "SIMPLE_CHEMICAL", 169, 178]]], ["It will be instructive to examine this approach further in the present context, as it marks the point of departure for the analysis of the informal fallacies that will be pursued in subsequent chapters.: : : to the Present DayAccording to Walton (2010), most of the informal fallacies are associated with an argumentation scheme and a corresponding parascheme.", [["fallacies", "CANCER", 275, 284], ["the analysis", "TEST", 119, 131], ["an argumentation scheme", "PROBLEM", 305, 328], ["fallacies", "OBSERVATION", 275, 284]]], ["The argumentation scheme is part of a newer (in evolutionary terms) cognitive system which operates in a controlled, conscious and slow manner.", [["The argumentation scheme", "TREATMENT", 0, 24]]], ["This scheme asks critical questions of arguments, questions which are likely to expose logical weaknesses, if such weaknesses exist.", [["such weaknesses exist", "PROBLEM", 110, 131]]], ["The parascheme is a shorter version of the argumentation scheme.", [["shorter", "OBSERVATION_MODIFIER", 20, 27]]], ["It is part of an older cognitive system which uses fast and frugal heuristics to achieve solutions to problems.", [["fast and frugal heuristics", "TREATMENT", 51, 77]]], ["Some of these heuristics involve jumping to conclusions, a cognitive strategy that can work well enough on some occasions but results in errors on other occasions.", [["a cognitive strategy", "TREATMENT", 57, 77]]], ["Walton demonstrates this heuristic view of the fallacies in relation to the argument from expert opinion (argumentum ad verecundiam).", [["fallacies", "OBSERVATION", 47, 56]]], ["Petitio principii or begging the question is one of several fallacies which 'do not appear to fit specific argumentation schemes, or benefit directly from schemes when it comes to analyzing them' (Walton 2010: 175).", [["Petitio principii", "ORGANISM", 0, 17], ["Petitio principii", "SPECIES", 0, 17], ["Petitio principii", "SPECIES", 0, 17], ["Petitio principii", "TREATMENT", 0, 17]]], ["Also, Walton conceives of heuristic reasoning in terms of the bypassing of critical questions which have the potential to reveal logical flaws in argument.", [["logical flaws in argument", "PROBLEM", 129, 154], ["flaws", "OBSERVATION", 137, 142]]], ["Indeed, there was evidence in the experimental study undertaken in Cummings (2014a) that subjects do pose and respond to these very questions.", [["the experimental study", "TEST", 30, 52]]], ["Rather, heuristics are characterized in terms of mental shortcuts through expert knowledge domains which lie beyond the cognitive grasp of the lay person.", [["person", "SPECIES", 147, 153]]], ["At the beginning of this section, it was described how the fallacies had undertaken a remarkable journey from their historical origin as weak or bad forms of reasoning and argument to their present-day characterization as facilitative cognitive heuristics.", [["this section", "TREATMENT", 20, 32]]], ["The challenge now is to develop a theoretical framework of these arguments that succeeds in capturing their logical merits in the adverse epistemic conditions that attend reasoning in a public health context.SummaryIt has been argued in this chapter that we must begin the task of developing a theory of public health reasoning by drawing on the concepts of a number of philosophical disciplines.", [["the adverse epistemic conditions", "PROBLEM", 126, 158]]], ["These disciplines include most prominently epistemology and logic, although contributions from the philosophy of science and the philosophy of mind are also not without relevance.", [["most prominently", "OBSERVATION_MODIFIER", 26, 42], ["not without", "UNCERTAINTY", 157, 168]]], ["However, it was argued that presumption needs to find a logical home if it is to gain any purchase in the reasoning of cognitive agents.", [["cognitive agents", "TREATMENT", 119, 135]]], ["The second part of the chapter charted the journey of these fallacies, from their characterization as flaws or errors in reasoning in the logical treatises of thinkers such as Aristotle and Mill to their recent analysis as cognitive heuristics.", [["fallacies", "OBSERVATION", 60, 69]]], ["However, it was cautioned that this remarkable journey of the fallacies is unlikely to be complete.", [["fallacies", "OBSERVATION", 62, 71], ["unlikely to be", "UNCERTAINTY", 75, 89]]], ["For these same arguments could yet make their most significant and enduring contribution to logic as facilitative heuristics in a theory of public health reasoning.Notes1.", [["Notes1", "PROTEIN", 164, 170]]], ["Some so-called legal presumptions are indefeasible.", [["legal presumptions", "OBSERVATION", 15, 33]]], ["At that stage their epistemic statusthough not their content -changes.", [["epistemic", "OBSERVATION", 20, 29]]], ["The central role of presumptions in practical rationality or reasoning is acknowledged by Walton (2000: 139): 'Practical reasoning involves an agent in a given set of present but changeable circumstances, trying to select a prudent course of action among a set of possible alternative courses of action.", [["an agent", "TREATMENT", 140, 148], ["alternative courses of action", "TREATMENT", 273, 302], ["central", "OBSERVATION_MODIFIER", 4, 11]]], ["Although it is predated by Hamblin's (1970) book Fallacies and Toulmin's (1958) text The Uses of Argument, Johnson and Blair's (1977) textbook Logical Self-Defense is credited by Groarke as the start of work in informal logic proper.Notes5.", [["Notes5", "PROTEIN", 233, 239]]], ["Several of these fallacies were given specific names by Aristotle or by later logicians and philosophers.", [["fallacies", "CANCER", 17, 26], ["fallacies", "OBSERVATION", 17, 26]]], ["In this way, the fallacy in (2) acquired the name secundum quid et simpliciter during the Middle Ages.", [["Middle", "ANATOMY_MODIFIER", 90, 96]]], ["Non causa pro causa is defined as 'taking for a cause that which is not a cause'.NotesIncluded under this sophism is another fallacy known as post hoc, ergo propter hoc.", [["Non causa pro causa", "SPECIES", 0, 19]]], ["Of incomplete enumeration, the Port-Royal Logic says: 'There is scarcely any vice of reasoning into which men fall more easily than that of making imperfect enumerations, and of not sufficiently considering all the ways in which a thing may exist, or take place, which leads them to conclude rashly, either that it does not exist, because it does not exist in a certain way, though it may exist in another, or that it exists in such and such a way, although it may still be in another way, which they have not considered' (Third Part, Chap.", [["men", "ORGANISM", 106, 109], ["men", "SPECIES", 106, 109], ["incomplete enumeration", "PROBLEM", 3, 25], ["incomplete", "OBSERVATION_MODIFIER", 3, 13], ["enumeration", "OBSERVATION", 14, 25]]], ["XIX, Part IV, p.", [["Part IV", "PROTEIN", 5, 12]]], ["Secundum quid or a dicto secundum quid ad dictum simpliciter, to give it its full name in the Port-Royal Logic, involves 'passing from what is true in some respect, to what is true absolutely'.", [["Secundum quid", "CHEMICAL", 0, 13], ["Secundum quid", "PROBLEM", 0, 13], ["quid", "OBSERVATION", 9, 13]]], ["These 'bad reasonings' bear more than a fleeting resemblance to the 'ad fallacies' which Locke is generally credited with first characterizing as fallacies.", [["fallacies", "OBSERVATION", 146, 155]]], ["These fallacies include argumentum ad hominem (argument against the man), argumentum ad baculum (appeal to force) and argumentum ad verecundiam (appeal to authority), amongst others.", [["man", "ORGANISM", 68, 71], ["man", "SPECIES", 68, 71], ["argumentum ad hominem", "PROBLEM", 24, 45], ["argumentum ad baculum", "PROBLEM", 74, 95]]], ["Locke does, however, use the term 'fallacies' in a discussion of the syllogism:Notes'Another reason that makes me doubt whether syllogism be the only proper instrument of reason, in the discovery of truth, is, that of whatever use mode and figure is pretended to be in the laying open of fallacy, [ : : : ] those scholastic forms of discourse are not less liable to fallacies than the plainer ways of argumentation : : : ' (Book IV, Chapter XVII: Of Reason).", [["syllogism", "DISEASE", 69, 78], ["syllogism", "PROBLEM", 128, 137]]], ["Watts states that 'when an argument is borrowed from any topics which are suited to engage the inclinations and passions of the hearers on the side of the speaker, rather than to convince the judgment, this is argumentum ad passiones, an address to the passions; or if it be made publicly, it is called ad populum, or an appeal to the people' (Part III, Chap.", [["people", "SPECIES", 335, 341]]], ["VIII, p.", [["VIII", "GENE_OR_GENE_PRODUCT", 0, 4], ["VIII", "PROTEIN", 0, 4]]]], "PMC7492232": [["ConclusionsAltogether, available evidence points toward two not-mutually exclusive mechanisms in differential gender susceptibility to COVID-19 by sex hormonal regulation of the two main actors in SARS-CoV-2 infection: ACE2 and TMPRSS2.", [["SARS", "DISEASE", 197, 201], ["infection", "DISEASE", 208, 217], ["COVID-19", "CHEMICAL", 135, 143], ["COVID-19", "GENE_OR_GENE_PRODUCT", 135, 143], ["SARS-CoV-2", "ORGANISM", 197, 207], ["ACE2", "GENE_OR_GENE_PRODUCT", 219, 223], ["TMPRSS2", "GENE_OR_GENE_PRODUCT", 228, 235], ["ACE2", "PROTEIN", 219, 223], ["TMPRSS2", "PROTEIN", 228, 235], ["SARS-CoV-2", "SPECIES", 197, 207], ["COVID", "TEST", 135, 140], ["SARS", "PROBLEM", 197, 201], ["CoV", "TEST", 202, 205], ["infection", "PROBLEM", 208, 217], ["ACE2", "TEST", 219, 223], ["TMPRSS2", "TEST", 228, 235], ["infection", "OBSERVATION", 208, 217]]], ["On one hand, ACE2 expression could be increased in women, either by estrogens or constitutively by skewed X chromosome inactivation, providing a larger reservoir of ACE2 to maintain the fundamental equilibrium of RAS-regulatory axis after viral infection on a multi-organ level.", [["chromosome", "ANATOMY", 108, 118], ["multi-organ", "ANATOMY", 260, 271], ["estrogens", "CHEMICAL", 68, 77], ["viral infection", "DISEASE", 239, 254], ["estrogens", "CHEMICAL", 68, 77], ["ACE2", "GENE_OR_GENE_PRODUCT", 13, 17], ["women", "ORGANISM", 51, 56], ["estrogens", "SIMPLE_CHEMICAL", 68, 77], ["chromosome", "CELLULAR_COMPONENT", 108, 118], ["ACE2", "GENE_OR_GENE_PRODUCT", 165, 169], ["RAS", "GENE_OR_GENE_PRODUCT", 213, 216], ["ACE2", "PROTEIN", 13, 17], ["X chromosome", "DNA", 106, 118], ["ACE2", "PROTEIN", 165, 169], ["RAS", "PROTEIN", 213, 216], ["women", "SPECIES", 51, 56], ["skewed X chromosome inactivation", "PROBLEM", 99, 131], ["a larger reservoir of ACE2", "TREATMENT", 143, 169], ["viral infection", "PROBLEM", 239, 254], ["increased", "OBSERVATION_MODIFIER", 38, 47], ["infection", "OBSERVATION", 245, 254]]], ["On the other hand, low levels of androgens in women may keep at low levels TMPRSS2 expression, representing a further protective factor for the development of COVID-19 infection.", [["COVID-19", "CHEMICAL", 159, 167], ["infection", "DISEASE", 168, 177], ["androgens", "CHEMICAL", 33, 42], ["androgens", "SIMPLE_CHEMICAL", 33, 42], ["women", "ORGANISM", 46, 51], ["TMPRSS2", "GENE_OR_GENE_PRODUCT", 75, 82], ["COVID-19", "ORGANISM", 159, 167], ["TMPRSS2", "PROTEIN", 75, 82], ["women", "SPECIES", 46, 51], ["COVID-19", "SPECIES", 159, 167], ["low levels of androgens", "PROBLEM", 19, 42], ["a further protective factor", "PROBLEM", 108, 135], ["COVID-19 infection", "PROBLEM", 159, 177], ["infection", "OBSERVATION", 168, 177]]], ["Both mechanisms consistently point to the role of sex hormones and chromosomes in the differential severity of SAR-CoV2 infection between sexes, thus representing a one-way avenue to the increased susceptibility to COVID-19 in men.", [["infection", "DISEASE", 120, 129], ["chromosomes", "CELLULAR_COMPONENT", 67, 78], ["SAR-CoV2", "GENE_OR_GENE_PRODUCT", 111, 119], ["men", "ORGANISM", 227, 230], ["chromosomes", "DNA", 67, 78], ["men", "SPECIES", 227, 230], ["SAR", "PROBLEM", 111, 114], ["CoV2 infection", "PROBLEM", 115, 129], ["the increased susceptibility", "PROBLEM", 183, 211], ["COVID", "TEST", 215, 220], ["infection", "OBSERVATION", 120, 129], ["increased", "OBSERVATION_MODIFIER", 187, 196]]], ["These aspects are worthy of further investigations regarding the epidemiological and biological aspects of this different susceptibility and lethality between sexes.", [["further investigations", "TEST", 28, 50]]], ["Finally, other gender-related risk factors should be taken into account, such as higher rates of hypertension, smoking, and coronary artery disease that are more predominant in men than women.", [["coronary artery", "ANATOMY", 124, 139], ["hypertension", "DISEASE", 97, 109], ["smoking", "CHEMICAL", 111, 118], ["coronary artery disease", "DISEASE", 124, 147], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 124, 139], ["men", "ORGANISM", 177, 180], ["women", "ORGANISM", 186, 191], ["men", "SPECIES", 177, 180], ["women", "SPECIES", 186, 191], ["hypertension", "PROBLEM", 97, 109], ["coronary artery disease", "PROBLEM", 124, 147], ["hypertension", "OBSERVATION", 97, 109], ["coronary artery", "ANATOMY", 124, 139], ["disease", "OBSERVATION", 140, 147], ["predominant", "OBSERVATION_MODIFIER", 162, 173]]], ["Altogether, these aspects point toward the man as the true weak sex in COVID-19 challenge.", [["man", "ORGANISM", 43, 46], ["man", "SPECIES", 43, 46], ["COVID", "TEST", 71, 76]]]], "8f3fffb6a99b0baa471ddd963ee04bfa71e1bb97": [["IntroductionInfectious bronchitis (IB) is a highly contagious disease of the respiratory and urogenital tract of chickens caused by infectious bronchitis virus (IBV).", [["respiratory", "ANATOMY", 77, 88], ["urogenital tract", "ANATOMY", 93, 109], ["IntroductionInfectious bronchitis (IB)", "DISEASE", 0, 38], ["disease of the respiratory and urogenital tract", "DISEASE", 62, 109], ["infectious bronchitis virus", "DISEASE", 132, 159], ["respiratory", "ORGAN", 77, 88], ["urogenital tract", "ORGANISM_SUBDIVISION", 93, 109], ["chickens", "ORGANISM", 113, 121], ["infectious bronchitis virus", "ORGANISM", 132, 159], ["IBV", "ORGANISM", 161, 164], ["chickens", "SPECIES", 113, 121], ["infectious bronchitis virus", "SPECIES", 132, 159], ["chickens", "SPECIES", 113, 121], ["infectious bronchitis virus", "SPECIES", 132, 159], ["IBV", "SPECIES", 161, 164], ["IntroductionInfectious bronchitis (IB)", "PROBLEM", 0, 38], ["a highly contagious disease of the respiratory and urogenital tract", "PROBLEM", 42, 109], ["infectious bronchitis virus", "PROBLEM", 132, 159], ["bronchitis", "OBSERVATION", 23, 33], ["highly", "OBSERVATION_MODIFIER", 44, 50], ["contagious", "OBSERVATION_MODIFIER", 51, 61], ["respiratory", "ANATOMY", 77, 88], ["urogenital tract", "ANATOMY", 93, 109], ["infectious", "OBSERVATION_MODIFIER", 132, 142], ["bronchitis", "OBSERVATION", 143, 153]]], ["IB causes severe economic losses to the poultry industry because it causes poor weight gain and feed efficiency in broilers and suboptimal egg production and egg quality in laying birds.", [["egg", "ANATOMY", 139, 142], ["egg", "ANATOMY", 158, 161], ["weight gain", "DISEASE", 80, 91], ["broilers", "ORGANISM_SUBDIVISION", 115, 123], ["egg", "ORGANISM_SUBDIVISION", 139, 142], ["egg", "ORGANISM_SUBDIVISION", 158, 161], ["birds", "ORGANISM", 180, 185], ["broilers", "SPECIES", 115, 123], ["severe economic losses", "PROBLEM", 10, 32], ["poor weight gain", "PROBLEM", 75, 91], ["suboptimal egg production", "PROBLEM", 128, 153], ["severe", "OBSERVATION_MODIFIER", 10, 16], ["economic", "OBSERVATION_MODIFIER", 17, 25], ["losses", "OBSERVATION", 26, 32], ["suboptimal egg production", "OBSERVATION", 128, 153]]], ["In addition, high mortality (<30%) sometimes occurs in young chickens due to kidney manifestations of some nephropathogenic strains.", [["kidney", "ANATOMY", 77, 83], ["chickens", "ORGANISM", 61, 69], ["kidney", "ORGAN", 77, 83], ["chickens", "SPECIES", 61, 69], ["chickens", "SPECIES", 61, 69], ["high mortality", "PROBLEM", 13, 27], ["kidney manifestations", "PROBLEM", 77, 98], ["some nephropathogenic strains", "PROBLEM", 102, 131], ["high", "OBSERVATION_MODIFIER", 13, 17], ["kidney", "ANATOMY", 77, 83], ["nephropathogenic strains", "OBSERVATION", 107, 131]]], ["The disease process is often complicated by secondary bacterial infections that cause increased mortality of birds and condemnation at processing [1, 2] .IntroductionThe existence of many serotypes of IBV that do not confer cross-protection against each other has been observed [1, 2] .", [["infections", "DISEASE", 64, 74], ["IBV", "ORGANISM", 201, 204], ["IBV", "SPECIES", 201, 204], ["The disease process", "PROBLEM", 0, 19], ["secondary bacterial infections", "PROBLEM", 44, 74], ["increased mortality of birds", "PROBLEM", 86, 114], ["many serotypes of IBV", "TREATMENT", 183, 204], ["disease", "OBSERVATION", 4, 11], ["secondary", "OBSERVATION_MODIFIER", 44, 53], ["bacterial", "OBSERVATION_MODIFIER", 54, 63], ["infections", "OBSERVATION", 64, 74], ["increased", "OBSERVATION_MODIFIER", 86, 95], ["mortality", "OBSERVATION_MODIFIER", 96, 105]]], ["Crossprotection tends to decrease as the degree of amino acid identity between the spike (S) glycoprotein S1 subunit of two IBV strains decreases [3] .", [["amino acid", "CHEMICAL", 51, 61], ["amino acid", "CHEMICAL", 51, 61], ["amino acid", "AMINO_ACID", 51, 61], ["spike (S) glycoprotein S1", "GENE_OR_GENE_PRODUCT", 83, 108], ["IBV", "ORGANISM", 124, 127], ["spike (S) glycoprotein S1 subunit", "PROTEIN", 83, 116], ["IBV", "SPECIES", 124, 127], ["Crossprotection", "TREATMENT", 0, 15], ["amino acid identity", "PROBLEM", 51, 70], ["the spike", "PROBLEM", 79, 88], ["glycoprotein S1 subunit", "TREATMENT", 93, 116], ["two IBV strains decreases", "PROBLEM", 120, 145], ["decrease", "OBSERVATION_MODIFIER", 25, 33]]], ["However, some strains occasionally confer broad protection against many heterologous serotypes.", [["some strains", "PROBLEM", 9, 21], ["broad protection", "TREATMENT", 42, 58], ["many heterologous serotypes", "PROBLEM", 67, 94], ["heterologous serotypes", "OBSERVATION", 72, 94]]], ["The concept of protectotypes [4] has been suggested as a valuable method that should be considered during the development of strategies to control IBV infections, and strains possessing cross-protective ability are generally considered to be useful vaccine candidates.", [["IBV infections", "DISEASE", 147, 161], ["IBV", "ORGANISM", 147, 150], ["IBV", "SPECIES", 147, 150], ["IBV infections", "PROBLEM", 147, 161]]], ["To date, the Massachusetts (Mass) and 4/91 strains have been primarily used as live vaccines due to their epizootic distributions and crossprotective ability [2, 5] .IntroductionDespite the widespread use of vaccines, economic losses caused by IBV infection have occurred continuously worldwide.", [["IBV infection", "DISEASE", 244, 257], ["4/91 strains", "ORGANISM", 38, 50], ["IBV", "ORGANISM", 244, 247], ["IBV", "SPECIES", 244, 247], ["strains", "PROBLEM", 43, 50], ["live vaccines", "TREATMENT", 79, 92], ["vaccines", "TREATMENT", 208, 216], ["economic losses", "PROBLEM", 218, 233], ["IBV infection", "PROBLEM", 244, 257], ["widespread", "OBSERVATION_MODIFIER", 190, 200], ["IBV", "OBSERVATION_MODIFIER", 244, 247], ["infection", "OBSERVATION", 248, 257]]], ["Indeed, outbreaks related to nephropathogenic strains of different serotypes have increased in many countries [6] [7] [8] , which have caused mortality related to nephritis and respiratory disease followed by airsaculitis.", [["respiratory", "ANATOMY", 177, 188], ["nephritis", "DISEASE", 163, 172], ["respiratory disease", "DISEASE", 177, 196], ["airsaculitis", "DISEASE", 209, 221], ["nephropathogenic strains of different serotypes", "PROBLEM", 29, 76], ["nephritis", "PROBLEM", 163, 172], ["respiratory disease", "PROBLEM", 177, 196], ["airsaculitis", "PROBLEM", 209, 221], ["increased", "OBSERVATION_MODIFIER", 82, 91], ["nephritis", "OBSERVATION", 163, 172], ["respiratory disease", "OBSERVATION", 177, 196]]], ["More recently, the QX-like nephropathogenic strain [9] appears to have become widespread in China [10] , Korea [11] , Russia [12] , and many countries in Europe [13, 14] Table 1 Origin and accession number of IBV strains isolated from flocks in Korea.IBV isolatesYear Tissue tropism Accession number Korean group I (respiratory type) B4 1986 Trachea FJ807932 EJ95 1995 Trachea FJ807933 EY95 1995 Trachea FJ807935 K620/97 1997 Trachea FJ807944 K348/99 1997 Trachea FJ807940 K571/99 1999 Trachea fore, it has been suggested that there is a need to develop new vaccines against these nephropathogenic strains.IBV isolatesPrevious studies have shown that Korean nephropathogenic IBV strains have been genetically stable [15] and possessed a broadspectrum ability to protect against some heterologous strains [8] .IBV isolatesIn the present study, we report the development of an attenuated IBV vaccine candidate using the Korean nephropathogenic IBV strain, K2/01.", [["FJ807944", "CHEMICAL", 434, 442], ["FJ807940", "CHEMICAL", 464, 472], ["QX", "GENE_OR_GENE_PRODUCT", 19, 21], ["IBV", "ORGANISM", 209, 212], ["IBV", "ORGANISM", 251, 254], ["IBV", "ORGANISM", 606, 609], ["Korean nephropathogenic IBV", "ORGANISM", 651, 678], ["IBV", "ORGANISM", 809, 812], ["IBV", "ORGANISM", 886, 889], ["IBV", "ORGANISM", 942, 945], ["IBV", "SPECIES", 209, 212], ["IBV", "SPECIES", 251, 254], ["Korean group I (respiratory type) B4 1986 Trachea FJ807932 EJ95 1995 Trachea FJ807933 EY95 1995 Trachea FJ807935", "SPECIES", 300, 412], ["IBV", "SPECIES", 606, 609], ["Korean nephropathogenic IBV", "SPECIES", 651, 678], ["IBV", "SPECIES", 809, 812], ["IBV", "SPECIES", 886, 889], ["Korean nephropathogenic IBV strain, K2/01", "SPECIES", 918, 959], ["the QX-like nephropathogenic strain", "PROBLEM", 15, 50], ["IBV strains", "PROBLEM", 209, 220], ["IBV isolates", "TREATMENT", 251, 263], ["Trachea", "TEST", 342, 349], ["Trachea", "TEST", 369, 376], ["Trachea", "TEST", 396, 403], ["new vaccines", "TREATMENT", 554, 566], ["these nephropathogenic strains", "PROBLEM", 575, 605], ["IBV isolates", "TEST", 606, 618], ["Previous studies", "TEST", 618, 634], ["Korean nephropathogenic IBV strains", "PROBLEM", 651, 686], ["some heterologous strains", "PROBLEM", 778, 803], ["IBV isolates", "TREATMENT", 809, 821], ["an attenuated IBV vaccine", "TREATMENT", 872, 897], ["the Korean nephropathogenic IBV strain", "TREATMENT", 914, 952], ["widespread", "OBSERVATION_MODIFIER", 78, 88], ["IBV strains", "OBSERVATION", 209, 220], ["Trachea", "ANATOMY", 342, 349], ["Trachea", "ANATOMY", 369, 376], ["Trachea", "ANATOMY", 396, 403], ["Trachea", "ANATOMY", 426, 433], ["Trachea", "ANATOMY", 456, 463], ["Trachea", "ANATOMY", 486, 493], ["stable", "OBSERVATION_MODIFIER", 709, 715], ["IBV", "OBSERVATION", 886, 889]]], ["The K2/01 strain was highly attenuated to remove pathogenicity and then characterized for attenuated phenotypes, after which its protective efficacy against challenge with homologous and heterologous strains was examined.", [["The K2/01 strain", "TEST", 0, 16], ["pathogenicity", "PROBLEM", 49, 62], ["attenuated phenotypes", "PROBLEM", 90, 111], ["heterologous strains", "PROBLEM", 187, 207]]], ["The results demonstrated that the newly developed vaccine candidate exhibits a desired level of immunogenicity and attenuation of virulence.VirusesTwenty-nine Korean IBV isolates (Table 1 ) obtained from natural outbreak cases of IB and two different commercially available vaccines (H120 and Ma5 of the Mass serotype produced by Intervet, International) were used.", [["IBV", "ORGANISM", 166, 169], ["Korean IBV", "SPECIES", 159, 169], ["H120", "SPECIES", 284, 288], ["virulence", "PROBLEM", 130, 139], ["VirusesTwenty", "TEST", 140, 153], ["IB", "PROBLEM", 230, 232], ["vaccines", "TREATMENT", 274, 282], ["H120", "TREATMENT", 284, 288], ["the Mass serotype", "TREATMENT", 300, 317], ["attenuation", "OBSERVATION_MODIFIER", 115, 126], ["virulence", "OBSERVATION", 130, 139]]], ["All isolates were propagated using specific-pathogen-free (SPF) embryonated eggs (Hy-Vac.com, IA, USA) and kept at \u221270 \u2022 C until use.ChickensSPF white leghorn chickens (Nam-Deog Sanitek Co., Korea) and commercial Ross broiler chickens (Sam Hwa Breeding Agri Inc., Korea) were maintained in positive pressure high-efficiency particulate air-filtered stainless steel isolation cabinets (Three Shine Inc., Korea) under constant illumination within a biosafety level 2 laboratory.", [["eggs", "ANATOMY", 76, 80], ["stainless steel", "CHEMICAL", 349, 364], ["chickens", "ORGANISM", 159, 167], ["chickens", "ORGANISM", 226, 234], ["chickens", "SPECIES", 159, 167], ["broiler", "SPECIES", 218, 225], ["chickens", "SPECIES", 226, 234], ["ChickensSPF white leghorn chickens", "SPECIES", 133, 167], ["Ross broiler chickens", "SPECIES", 213, 234], ["All isolates", "TREATMENT", 0, 12], ["ChickensSPF white leghorn chickens", "PROBLEM", 133, 167], ["commercial Ross broiler chickens", "TREATMENT", 202, 234], ["stainless steel isolation cabinets", "TREATMENT", 349, 383], ["stainless steel", "OBSERVATION", 349, 364]]], ["All study procedures and animal care activities were conducted in accordance with the national and institutional guidelines for the care and use of laboratory animals.AttenuationThe virulent nephropathogenic field strain K2/01 (K2parent) was passaged 190 times in the allantoic cavity of 9-11day-old embryonated specific-pathogen-free (SPF) chicken eggs (0.1 ml/egg), and the 170th passage virus (K2p170) was evaluated as live attenuated IBV vaccine candidate.", [["allantoic cavity", "ANATOMY", 268, 284], ["eggs", "ANATOMY", 349, 353], ["egg", "ANATOMY", 362, 365], ["K2p170", "CHEMICAL", 397, 403], ["allantoic cavity", "MULTI-TISSUE_STRUCTURE", 268, 284], ["chicken", "ORGANISM", 341, 348], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 349, 353], ["IBV", "ORGANISM", 438, 441], ["chicken", "SPECIES", 341, 348], ["SPF", "SPECIES", 336, 339], ["chicken", "SPECIES", 341, 348], ["IBV", "SPECIES", 438, 441], ["All study procedures", "TEST", 0, 20], ["the allantoic cavity", "TEST", 264, 284], ["pathogen", "PROBLEM", 321, 329], ["SPF) chicken eggs", "TREATMENT", 336, 353], ["virulent", "OBSERVATION_MODIFIER", 182, 190], ["nephropathogenic", "OBSERVATION_MODIFIER", 191, 207], ["field", "OBSERVATION_MODIFIER", 208, 213], ["allantoic cavity", "ANATOMY", 268, 284]]], ["The allantoic fluid was harvested after incubation for 30 h at 37 \u2022 C. A dot-immunoblot assay was performed as previously described [16] to detect the virus, and the allantoic fluid was titrated at every 10 passages.", [["allantoic fluid", "ANATOMY", 4, 19], ["allantoic fluid", "ANATOMY", 166, 181], ["allantoic fluid", "ORGANISM_SUBSTANCE", 4, 19], ["allantoic fluid", "ORGANISM_SUBSTANCE", 166, 181], ["The allantoic fluid", "TREATMENT", 0, 19], ["A dot-immunoblot assay", "TEST", 71, 93], ["the virus", "PROBLEM", 147, 156], ["the allantoic fluid", "TREATMENT", 162, 181], ["allantoic", "ANATOMY", 4, 13], ["fluid", "OBSERVATION", 14, 19], ["virus", "OBSERVATION", 151, 156]]], ["For next inoculation, we prepared allantoic fluid with the titers adjusted to 10 5.5 to 10 6.5 EID 50 /ml, if the undiluted allantoic fluid induced early embryo mortality within 30 h post-inoculation.Reverse transcription-polymerase chain reaction (RT-PCR) and sequencingViral RNA used in the RT-PCR was extracted from virus containing allantoic fluid using an RNeasy minikit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions.", [["allantoic fluid", "ANATOMY", 34, 49], ["allantoic fluid", "ANATOMY", 124, 139], ["embryo", "ANATOMY", 154, 160], ["allantoic fluid", "ANATOMY", 336, 351], ["allantoic fluid", "ORGANISM_SUBSTANCE", 34, 49], ["allantoic fluid", "ORGANISM_SUBSTANCE", 124, 139], ["embryo", "DEVELOPING_ANATOMICAL_STRUCTURE", 154, 160], ["allantoic fluid", "ORGANISM_SUBSTANCE", 336, 351], ["Viral RNA", "RNA", 271, 280], ["allantoic fluid", "TREATMENT", 34, 49], ["the titers", "TREATMENT", 55, 65], ["the undiluted allantoic fluid", "PROBLEM", 110, 139], ["early embryo mortality", "PROBLEM", 148, 170], ["Reverse transcription", "TEST", 200, 221], ["polymerase chain reaction", "PROBLEM", 222, 247], ["RT-PCR", "TEST", 249, 255], ["sequencingViral RNA", "PROBLEM", 261, 280], ["the RT-PCR", "TEST", 289, 299], ["virus", "PROBLEM", 319, 324], ["allantoic fluid", "TREATMENT", 336, 351], ["an RNeasy minikit", "TREATMENT", 358, 375]]], ["The first strand was then synthesized following a previously described method using BeauS1R3, 5 -CAT AAC TAA CAT AAG GGC AA-3 [8, 15] or IBV-212, 5 -ATA CAA AAT CTG CCA TAA-3 [10] .", [["IBV-212", "CHEMICAL", 137, 144], ["CAA", "CHEMICAL", 153, 156], ["BeauS1R3", "SIMPLE_CHEMICAL", 84, 92], ["5 -CAT", "SIMPLE_CHEMICAL", 94, 100], ["IBV-212", "SIMPLE_CHEMICAL", 137, 144], ["5 -ATA CAA AAT", "SIMPLE_CHEMICAL", 146, 160], ["BeauS1R3, 5 -CAT AAC TAA CAT AAG GGC AA-3 [8, 15] or IBV-212, 5 -ATA CAA AAT CTG CCA TAA-3 [10]", "DNA", 84, 179], ["BeauS1R3", "TEST", 84, 92], ["AA", "TEST", 121, 123], ["IBV", "TEST", 137, 140], ["ATA CAA", "TEST", 149, 156], ["TAA", "TEST", 169, 172]]], ["For subsequent PCR amplification, primer BeauS1F3, 5 -TTT GAA AAC TGA ACA AAA GA-3 was added and amplification was conducted using the GeneAmp PCR system 9600 (Perkin Elmer, Waltham, MA, USA) as previously described [8] .", [["primer BeauS1F3, 5 -TTT GAA AAC TGA ACA AAA GA-3", "DNA", 34, 82], ["subsequent PCR amplification", "TEST", 4, 32], ["primer BeauS1F3", "TEST", 34, 49], ["TTT GAA AAC TGA ACA AAA GA", "TREATMENT", 54, 80], ["the GeneAmp PCR system", "TEST", 131, 153]]], ["The PCR products were analyzed on a 1.5% agarose gel and sequenced after cloning into the pGEMT-easy vector (Promega, Madison, WI, USA).", [["pGEMT", "GENE_OR_GENE_PRODUCT", 90, 95], ["PCR products", "DNA", 4, 16], ["pGEMT", "DNA", 90, 95], ["The PCR products", "TREATMENT", 0, 16], ["a 1.5% agarose gel", "TREATMENT", 34, 52]]], ["The DNA sequence was then determined using the Dye Terminator Cycle Sequencing method and analyzed using an ABI 377 autosequencer (Applied Biosystems, Foster City, CA, USA).Comparison of S1 genes and phylogenetic analysesThe nucleotide sequences of the S1 gene of the 29 IBV isolates (Table 1) were assembled, aligned and compared with reference IBV strains (Table A1 ) using the CLUSTAL W method with the Bioedit software http://www.mbio.ncsu.edu/BioEdit/bioedit.html [17] .", [["nucleotide", "CHEMICAL", 225, 235], ["nucleotide", "CHEMICAL", 225, 235], ["DNA", "CELLULAR_COMPONENT", 4, 7], ["S1", "GENE_OR_GENE_PRODUCT", 187, 189], ["S1", "GENE_OR_GENE_PRODUCT", 253, 255], ["IBV", "ORGANISM", 271, 274], ["DNA sequence", "DNA", 4, 16], ["S1 genes", "DNA", 187, 195], ["S1 gene", "DNA", 253, 260], ["IBV", "SPECIES", 271, 274], ["IBV", "SPECIES", 346, 349], ["The DNA sequence", "TEST", 0, 16], ["the Dye Terminator Cycle", "TREATMENT", 43, 67], ["an ABI", "TEST", 105, 111], ["S1 genes", "TEST", 187, 195], ["phylogenetic analyses", "TEST", 200, 221], ["The nucleotide sequences", "TEST", 221, 245], ["the CLUSTAL W method", "TREATMENT", 376, 396], ["S1", "ANATOMY", 253, 255]]], ["Phylogenetic and molecular evolutionary analyses were conducted using MEGA version 3.1 http://www.megasoftware.net/ [18] .", [["Phylogenetic and molecular evolutionary analyses", "PROBLEM", 0, 48], ["MEGA version", "TEST", 70, 82]]], ["The reliability of the resulting trees was evaluated by the bootstrap method with 1000 replications.Comparison of S1 genes and phylogenetic analyses2.6.", [["S1", "GENE_OR_GENE_PRODUCT", 114, 116], ["S1 genes", "DNA", 114, 122], ["phylogenetic analyses2.6", "TEST", 127, 151]]], ["Safety study 2.6.1.", [["Safety study", "TEST", 0, 12]]], ["In specific-pathogen-free (SPF) chickensComparison of S1 genes and phylogenetic analysesThe safety of viruses was initially ascertained in 1-day-old SPF chickens.", [["SPF", "ORGANISM", 149, 152], ["chickens", "ORGANISM", 153, 161], ["S1 genes", "DNA", 54, 62], ["chickens", "SPECIES", 32, 40], ["chickens", "SPECIES", 153, 161], ["chickens", "SPECIES", 32, 40], ["chickens", "SPECIES", 153, 161], ["S1 genes", "TEST", 54, 62], ["phylogenetic analyses", "TEST", 67, 88], ["viruses", "PROBLEM", 102, 109], ["viruses", "OBSERVATION", 102, 109]]], ["The birds in the experimental group were inoculated by the eye drop method with the IBV strains (K2parent, K2p170, H120 and Ma5) at 10 4.5 EID 50 /bird, while those in the control group were inoculated with phosphate buffered saline (PBS) ( Table 2 ).", [["eye", "ANATOMY", 59, 62], ["phosphate", "CHEMICAL", 207, 216], ["phosphate", "CHEMICAL", 207, 216], ["birds", "ORGANISM", 4, 9], ["eye", "ORGAN", 59, 62], ["IBV", "ORGANISM", 84, 87], ["phosphate buffered saline", "SIMPLE_CHEMICAL", 207, 232], ["IBV", "SPECIES", 84, 87], ["the IBV strains", "PROBLEM", 80, 95], ["K2parent", "TEST", 97, 105], ["K2p170", "TEST", 107, 113], ["H120", "TEST", 115, 119], ["Ma5", "TEST", 124, 127], ["phosphate buffered saline", "TREATMENT", 207, 232], ["eye", "ANATOMY", 59, 62]]], ["To determine the pathologic characteristics of IBV, we observed birds twice daily for clinical signs for 14 days.", [["IBV", "ORGANISM", 47, 50], ["birds", "ORGANISM", 64, 69], ["IBV", "SPECIES", 47, 50], ["IBV", "PROBLEM", 47, 50], ["clinical signs", "TEST", 86, 100], ["IBV", "OBSERVATION", 47, 50]]], ["Then, chickens were sacrificed and their tracheas and kidneys were collected, fixed with 10% neutral buffered formalin, and routinely processed in paraffin, after which 5 m sections were cut for hematoxylin and eosin staining for histological studies.", [["tracheas", "ANATOMY", 41, 49], ["kidneys", "ANATOMY", 54, 61], ["m sections", "ANATOMY", 171, 181], ["formalin", "CHEMICAL", 110, 118], ["paraffin", "CHEMICAL", 147, 155], ["hematoxylin", "CHEMICAL", 195, 206], ["eosin", "CHEMICAL", 211, 216], ["chickens", "ORGANISM", 6, 14], ["tracheas", "ORGAN", 41, 49], ["kidneys", "ORGAN", 54, 61], ["formalin", "SIMPLE_CHEMICAL", 110, 118], ["hematoxylin", "SIMPLE_CHEMICAL", 195, 206], ["eosin", "SIMPLE_CHEMICAL", 211, 216], ["chickens", "SPECIES", 6, 14], ["chickens", "SPECIES", 6, 14], ["chickens", "TREATMENT", 6, 14], ["10% neutral buffered formalin", "TREATMENT", 89, 118], ["hematoxylin", "TREATMENT", 195, 206], ["eosin staining", "TEST", 211, 225], ["histological studies", "TEST", 230, 250], ["tracheas", "ANATOMY", 41, 49], ["kidneys", "ANATOMY", 54, 61]]], ["The tracheal lesions scored included epithelium deciliation, proliferation, degeneration, exudate, congestion, and hemorrhage.", [["tracheal lesions", "ANATOMY", 4, 20], ["epithelium", "ANATOMY", 37, 47], ["exudate", "ANATOMY", 90, 97], ["congestion", "DISEASE", 99, 109], ["hemorrhage", "DISEASE", 115, 125], ["tracheal lesions", "PATHOLOGICAL_FORMATION", 4, 20], ["epithelium", "TISSUE", 37, 47], ["The tracheal lesions", "PROBLEM", 0, 20], ["epithelium deciliation", "PROBLEM", 37, 59], ["proliferation", "PROBLEM", 61, 74], ["degeneration", "PROBLEM", 76, 88], ["exudate", "PROBLEM", 90, 97], ["congestion", "PROBLEM", 99, 109], ["hemorrhage", "PROBLEM", 115, 125], ["tracheal", "ANATOMY", 4, 12], ["lesions", "OBSERVATION", 13, 20], ["epithelium deciliation", "OBSERVATION", 37, 59], ["proliferation", "OBSERVATION_MODIFIER", 61, 74], ["degeneration", "OBSERVATION_MODIFIER", 76, 88], ["exudate", "OBSERVATION_MODIFIER", 90, 97], ["congestion", "OBSERVATION", 99, 109], ["hemorrhage", "OBSERVATION", 115, 125]]], ["The renal lesions scored included epithelial Two weeks after challenge, chicks were sacrificed and tissues were collected to observe the histological lesions.Comparison of S1 genes and phylogenetic analysesc ++, coughing in more than 30% without dyspnea; -, no coughing. d Examined dead chickens only (++, moderate; -, mild). e Scores of histological lesions: 0, normal; 1, extensively focal; 2, multifocal; 3, diffuse.", [["renal lesions", "ANATOMY", 4, 17], ["epithelial", "ANATOMY", 34, 44], ["tissues", "ANATOMY", 99, 106], ["lesions", "ANATOMY", 150, 157], ["lesions", "ANATOMY", 351, 358], ["dyspnea", "DISEASE", 246, 253], ["coughing", "DISEASE", 261, 269], ["renal lesions", "PATHOLOGICAL_FORMATION", 4, 17], ["epithelial", "CELL", 34, 44], ["chicks", "ORGANISM", 72, 78], ["tissues", "TISSUE", 99, 106], ["histological lesions", "CANCER", 137, 157], ["S1", "GENE_OR_GENE_PRODUCT", 172, 174], ["chickens", "ORGANISM", 287, 295], ["histological lesions", "CANCER", 338, 358], ["S1 genes", "DNA", 172, 180], ["chickens", "SPECIES", 287, 295], ["The renal lesions", "PROBLEM", 0, 17], ["the histological lesions", "PROBLEM", 133, 157], ["S1 genes", "TEST", 172, 180], ["phylogenetic analysesc", "TEST", 185, 207], ["coughing", "PROBLEM", 212, 220], ["dyspnea", "PROBLEM", 246, 253], ["coughing", "PROBLEM", 261, 269], ["dead chickens", "TEST", 282, 295], ["histological lesions", "PROBLEM", 338, 358], ["renal", "ANATOMY", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["epithelial", "ANATOMY_MODIFIER", 34, 44], ["histological", "OBSERVATION_MODIFIER", 137, 149], ["lesions", "OBSERVATION", 150, 157], ["no", "UNCERTAINTY", 258, 260], ["coughing", "OBSERVATION", 261, 269], ["moderate", "OBSERVATION_MODIFIER", 306, 314], ["mild", "OBSERVATION_MODIFIER", 319, 323], ["histological", "OBSERVATION_MODIFIER", 338, 350], ["lesions", "OBSERVATION", 351, 358], ["normal", "OBSERVATION", 363, 369], ["focal", "OBSERVATION_MODIFIER", 386, 391], ["multifocal", "OBSERVATION_MODIFIER", 396, 406], ["diffuse", "OBSERVATION_MODIFIER", 411, 418]]], ["6/10 0/10 1/10 0/10 1/10 None 0/10 0/10 0/10 0/10 0/10 a One-day-old SPF chicks were inoculated with IBV (10 4.5 EID50/bird) via the intraocular route.Comparison of S1 genes and phylogenetic analysesb Seven days after challenge chicks were sacrificed and tissues were collected for re-isolation of the challenge virus.", [["intraocular", "ANATOMY", 133, 144], ["tissues", "ANATOMY", 255, 262], ["SPF", "ORGANISM", 69, 72], ["chicks", "ORGANISM", 73, 79], ["IBV", "ORGANISM", 101, 104], ["S1", "GENE_OR_GENE_PRODUCT", 165, 167], ["chicks", "ORGANISM", 228, 234], ["tissues", "TISSUE", 255, 262], ["S1 genes", "DNA", 165, 173], ["chicks", "SPECIES", 73, 79], ["IBV", "SPECIES", 101, 104], ["IBV", "TREATMENT", 101, 104], ["the intraocular route", "TREATMENT", 129, 150], ["S1 genes", "PROBLEM", 165, 173], ["phylogenetic analysesb", "TEST", 178, 200], ["challenge chicks", "TREATMENT", 218, 234], ["the challenge virus", "TREATMENT", 298, 317]]], ["Data are the number of chicks from which the virus was isolated/number of chicks inoculated with the virus. degeneration, tubulo nephrosis, interstitial nephritis, and regeneration.", [["interstitial", "ANATOMY", 140, 152], ["degeneration", "DISEASE", 108, 120], ["nephrosis", "DISEASE", 129, 138], ["interstitial nephritis", "DISEASE", 140, 162], ["chicks", "ORGANISM", 23, 29], ["chicks", "ORGANISM", 74, 80], ["the virus", "PROBLEM", 41, 50], ["the virus", "PROBLEM", 97, 106], ["degeneration", "PROBLEM", 108, 120], ["tubulo nephrosis", "PROBLEM", 122, 138], ["interstitial nephritis", "PROBLEM", 140, 162], ["regeneration", "PROBLEM", 168, 180], ["tubulo", "OBSERVATION_MODIFIER", 122, 128], ["nephrosis", "OBSERVATION", 129, 138], ["interstitial", "ANATOMY_MODIFIER", 140, 152], ["nephritis", "OBSERVATION", 153, 162], ["regeneration", "OBSERVATION_MODIFIER", 168, 180]]], ["Lesions were scored as follows: 0 for normal, 1 for extensively focal lesions, 2 for multifocal lesions, and 3 for diffuse lesions.", [["focal lesions", "ANATOMY", 64, 77], ["multifocal lesions", "ANATOMY", 85, 103], ["diffuse lesions", "ANATOMY", 115, 130], ["focal lesions", "CANCER", 64, 77], ["multifocal lesions", "CANCER", 85, 103], ["diffuse lesions", "CANCER", 115, 130], ["Lesions", "PROBLEM", 0, 7], ["extensively focal lesions", "PROBLEM", 52, 77], ["multifocal lesions", "PROBLEM", 85, 103], ["diffuse lesions", "PROBLEM", 115, 130], ["focal", "OBSERVATION_MODIFIER", 64, 69], ["lesions", "OBSERVATION", 70, 77], ["multifocal", "OBSERVATION_MODIFIER", 85, 95], ["lesions", "OBSERVATION", 96, 103], ["diffuse", "OBSERVATION_MODIFIER", 115, 122], ["lesions", "OBSERVATION", 123, 130]]], ["Additionally, we determined tissue tropisms of K2p170 in comparison with K2parent and respiratory strain K571/99 in 1-day-old SPF chickens (Table 3 ).", [["tissue", "ANATOMY", 28, 34], ["tissue", "TISSUE", 28, 34], ["K2p170", "GENE_OR_GENE_PRODUCT", 47, 53], ["chickens", "ORGANISM", 130, 138], ["K2p170", "PROTEIN", 47, 53], ["chickens", "SPECIES", 130, 138], ["chickens", "SPECIES", 130, 138], ["tissue tropisms", "TEST", 28, 43], ["respiratory strain", "TEST", 86, 104], ["respiratory strain", "OBSERVATION", 86, 104]]], ["At 7 days after intraocular challenge with IBV at 10 4.5 EID 50 /bird, the trachea, lung, cecal tonsil, kidney, and bursa of Fabricius tissues were collected from the birds and then used for re-isolation of the virus by inoculating 9-11-day-old embryonated SPF chicken eggs to determine the tissue tropism of IBV.In broiler chickensTo examine the incidence of adverse reactions in commercial broilers after spray administration, 120 one-day-old broiler chicks were divided into 3 groups with 40 chicks in each group (Table 4 ).", [["intraocular", "ANATOMY", 16, 27], ["trachea", "ANATOMY", 75, 82], ["lung", "ANATOMY", 84, 88], ["cecal tonsil", "ANATOMY", 90, 102], ["kidney", "ANATOMY", 104, 110], ["bursa", "ANATOMY", 116, 121], ["Fabricius tissues", "ANATOMY", 125, 142], ["eggs", "ANATOMY", 269, 273], ["tissue", "ANATOMY", 291, 297], ["intraocular", "IMMATERIAL_ANATOMICAL_ENTITY", 16, 27], ["IBV", "ORGANISM", 43, 46], ["trachea", "MULTI-TISSUE_STRUCTURE", 75, 82], ["lung", "ORGAN", 84, 88], ["cecal tonsil", "MULTI-TISSUE_STRUCTURE", 90, 102], ["kidney", "ORGAN", 104, 110], ["bursa", "ORGAN", 116, 121], ["Fabricius tissues", "TISSUE", 125, 142], ["birds", "ORGANISM", 167, 172], ["SPF", "ORGANISM", 257, 260], ["chicken", "ORGANISM", 261, 268], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 269, 273], ["tissue", "TISSUE", 291, 297], ["IBV", "ORGANISM", 309, 312], ["chickens", "ORGANISM", 324, 332], ["broilers", "ORGANISM_SUBDIVISION", 392, 400], ["chicks", "ORGANISM", 453, 459], ["chicken", "SPECIES", 261, 268], ["chickens", "SPECIES", 324, 332], ["broilers", "SPECIES", 392, 400], ["chicks", "SPECIES", 453, 459], ["IBV", "SPECIES", 43, 46], ["SPF", "SPECIES", 257, 260], ["chicken", "SPECIES", 261, 268], ["IBV", "SPECIES", 309, 312], ["chickens", "SPECIES", 324, 332], ["broilers", "SPECIES", 392, 400], ["intraocular challenge", "TREATMENT", 16, 37], ["IBV", "TREATMENT", 43, 46], ["Fabricius tissues", "PROBLEM", 125, 142], ["re-isolation", "TREATMENT", 191, 203], ["the virus", "PROBLEM", 207, 216], ["embryonated SPF chicken eggs", "TREATMENT", 245, 273], ["IBV", "PROBLEM", 309, 312], ["adverse reactions", "PROBLEM", 360, 377], ["spray administration", "TREATMENT", 407, 427], ["old broiler chicks", "TREATMENT", 441, 459], ["trachea", "ANATOMY", 75, 82], ["lung", "ANATOMY", 84, 88], ["cecal tonsil", "ANATOMY", 90, 102], ["kidney", "ANATOMY", 104, 110], ["bursa", "ANATOMY", 116, 121], ["Fabricius tissues", "ANATOMY", 125, 142], ["broiler chickens", "OBSERVATION", 316, 332]]], ["Chicks were obtained from a parent flock vaccinated with commercially available IB inactivated combine vaccines comprising Mass and Korean nephropathogenic strain.", [["Chicks", "ORGANISM", 0, 6], ["Chicks", "SPECIES", 0, 6], ["Chicks", "TEST", 0, 6], ["a parent flock vaccinated", "TREATMENT", 26, 51], ["IB inactivated combine vaccines", "TREATMENT", 80, 111], ["Mass", "PROBLEM", 123, 127], ["Korean nephropathogenic strain", "PROBLEM", 132, 162], ["Mass", "OBSERVATION", 123, 127], ["nephropathogenic strain", "OBSERVATION", 139, 162]]], ["These birds were housed in separate isolators, and 20 birds in each group were assigned for evaluation of safety, while another 20 birds were assigned for assessment of the weight gain over time.", [["weight gain", "DISEASE", 173, 184], ["birds", "ORGANISM", 6, 11], ["birds", "ORGANISM", 54, 59], ["birds", "ORGANISM", 131, 136], ["evaluation", "TEST", 92, 102], ["assessment", "TEST", 155, 165]]], ["Birds in the experimental group were immunized by K2p170 or H120 at 10 4.5 ID 50 /bird using a coarse sprayer (Desvac \u00ae , Desvac Inc., France, droplet size = 115 m), while those in the control group were inoculated with PBS.", [["K2p170", "CHEMICAL", 50, 56], ["H120", "CHEMICAL", 60, 64], ["a coarse sprayer", "TREATMENT", 93, 109]]], ["During the observation of clinical signs for 14 days, 5 birds in each group was euthanized and used to score rale sound, ciliostasis, and histological lesions of the trachea, lung, and kidney at days 4, 8, 11, and 14 post-inoculation.", [["lesions", "ANATOMY", 151, 158], ["trachea", "ANATOMY", 166, 173], ["lung", "ANATOMY", 175, 179], ["kidney", "ANATOMY", 185, 191], ["birds", "ORGANISM", 56, 61], ["lesions", "PATHOLOGICAL_FORMATION", 151, 158], ["trachea", "MULTI-TISSUE_STRUCTURE", 166, 173], ["lung", "ORGAN", 175, 179], ["kidney", "ORGAN", 185, 191], ["clinical signs", "TEST", 26, 40], ["ciliostasis", "PROBLEM", 121, 132], ["histological lesions of the trachea, lung, and kidney", "PROBLEM", 138, 191], ["histological", "OBSERVATION_MODIFIER", 138, 150], ["lesions", "OBSERVATION", 151, 158], ["trachea", "ANATOMY", 166, 173], ["lung", "ANATOMY", 175, 179], ["kidney", "ANATOMY", 185, 191], ["inoculation", "OBSERVATION", 222, 233]]], ["Histopathologic lesion scoring was conducted as described in the safety study in SPF chickens, and lung lesions were assessed for lympho-histiocytic and intertitial pneumonia.Virulence reversionTo examine the in vivo reversion of virulence of K2p170, 1-dayold SPF chicks were divided into two groups of three chicks.", [["lesion", "ANATOMY", 16, 22], ["lung lesions", "ANATOMY", 99, 111], ["lympho-histiocytic", "ANATOMY", 130, 148], ["lung lesions", "DISEASE", 99, 111], ["pneumonia", "DISEASE", 165, 174], ["chickens", "ORGANISM", 85, 93], ["lung lesions", "CANCER", 99, 111], ["K2p170", "ORGANISM", 243, 249], ["1-dayold SPF chicks", "ORGANISM", 251, 270], ["chicks", "ORGANISM", 309, 315], ["chickens", "SPECIES", 85, 93], ["chicks", "SPECIES", 264, 270], ["chicks", "SPECIES", 309, 315], ["SPF", "SPECIES", 81, 84], ["chickens", "SPECIES", 85, 93], ["Histopathologic lesion scoring", "PROBLEM", 0, 30], ["the safety study", "TEST", 61, 77], ["SPF chickens", "PROBLEM", 81, 93], ["lung lesions", "PROBLEM", 99, 111], ["lympho-histiocytic", "PROBLEM", 130, 148], ["intertitial pneumonia", "PROBLEM", 153, 174], ["K2p", "TEST", 243, 246], ["1-dayold SPF chicks", "TREATMENT", 251, 270], ["lesion", "OBSERVATION", 16, 22], ["lung", "ANATOMY", 99, 103], ["lesions", "OBSERVATION", 104, 111], ["intertitial", "OBSERVATION_MODIFIER", 153, 164], ["pneumonia", "OBSERVATION", 165, 174]]], ["The inoculated group received K2p170 intranasally at 10 4.5 EID 50 /bird and were observed twice daily for clinical signs for 5 days.", [["K2p170", "CHEMICAL", 30, 36]]], ["At 5 days postinoculation, the kidneys and tracheas were collected from all birds for virus detection by RT-PCR.", [["kidneys", "ANATOMY", 31, 38], ["tracheas", "ANATOMY", 43, 51], ["kidneys", "ORGAN", 31, 38], ["tracheas", "ORGAN", 43, 51], ["birds", "ORGANISM", 76, 81], ["virus detection", "TEST", 86, 101], ["RT-PCR", "TEST", 105, 111], ["kidneys", "ANATOMY", 31, 38], ["tracheas", "ANATOMY", 43, 51]]], ["After determination of the presence of the inoculated virus, the tissue homogenates were prepared in PBS with antibiotics and subsequently inoculated into the next group of chicks.", [["tissue homogenates", "ANATOMY", 65, 83], ["tissue homogenates", "ORGANISM_SUBSTANCE", 65, 83], ["chicks", "ORGANISM", 173, 179], ["chicks", "SPECIES", 173, 179], ["the inoculated virus", "PROBLEM", 39, 59], ["the tissue homogenates", "PROBLEM", 61, 83], ["antibiotics", "TREATMENT", 110, 121], ["inoculated virus", "OBSERVATION", 43, 59]]], ["After the fifth chick-passage, 10 one-day-old SPF chicks were inoculated intranasally with 10 4.5 EID 50 /bird of tissue homogenates and then observed twice daily for clinical signs for 14 days.", [["intranasally", "ANATOMY", 73, 85], ["tissue homogenates", "ANATOMY", 114, 132], ["chick", "ORGANISM", 16, 21], ["SPF", "ORGANISM", 46, 49], ["chicks", "ORGANISM", 50, 56], ["tissue homogenates", "ORGANISM_SUBSTANCE", 114, 132], ["chicks", "SPECIES", 50, 56], ["old SPF chicks", "TREATMENT", 42, 56], ["clinical signs", "TEST", 167, 181]]], ["Two weeks after challenge, birds were sacrificed, and histopathological scoring of the tracheas and kidneys was conducted as described in the safety study of SPF chickens.", [["tracheas", "ANATOMY", 87, 95], ["kidneys", "ANATOMY", 100, 107], ["birds", "ORGANISM", 27, 32], ["tracheas", "ORGAN", 87, 95], ["kidneys", "ORGAN", 100, 107], ["chickens", "ORGANISM", 162, 170], ["chickens", "SPECIES", 162, 170], ["chickens", "SPECIES", 162, 170], ["the safety study", "TEST", 138, 154], ["tracheas", "ANATOMY", 87, 95], ["kidneys", "ANATOMY", 100, 107]]], ["Table 4 Responsiveness of 1-day-old broiler chickens to vaccination with the K2p170 vaccine by spray. c On days 4, 8, 11, and 14 post-vaccination, tracheas were removed from five chickens in each group (the same animals used for histological sampling).", [["tracheas", "ANATOMY", 147, 155], ["K2p170", "CHEMICAL", 77, 83], ["chickens", "ORGANISM", 44, 52], ["tracheas", "ORGAN", 147, 155], ["chickens", "ORGANISM", 179, 187], ["chickens", "SPECIES", 44, 52], ["chickens", "SPECIES", 179, 187], ["chickens", "SPECIES", 44, 52], ["chickens", "SPECIES", 179, 187], ["vaccination", "TREATMENT", 56, 67], ["the K2p", "TREATMENT", 73, 80], ["vaccination", "TREATMENT", 134, 145], ["tracheas", "TREATMENT", 147, 155], ["histological sampling", "TEST", 229, 250], ["tracheas", "ANATOMY", 147, 155]]], ["Ten trachea rings per chick were prepared (three upper, four middle, and three lower trachea rings).", [["trachea rings", "ANATOMY", 4, 17], ["chick", "ANATOMY", 22, 27], ["lower trachea rings", "ANATOMY", 79, 98], ["trachea rings", "MULTI-TISSUE_STRUCTURE", 4, 17], ["chick", "ORGANISM", 22, 27], ["upper", "ORGANISM_SUBDIVISION", 49, 54], ["trachea rings", "MULTI-TISSUE_STRUCTURE", 85, 98], ["trachea", "ANATOMY", 4, 11], ["rings", "ANATOMY_MODIFIER", 12, 17], ["middle", "ANATOMY_MODIFIER", 61, 67], ["lower", "ANATOMY_MODIFIER", 79, 84], ["trachea rings", "ANATOMY", 85, 98]]], ["The rings were examined under low-power magnification and ciliary activity was scored as follows: 0, no ciliostasis; 1, 25% ciliostasis; 2, 50% ciliostasis; 3, 75% ciliostasis; 4, 100% ciliostasis. d Histopathology of the trachea, lung, and kidney at 4 days post-challenge with IBV was reported as histopathologic lesion scores.", [["ciliary", "ANATOMY", 58, 65], ["trachea", "ANATOMY", 222, 229], ["lung", "ANATOMY", 231, 235], ["kidney", "ANATOMY", 241, 247], ["lesion", "ANATOMY", 314, 320], ["ciliostasis", "DISEASE", 124, 135], ["ciliostasis", "DISEASE", 144, 155], ["ciliostasis", "DISEASE", 164, 175], ["ciliostasis", "DISEASE", 185, 196], ["ciliary", "MULTI-TISSUE_STRUCTURE", 58, 65], ["trachea", "MULTI-TISSUE_STRUCTURE", 222, 229], ["lung", "ORGAN", 231, 235], ["kidney", "ORGAN", 241, 247], ["IBV", "ORGANISM", 278, 281], ["IBV", "SPECIES", 278, 281], ["ciliostasis", "TEST", 104, 115], ["ciliostasis", "TEST", 124, 135], ["ciliostasis", "TEST", 144, 155], ["ciliostasis", "TEST", 164, 175], ["d Histopathology of the trachea, lung, and kidney", "PROBLEM", 198, 247], ["IBV", "TREATMENT", 278, 281], ["histopathologic lesion scores", "PROBLEM", 298, 327], ["rings", "ANATOMY_MODIFIER", 4, 9], ["no", "UNCERTAINTY", 101, 103], ["Histopathology", "OBSERVATION", 200, 214], ["trachea", "ANATOMY", 222, 229], ["lung", "ANATOMY", 231, 235], ["kidney", "ANATOMY", 241, 247], ["lesion", "OBSERVATION", 314, 320]]], ["Total 180 three-week-old SPF chickens were divided into 18 groups of 10 chicks.", [["SPF", "ORGANISM", 25, 28], ["chickens", "ORGANISM", 29, 37], ["chickens", "SPECIES", 29, 37], ["chickens", "SPECIES", 29, 37], ["old SPF chickens", "TREATMENT", 21, 37]]], ["Three weeks after immunization, all birds were challenged intraocularly with 10 4.5 EID 50 of three respiratory strains belonged to Mass group (Mass41) and Korean group I (K571/99, and K107/04) and three nephropathogenic strains belonged to Korean group II (K2parent, KM91, and K1277/03) ( Table 5 and Fig. 1 ).", [["birds", "ORGANISM", 36, 41], ["Korean group I", "SPECIES", 156, 170], ["immunization", "TREATMENT", 18, 30], ["three respiratory strains", "PROBLEM", 94, 119], ["K571/99", "TEST", 172, 179], ["K107/04", "TEST", 185, 192], ["three nephropathogenic strains", "PROBLEM", 198, 228], ["K2parent", "TEST", 258, 266], ["KM91", "TEST", 268, 272]]], ["Five days after challenge, we re-isolated the challenge virus from the trachea and kidney of birds by inoculating 9-11-day-old embryonated SPF chicken eggs to evaluate the protective efficacy of the vaccines.Neutralizing indexSera from chicks of all groups in the efficacy studies were collected at 3 weeks after immunization and inactivated at 56 \u2022 C for 30 min prior to use in viral neutralization test [19] .", [["trachea", "ANATOMY", 71, 78], ["kidney", "ANATOMY", 83, 89], ["trachea", "ORGAN", 71, 78], ["kidney", "ORGAN", 83, 89], ["birds", "ORGANISM", 93, 98], ["SPF", "ORGANISM", 139, 142], ["chicken", "ORGANISM", 143, 150], ["chicks", "ORGANISM", 236, 242], ["chicken", "SPECIES", 143, 150], ["chicks", "SPECIES", 236, 242], ["SPF", "SPECIES", 139, 142], ["chicken", "SPECIES", 143, 150], ["the challenge virus", "TREATMENT", 42, 61], ["embryonated SPF chicken eggs", "TREATMENT", 127, 155], ["the vaccines", "TREATMENT", 195, 207], ["Neutralizing indexSera", "PROBLEM", 208, 230], ["the efficacy studies", "TEST", 260, 280], ["immunization", "TREATMENT", 313, 325], ["viral neutralization test", "TEST", 379, 404], ["trachea", "ANATOMY", 71, 78], ["kidney", "ANATOMY", 83, 89]]], ["Briefly, the viruses used for immunization were 10-fold serially diluted before mixing with an equal volume of inactivated serum samples.", [["serum samples", "ANATOMY", 123, 136], ["serum samples", "ORGANISM_SUBSTANCE", 123, 136], ["the viruses", "PROBLEM", 9, 20], ["immunization", "TREATMENT", 30, 42], ["serum samples", "TEST", 123, 136]]], ["The virus-serum mixtures were placed for 1 h at 25 \u2022 C prior to inoculating 10-day-old embryonated SPF eggs (0.1 ml/egg, five eggs per diluents).", [["serum", "ANATOMY", 10, 15], ["eggs", "ANATOMY", 103, 107], ["egg", "ANATOMY", 116, 119], ["eggs", "ANATOMY", 126, 130], ["serum", "ORGANISM_SUBSTANCE", 10, 15], ["SPF", "ORGANISM", 99, 102], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 103, 107], ["SPF", "SPECIES", 99, 102], ["The virus-serum mixtures", "TEST", 0, 24], ["embryonated SPF eggs", "TREATMENT", 87, 107], ["virus", "OBSERVATION", 4, 9]]], ["The inoculated eggs were incubated for 7-8 days at 37 \u2022 C, and eggs that died within 24 h were discarded.", [["eggs", "ANATOMY", 15, 19], ["eggs", "ANATOMY", 63, 67]]], ["At the end of the experimental period, the remaining live eggs were examined for IB lesions to determine EID 50 of inoculated viruses and the neutralizing index (NI) was calculated.Statistical analysisA one-tailed Fisher's exact test was used to compare results among groups in the present study.", [["eggs", "ANATOMY", 58, 62], ["IB lesions", "ANATOMY", 81, 91], ["IB lesions", "CANCER", 81, 91], ["IB lesions", "PROBLEM", 81, 91], ["inoculated viruses", "PROBLEM", 115, 133], ["the neutralizing index", "TEST", 138, 160], ["Fisher's exact test", "TEST", 214, 233], ["the present study", "TEST", 278, 295]]], ["A p-value of <0.05 was considered to be statistically significant.Phylogenetic analyses of Korean IBV strainsA phylogenetic tree was generated to describe the relationship between nucleotide sequences of the S1 gene of the K2parent and other field isolates in Korea (Fig. 1) .", [["nucleotide", "CHEMICAL", 180, 190], ["nucleotide", "CHEMICAL", 180, 190], ["S1", "GENE_OR_GENE_PRODUCT", 208, 210], ["S1 gene", "DNA", 208, 215], ["Korean IBV", "SPECIES", 91, 101], ["A p-value", "TEST", 0, 9], ["Phylogenetic analyses", "TEST", 66, 87], ["Korean IBV strains", "PROBLEM", 91, 109], ["nucleotide sequences", "TEST", 180, 200], ["S1", "ANATOMY", 208, 210]]], ["The Korean IBV strains were separated into two distinct genetic groups (Korean group I and Korean group II), except RB86 and K110/06 formed a separate cluster with the Mass group (Table 1 and Fig. 1 ).", [["IBV", "ORGANISM", 11, 14], ["Korean IBV", "SPECIES", 4, 14], ["The Korean IBV strains", "TREATMENT", 0, 22], ["RB86", "TEST", 116, 120], ["Mass", "OBSERVATION", 168, 172]]], ["Korean group I included all respiratory strains that split into a unique genetic group, while all nephropathogenic strains were included in Korean group II.", [["all respiratory strains", "PROBLEM", 24, 47], ["all nephropathogenic strains", "PROBLEM", 94, 122], ["respiratory strains", "OBSERVATION", 28, 47]]], ["These results were identical with previous classification of Korean IBV isolates [15] and suggested that tissue tropism of IBV correlated with genotype based on the S gene sequence.", [["tissue", "ANATOMY", 105, 111], ["IBV", "ORGANISM", 68, 71], ["tissue", "TISSUE", 105, 111], ["IBV", "ORGANISM", 123, 126], ["S gene sequence", "DNA", 165, 180], ["Korean IBV", "SPECIES", 61, 71], ["IBV", "SPECIES", 123, 126], ["Korean IBV isolates", "TEST", 61, 80], ["tissue tropism of IBV", "PROBLEM", 105, 126], ["genotype", "TEST", 143, 151], ["the S gene sequence", "TEST", 161, 180]]], ["However, Korean group II was subsequently divided into two separate subgroups identified as KM91-like subgroup and QX-like subgroup.", [["KM91", "GENE_OR_GENE_PRODUCT", 92, 96], ["KM91", "PROTEIN", 92, 96], ["QX", "PROTEIN", 115, 117], ["KM91", "TEST", 92, 96]]], ["The IBV isolates detected in the 1990s to the early 2000s in Korea belonged Fig. 1 .", [["IBV", "ORGANISM", 4, 7], ["IBV", "SPECIES", 4, 7], ["The IBV isolates", "TEST", 0, 16]]], ["Phylogenetic tree showing partial S1 gene relationships between Korean IBV isolates and reference strains.", [["IBV", "ORGANISM", 71, 74], ["S1 gene", "DNA", 34, 41], ["Korean IBV", "SPECIES", 64, 74], ["Phylogenetic tree", "PROBLEM", 0, 17], ["partial S1 gene relationships", "PROBLEM", 26, 55], ["Korean IBV isolates", "TREATMENT", 64, 83], ["partial S1 gene", "OBSERVATION", 26, 41]]], ["ClustalW alignment method for S1 nucleotide positions 1-1611 corresponding to those of strain Massachusetts (GenBank accession number X04722).", [["nucleotide", "CHEMICAL", 33, 43], ["nucleotide", "CHEMICAL", 33, 43]]], ["The unrooted phylogenetic trees were generated by the distancebased neighbor-joining method and the Kimura-2 parameter model using MEGA 3.1.", [["the Kimura", "TEST", 96, 106], ["MEGA", "TEST", 131, 135], ["phylogenetic trees", "OBSERVATION", 13, 31]]], ["Reliability of the trees was assessed by bootstrap analysis in 1000 replications.", [["bootstrap analysis", "TEST", 41, 59]]], ["Bootstrap values >90% are displayed above the branch nodes.", [["branch nodes", "ANATOMY", 46, 58], ["branch nodes", "MULTI-TISSUE_STRUCTURE", 46, 58], ["Bootstrap values", "TEST", 0, 16], ["branch", "ANATOMY_MODIFIER", 46, 52], ["nodes", "OBSERVATION", 53, 58]]], ["Viruses isolated in the present study are in bold, and the K2parent (K2/01) is underlined.Phylogenetic analyses of Korean IBV strainsto the KM91-like subgroup containing the K2parent, while IBV isolates obtained after 2003 belonged to the QX-like subgroup that included the QX strain, which is a representative Chinese strain related to nephritis [10] .", [["nephritis", "DISEASE", 337, 346], ["IBV", "ORGANISM", 122, 125], ["KM91", "GENE_OR_GENE_PRODUCT", 140, 144], ["IBV", "ORGANISM", 190, 193], ["KM91", "DNA", 140, 144], ["K2parent", "DNA", 174, 182], ["QX", "DNA", 239, 241], ["Korean IBV strainsto", "SPECIES", 115, 135], ["IBV", "SPECIES", 190, 193], ["Viruses", "PROBLEM", 0, 7], ["Phylogenetic analyses", "TEST", 90, 111], ["Korean IBV", "TREATMENT", 115, 125], ["the KM91", "TEST", 136, 144], ["IBV isolates", "TEST", 190, 202], ["the QX strain", "PROBLEM", 270, 283], ["nephritis", "PROBLEM", 337, 346], ["nephritis", "OBSERVATION", 337, 346]]], ["The nucleotide identity of the QX-like subgroup strains with the KM91 was below 90% (84.6-85.2%) in spite of similar renal pathogenicity.", [["renal", "ANATOMY", 117, 122], ["nucleotide", "CHEMICAL", 4, 14], ["nucleotide", "CHEMICAL", 4, 14], ["QX", "GENE_OR_GENE_PRODUCT", 31, 33], ["renal", "ORGAN", 117, 122], ["QX", "DNA", 31, 33], ["KM91", "DNA", 65, 69], ["the KM91", "TEST", 61, 69], ["similar renal pathogenicity", "PROBLEM", 109, 136], ["similar", "OBSERVATION_MODIFIER", 109, 116], ["renal", "ANATOMY", 117, 122], ["pathogenicity", "OBSERVATION", 123, 136]]], ["The nucleotide sequences of the 28 isolates in the present study have been deposited in GenBank under the accession numbers listed in Table 1 .Biological and molecular characterization of the vaccine candidate strainWith continuing passages, K2parent became adapted to embryonated eggs showing the typical embryonic changes such as the dwarfing, stunting, or curling of embryos since the 10th passages.", [["eggs", "ANATOMY", 281, 285], ["embryonic", "ANATOMY", 306, 315], ["embryos", "ANATOMY", 370, 377], ["nucleotide", "CHEMICAL", 4, 14], ["stunting", "DISEASE", 346, 354], ["nucleotide", "CHEMICAL", 4, 14], ["embryonic", "DEVELOPING_ANATOMICAL_STRUCTURE", 306, 315], ["embryos", "DEVELOPING_ANATOMICAL_STRUCTURE", 370, 377], ["The nucleotide sequences", "TEST", 0, 24], ["the present study", "TEST", 47, 64], ["the vaccine", "TREATMENT", 188, 199], ["embryonated eggs", "PROBLEM", 269, 285], ["the typical embryonic changes", "PROBLEM", 294, 323], ["the dwarfing", "PROBLEM", 332, 344], ["stunting", "PROBLEM", 346, 354], ["curling of embryos", "PROBLEM", 359, 377], ["embryonic changes", "OBSERVATION", 306, 323]]], ["The virus initially replicated in embryonated eggs to titers below 10 6.5 EID 50 /ml.", [["eggs", "ANATOMY", 46, 50], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 46, 50], ["The virus", "PROBLEM", 0, 9], ["virus", "OBSERVATION", 4, 9]]], ["After the 160th passages, however, the virus showed high-growth properties, reaching the titers over 10 7.5 EID 50 /ml, and the undiluted virus induced early embryo mortality within 30 h post-inoculation.", [["embryo", "ANATOMY", 158, 164], ["embryo", "DEVELOPING_ANATOMICAL_STRUCTURE", 158, 164], ["the 160th passages", "TEST", 6, 24], ["the virus", "TEST", 35, 44], ["high-growth properties", "PROBLEM", 52, 74], ["the undiluted virus", "PROBLEM", 124, 143], ["early embryo mortality", "PROBLEM", 152, 174], ["high", "OBSERVATION_MODIFIER", 52, 56], ["growth properties", "OBSERVATION_MODIFIER", 57, 74], ["embryo mortality", "OBSERVATION", 158, 174]]], ["Therefore, the virus titers were adjusted to 10 5.5 to 10 6.5 EID 50 /ml for next inoculation, and the diluted virus induced embryo mortality starting from 2 or 3 days post-inoculation.", [["embryo", "ANATOMY", 125, 131], ["embryo", "DEVELOPING_ANATOMICAL_STRUCTURE", 125, 131], ["the virus titers", "TREATMENT", 11, 27], ["next inoculation", "PROBLEM", 77, 93], ["the diluted virus", "TREATMENT", 99, 116], ["embryo mortality", "PROBLEM", 125, 141]]], ["The deduced amino acid sequences of the S1 protein of K2p170 were compared with those of K2parent and nine point mutations caused by amino acid substitutions were found ( Table 6 ).Safety in SPF chickensWhen administered intraocularly, K2parent was pathogenic to 1-day-old chicks, inducing 30% mortality as well as moderate nephritis; however, K2p170 was no longer pathogenic for 1-day-old chicks, as demonstrated by the absence of any clinical signs ( Table 2 ).", [["amino acid", "CHEMICAL", 12, 22], ["amino acid", "CHEMICAL", 133, 143], ["nephritis", "DISEASE", 324, 333], ["amino acid", "CHEMICAL", 12, 22], ["amino acid", "CHEMICAL", 133, 143], ["amino acid", "AMINO_ACID", 12, 22], ["K2p170", "GENE_OR_GENE_PRODUCT", 54, 60], ["amino acid", "AMINO_ACID", 133, 143], ["chickens", "ORGANISM", 195, 203], ["chicks", "ORGANISM", 273, 279], ["chicks", "ORGANISM", 390, 396], ["S1 protein", "PROTEIN", 40, 50], ["K2p170", "PROTEIN", 54, 60], ["K2parent", "PROTEIN", 89, 97], ["chickens", "SPECIES", 195, 203], ["chicks", "SPECIES", 273, 279], ["chickens", "SPECIES", 195, 203], ["The deduced amino acid sequences", "TEST", 0, 32], ["the S1 protein", "TEST", 36, 50], ["nine point mutations", "PROBLEM", 102, 122], ["amino acid substitutions", "PROBLEM", 133, 157], ["pathogenic", "PROBLEM", 249, 259], ["old chicks", "PROBLEM", 269, 279], ["moderate nephritis", "PROBLEM", 315, 333], ["longer pathogenic", "PROBLEM", 358, 375], ["old chicks", "PROBLEM", 386, 396], ["amino acid", "OBSERVATION", 12, 22], ["moderate", "OBSERVATION_MODIFIER", 315, 323], ["nephritis", "OBSERVATION", 324, 333], ["no longer", "UNCERTAINTY", 355, 364]]], ["In addition, the histopathologic lesion scores of tracheas from birds inoculated with K2p170 did not differ significantly from those of birds inoculated with the commercial vaccines, H120 and Ma5.", [["lesion", "ANATOMY", 33, 39], ["tracheas", "ANATOMY", 50, 58], ["tracheas", "ORGAN", 50, 58], ["birds", "ORGANISM", 64, 69], ["birds", "ORGANISM", 136, 141], ["Ma5", "GENE_OR_GENE_PRODUCT", 192, 195], ["the histopathologic lesion scores of tracheas", "PROBLEM", 13, 58], ["the commercial vaccines", "TREATMENT", 158, 181], ["histopathologic", "OBSERVATION_MODIFIER", 17, 32], ["lesion", "OBSERVATION", 33, 39], ["tracheas", "ANATOMY", 50, 58]]], ["In the kidneys, K2p170 and H120 did not induce any histopathologic lesions when compared with the non-vaccinated control.", [["kidneys", "ANATOMY", 7, 14], ["lesions", "ANATOMY", 67, 74], ["kidneys", "ORGAN", 7, 14], ["K2p170", "GENE_OR_GENE_PRODUCT", 16, 22], ["lesions", "PATHOLOGICAL_FORMATION", 67, 74], ["K2p170", "TEST", 16, 22], ["any histopathologic lesions", "PROBLEM", 47, 74], ["the non-vaccinated control", "TREATMENT", 94, 120], ["kidneys", "ANATOMY", 7, 14], ["histopathologic", "OBSERVATION_MODIFIER", 51, 66], ["lesions", "OBSERVATION", 67, 74]]], ["To further examine the pathogenicity of K2p170, we compared the tissue tropism of K2p170 with K2parent and the respiratory strain K571/99.", [["tissue", "ANATOMY", 64, 70], ["K2p170", "GENE_OR_GENE_PRODUCT", 40, 46], ["tissue", "TISSUE", 64, 70], ["K2p170", "GENE_OR_GENE_PRODUCT", 82, 88], ["K2p170", "PROTEIN", 40, 46], ["the tissue tropism", "TEST", 60, 78], ["the respiratory strain", "PROBLEM", 107, 129], ["respiratory strain", "OBSERVATION", 111, 129]]], ["As shown in Table 3 , K2parent replicated well in the various organs including the kidneys, whereas replication of K2p170 was confined to the respiratory tract, similar to respiratory strain K571/99.Safety in broiler chickensTo determine if administration of K2p170 by coarse spray induced severe respiratory reactions, 1-day-old broiler chicks were given 10 4.5 EID 50 /bird of K2p170 or H120.", [["organs", "ANATOMY", 62, 68], ["kidneys", "ANATOMY", 83, 90], ["respiratory tract", "ANATOMY", 142, 159], ["respiratory", "ANATOMY", 297, 308], ["K2p170", "CHEMICAL", 259, 265], ["respiratory reactions", "DISEASE", 297, 318], ["organs", "ORGAN", 62, 68], ["kidneys", "ORGAN", 83, 90], ["K2p170", "GENE_OR_GENE_PRODUCT", 115, 121], ["respiratory tract", "ORGANISM_SUBDIVISION", 142, 159], ["chickens", "ORGANISM", 217, 225], ["K2p170", "SIMPLE_CHEMICAL", 259, 265], ["chicks", "ORGANISM", 338, 344], ["K2p170", "PROTEIN", 115, 121], ["chickens", "SPECIES", 217, 225], ["chicks", "SPECIES", 338, 344], ["chickens", "SPECIES", 217, 225], ["respiratory strain", "PROBLEM", 172, 190], ["K2p170", "TREATMENT", 259, 265], ["coarse spray", "TREATMENT", 269, 281], ["severe respiratory reactions", "PROBLEM", 290, 318], ["old broiler chicks", "TREATMENT", 326, 344], ["H120", "TREATMENT", 389, 393], ["kidneys", "ANATOMY", 83, 90], ["respiratory tract", "ANATOMY", 142, 159], ["respiratory strain", "OBSERVATION", 172, 190], ["severe", "OBSERVATION_MODIFIER", 290, 296], ["respiratory reactions", "OBSERVATION", 297, 318]]], ["Despite existence of serum maternal antibody specific both to Mass and Korean nephropathogenic strains in chicks, two IBV strains including H120 (Mass strain) and K2p170 (Korean nephropathogenic strain) induced ciliostasis in the tracheal epithelium in both inoculated groups during the period from 8 to 14 days post-inoculation.", [["serum", "ANATOMY", 21, 26], ["tracheal epithelium", "ANATOMY", 230, 249], ["serum", "ORGANISM_SUBSTANCE", 21, 26], ["chicks", "ORGANISM", 106, 112], ["IBV", "ORGANISM", 118, 121], ["Mass strain", "ORGANISM", 146, 157], ["Korean nephropathogenic strain", "ORGANISM", 171, 201], ["tracheal epithelium", "TISSUE", 230, 249], ["serum maternal antibody", "PROTEIN", 21, 44], ["chicks", "SPECIES", 106, 112], ["IBV", "SPECIES", 118, 121], ["H120", "SPECIES", 140, 144], ["serum maternal antibody", "TEST", 21, 44], ["Mass", "PROBLEM", 62, 66], ["Korean nephropathogenic strains in chicks", "PROBLEM", 71, 112], ["two IBV strains", "PROBLEM", 114, 129], ["H120 (Mass strain", "PROBLEM", 140, 157], ["K2p170", "PROBLEM", 163, 169], ["Korean nephropathogenic strain)", "PROBLEM", 171, 202], ["ciliostasis in the tracheal epithelium", "PROBLEM", 211, 249], ["Mass", "OBSERVATION", 62, 66], ["nephropathogenic strains", "OBSERVATION", 78, 102], ["tracheal", "ANATOMY", 230, 238], ["epithelium", "ANATOMY_MODIFIER", 239, 249], ["both", "ANATOMY_MODIFIER", 253, 257], ["inoculated groups", "OBSERVATION", 258, 275]]], ["The mean ciliostasis scores in both inoculated groups peaked at 8 days and subsequently declined as the chicks grew, but there was no significant difference between two groups.", [["chicks", "ORGANISM", 104, 110], ["The mean ciliostasis scores", "TEST", 0, 27], ["significant difference between two groups", "PROBLEM", 134, 175], ["mean", "OBSERVATION_MODIFIER", 4, 8], ["both", "OBSERVATION_MODIFIER", 31, 35], ["inoculated", "OBSERVATION", 36, 46], ["no", "UNCERTAINTY", 131, 133], ["significant", "OBSERVATION_MODIFIER", 134, 145], ["difference", "OBSERVATION", 146, 156]]], ["Rale sound and histopathgologic lesion scores of respiratory organs changed in a similar pattern as ciliostasis, and focal histopathologic lesions were observed only in the upper part of the tracheas.", [["histopathgologic lesion", "ANATOMY", 15, 38], ["respiratory organs", "ANATOMY", 49, 67], ["focal histopathologic lesions", "ANATOMY", 117, 146], ["upper part", "ANATOMY", 173, 183], ["tracheas", "ANATOMY", 191, 199], ["histopathgologic lesion", "PATHOLOGICAL_FORMATION", 15, 38], ["organs", "ORGAN", 61, 67], ["focal histopathologic lesions", "PATHOLOGICAL_FORMATION", 117, 146], ["upper part", "ORGANISM_SUBDIVISION", 173, 183], ["tracheas", "ORGAN", 191, 199], ["Rale sound", "TEST", 0, 10], ["histopathgologic lesion scores of respiratory organs", "PROBLEM", 15, 67], ["ciliostasis", "PROBLEM", 100, 111], ["focal histopathologic lesions", "PROBLEM", 117, 146], ["sound", "OBSERVATION_MODIFIER", 5, 10], ["histopathgologic", "OBSERVATION_MODIFIER", 15, 31], ["lesion", "OBSERVATION", 32, 38], ["respiratory organs", "OBSERVATION", 49, 67], ["focal", "OBSERVATION_MODIFIER", 117, 122], ["histopathologic", "OBSERVATION_MODIFIER", 123, 138], ["lesions", "OBSERVATION", 139, 146], ["upper part", "ANATOMY_MODIFIER", 173, 183], ["tracheas", "ANATOMY", 191, 199]]], ["In kidneys, no significant histopathological changes were observed in birds inoculated with K2p170.", [["kidneys", "ANATOMY", 3, 10], ["K2p170", "CHEMICAL", 92, 98], ["kidneys", "ORGAN", 3, 10], ["birds", "ORGANISM", 70, 75], ["significant histopathological changes", "PROBLEM", 15, 52], ["K2p", "TEST", 92, 95], ["kidneys", "ANATOMY", 3, 10], ["no", "UNCERTAINTY", 12, 14], ["significant", "OBSERVATION_MODIFIER", 15, 26], ["histopathological", "OBSERVATION", 27, 44]]], ["Indeed, no difference in average body weight was found between the experimental and control groups for 2 weeks after challenge (data not shown).Virulence reversionWe detected IBV in tissue homogenates of inoculated groups at every passage, but not in control chickens.", [["body", "ANATOMY", 33, 37], ["tissue homogenates", "ANATOMY", 182, 200], ["body", "ORGANISM_SUBDIVISION", 33, 37], ["IBV", "ORGANISM", 175, 178], ["tissue homogenates", "TISSUE", 182, 200], ["chickens", "ORGANISM", 259, 267], ["chickens", "SPECIES", 259, 267], ["IBV", "SPECIES", 175, 178], ["chickens", "SPECIES", 259, 267], ["average body weight", "TEST", 25, 44], ["Virulence reversionWe", "TREATMENT", 144, 165], ["no", "UNCERTAINTY", 8, 10], ["difference", "OBSERVATION_MODIFIER", 11, 21], ["IBV", "OBSERVATION", 175, 178], ["tissue", "OBSERVATION_MODIFIER", 182, 188], ["homogenates", "OBSERVATION_MODIFIER", 189, 200], ["inoculated groups", "OBSERVATION_MODIFIER", 204, 221]]], ["No clinical signs or deaths were observed upon five passages.", [["deaths", "DISEASE", 21, 27], ["clinical signs", "PROBLEM", 3, 17], ["deaths", "PROBLEM", 21, 27]]], ["Histological examination revealed the presence of mild tracheal lesions with loss of cilia and epithelial degeneration in chicks inoculated with viruses obtained following the fifth passage.", [["tracheal lesions", "ANATOMY", 55, 71], ["cilia", "ANATOMY", 85, 90], ["epithelial", "ANATOMY", 95, 105], ["tracheal lesions", "DISEASE", 55, 71], ["tracheal lesions", "PATHOLOGICAL_FORMATION", 55, 71], ["cilia", "CELLULAR_COMPONENT", 85, 90], ["epithelial", "TISSUE", 95, 105], ["chicks", "ORGANISM", 122, 128], ["chicks", "SPECIES", 122, 128], ["Histological examination", "TEST", 0, 24], ["mild tracheal lesions", "PROBLEM", 50, 71], ["loss of cilia", "PROBLEM", 77, 90], ["epithelial degeneration", "PROBLEM", 95, 118], ["viruses", "PROBLEM", 145, 152], ["mild", "OBSERVATION_MODIFIER", 50, 54], ["tracheal", "ANATOMY", 55, 63], ["lesions", "OBSERVATION", 64, 71], ["loss", "OBSERVATION_MODIFIER", 77, 81], ["cilia", "ANATOMY_MODIFIER", 85, 90], ["epithelial", "ANATOMY_MODIFIER", 95, 105], ["degeneration", "OBSERVATION", 106, 118], ["chicks", "OBSERVATION_MODIFIER", 122, 128], ["inoculated", "OBSERVATION_MODIFIER", 129, 139], ["viruses", "OBSERVATION", 145, 152]]], ["However, the tracheal and renal lesion scores were not significantly different from those induced by K2p170 before passage in the chickens and H120 (data not shown).", [["tracheal", "ANATOMY", 13, 21], ["renal lesion", "ANATOMY", 26, 38], ["tracheal", "MULTI-TISSUE_STRUCTURE", 13, 21], ["renal lesion", "PATHOLOGICAL_FORMATION", 26, 38], ["K2p170", "GENE_OR_GENE_PRODUCT", 101, 107], ["chickens", "ORGANISM", 130, 138], ["K2p170", "PROTEIN", 101, 107], ["chickens", "SPECIES", 130, 138], ["chickens", "SPECIES", 130, 138], ["the tracheal and renal lesion scores", "PROBLEM", 9, 45], ["tracheal", "ANATOMY", 13, 21], ["renal", "ANATOMY", 26, 31], ["lesion", "OBSERVATION", 32, 38], ["significantly different", "OBSERVATION_MODIFIER", 55, 78]]], ["These results indicate that no virulence reversion of K2p170 occurred in the chickens.Protective efficacy of K2p170As shown in Table 6 , chickens immunized with K2p170 were challenged with two nephropathogenic strains belonging to the KM91-like subgroup (K2parent and KM91), one nephropathogenic strain belonging to the QX-like subgroup (K1277/03), and three respiratory strains belonging to the Mass group (Mass41) and Korean group I (K571/99 and K107/04).", [["K2p170", "CHEMICAL", 54, 60], ["K2p170As", "CHEMICAL", 109, 117], ["K2p170", "GENE_OR_GENE_PRODUCT", 54, 60], ["chickens", "ORGANISM", 77, 85], ["K2p170As", "SIMPLE_CHEMICAL", 109, 117], ["chickens", "ORGANISM", 137, 145], ["K2p170", "GENE_OR_GENE_PRODUCT", 161, 167], ["KM91", "GENE_OR_GENE_PRODUCT", 235, 239], ["K2p170", "DNA", 54, 60], ["K2p170As", "PROTEIN", 109, 117], ["KM91", "PROTEIN", 235, 239], ["chickens", "SPECIES", 77, 85], ["chickens", "SPECIES", 137, 145], ["chickens", "SPECIES", 77, 85], ["chickens", "SPECIES", 137, 145], ["Korean group I", "SPECIES", 420, 434], ["virulence reversion of K2p170", "PROBLEM", 31, 60], ["K2p170As", "TEST", 109, 117], ["two nephropathogenic strains", "PROBLEM", 189, 217], ["the KM91", "TEST", 231, 239], ["one nephropathogenic strain", "PROBLEM", 275, 302], ["three respiratory strains", "PROBLEM", 353, 378], ["K107/04", "TEST", 448, 455], ["no", "UNCERTAINTY", 28, 30], ["virulence reversion", "OBSERVATION", 31, 50], ["Mass", "OBSERVATION", 396, 400]]], ["In groups of chickens vaccinated with H120, complete protection of the respiratory tract against homologous strain Mass41 (p < 0.001) was observed, but partial protection against other challenge viruses was observed (p > 0.05).", [["respiratory tract", "ANATOMY", 71, 88], ["H120", "CHEMICAL", 38, 42], ["chickens", "ORGANISM", 13, 21], ["respiratory tract", "ORGANISM_SUBDIVISION", 71, 88], ["chickens", "SPECIES", 13, 21], ["chickens", "SPECIES", 13, 21], ["H120", "SPECIES", 38, 42], ["chickens vaccinated", "TREATMENT", 13, 32], ["H120", "TREATMENT", 38, 42], ["the respiratory tract", "PROBLEM", 67, 88], ["homologous strain Mass41", "PROBLEM", 97, 121], ["other challenge viruses", "PROBLEM", 179, 202], ["respiratory tract", "ANATOMY", 71, 88]]], ["In the kidneys, H120 provided little protection against the nephropathogenic strain K2parent and KM91.", [["kidneys", "ANATOMY", 7, 14], ["H120", "CHEMICAL", 16, 20], ["KM91", "CHEMICAL", 97, 101], ["kidneys", "ORGAN", 7, 14], ["kidneys", "ANATOMY", 7, 14]]], ["Conversely, chickens immunized with K2p170 showed significantly higher levels of protection against challenge with all of the viruses except K107/04 at the kidney and trachea levels (p < 0.01 or better).", [["kidney", "ANATOMY", 156, 162], ["trachea", "ANATOMY", 167, 174], ["K2p170", "CHEMICAL", 36, 42], ["chickens", "ORGANISM", 12, 20], ["K107/04", "SIMPLE_CHEMICAL", 141, 148], ["kidney", "ORGAN", 156, 162], ["trachea", "ORGAN", 167, 174], ["chickens", "SPECIES", 12, 20], ["chickens", "SPECIES", 12, 20], ["trachea levels", "TEST", 167, 181], ["viruses", "OBSERVATION", 126, 133], ["kidney", "ANATOMY", 156, 162], ["trachea", "ANATOMY", 167, 174]]], ["However, K2p170 conferred better tracheal protection than H120 against challenge with K107/04.", [["tracheal", "ANATOMY", 33, 41], ["K2p170", "CHEMICAL", 9, 15], ["H120", "CHEMICAL", 58, 62], ["K107/04", "CHEMICAL", 86, 93], ["K2p170", "GENE_OR_GENE_PRODUCT", 9, 15], ["tracheal", "MULTI-TISSUE_STRUCTURE", 33, 41], ["K2p170", "PROTEIN", 9, 15], ["K107/04", "TREATMENT", 86, 93]]], ["Sera from immunized birds were collected at 3 weeks post-immunization and the neutralization index (NI) of the experimental group was examined.", [["Sera", "ANATOMY", 0, 4], ["Sera", "ORGANISM_SUBSTANCE", 0, 4], ["birds", "ORGANISM", 20, 25], ["Sera", "TEST", 0, 4], ["the neutralization index", "TEST", 74, 98]]], ["IB vaccine is defined as being effective if the NI of immunized groups exceeds 2.0 and the NI of the non-immunized control group is <1.0.", [["IB vaccine", "TREATMENT", 0, 10]]], ["The NI of immunized chickens by K2p170 and H120 was 4.5 and 1.8, respectively, whereas that of the non-immunized control was 0.6 (data not shown).DiscussionAlthough attenuation of viruses is usually achieved by passage of the virus in a foreign host such as embryonated eggs or tissue culture cells [20] , it has been found that IBV, which is a member of the coronavirus family, was not easily attenuated using this method.", [["eggs", "ANATOMY", 270, 274], ["tissue culture cells", "ANATOMY", 278, 298], ["chickens", "ORGANISM", 20, 28], ["tissue culture cells", "CELL", 278, 298], ["IBV", "ORGANISM", 329, 332], ["coronavirus", "ORGANISM", 359, 370], ["tissue culture cells", "CELL_TYPE", 278, 298], ["chickens", "SPECIES", 20, 28], ["chickens", "SPECIES", 20, 28], ["IBV", "SPECIES", 329, 332], ["immunized chickens", "TREATMENT", 10, 28], ["K2p170", "TEST", 32, 38], ["the non-immunized control", "TREATMENT", 95, 120], ["attenuation of viruses", "PROBLEM", 165, 187], ["the virus", "PROBLEM", 222, 231], ["a foreign host", "TREATMENT", 235, 249], ["embryonated eggs", "PROBLEM", 258, 274], ["tissue culture cells", "TEST", 278, 298], ["IBV", "PROBLEM", 329, 332], ["this method", "TREATMENT", 411, 422], ["viruses", "OBSERVATION", 180, 187], ["IBV", "OBSERVATION", 329, 332]]], ["In fact, long-term passage in embryonated eggs is necessary to reduce the virulence of IBV, and most commercially available IBV vaccines (e.g., H52, H120, 4/91 and GA98) are produced by more than 50 serial passages [5, 21] .", [["eggs", "ANATOMY", 42, 46], ["IBV", "ORGANISM", 87, 90], ["IBV", "ORGANISM", 124, 127], ["GA98", "GENE_OR_GENE_PRODUCT", 164, 168], ["IBV", "SPECIES", 87, 90], ["IBV", "SPECIES", 124, 127], ["long-term passage in embryonated eggs", "TREATMENT", 9, 46], ["IBV", "PROBLEM", 87, 90], ["IBV vaccines", "TREATMENT", 124, 136], ["long-term", "OBSERVATION_MODIFIER", 9, 18]]], ["In a previous study, the 120th passage virus of the Mass serotype (the H120 strain) did not induce any mortality in day-old chicks [5] .", [["Mass serotype", "ORGANISM", 52, 65], ["a previous study", "TEST", 3, 19], ["the Mass serotype", "PROBLEM", 48, 65], ["Mass", "OBSERVATION", 52, 56]]], ["However, in this study, 120th passage virus of the K2parent did not induce mortality in day-old chicks by intraocular administration, but still induced mortality (<30%) in day-old chicks after coarse spray administration (data not shown).", [["intraocular", "ANATOMY", 106, 117], ["120th passage virus", "ORGANISM", 24, 43], ["chicks", "ORGANISM", 96, 102], ["intraocular", "IMMATERIAL_ANATOMICAL_ENTITY", 106, 117], ["chicks", "ORGANISM", 180, 186], ["this study", "TEST", 12, 22], ["intraocular administration", "TREATMENT", 106, 132], ["coarse spray administration", "TREATMENT", 193, 220]]], ["Therefore, we found that nephropathogenic strains required additional egg passages when compared to Mass strains for complete attenuation.", [["egg", "ANATOMY", 70, 73], ["nephropathogenic strains", "PROBLEM", 25, 49], ["additional egg passages", "TREATMENT", 59, 82], ["Mass strains", "PROBLEM", 100, 112], ["egg passages", "OBSERVATION", 70, 82], ["attenuation", "OBSERVATION_MODIFIER", 126, 137]]], ["On the other hand, the 170th passage virus (K2p170) was considered to be completely attenuated because it was nonpathogenic to day-old chicks.", [["K2p170", "CHEMICAL", 44, 50], ["170th passage virus", "ORGANISM", 23, 42], ["chicks", "ORGANISM", 135, 141], ["chicks", "SPECIES", 135, 141], ["old chicks", "PROBLEM", 131, 141]]], ["To our knowledge, the K2p170 seems to be the most highly egg passaged strain commercial IBV vaccine strains in the world [5] .DiscussionThe S protein of coronavirus has been shown to be related to the attenuation of virulence and to broadening host ranges or cell types [22, 23] .", [["cell", "ANATOMY", 259, 263], ["K2p170", "GENE_OR_GENE_PRODUCT", 22, 28], ["IBV", "ORGANISM", 88, 91], ["coronavirus", "ORGANISM", 153, 164], ["cell", "CELL", 259, 263], ["S protein", "PROTEIN", 140, 149], ["IBV", "SPECIES", 88, 91], ["commercial IBV vaccine strains", "TREATMENT", 77, 107], ["coronavirus", "PROBLEM", 153, 164], ["the attenuation of virulence", "PROBLEM", 197, 225]]], ["Casais et al. [24] demonstrated that the S protein is a determinant of cell tropism of IBV, and it has been suggested that some amino acid residues contributed to attenuation of IBV [25, 26] .", [["cell", "ANATOMY", 71, 75], ["amino acid", "CHEMICAL", 128, 138], ["amino acid", "CHEMICAL", 128, 138], ["cell", "CELL", 71, 75], ["IBV", "ORGANISM", 87, 90], ["amino acid", "AMINO_ACID", 128, 138], ["IBV", "ORGANISM", 178, 181], ["S protein", "PROTEIN", 41, 50], ["IBV", "SPECIES", 87, 90], ["IBV", "SPECIES", 178, 181], ["the S protein", "TEST", 37, 50], ["cell tropism of IBV", "TREATMENT", 71, 90], ["some amino acid residues", "TREATMENT", 123, 147], ["attenuation of IBV", "TREATMENT", 163, 181]]], ["However, amino acid changes in the S protein of K2p170 were not identical to these substitutions, even though K2p170 undergo distinct alteration of biological features including restriction in the tracheas and lack of renal pathogenicity.", [["tracheas", "ANATOMY", 197, 205], ["renal", "ANATOMY", 218, 223], ["amino acid", "CHEMICAL", 9, 19], ["amino acid", "CHEMICAL", 9, 19], ["amino acid", "AMINO_ACID", 9, 19], ["K2p170", "GENE_OR_GENE_PRODUCT", 48, 54], ["K2p170", "GENE_OR_GENE_PRODUCT", 110, 116], ["tracheas", "ORGAN", 197, 205], ["renal", "ORGAN", 218, 223], ["S protein", "PROTEIN", 35, 44], ["K2p170", "PROTEIN", 48, 54], ["K2p170", "PROTEIN", 110, 116], ["amino acid changes", "PROBLEM", 9, 27], ["the S protein", "TEST", 31, 44], ["restriction in the tracheas", "PROBLEM", 178, 205], ["renal pathogenicity", "PROBLEM", 218, 237], ["amino acid", "OBSERVATION", 9, 19], ["distinct", "OBSERVATION_MODIFIER", 125, 133], ["alteration", "OBSERVATION", 134, 144], ["biological features", "OBSERVATION", 148, 167], ["tracheas", "ANATOMY", 197, 205], ["renal", "ANATOMY", 218, 223], ["pathogenicity", "OBSERVATION", 224, 237]]], ["In agreement with previous studies conducted to determine a region that leads to the pathogenic phenotype of IBV [15, 27] , our findings suggest that the renal tropism and pathogenicity of K2p170 are not related to the S1 gene, but to other genes [28] .", [["renal", "ANATOMY", 154, 159], ["IBV", "ORGANISM", 109, 112], ["renal", "ORGAN", 154, 159], ["K2p170", "GENE_OR_GENE_PRODUCT", 189, 195], ["S1", "GENE_OR_GENE_PRODUCT", 219, 221], ["K2p170", "DNA", 189, 195], ["S1 gene", "DNA", 219, 226], ["IBV", "SPECIES", 109, 112], ["previous studies", "TEST", 18, 34], ["the renal tropism", "PROBLEM", 150, 167], ["pathogenicity of K2p170", "PROBLEM", 172, 195], ["renal", "ANATOMY", 154, 159], ["tropism", "OBSERVATION", 160, 167]]], ["Further genetic investigation of K2p170, such as comparison of the entire genome of attenuated IBV strains with its parent strains [29] , may provide a better understanding of the pathogenicity related to renal tropism of IBV.DiscussionDespite a lack of renal tropism after attenuation, K2p170 was still able to replicate in the tracheas, which induced mild ciliostasis and histological lesions.", [["renal", "ANATOMY", 205, 210], ["renal", "ANATOMY", 254, 259], ["tracheas", "ANATOMY", 329, 337], ["lesions", "ANATOMY", 387, 394], ["ciliostasis", "DISEASE", 358, 369], ["K2p170", "GENE_OR_GENE_PRODUCT", 33, 39], ["IBV strains", "ORGANISM", 95, 106], ["renal", "ORGAN", 205, 210], ["IBV", "ORGANISM", 222, 225], ["renal", "ORGAN", 254, 259], ["tracheas", "ORGAN", 329, 337], ["histological lesions", "CANCER", 374, 394], ["K2p170", "DNA", 33, 39], ["IBV", "SPECIES", 95, 98], ["IBV", "SPECIES", 222, 225], ["Further genetic investigation", "TEST", 0, 29], ["attenuated IBV strains", "PROBLEM", 84, 106], ["the pathogenicity", "PROBLEM", 176, 193], ["renal tropism of IBV", "TREATMENT", 205, 225], ["renal tropism", "PROBLEM", 254, 267], ["mild ciliostasis", "PROBLEM", 353, 369], ["histological lesions", "PROBLEM", 374, 394], ["renal", "ANATOMY", 205, 210], ["tropism", "OBSERVATION", 211, 218], ["renal", "ANATOMY", 254, 259], ["tropism", "OBSERVATION", 260, 267], ["tracheas", "ANATOMY", 329, 337], ["mild", "OBSERVATION_MODIFIER", 353, 357], ["ciliostasis", "OBSERVATION", 358, 369], ["histological", "OBSERVATION_MODIFIER", 374, 386], ["lesions", "OBSERVATION", 387, 394]]], ["It is likely that some damage to the tracheal mucosa is necessary for the development of local immunity against IBV [21] .", [["tracheal mucosa", "ANATOMY", 37, 52], ["tracheal mucosa", "MULTI-TISSUE_STRUCTURE", 37, 52], ["IBV", "ORGANISM", 112, 115], ["IBV", "SPECIES", 112, 115], ["some damage to the tracheal mucosa", "PROBLEM", 18, 52], ["IBV", "PROBLEM", 112, 115], ["is likely", "UNCERTAINTY", 3, 12], ["damage", "OBSERVATION", 23, 29], ["tracheal mucosa", "ANATOMY", 37, 52]]], ["The level of damage was found to be comparable to that of commercial vaccines (H120 and Ma5), and was in agreement with recent studies conducted to determine the attenuation phenotypes of the GA98 serotype vaccine via evaluation of tracheal lesion scores following challenge [21] .", [["tracheal lesion", "ANATOMY", 232, 247], ["GA98", "CHEMICAL", 192, 196], ["GA98 serotype", "ORGANISM", 192, 205], ["tracheal lesion", "PATHOLOGICAL_FORMATION", 232, 247], ["damage", "PROBLEM", 13, 19], ["commercial vaccines", "TREATMENT", 58, 77], ["recent studies", "TEST", 120, 134], ["the attenuation phenotypes", "PROBLEM", 158, 184], ["the GA98 serotype vaccine", "TREATMENT", 188, 213], ["evaluation", "TEST", 218, 228], ["tracheal lesion scores", "PROBLEM", 232, 254], ["damage", "OBSERVATION", 13, 19], ["tracheal", "ANATOMY", 232, 240], ["lesion", "OBSERVATION", 241, 247]]], ["Moreover, K2p170 caused limited damage to the respiratory tract and did not affect the growth performance of broilers, even after coarse spray.", [["respiratory tract", "ANATOMY", 46, 63], ["K2p170", "CHEMICAL", 10, 16], ["damage to the respiratory tract", "DISEASE", 32, 63], ["K2p170", "SIMPLE_CHEMICAL", 10, 16], ["respiratory tract", "ORGANISM_SUBDIVISION", 46, 63], ["broilers", "ORGANISM_SUBDIVISION", 109, 117], ["K2p170", "PROTEIN", 10, 16], ["broilers", "SPECIES", 109, 117], ["limited damage to the respiratory tract", "PROBLEM", 24, 63], ["coarse spray", "TREATMENT", 130, 142], ["respiratory tract", "ANATOMY", 46, 63]]], ["In addition, no virulence reversion of the K2p170 occurred in SPF chickens, as demonstrated by the absence of clinical signs and mild histological lesions following in vivo back passage.", [["lesions", "ANATOMY", 147, 154], ["K2p170", "GENE_OR_GENE_PRODUCT", 43, 49], ["SPF chickens", "ORGANISM", 62, 74], ["histological lesions", "PATHOLOGICAL_FORMATION", 134, 154], ["K2p170", "DNA", 43, 49], ["chickens", "SPECIES", 66, 74], ["SPF", "SPECIES", 62, 65], ["chickens", "SPECIES", 66, 74], ["virulence reversion", "PROBLEM", 16, 35], ["the K2p170", "PROBLEM", 39, 49], ["clinical signs", "PROBLEM", 110, 124], ["mild histological lesions", "PROBLEM", 129, 154], ["vivo back passage", "TREATMENT", 168, 185], ["no", "UNCERTAINTY", 13, 15], ["virulence reversion", "OBSERVATION", 16, 35], ["SPF chickens", "OBSERVATION", 62, 74], ["mild", "OBSERVATION_MODIFIER", 129, 133], ["histological", "OBSERVATION_MODIFIER", 134, 146], ["lesions", "OBSERVATION", 147, 154]]], ["These findings suggest that K2p170 is useful for hatchery spray vaccination, which is a method of mass vaccination for IBV that is used worldwide [2] .", [["K2p170", "CHEMICAL", 28, 34], ["K2p170", "GENE_OR_GENE_PRODUCT", 28, 34], ["IBV", "ORGANISM", 119, 122], ["IBV", "SPECIES", 119, 122], ["hatchery spray vaccination", "TREATMENT", 49, 75], ["a method of mass vaccination", "TREATMENT", 86, 114], ["IBV", "TREATMENT", 119, 122]]], ["On the basis of its safety in dayold chicks demonstrated, delivery of K2p170 in ovo can be further attempted as a novel vaccination route of choice for IB vaccines [30] .DiscussionLong-term passage may be beneficial for vaccine safety, but it is possible that over-attenuation of the virus leads to poor protection due to insufficient replication [31] .", [["K2p170", "CHEMICAL", 70, 76], ["K2p170", "GENE_OR_GENE_PRODUCT", 70, 76], ["ovo", "ORGANISM", 80, 83], ["delivery of K2p170", "TREATMENT", 58, 76], ["a novel vaccination route of choice", "TREATMENT", 112, 147], ["IB vaccines", "TREATMENT", 152, 163], ["DiscussionLong-term passage", "TREATMENT", 170, 197], ["vaccine safety", "TREATMENT", 220, 234], ["the virus", "PROBLEM", 280, 289], ["insufficient replication", "PROBLEM", 322, 346]]], ["In the present study, the K2p170 induced strong local immunity following replication in the trachea, as evidenced by the complete protection of the tracheas against the homologous K2parent strain.", [["trachea", "ANATOMY", 92, 99], ["tracheas", "ANATOMY", 148, 156], ["K2p170", "CHEMICAL", 26, 32], ["K2p170", "GENE_OR_GENE_PRODUCT", 26, 32], ["trachea", "ORGAN", 92, 99], ["tracheas", "ORGAN", 148, 156], ["K2p170", "PROTEIN", 26, 32], ["the present study", "TEST", 3, 20], ["the tracheas", "TREATMENT", 144, 156], ["the homologous K2parent strain", "PROBLEM", 165, 195], ["trachea", "ANATOMY", 92, 99], ["tracheas", "ANATOMY", 148, 156]]], ["Despite restricted replication in the trachea, neutralizing antibodies to the K2p170 were induced (NI of K2p170 was 4.5), and K2p170 induced complete protection of the kidneys.", [["trachea", "ANATOMY", 38, 45], ["kidneys", "ANATOMY", 168, 175], ["trachea", "ORGAN", 38, 45], ["K2p170", "GENE_OR_GENE_PRODUCT", 78, 84], ["K2p170", "GENE_OR_GENE_PRODUCT", 126, 132], ["kidneys", "ORGAN", 168, 175], ["neutralizing antibodies", "PROTEIN", 47, 70], ["K2p170", "PROTEIN", 78, 84], ["K2p170", "PROTEIN", 126, 132], ["restricted replication in the trachea", "PROBLEM", 8, 45], ["neutralizing antibodies", "TEST", 47, 70], ["the K2p", "TEST", 74, 81], ["NI", "TEST", 99, 101], ["K2p170", "TEST", 105, 111], ["restricted", "OBSERVATION_MODIFIER", 8, 18], ["replication", "OBSERVATION", 19, 30], ["trachea", "ANATOMY", 38, 45], ["kidneys", "ANATOMY", 168, 175]]], ["These findings indicate that K2p170 is highly immunogenic.", [["K2p170", "CHEMICAL", 29, 35], ["K2p170", "GENE_OR_GENE_PRODUCT", 29, 35], ["K2p170", "PROTEIN", 29, 35], ["highly", "OBSERVATION_MODIFIER", 39, 45], ["immunogenic", "OBSERVATION", 46, 57]]], ["As seen in a previous study describing the genetic stability of Korean nephropathogenic strains sharing 96% homology of the S1 gene for 10 years [15] , we observed only eight amino acid changes in the S1 protein of K2p170.", [["amino acid", "CHEMICAL", 175, 185], ["amino acid", "CHEMICAL", 175, 185], ["amino acid", "AMINO_ACID", 175, 185], ["K2p170", "GENE_OR_GENE_PRODUCT", 215, 221], ["S1 gene", "DNA", 124, 131], ["S1 protein", "PROTEIN", 201, 211], ["K2p170", "PROTEIN", 215, 221], ["a previous study", "TEST", 11, 27], ["Korean nephropathogenic strains", "PROBLEM", 64, 95], ["eight amino acid changes", "PROBLEM", 169, 193], ["S1", "ANATOMY", 124, 126], ["amino acid", "OBSERVATION", 175, 185]]], ["Interestingly, most altered residues were located outside of the hypervariable region (HVR), which is associated with the neutralizing epitope [1] .", [["hypervariable region", "PROTEIN", 65, 85], ["most altered residues", "PROBLEM", 15, 36], ["altered", "OBSERVATION_MODIFIER", 20, 27], ["residues", "OBSERVATION", 28, 36], ["hypervariable", "OBSERVATION_MODIFIER", 65, 78], ["region", "OBSERVATION_MODIFIER", 79, 85]]], ["Because the S1 protein has been identified as a major inducer of protective immune responses, our findings lead to the conclusion that the genetic stability of K2p170 contributes to maintenance of constant immunogenicity, even after prolonged passage in embryonated eggs.", [["eggs", "ANATOMY", 266, 270], ["K2p170", "CHEMICAL", 160, 166], ["S1", "GENE_OR_GENE_PRODUCT", 12, 14], ["K2p170", "GENE_OR_GENE_PRODUCT", 160, 166], ["S1 protein", "PROTEIN", 12, 22], ["K2p170", "PROTEIN", 160, 166], ["the S1 protein", "TEST", 8, 22], ["constant immunogenicity", "PROBLEM", 197, 220], ["prolonged passage in embryonated eggs", "PROBLEM", 233, 270]]], ["Although K2parent was chosen based on its cross-protective ability [8] , it is not clear if the fully attenuated K2p170 still induced cross-protection.", [["K2p170", "CHEMICAL", 113, 119]]], ["In efficacy studies, K2p170 provided almost complete protection against distinct QX-like subgroup strain of Korean group II (K1277/03) and significant protection against heterologous IBV strains belonged to Mass group (Mass41) and Korean group I (K107/04).", [["K2p170", "CHEMICAL", 21, 27], ["QX", "CHEMICAL", 81, 83], ["K2p170", "SIMPLE_CHEMICAL", 21, 27], ["QX", "GENE_OR_GENE_PRODUCT", 81, 83], ["IBV", "ORGANISM", 183, 186], ["Korean group II", "SPECIES", 108, 123], ["IBV", "SPECIES", 183, 186], ["efficacy studies", "TEST", 3, 19], ["K2p", "TEST", 21, 24], ["heterologous IBV strains", "PROBLEM", 170, 194]]], ["It has been proposed that the use of a combination of two commercial vaccines, Mass and 4/91, could be partly effective against heterologous IBV strains, including QX-like strains [32] .", [["4/91", "CHEMICAL", 88, 92], ["4/91", "SIMPLE_CHEMICAL", 88, 92], ["IBV", "ORGANISM", 141, 144], ["QX-like strains", "ORGANISM", 164, 179], ["IBV", "SPECIES", 141, 144], ["two commercial vaccines", "TREATMENT", 54, 77], ["Mass", "PROBLEM", 79, 83], ["heterologous IBV strains", "PROBLEM", 128, 152], ["QX-like strains", "PROBLEM", 164, 179], ["Mass", "OBSERVATION", 79, 83]]], ["However, the use of multiple strains of live vaccines should be practiced with caution due to concerns regarding the formation of variant viruses by recombination with field strains resulting from the spread of vaccine strains [33] .", [["live vaccines", "TREATMENT", 40, 53], ["variant viruses", "PROBLEM", 130, 145], ["field strains", "PROBLEM", 168, 181], ["vaccine strains", "PROBLEM", 211, 226]]], ["Conversely, the results presented here suggest that single administration of the K2p170 is markedly effective and economical due to its cross-protective ability.", [["K2p170", "CHEMICAL", 81, 87], ["K2p170", "GENE_OR_GENE_PRODUCT", 81, 87], ["the K2p170", "TREATMENT", 77, 87]]], ["It will be important to determine the range of cross-protection conferred by K2p170 against other heterologous IBV strains.DiscussionMass serotype vaccines have been used worldwide for almost 50 years due to their cross-protective ability.", [["K2p170", "CHEMICAL", 77, 83], ["K2p170", "GENE_OR_GENE_PRODUCT", 77, 83], ["IBV", "ORGANISM", 111, 114], ["IBV", "SPECIES", 111, 114], ["other heterologous IBV strains", "PROBLEM", 92, 122], ["DiscussionMass serotype vaccines", "TREATMENT", 123, 155]]], ["Nevertheless, nephropathogenic strains appear to be the 3rd epizootic strain with Mass and 4/91 strains in many parts of the world.", [["nephropathogenic strains", "PROBLEM", 14, 38], ["the 3rd epizootic strain", "PROBLEM", 52, 76], ["Mass", "PROBLEM", 82, 86], ["strains", "PROBLEM", 96, 103], ["Mass", "OBSERVATION", 82, 86]]], ["Based on the data presented in this study, K2p170 has broad-spectrum protective ability.", [["K2p170", "CHEMICAL", 43, 49], ["K2p170", "GENE_OR_GENE_PRODUCT", 43, 49], ["the data", "TEST", 9, 17], ["this study", "TEST", 31, 41], ["K2p", "TEST", 43, 46]]], ["Furthermore, the attenuation and immunogenicity of the virus were comparable to currently available commercial vaccines, which indicate that K2p170 is suitable for field application to young chicks in hatcheries and farms.", [["K2p170", "CHEMICAL", 141, 147], ["K2p170", "GENE_OR_GENE_PRODUCT", 141, 147], ["chicks", "SPECIES", 191, 197], ["the attenuation", "PROBLEM", 13, 28], ["the virus", "PROBLEM", 51, 60], ["commercial vaccines", "TREATMENT", 100, 119], ["attenuation", "OBSERVATION_MODIFIER", 17, 28]]], ["Therefore, K2p170 merits consideration as a novel live vaccine candidate for the reduction of economic losses caused by newly evolving nephropathogenic IBV strains and the many IBV variants that have been reported worldwide.", [["K2p170", "GENE_OR_GENE_PRODUCT", 11, 17], ["IBV", "ORGANISM", 152, 155], ["IBV", "ORGANISM", 177, 180], ["K2p170", "PROTEIN", 11, 17], ["IBV", "SPECIES", 152, 155], ["IBV", "SPECIES", 177, 180], ["a novel live vaccine", "TREATMENT", 42, 62], ["economic losses", "PROBLEM", 94, 109], ["newly evolving nephropathogenic IBV strains", "PROBLEM", 120, 163], ["the many IBV variants", "PROBLEM", 168, 189], ["economic losses", "OBSERVATION", 94, 109], ["nephropathogenic IBV strains", "OBSERVATION", 135, 163], ["many", "OBSERVATION_MODIFIER", 172, 176], ["IBV variants", "OBSERVATION", 177, 189]]]], "PMC3151452": [["Integral to this paradigm are the roles of economic status\u2013often captured by the level of income and its distribution or some measure of deprivation and poverty\u2013education, employment status and working conditions, housing, early childhood development, social cohesion and inclusion, gender, race, systems of social security, and equitable access to appropriate health care.IntroductionThe fundamental view that underlies this new paradigm is that socioeconomic and political contexts in which people live have significant bearing upon their health and well-being.", [["people", "ORGANISM", 493, 499], ["people", "SPECIES", 493, 499], ["poverty\u2013education", "TREATMENT", 153, 170], ["The fundamental view", "TEST", 385, 405], ["significant", "OBSERVATION_MODIFIER", 510, 521]]], ["Numerous studies have documented the contribution of socioeconomic factors to individual and population health.", [["Numerous studies", "TEST", 0, 16], ["socioeconomic factors", "PROBLEM", 53, 74]]], ["Also, a few studies have investigated the (indirect) role of political factors on health and quality of life through their mediation with the labour market relationships and the welfare state institutions and policies in a number of (mostly European) countries (Navarro, 2004).", [["a few studies", "TEST", 6, 19]]], ["Even fewer studies have explored the direct effects of political factors and systems on people's health.IntroductionThe role of democracy and political freedom in population health has been recognized as early as the mid 19th century by the prominent pathologist Rudolph Virchow (1948/1985).", [["people", "ORGANISM", 88, 94], ["people", "SPECIES", 88, 94]]], ["Since then, however, such factors have been totally ignored in subsequent studies of the etiology of disease and population health.", [["disease", "PROBLEM", 101, 108], ["disease", "OBSERVATION", 101, 108]]], ["There are a few exceptions, however.", [["few", "OBSERVATION_MODIFIER", 12, 15]]], ["One study (Lena and London, 1993) examines the impact of regime ideology on measures of population health and mortality rates.", [["One study", "TEST", 0, 9], ["mortality rates", "TEST", 110, 125]]], ["Another study (Shandra et al., 2004) considers the role of political democracy, along with a set of socioeconomic indicators on infant mortality rates in a sample of 50-60 developing countries.", [["Another study", "TEST", 0, 13], ["infant mortality rates", "TEST", 128, 150]]], ["However, the results of this study for the separate role of political democracy are neither statistically significant nor empirically conclusive.", [["this study", "TEST", 24, 34], ["political democracy", "OBSERVATION", 60, 79]]], ["Yet another study (Franco et al., 2004) investigates the effect of democracy on some measures of population health.", [["another study", "TEST", 4, 17]]], ["This study finds longer life expectancies and lower infant and maternal mortality rates in \u201cpartially free\u201d and \u201cfree\u201d countries compared with \u201cnot free\u201d countries.", [["This study", "TEST", 0, 10], ["lower infant and maternal mortality rates", "PROBLEM", 46, 87]]], ["In a more recent study (Ruger, 2005), the link between democracy and health in China is noted by looking into three epidemics of famine, SARS (Severe Acute Respiratory Syndrome), and HIV/AIDS.", [["famine", "DISEASE", 129, 135], ["SARS", "DISEASE", 137, 141], ["Acute Respiratory Syndrome", "DISEASE", 150, 176], ["HIV/AIDS", "DISEASE", 183, 191], ["HIV", "SPECIES", 183, 186], ["HIV", "SPECIES", 183, 186], ["SARS (Severe Acute Respiratory Syndrome", "PROBLEM", 137, 176], ["HIV/AIDS", "PROBLEM", 183, 191], ["democracy", "OBSERVATION", 55, 64], ["Severe", "OBSERVATION_MODIFIER", 143, 149], ["Acute", "OBSERVATION_MODIFIER", 150, 155], ["Respiratory Syndrome", "OBSERVATION", 156, 176]]], ["The study blames the authoritarian regime in China for the massive death and hardship resulting from those epidemics.", [["death", "DISEASE", 67, 72], ["The study", "TEST", 0, 9], ["the authoritarian regime", "TREATMENT", 17, 41], ["the massive death", "PROBLEM", 55, 72], ["those epidemics", "PROBLEM", 101, 116], ["massive", "OBSERVATION_MODIFIER", 59, 66], ["death", "OBSERVATION", 67, 72]]], ["Finally, in two related studies based on different methodology and data, the role of political freedom and democracy on a number of measures of population health for both men and women across a large sample of developing and developed countries are examined (Safaei, 2005, 2006).", [["men", "ORGANISM", 171, 174], ["women", "ORGANISM", 179, 184], ["men", "SPECIES", 171, 174], ["women", "SPECIES", 179, 184], ["large", "OBSERVATION_MODIFIER", 194, 199]]], ["The latter studies find that democracy is consistently associated with better health, in terms of lower mortality rates and higher life expectancies.IntroductionAlthough both studies consider the effects of democracy (or lack thereof) separately for men and women, they are not dealing with women's health per se.", [["men", "ORGANISM", 250, 253], ["women", "ORGANISM", 258, 263], ["women", "ORGANISM", 291, 296], ["men", "SPECIES", 250, 253], ["women", "SPECIES", 258, 263], ["women", "SPECIES", 291, 296], ["The latter studies", "TEST", 0, 18], ["lower mortality rates", "PROBLEM", 98, 119], ["democracy", "OBSERVATION", 29, 38]]], ["This article explores the implications of democracy and human rights for women's health and well-being.", [["human", "ORGANISM", 56, 61], ["women", "ORGANISM", 73, 78], ["human", "SPECIES", 56, 61], ["women", "SPECIES", 73, 78], ["human", "SPECIES", 56, 61]]], ["In so doing, it first articulates some of the main health risks and vulnerabilities to which women are particularly exposed.", [["women", "ORGANISM", 93, 98], ["women", "SPECIES", 93, 98]]], ["It then uses a conceptual model to configure and explain, in broad terms, how democracy and respect for human rights could affect various manifestations of women's health vulnerabilities as previously identified.", [["human", "ORGANISM", 104, 109], ["women", "ORGANISM", 156, 161], ["human", "SPECIES", 104, 109], ["women", "SPECIES", 156, 161], ["human", "SPECIES", 104, 109]]], ["Finally, it provides some aggregate international data as a partial support for the conjectured relationships in the conceptual model.Risks of Sexual Exploitation and Violence ::: Women's Health Risks and VulnerabilitiesWomen's sexuality has been a major risk for health and well-being of women over time and across space.", [["Violence", "DISEASE", 167, 175], ["women", "ORGANISM", 289, 294], ["Women", "SPECIES", 180, 185], ["women", "SPECIES", 289, 294], ["a partial support", "TREATMENT", 58, 75]]], ["This major risk has manifested itself in various forms of sexual exploitation, coercion into unsafe sexual relationship, rape, forced pregnancy, female genital mutilation, trafficking and sexual slavery, and violence by intimate partners and nonpartners.", [["genital", "ANATOMY", 152, 159], ["genital mutilation", "DISEASE", 152, 170], ["violence", "DISEASE", 208, 216], ["genital", "ORGANISM_SUBDIVISION", 152, 159], ["forced pregnancy", "PROBLEM", 127, 143]]], ["Expectations for sexual favour from women in return for employment and other opportunities are prevalent in many parts of the world.", [["women", "ORGANISM", 36, 41], ["women", "SPECIES", 36, 41]]], ["Lacking the right to own or inherit land and property leaves women and girls exposed to increased sexual exploitation and violence, especially after the death of their partners or parents.", [["increased sexual exploitation and violence", "DISEASE", 88, 130], ["death", "DISEASE", 153, 158], ["women", "ORGANISM", 61, 66], ["women", "SPECIES", 61, 66], ["girls", "SPECIES", 71, 76], ["right", "ANATOMY_MODIFIER", 12, 17]]], ["In more serious situations, like during humanitarian crises, girls and women who are faced with limited economic opportunities may be forced into alliances with military forces, including peacekeepers and humanitarian personnel, to survive or support themselves and their families (UNICEF, 2003).", [["women", "ORGANISM", 71, 76], ["girls", "SPECIES", 61, 66], ["women", "SPECIES", 71, 76]]], ["Violence against women has been documented in many studies (e.g., Koss, 1993; Golding, 1996; Heise et al., 1999; Lievore, 2003; Kishor and Johnson, 2004; Naved et al., 2006; Gross et al., 2006; Dasgupta, 2007; Castro et al., 2008).", [["Violence", "DISEASE", 0, 8], ["women", "ORGANISM", 17, 22], ["women", "SPECIES", 17, 22]]], ["Such studies show significantly high prevalence rates, albeit variable across countries, of sexual and physical abuse toward women.", [["sexual and physical abuse", "DISEASE", 92, 117], ["women", "ORGANISM", 125, 130], ["women", "SPECIES", 125, 130], ["Such studies", "TEST", 0, 12], ["significantly high prevalence rates", "PROBLEM", 18, 53], ["significantly", "OBSERVATION_MODIFIER", 18, 31], ["high prevalence", "OBSERVATION_MODIFIER", 32, 47]]], ["World Health Organization (WHO) estimates that about 100-140 million girls and women in some 28 countries have undergone some form of female genital mutilation, with the highest incidence in parts of Africa (Sen et al., 2006).", [["genital", "ANATOMY", 141, 148], ["genital mutilation", "DISEASE", 141, 159], ["women", "ORGANISM", 79, 84], ["genital", "ORGANISM_SUBDIVISION", 141, 148], ["girls", "SPECIES", 69, 74], ["women", "SPECIES", 79, 84], ["female genital mutilation", "PROBLEM", 134, 159]]], ["The WHO Multicountry Study on Violence against Women (WHO, 2005) reports the proportion of ever-partnered women who had ever experienced physical or sexual violence, or both, by an intimate partner in their lifetime in the range of 15\u201371%.", [["Violence", "DISEASE", 30, 38], ["physical or sexual violence", "DISEASE", 137, 164], ["women", "ORGANISM", 106, 111], ["Women", "SPECIES", 47, 52], ["women", "SPECIES", 106, 111]]], ["For nonpartner violence after the age of 15, the figures ranged from 5% to 65% (WHO, 2005).", [["nonpartner violence", "DISEASE", 4, 23], ["the figures", "TEST", 45, 56]]], ["The consequences of injuries from physical and sexual violence for women's physical and mental health are substantial.", [["injuries", "DISEASE", 20, 28], ["physical and sexual violence", "DISEASE", 34, 62], ["women", "ORGANISM", 67, 72], ["women", "SPECIES", 67, 72], ["injuries", "PROBLEM", 20, 28], ["injuries", "OBSERVATION", 20, 28]]], ["They include cuts and bruises, permanents disabilities, sexually transmitted infections, HIV infections and AIDS, unwanted pregnancies, gynecological problems, miscarriages, still birth, chronic pelvic pain and pelvic inflammatory disease, depression, post-traumatic disorder, and suicide (Sen et al., 2006).Reproductive Health Risks ::: Women's Health Risks and VulnerabilitiesPregnancy, child birth, and puerperium put women through significant physiological, physical, and emotional changes with their consequent health risks.", [["gynecological", "ANATOMY", 136, 149], ["pelvic", "ANATOMY", 195, 201], ["pelvic", "ANATOMY", 211, 217], ["permanents disabilities", "DISEASE", 31, 54], ["sexually transmitted infections", "DISEASE", 56, 87], ["HIV infections", "DISEASE", 89, 103], ["AIDS", "DISEASE", 108, 112], ["gynecological problems", "DISEASE", 136, 158], ["miscarriages", "DISEASE", 160, 172], ["chronic pelvic pain", "DISEASE", 187, 206], ["pelvic inflammatory disease", "DISEASE", 211, 238], ["depression", "DISEASE", 240, 250], ["traumatic disorder", "DISEASE", 257, 275], ["pelvic", "ORGAN", 195, 201], ["Women", "ORGANISM", 338, 343], ["women", "ORGANISM", 421, 426], ["HIV", "SPECIES", 89, 92], ["Women", "SPECIES", 338, 343], ["women", "SPECIES", 421, 426], ["HIV", "SPECIES", 89, 92], ["bruises", "PROBLEM", 22, 29], ["sexually transmitted infections", "PROBLEM", 56, 87], ["HIV infections", "PROBLEM", 89, 103], ["AIDS", "PROBLEM", 108, 112], ["unwanted pregnancies", "PROBLEM", 114, 134], ["gynecological problems", "PROBLEM", 136, 158], ["miscarriages", "PROBLEM", 160, 172], ["still birth", "PROBLEM", 174, 185], ["chronic pelvic pain", "PROBLEM", 187, 206], ["pelvic inflammatory disease", "PROBLEM", 211, 238], ["depression", "PROBLEM", 240, 250], ["post-traumatic disorder", "PROBLEM", 252, 275], ["VulnerabilitiesPregnancy", "PROBLEM", 363, 387], ["infections", "OBSERVATION", 77, 87], ["chronic", "OBSERVATION_MODIFIER", 187, 194], ["pelvic", "ANATOMY", 195, 201], ["pain", "OBSERVATION", 202, 206], ["pelvic", "ANATOMY", 211, 217], ["inflammatory", "OBSERVATION", 218, 230], ["traumatic disorder", "OBSERVATION", 257, 275]]], ["Each year, an estimated 210 million women have life-threatening complications of pregnancy, often leading to serious disability, and a further half a million women die in pregnancy, child birth, and the puerperium, nearly all of them in developing countries (WHO, 2004a).", [["disability", "DISEASE", 117, 127], ["women", "ORGANISM", 36, 41], ["women", "ORGANISM", 158, 163], ["women", "SPECIES", 36, 41], ["women", "SPECIES", 158, 163], ["pregnancy", "PROBLEM", 81, 90]]], ["Each year 80 million women have unwanted or unintended pregnancies, 45 million of which are terminated (Alan Guttmacher Institute, 1999).", [["women", "ORGANISM", 21, 26], ["women", "SPECIES", 21, 26], ["unintended pregnancies", "PROBLEM", 44, 66]]], ["Of the 45 million abortions, 19 million are unsafe, and about 68,000 women die every year from complications of unsafe abortion (WHO, 2004b).", [["abortions", "DISEASE", 18, 27], ["women", "ORGANISM", 69, 74], ["women", "SPECIES", 69, 74]]], ["Moreover, an estimated 340 million new cases of four common sexually transmitted bacterial and protozoan infections are acquired every year, contributing to infertility of more than 180 million couples in developing countries (Rutstein and Shah, 2004).", [["sexually transmitted bacterial and protozoan infections", "DISEASE", 60, 115], ["infertility", "DISEASE", 157, 168], ["protozoan infections", "PROBLEM", 95, 115], ["infertility", "PROBLEM", 157, 168], ["protozoan", "OBSERVATION_MODIFIER", 95, 104], ["infections", "OBSERVATION", 105, 115]]], ["Nearly 5 million new HIV infections (UNAIDS, 2005) and 257,000 deaths from cervical cancer (Mathers and Loncar, 2005) add to the enormous burden of morbidity and mortality related to the reproductive role of women.Health Risks of Child Rearing and Domestic Work ::: Women's Health Risks and VulnerabilitiesAside from the risks of morbidity and mortality from maternity, women endure hardship feeding, tending, and caring around the clock for their children.", [["cervical cancer", "ANATOMY", 75, 90], ["HIV infections", "DISEASE", 21, 35], ["deaths", "DISEASE", 63, 69], ["cervical cancer", "DISEASE", 75, 90], ["cervical cancer", "CANCER", 75, 90], ["women", "ORGANISM", 208, 213], ["women", "ORGANISM", 370, 375], ["children", "ORGANISM", 448, 456], ["HIV", "SPECIES", 21, 24], ["women", "SPECIES", 208, 213], ["Women", "SPECIES", 266, 271], ["women", "SPECIES", 370, 375], ["children", "SPECIES", 448, 456], ["HIV", "SPECIES", 21, 24], ["new HIV infections", "PROBLEM", 17, 35], ["cervical cancer", "PROBLEM", 75, 90], ["morbidity", "PROBLEM", 148, 157], ["morbidity", "PROBLEM", 330, 339], ["new", "OBSERVATION_MODIFIER", 17, 20], ["HIV infections", "OBSERVATION", 21, 35], ["cervical", "ANATOMY", 75, 83], ["cancer", "OBSERVATION", 84, 90], ["morbidity", "OBSERVATION", 148, 157]]], ["Although they may endure it out of their unconditional love for their children, the tax on their health from such intensive care cannot be ignored.", [["children", "ORGANISM", 70, 78], ["tax", "PROTEIN", 84, 87], ["children", "SPECIES", 70, 78], ["such intensive care", "TREATMENT", 109, 128]]], ["In the absence of institutional care outside of the family in most developing countries, women are tasked to take care of their many children, often without any support from other members of the family.", [["women", "ORGANISM", 89, 94], ["children", "ORGANISM", 133, 141], ["women", "SPECIES", 89, 94], ["children", "SPECIES", 133, 141], ["institutional care", "TREATMENT", 18, 36]]], ["The burden of domestic work prevents women from seeking paid employment outside the home.", [["women", "ORGANISM", 37, 42], ["women", "SPECIES", 37, 42], ["burden", "OBSERVATION_MODIFIER", 4, 10]]], ["Moreover, in rural areas of many developing countries, women work the land along with their household duties.", [["women", "ORGANISM", 55, 60], ["women", "SPECIES", 55, 60]]], ["The toll on women's health of such immense burden, though significant, is not easy to quantify.Health Risks of Child Rearing and Domestic Work ::: Women's Health Risks and VulnerabilitiesAt the same time, women are traditionally tasked with the care of the sick and elderly members in their immediate or extended families.", [["women", "ORGANISM", 12, 17], ["women", "ORGANISM", 205, 210], ["women", "SPECIES", 12, 17], ["Women", "SPECIES", 147, 152], ["women", "SPECIES", 205, 210]]], ["This so-called \u201clabour of love\u201d rests on the caring and affectionate nature of women as mothers.", [["women", "ORGANISM", 79, 84], ["women", "SPECIES", 79, 84]]], ["Again, the lack of institutional or community based care as well as prevalent social norms put extra burden on women for the routine care of the sick and old.Discriminatory Sociocultural Practices and Attitudes toward Women ::: Women's Health Risks and VulnerabilitiesBy and large, all societies bear a certain degree of discriminatory biases against women.", [["women", "ORGANISM", 111, 116], ["women", "ORGANISM", 351, 356], ["women", "SPECIES", 111, 116], ["Women", "SPECIES", 218, 223], ["Women", "SPECIES", 228, 233], ["women", "SPECIES", 351, 356], ["community based care", "TREATMENT", 36, 56], ["large", "OBSERVATION_MODIFIER", 275, 280]]], ["Traditional societies that are typically underdeveloped witness a more pronounced prevalence of discriminatory behaviours toward women.", [["women", "ORGANISM", 129, 134], ["women", "SPECIES", 129, 134]]], ["In these highly gendered societies, those who wield gender power (obviously men) in family, community, and religious hierarchies fiercely resist any threat to their interests, which may arise from groups of women or their advocates asking for justice and a more equitable share of decision making power.", [["men", "ORGANISM", 76, 79], ["women", "ORGANISM", 207, 212], ["men", "SPECIES", 76, 79], ["women", "SPECIES", 207, 212], ["highly", "OBSERVATION_MODIFIER", 9, 15], ["gendered", "OBSERVATION_MODIFIER", 16, 24], ["societies", "OBSERVATION", 25, 34]]], ["Examples of socially condoned discriminations that have direct consequences on women's health and well-being include the age-old custom of chhaupadi (a social tradition in the western part of Nepal that prevents Hindu women from participating in normal family activities during menstruation because they are considered impure, forcing women out of the house to live in the shed with cows and other animals; Sen et al., 2006), various forms of female genital mutilation, marriage of under-age girls, honor killings, sex-selective abortion, female infanticide, domestic violence, and polygamy.", [["genital", "ANATOMY", 450, 457], ["genital mutilation", "DISEASE", 450, 468], ["abortion", "DISEASE", 529, 537], ["infanticide", "DISEASE", 546, 557], ["domestic violence", "DISEASE", 559, 576], ["women", "ORGANISM", 79, 84], ["women", "ORGANISM", 218, 223], ["women", "ORGANISM", 335, 340], ["genital", "ORGANISM_SUBDIVISION", 450, 457], ["women", "SPECIES", 79, 84], ["women", "SPECIES", 218, 223], ["women", "SPECIES", 335, 340], ["girls", "SPECIES", 492, 497]]], ["Also, as a result of discriminatory traditions, often built into laws, women are denied entitlement to land and other property, are deprived of inheritance, and are given little say, if any, in matters of divorce and child custody.", [["women", "ORGANISM", 71, 76], ["women", "SPECIES", 71, 76]]], ["These injustices simply drive women into greater depths of insecurity and poverty.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesPoverty and economic inequalities are not unique to women.", [["poverty", "DISEASE", 74, 81], ["women", "ORGANISM", 30, 35], ["women", "ORGANISM", 212, 217], ["women", "SPECIES", 30, 35], ["Women", "SPECIES", 120, 125], ["women", "SPECIES", 212, 217]]], ["However, women shoulder a much bigger burden of deprivation and lack of economic opportunities.", [["women", "ORGANISM", 9, 14], ["women", "SPECIES", 9, 14], ["shoulder", "ANATOMY", 15, 23]]], ["More than 1 billion people live in poverty around the world, and a great majority of them are women (UN-INSTRAW, 2005); the annual death toll from poverty-related causes is around 18 million (WHO, 2004c).", [["death", "DISEASE", 131, 136], ["poverty", "DISEASE", 147, 154], ["people", "ORGANISM", 20, 26], ["women", "ORGANISM", 94, 99], ["people", "SPECIES", 20, 26], ["women", "SPECIES", 94, 99]]], ["The copious literature on development is replete with narratives and evidence on women's economic subordination, insecurity and vulnerability.", [["women", "ORGANISM", 81, 86], ["women", "SPECIES", 81, 86], ["vulnerability", "PROBLEM", 128, 141], ["copious", "OBSERVATION_MODIFIER", 4, 11]]], ["However, such adversity is not necessarily the result of underdevelopment.", [["underdevelopment", "PROBLEM", 57, 73], ["underdevelopment", "OBSERVATION", 57, 73]]], ["Women face deprivation and inequity even in the most developed countries, albeit to a far lesser extent.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesThe distribution of income and other economic resources within the families, even the well-to-do ones, is not equitable in many societies.", [["Women", "SPECIES", 0, 5], ["Women", "SPECIES", 142, 147], ["Women face deprivation", "PROBLEM", 0, 22]]], ["This maldistribution is even more serious for very poor families, where the issue is not having a little more or less, but one of survival.", [["more serious", "OBSERVATION_MODIFIER", 29, 41]]], ["Moreover, women have the added responsibility of nursing and feeding their children out of their own share of the food, which further undermines their health in view of their more than proportionate share of burdensome duties within the families.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesDespite a high and growing global average income, billions of human beings are still condemned to life long severe poverty, with all its attendant evils of low life expectancy, social exclusion, ill health, illiteracy, dependency and effective enslavement (Pogge, 2005).", [["poverty", "DISEASE", 439, 446], ["women", "ORGANISM", 10, 15], ["children", "ORGANISM", 75, 83], ["human", "ORGANISM", 386, 391], ["women", "SPECIES", 10, 15], ["children", "SPECIES", 75, 83], ["Women", "SPECIES", 284, 289], ["human", "SPECIES", 386, 391], ["human", "SPECIES", 386, 391]]], ["The root cause of poverty and economic injustice is in the highly stratified structures of societies that divert resources and opportunities to those in positions of power and status.", [["root", "ANATOMY", 4, 8], ["poverty", "DISEASE", 18, 25], ["root", "ORGAN", 4, 8], ["poverty and economic injustice", "PROBLEM", 18, 48], ["root", "OBSERVATION_MODIFIER", 4, 8]]], ["The gulf of inequity between the rich and the poor, who are predominantly represented by women and children, has been growing wide and deep over time and across the world, especially in recent decades because of globalization.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesPoverty robs people of their very basic necessities of life, assaulting their human dignity and minimizing their capacity to sustain life and avoid illness and death.", [["illness", "DISEASE", 452, 459], ["death", "DISEASE", 464, 469], ["women", "ORGANISM", 89, 94], ["children", "ORGANISM", 99, 107], ["Women", "ORGANISM", 264, 269], ["human", "ORGANISM", 382, 387], ["women", "SPECIES", 89, 94], ["children", "SPECIES", 99, 107], ["Women", "SPECIES", 264, 269], ["people", "SPECIES", 317, 323], ["human", "SPECIES", 382, 387], ["human", "SPECIES", 382, 387], ["illness", "PROBLEM", 452, 459], ["death", "PROBLEM", 464, 469], ["poor", "OBSERVATION_MODIFIER", 46, 50], ["growing", "OBSERVATION_MODIFIER", 118, 125], ["wide", "OBSERVATION_MODIFIER", 126, 130], ["deep", "OBSERVATION_MODIFIER", 135, 139]]], ["\u201cMore importantly, the poor, assailed by life's vicissitudes and society's callousness, may learn to accept their fate and sink further into the morass of poverty, disease and deprivation\u201d (Singh and Singh, 2008).Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesPoverty is the mother of all ills.", [["poverty", "DISEASE", 155, 162], ["Women", "SPECIES", 251, 256], ["disease", "PROBLEM", 164, 171]]], ["However, despite numerous initiatives, legal tools, national and international conferences, resolutions, and conventions, the number of women living in poverty has been steadily increasing (UN-INSTRAW, 2005).", [["women", "ORGANISM", 136, 141], ["women", "SPECIES", 136, 141]]], ["The world has still a long way to go to address poverty and inequality in any meaningful and effective way.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesAlthough poverty and inequality has been considered as a distinct category of women's health risks and vulnerabilities, in light of the above discussion, it must be emphasized here that women's impoverishment and economic dependence is the main contributor to the other health vulnerabilities and risks to which women and girls are subjected.", [["women", "ORGANISM", 263, 268], ["women", "ORGANISM", 371, 376], ["women", "ORGANISM", 497, 502], ["Women", "SPECIES", 145, 150], ["women", "SPECIES", 263, 268], ["women", "SPECIES", 371, 376], ["women", "SPECIES", 497, 502], ["girls", "SPECIES", 507, 512], ["economic dependence", "PROBLEM", 398, 417]]], ["The persistence of unjust socioeconomic conditions and their horrendous implications for ill health of the poor has been referred to as structural violence by the well-known physician-anthropologist Paul Farmer (2005).", [["unjust socioeconomic conditions", "PROBLEM", 19, 50], ["persistence", "OBSERVATION_MODIFIER", 4, 15]]], ["This is a fundamental violence that allows and perpetuates all other manifestations of violence toward the weak and the oppressed, as women are in many societies.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesIf women are to gain their respectful rights to dignity, independence, self-worth, and be able to actualize their selves and live a full, meaningful and healthy life they so deserve, they have to be free from the subjugation of structural violence and their human rights reinstated.", [["violence", "DISEASE", 87, 95], ["women", "ORGANISM", 134, 139], ["women", "ORGANISM", 243, 248], ["human", "ORGANISM", 498, 503], ["women", "SPECIES", 134, 139], ["Women", "SPECIES", 200, 205], ["women", "SPECIES", 243, 248], ["human", "SPECIES", 498, 503], ["human", "SPECIES", 498, 503], ["weak", "OBSERVATION_MODIFIER", 107, 111]]], ["This leads us to a discussion of the role of human rights and democracy in women's health.Poverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesBefore we do so, in the light of the above, it may be asked, \u201cAre the risks to women's health examined above, that is, risks of sexual exploitation and violence, reproductive health risks, health risks of child rearing and domestic work, and discriminatory sociocultural practices and attitudes toward women less in democracies?", [["violence", "DISEASE", 320, 328], ["human", "ORGANISM", 45, 50], ["women", "ORGANISM", 75, 80], ["women", "ORGANISM", 247, 252], ["women", "ORGANISM", 470, 475], ["human", "SPECIES", 45, 50], ["women", "SPECIES", 75, 80], ["Women", "SPECIES", 128, 133], ["women", "SPECIES", 247, 252], ["women", "SPECIES", 470, 475], ["human", "SPECIES", 45, 50]]], ["And if so, what is the available evidence?\u201dPoverty and Economic Inequalities ::: Women's Health Risks and VulnerabilitiesThe discussion in the next section and presentation of some aggregate data in the following section will shed some light on the above questions.", [["Women", "SPECIES", 81, 86]]], ["Suffice to say at this point that the extent of those risks as confounded by the lack of adequate services and support available to women are most likely greater in nondemocratic countries than in democratic ones.", [["women", "ORGANISM", 132, 137], ["women", "SPECIES", 132, 137], ["most likely", "UNCERTAINTY", 142, 153], ["greater", "OBSERVATION_MODIFIER", 154, 161]]], ["Moreover, lack of freedom of the press, widespread censorship and approving social norms in many nondemocratic countries lead to systematic underreporting of incidents related to those health risks (Lievore, 2003).A Conceptual Model ::: Democracy, Human Rights, and Women's HealthThe pathways through which democracy affects women's health outcomes are varied and complex.", [["Human", "ORGANISM", 248, 253], ["women", "ORGANISM", 325, 330], ["Human", "SPECIES", 248, 253], ["Women", "SPECIES", 266, 271], ["women", "SPECIES", 325, 330], ["freedom", "OBSERVATION_MODIFIER", 18, 25], ["widespread", "OBSERVATION_MODIFIER", 40, 50], ["censorship", "OBSERVATION_MODIFIER", 51, 61]]], ["The notion of democracy that underlies the discussion here is one of institutionalized democracy, which is conceived as three essential and interdependent elements: (1) the presence of institutions and procedures through which citizens can express effective preferences about alternative policies and leaders; (2) the existence of institutionalized constraints on the exercise of power by the executive; and (3) the guarantee of civil liberties to all citizens in their daily lives and in acts of political participation (Marshal and Jaggers, 2002).", [["procedures", "TREATMENT", 202, 212], ["democracy", "OBSERVATION", 14, 23]]], ["Other aspects of plural democracy, such as the rule of law, systems of checks and balances, freedom of the press, and so on are considered as means or specific manifestations of these essential elements (Marshal and Jaggers, 2002).A Conceptual Model ::: Democracy, Human Rights, and Women's HealthTo organize the ideas and identify the pathways through which democracy interacts, both directly and indirectly, with the health and well-being of women, the schematic model shown in Figure 1 may prove useful.Direct Pathways ::: Democracy, Human Rights, and Women's HealthDemocratic regimes are expected to uphold their citizens\u2019 human rights and dignities and provide mechanisms by which such rights are actualized.", [["Human", "ORGANISM", 265, 270], ["women", "ORGANISM", 444, 449], ["Human", "ORGANISM", 537, 542], ["human", "ORGANISM", 627, 632], ["Human", "SPECIES", 265, 270], ["Women", "SPECIES", 283, 288], ["women", "SPECIES", 444, 449], ["Human", "SPECIES", 537, 542], ["Women", "SPECIES", 555, 560], ["human", "SPECIES", 627, 632], ["human", "SPECIES", 627, 632], ["Women's HealthDemocratic regimes", "TREATMENT", 555, 587], ["plural", "ANATOMY", 17, 23], ["democracy", "OBSERVATION", 24, 33]]], ["This has been extremely important for women whose rights and dignities have historically been trampled upon by the tyranny of authoritarian regimes and the unjust, rigid, and crippling social traditions they support.", [["women", "ORGANISM", 38, 43], ["women", "SPECIES", 38, 43], ["authoritarian regimes", "TREATMENT", 126, 147]]], ["Women are increasingly finding their rightful place in various arenas of social and political life and are demanding their rights to self-determination, and their entitlements to an equitable share of society's resources that they have been denied for so long.Direct Pathways ::: Democracy, Human Rights, and Women's HealthUpholding the rule of law and protection of the vulnerable against aggressions of the powerful in democratic countries has significantly reduced systematic violations of women's rights and dignities.", [["aggressions", "DISEASE", 390, 401], ["Women", "ORGANISM", 0, 5], ["Human", "ORGANISM", 291, 296], ["women", "ORGANISM", 493, 498], ["Women", "SPECIES", 0, 5], ["Human", "SPECIES", 291, 296], ["Women", "SPECIES", 309, 314], ["women", "SPECIES", 493, 498]]], ["It is true that pockets of violations happen here and there in democratic countries, but that is no comparison to the gross, systematic, and widespread violations of women's right in the undemocratic ones.", [["women", "ORGANISM", 166, 171], ["women", "SPECIES", 166, 171], ["pockets", "OBSERVATION_MODIFIER", 16, 23], ["violations", "OBSERVATION", 27, 37], ["widespread", "OBSERVATION_MODIFIER", 141, 151], ["violations", "OBSERVATION", 152, 162], ["right", "ANATOMY_MODIFIER", 174, 179], ["undemocratic ones", "ANATOMY", 187, 204]]], ["The aforementioned health vulnerabilities of women\u2013including sexual exploitation and violence, reproductive and childbearing health risks, burdens of child rearing and care for the sick and elderly, domestic labour and harsh work in the field or factory, discriminatory traditions and social biases, and poverty and economic inequality\u2013have been drastically reduced in varying degrees in democracies as a result of recognition and respect for women's rights.Direct Pathways ::: Democracy, Human Rights, and Women's HealthThanks to free and accessible education, free press, and relatively free flow of information in democracies, girls and women are increasingly aware of their rights.", [["women", "ORGANISM", 443, 448], ["Human", "ORGANISM", 489, 494], ["women", "ORGANISM", 640, 645], ["women", "SPECIES", 443, 448], ["Human", "SPECIES", 489, 494], ["Women", "SPECIES", 507, 512], ["girls", "SPECIES", 630, 635], ["women", "SPECIES", 640, 645], ["varying degrees", "OBSERVATION_MODIFIER", 369, 384]]], ["However, women of most developing countries are still chained in repressive traditions and oppressive regimes that deny them their right to self-expression.", [["women", "ORGANISM", 9, 14], ["women", "SPECIES", 9, 14], ["oppressive regimes", "TREATMENT", 91, 109], ["right", "ANATOMY_MODIFIER", 131, 136]]], ["In an environment of widespread censorship no real debate of important women's issues takes place and usually policies are designed from a male gender perspective that surely miss the insights and the interests of women for whom such policies are unilaterally prescribed.", [["women", "ORGANISM", 71, 76], ["women", "ORGANISM", 214, 219], ["women", "SPECIES", 71, 76], ["women", "SPECIES", 214, 219]]], ["The harm from such policies for women's health is all too well known.Indirect Pathways ::: Democracy, Human Rights, and Women's HealthIn addition to the above direct interactions, democracies interact with women's health indirectly by affecting the socioeconomic determinants of health.", [["women", "ORGANISM", 32, 37], ["Human", "ORGANISM", 102, 107], ["women", "ORGANISM", 206, 211], ["women", "SPECIES", 32, 37], ["Human", "SPECIES", 102, 107], ["Women", "SPECIES", 120, 125], ["women", "SPECIES", 206, 211], ["harm", "OBSERVATION", 4, 8]]], ["Patterns of ownership of economic resources, distribution of income and wealth, access to employment opportunities, social security provisions, and socioeconomic mobility are more equitable for women in democratic countries.", [["women", "ORGANISM", 194, 199], ["women", "SPECIES", 194, 199]]], ["Equity is not guaranteed by political freedom alone.", [["not", "UNCERTAINTY", 10, 13]]], ["A commitment to social equality and solidarity and true respect for human rights must come from a moral perspective that cares about society as a whole, and not the interests of the powerful minority.", [["human", "ORGANISM", 68, 73], ["human", "SPECIES", 68, 73], ["human", "SPECIES", 68, 73]]], ["That is why countries with a social democratic political tradition have fared so well in improving the lot of their people, women in particular, in achieving economic prosperity and improved health and well-being, as compared with democratic countries with liberal or other political philosophies.", [["people", "ORGANISM", 116, 122], ["women", "ORGANISM", 124, 129], ["people", "SPECIES", 116, 122], ["women", "SPECIES", 124, 129], ["political philosophies", "OBSERVATION", 274, 296]]], ["For the same time period, female (as well as male) life expectancy at birth was highest in the social democratic countries, followed by the Christian democratic countries, and then followed by the liberal countries (Navarro et al., 2004).Indirect Pathways ::: Democracy, Human Rights, and Women's HealthThe superior performance of the social democracies has significant implications for both democratic and nondemocratic countries.", [["Human", "ORGANISM", 271, 276], ["Human", "SPECIES", 271, 276], ["Women", "SPECIES", 289, 294], ["superior", "OBSERVATION_MODIFIER", 307, 315]]], ["It signifies to the democratic countries that improving the health and well-being of all people requires a genuine commitment to social well-being as opposed to the well-being of a segment of the population which is influential in supporting the current government and reelection of the next.", [["people", "ORGANISM", 89, 95], ["people", "SPECIES", 89, 95], ["democratic", "OBSERVATION_MODIFIER", 20, 30]]], ["To the nondemocratic countries, it sends the message that upholding the ideals of socialism would only be possible in a free and truly democratic society, and not in the ideological dictatorships pretending to uphold the interests of people.Indirect Pathways ::: Democracy, Human Rights, and Women's HealthIn a majority of politically repressed developing countries, especially in Africa, issues of poverty, injustice, corruption, and the like for both women and men are yet to be acknowledged, let alone being voiced or addressed.", [["poverty", "DISEASE", 399, 406], ["people", "ORGANISM", 234, 240], ["Human", "ORGANISM", 274, 279], ["women", "ORGANISM", 453, 458], ["men", "ORGANISM", 463, 466], ["people", "SPECIES", 234, 240], ["Human", "SPECIES", 274, 279], ["Women", "SPECIES", 292, 297], ["women", "SPECIES", 453, 458], ["men", "SPECIES", 463, 466]]], ["Many people in these countries have been looking to developed countries as a window of hope, yet the international community has failed to assist them in their struggle for freedom and prosperity.", [["people", "ORGANISM", 5, 11], ["people", "SPECIES", 5, 11]]], ["The conditional, and often misguided, support of the international community as provided through international agencies has not addressed the fundamental issues of human rights violations by the aid receiving countries which are often ruled by corrupt and oppressive regimes.", [["human", "ORGANISM", 164, 169], ["human", "SPECIES", 164, 169], ["human", "SPECIES", 164, 169], ["oppressive regimes", "TREATMENT", 256, 274]]], ["The recent tragedy in Burma is an extreme example of how far a dictatorship would go to deprive its people from the vital necessities offered by donating countries.", [["people", "ORGANISM", 100, 106], ["people", "SPECIES", 100, 106]]], ["As it happens, during natural or manmade disasters, it is the women and children who suffer most, simply because they are too weak to assume their rightful entitlement and more vulnerable to such disastrous situations.Indirect Pathways ::: Democracy, Human Rights, and Women's HealthPublic health measures, such as access to safe water, sanitation and sewage disposal, food and nutrition, are known to be more important in disease prevention and reduced mortality than medical interventions.", [["women", "ORGANISM", 62, 67], ["children", "ORGANISM", 72, 80], ["Human", "ORGANISM", 251, 256], ["women", "SPECIES", 62, 67], ["children", "SPECIES", 72, 80], ["Human", "SPECIES", 251, 256], ["Women", "SPECIES", 269, 274], ["Women's HealthPublic health measures", "TREATMENT", 269, 305], ["medical interventions", "TREATMENT", 469, 490]]], ["Such health measures require nationwide investments in physical infrastructure, environmental safety, as well as educational and extension programmes, that need to be directed mostly at women as the caregivers of children and other household members, all having significant claims to public resources.", [["women", "ORGANISM", 186, 191], ["children", "ORGANISM", 213, 221], ["women", "SPECIES", 186, 191], ["children", "SPECIES", 213, 221]]], ["Democratically representative and accountable regimes have been committed to such investments and have realized significant improvements in increased life expectancies and reduced mortality rates in their populations, even though there is still some degree of health inequality along gender, ethnic and socioeconomic dimensions.Indirect Pathways ::: Democracy, Human Rights, and Women's HealthDespite increased economic opportunities for women and the narrowing gender inequality in democratic countries, women are often too burdened with the responsibilities at home and may be unwilling, or unable, to take full advantage of the opportunities in furthering their economic status.", [["Human", "ORGANISM", 361, 366], ["women", "ORGANISM", 438, 443], ["women", "ORGANISM", 505, 510], ["Human", "SPECIES", 361, 366], ["Women", "SPECIES", 379, 384], ["women", "SPECIES", 438, 443], ["women", "SPECIES", 505, 510], ["increased life expectancies", "PROBLEM", 140, 167], ["reduced mortality rates", "PROBLEM", 172, 195], ["the narrowing gender inequality", "PROBLEM", 448, 479], ["significant", "OBSERVATION_MODIFIER", 112, 123], ["improvements", "OBSERVATION_MODIFIER", 124, 136], ["increased", "OBSERVATION_MODIFIER", 140, 149], ["health inequality", "OBSERVATION", 260, 277], ["socioeconomic dimensions", "OBSERVATION_MODIFIER", 303, 327], ["narrowing", "OBSERVATION", 452, 461]]], ["In recognition of such commitments by women, systems of welfare state or social security that vary in their generosity and reach have been developed in all democracies starting as early as late forties and fifties.", [["women", "ORGANISM", 38, 43], ["women", "SPECIES", 38, 43]]], ["These measures grew out of concern for the poor and less privileged, mainly in response to the strong demands by organized labour, and activists for women's rights.", [["women", "ORGANISM", 149, 154], ["women", "SPECIES", 149, 154]]], ["That is why such programmes are more generous in Scandinavian democracies with pro-labour institutions and stronger women's coalitions.", [["women", "ORGANISM", 116, 121], ["women", "SPECIES", 116, 121], ["pro-labour institutions", "TREATMENT", 79, 102], ["generous", "OBSERVATION_MODIFIER", 37, 45]]], ["People in the latter countries must press their governments for establishing and expanding social security programmes, especially for the women who are often insecure and unprovided for.", [["women", "ORGANISM", 138, 143], ["People", "SPECIES", 0, 6], ["women", "SPECIES", 138, 143]]], ["By the same token, the international community should direct its support and assistance in furthering social welfare programmes in poor countries, reversing the current policy of dismantling such programmes.Indirect Pathways ::: Democracy, Human Rights, and Women's HealthA question maybe asked here, \u201cHow is Figure 1 different in other governances?", [["Human", "ORGANISM", 240, 245], ["Human", "SPECIES", 240, 245], ["Women", "SPECIES", 258, 263]]], ["If the term \u2018Democracy\u2019 there were to be replaced by \u2018Dictatorship,\u2019 or other polities, how would the interactions change?\u201dIndirect Pathways ::: Democracy, Human Rights, and Women's HealthGiven the general nature of the conceptual model, there would be no difference in Figure 1 if \u201cDemocracy\u201d was replaced with \u201cDictatorship.\u201d", [["Human", "ORGANISM", 156, 161], ["Human", "SPECIES", 156, 161], ["Women", "SPECIES", 174, 179]]], ["The differential impacts of democracy versus dictatorship would be reflected in the differential health outcomes that women would experience under either polity (i.e., better women's health for democracy, and worse for dictatorship).", [["women", "ORGANISM", 118, 123], ["women", "ORGANISM", 175, 180], ["women", "SPECIES", 118, 123], ["women", "SPECIES", 175, 180], ["differential", "OBSERVATION_MODIFIER", 4, 16], ["impacts", "OBSERVATION_MODIFIER", 17, 24], ["democracy", "OBSERVATION", 28, 37]]], ["And that would be a crucial difference from the study's point of view here.Some Aggregate International DataTo provide some empirical support for the conjectured relationships in the conceptual model, Table 1 below reports the average measures of health outcome along two indices of democracy.", [["the study", "TEST", 44, 53], ["some empirical support", "TREATMENT", 119, 141], ["democracy", "OBSERVATION", 283, 292]]], ["The health outcomes include female life and healthy life expectancies at birth, maternal mortality ratio, and female mortality rate.", [["maternal mortality ratio", "PROBLEM", 80, 104]]], ["As well, neonatal, infant, and child (under 5 years) mortality rates are considered because they are closely related to women's health and well-being.", [["women", "ORGANISM", 120, 125], ["infant", "SPECIES", 19, 25], ["women", "SPECIES", 120, 125]]], ["Given the higher rates of TB and HIV/AIDS among women, prevalence of TB and HIV/AIDS for the entire population is also included.", [["TB", "DISEASE", 26, 28], ["HIV/AIDS", "DISEASE", 33, 41], ["TB", "DISEASE", 69, 71], ["HIV/AIDS", "DISEASE", 76, 84], ["women", "ORGANISM", 48, 53], ["HIV", "SPECIES", 33, 36], ["women", "SPECIES", 48, 53], ["HIV", "SPECIES", 76, 79], ["HIV", "SPECIES", 33, 36], ["HIV", "SPECIES", 76, 79], ["TB", "PROBLEM", 26, 28], ["HIV/AIDS", "PROBLEM", 33, 41], ["TB", "PROBLEM", 69, 71], ["HIV/AIDS", "PROBLEM", 76, 84]]], ["Such data were not available for males and females separately.", [["Such data", "TEST", 0, 9]]], ["Data on health outcomes for four categories of countries\u2013low-income, lower middle-income, upper middle-income and high-income countries\u2013are taken from World Health Report 2008 (WHO, 2008).Some Aggregate International DataThe two indices of democracy are the average score of governance for Voice and Accountability (Score 1), and the average score of governance for the Rule of Law (Score 2) as provided by Worldwide Governance Indicators (Governance Matters, 2008) for more than 200 countries around the world.", [["middle", "ANATOMY_MODIFIER", 75, 81], ["upper", "ANATOMY_MODIFIER", 90, 95], ["middle", "ANATOMY_MODIFIER", 96, 102], ["democracy", "OBSERVATION", 240, 249]]], ["Each score ranges from \u22122.5 to 2.5.", [["Each score", "TEST", 0, 10]]], ["Although there are scores on other aspects of governance, these two scores appear to better capture the spirit of democracy.", [["democracy", "OBSERVATION", 114, 123]]], ["The closer the score to the upper limit of this range the higher the level of good governance or democracy in a country.", [["upper limit", "OBSERVATION_MODIFIER", 28, 39]]], ["More pertinent to the focus of this study is the consistent improvement in the two indices of democracy (Scores 1 and 2) from low-income to high-income countries.", [["this study", "TEST", 31, 41], ["democracy (Scores", "TEST", 94, 111], ["improvement", "OBSERVATION_MODIFIER", 60, 71], ["democracy", "OBSERVATION", 94, 103]]], ["To disentangle the direct interactions between democracy and women's health outcomes from indirect ones, a statistical analysis of individual countries would be needed.", [["women", "ORGANISM", 61, 66], ["women", "SPECIES", 61, 66], ["a statistical analysis", "TEST", 105, 127]]], ["Such analysis is beyond the scope of the present study, but could be its logical extension in a future work.", [["Such analysis", "TEST", 0, 13], ["the present study", "TEST", 37, 54]]], ["Nevertheless, it should be helpful to explain here broadly how one might ago about isolating the effect of democracy on women\u2019 health from other confounding factors such as income.", [["women", "ORGANISM", 120, 125], ["women", "SPECIES", 120, 125]]], ["To capture the separate impact of democracy on women's health, one needs to regress measures of women's health on scores of democracy along with socioeconomic measures from individual countries in a multiple regression model.", [["women", "ORGANISM", 47, 52], ["women", "ORGANISM", 96, 101], ["women", "SPECIES", 47, 52], ["women", "SPECIES", 96, 101], ["socioeconomic measures", "TREATMENT", 145, 167], ["democracy", "OBSERVATION", 34, 43], ["democracy", "OBSERVATION", 124, 133]]], ["Short of that, one could examine the association or correlation between democracy and women\u2019 health within each group of countries with similar income (e.g., low-income countries).", [["women", "ORGANISM", 86, 91], ["women", "SPECIES", 86, 91]]], ["However, the latter would be a crude way of disentangling the effect of democracy on women's health as it fails to control for other nonincome socioeconomic factors.Some Aggregate International DataNotwithstanding the need for a detailed analysis, the aggregate data provided in Table 1 do support the conjectured interactions in the conceptual model, namely, that democracy improves the health and well-being of women upholding their human rights and enhancing their socioeconomic position.Take Home Message ::: Concluding Remarks", [["women", "ORGANISM", 85, 90], ["women", "ORGANISM", 413, 418], ["human", "ORGANISM", 435, 440], ["nonincome socioeconomic factors", "PROTEIN", 133, 164], ["women", "SPECIES", 85, 90], ["women", "SPECIES", 413, 418], ["human", "SPECIES", 435, 440], ["human", "SPECIES", 435, 440], ["other nonincome socioeconomic factors", "PROBLEM", 127, 164], ["a detailed analysis", "TEST", 227, 246]]]], "63dca144181b493effa2cff2a122cfa6fd13c054": [["T lymphocytes are crucial for antiviral responses and provide a promising repertoire for potential therapies of viral diseases such as cytomegalovirus (CMV) infection 1 and the ongoing COVID-19 pandemic caused by SARS-CoV-2.", [["T lymphocytes", "ANATOMY", 0, 13], ["viral diseases such as cytomegalovirus (CMV) infection", "DISEASE", 112, 166], ["T lymphocytes", "CELL", 0, 13], ["cytomegalovirus", "ORGANISM", 135, 150], ["CMV", "ORGANISM", 152, 155], ["COVID-19", "ORGANISM", 185, 193], ["SARS-CoV-2", "ORGANISM", 213, 223], ["T lymphocytes", "CELL_TYPE", 0, 13], ["CMV", "SPECIES", 152, 155], ["SARS-CoV", "SPECIES", 213, 221], ["antiviral responses", "TREATMENT", 30, 49], ["viral diseases", "PROBLEM", 112, 126], ["cytomegalovirus (CMV) infection", "PROBLEM", 135, 166], ["the ongoing COVID", "TEST", 173, 190], ["pandemic", "PROBLEM", 194, 202], ["SARS", "PROBLEM", 213, 217], ["lymphocytes", "ANATOMY", 2, 13], ["viral diseases", "OBSERVATION", 112, 126], ["cytomegalovirus", "OBSERVATION", 135, 150]]], ["2 CMV-related diseases occur once the host immune system is impaired or lacks a protective repertoire of virus-specific T lymphocytes.", [["immune system", "ANATOMY", 43, 56], ["T lymphocytes", "ANATOMY", 120, 133], ["CMV", "ORGANISM", 2, 5], ["T lymphocytes", "CELL", 120, 133], ["T lymphocytes", "CELL_TYPE", 120, 133], ["2 CMV-related diseases", "PROBLEM", 0, 22], ["CMV", "OBSERVATION", 2, 5], ["diseases", "OBSERVATION", 14, 22], ["impaired", "OBSERVATION", 60, 68]]], ["3 Adoptive transfer of Tcell receptor (TCR)-engineered T cells (TCR-Ts) provides an encouraging alternative treatment option for patients with CMV reactivation.", [["T cells", "ANATOMY", 55, 62], ["TCR-Ts", "ANATOMY", 64, 70], ["TCR-Ts", "CHEMICAL", 64, 70], ["Tcell receptor", "GENE_OR_GENE_PRODUCT", 23, 37], ["TCR", "GENE_OR_GENE_PRODUCT", 39, 42], ["TCR-Ts", "GENE_OR_GENE_PRODUCT", 64, 70], ["patients", "ORGANISM", 129, 137], ["CMV", "ORGANISM", 143, 146], ["Tcell receptor (TCR)-engineered T cells", "CELL_LINE", 23, 62], ["TCR", "PROTEIN", 64, 67], ["patients", "SPECIES", 129, 137], ["CMV", "SPECIES", 143, 146], ["Tcell receptor", "TREATMENT", 23, 37], ["an encouraging alternative treatment option", "TREATMENT", 81, 124], ["CMV reactivation", "TREATMENT", 143, 159]]], ["4 However, generating TCR-Ts requires the identification of epitope-specific and functional TCR pairs.", [["TCR", "CHEMICAL", 22, 25], ["TCR-Ts", "GENE_OR_GENE_PRODUCT", 22, 28], ["TCR", "GENE_OR_GENE_PRODUCT", 92, 95], ["TCR", "PROTEIN", 22, 25], ["TCR pairs", "DNA", 92, 101], ["epitope", "PROBLEM", 60, 67]]], ["Modern singlecell sequencing techniques open up the ability to unravel TCR repertoires, 5 which offers a potential opportunity to screen functional TCR pairs for TCR-T therapy.", [["TCR", "CHEMICAL", 162, 165], ["TCR", "GENE_OR_GENE_PRODUCT", 71, 74], ["TCR", "GENE_OR_GENE_PRODUCT", 148, 151], ["TCR-T", "GENE_OR_GENE_PRODUCT", 162, 167], ["TCR repertoires", "PROTEIN", 71, 86], ["TCR pairs", "DNA", 148, 157], ["TCR", "PROTEIN", 162, 165], ["Modern singlecell sequencing techniques", "TREATMENT", 0, 39], ["TCR-T therapy", "TREATMENT", 162, 175]]], ["Here, we report an efficient approach that combines ex vivo CD8+ T-cell stimulation with single-cell RNA and TCR V(D)J sequencing to identify CMV-specific TCRs for generating TCR-Ts.", [["CD8+ T-cell", "ANATOMY", 60, 71], ["CD8", "GENE_OR_GENE_PRODUCT", 60, 63], ["CMV", "ORGANISM", 142, 145], ["TCRs", "GENE_OR_GENE_PRODUCT", 155, 159], ["TCR", "GENE_OR_GENE_PRODUCT", 175, 178], ["CD8", "PROTEIN", 60, 63], ["TCRs", "PROTEIN", 155, 159], ["TCR", "PROTEIN", 175, 178], ["T-cell stimulation", "TREATMENT", 65, 83], ["single-cell RNA", "TREATMENT", 89, 104], ["TCR V(D)J sequencing", "TREATMENT", 109, 129], ["CMV", "TEST", 142, 145], ["CMV", "OBSERVATION", 142, 145]]]], "e5a88ea444633c1e8d2238c78727a370328681a8": [["J o u r n a l P r e -p r o o fMATERIAL Y M\u00c9TODOSDesde el grupo de trabajo de CC de la Sociedad Espa\u00f1ola de Cirug\u00eda Cardiovascular y Endovascular (SECCE), se envi\u00f3 una encuesta a todos los miembros del grupo en el que est\u00e1n representados los 13 servicios donde se realiza el grueso de la cirug\u00eda de CC del pa\u00eds.", [["Cardiovascular y", "DISEASE", 115, 131]]], ["Distinguimos entre cirug\u00eda con circulaci\u00f3n extracorp\u00f3rea (CEC) y cirug\u00eda mayor, entendiendo esta \u00faltima como la suma de las CEC y la cirug\u00eda no extracorp\u00f3rea reportada en nuestro registro anual (ligadura ductal, anillo vascular, coartaci\u00f3n, f\u00edstula sist\u00e9mico-pulmonar y cerclaje de arteria pulmonar).", [["ductal", "ANATOMY", 204, 210], ["ductal", "TISSUE", 204, 210], ["vascular", "TISSUE", 219, 227], ["Distinguimos", "PROBLEM", 0, 12], ["coartaci\u00f3n", "TEST", 229, 239], ["f\u00edstula sist\u00e9mico", "TREATMENT", 241, 258], ["vascular", "ANATOMY", 219, 227], ["arteria pulmonar", "ANATOMY", 282, 298]]], ["Se estudi\u00f3 tambi\u00e9n el grado de implicaci\u00f3n de cada servicio en la ayuda de otras necesidades del hospital para la atenci\u00f3n de pacientes COVID-19 realizando actividad no propia de cirug\u00eda cardiovascular, y por \u00faltimo se preguntaba por los profesionales de cada servicio de CC que hab\u00edan estado de baja laboral durante este per\u00edodo.", [["COVID", "TEST", 136, 141]]], ["Todos los autores han aportado los datos de sus centros y han revisado el manuscrito.MATERIAL Y M\u00c9TODOSLos datos expuestos acerca de la COVID-19 en Espa\u00f1a se han consultado en las p\u00e1ginas web del institutoRESULTADOSTodos los centros disminuimos nuestra actividad durante este per\u00edodo, adapt\u00e1ndose cada hospital a las normas dictadas por las autoridades competentes seg\u00fan la incidencia de la pandemia.", [["la incidencia de la pandemia", "PROBLEM", 371, 399], ["la pandemia", "OBSERVATION", 388, 399]]], ["En estos 2 meses se han operado en Espa\u00f1a 142 cirug\u00edas mayores de CC, 105 de las cuales corresponden a cirug\u00edas con CEC.", [["CC", "CHEMICAL", 66, 68]]], ["Analizando las cifras globales, vemos que toda la cirug\u00eda mayor se redujo un 51%, y la cirug\u00eda extracorp\u00f3rea un 54% en comparaci\u00f3n con nuestros datos del a\u00f1o previo.J o u r n a l P r e -p r o o fSiempre se atendieron cirug\u00edas urgentes y emergentes, destacando la realizaci\u00f3n de 4 trasplantes cardiacos (3 infantiles y 1 adulto con CC) y 1 trasplante bipulmonar infantil que se encontraba previamente con asistencia respiratoria de tipo oxigenador de membrana extracorp\u00f3rea.", [["CC", "CHEMICAL", 331, 333], ["Analizando las cifras globales", "TREATMENT", 0, 30], ["fSiempre", "PROBLEM", 194, 202]]], ["Otro trasplante cardiaco se realiz\u00f3 en una ni\u00f1a con una miocardiopat\u00eda tras superar la COVID-19 y negativizar su PCR.", [["Otro", "TEST", 0, 4]]], ["S\u00ed se operaron 2 pacientes con PCR positiva en este periodo, recibiendo cirug\u00eda cerrada sin extracorp\u00f3rea, que suponen un 1,4% del total de casos con CC intervenidos.", [["CC", "CHEMICAL", 150, 152], ["PCR", "TEST", 31, 34], ["total de casos con CC intervenidos", "TREATMENT", 131, 165]]], ["Uno de estos 2 pacientes operados era un lactante con canal aur\u00edculo-ventricular infectado COVID-19 y descompensado, que se pali\u00f3 con un cerclaje de la arteria pulmonar para evitar el uso de CEC en una reparaci\u00f3n completa.J o u r n a l P r e -p r o o fLa Figura-1 muestra el porcentaje de reducci\u00f3n de actividad especificado por CCAA y la incidencia de casos de COVID-19 confirmados por PCR en esas comunidades con fecha 14-05-2020.", [["aur\u00edculo", "TEST", 60, 68], ["ventricular infectado COVID", "PROBLEM", 69, 96], ["que se pali\u00f3 con un cerclaje", "TEST", 117, 145], ["a l P r e -p r o o fLa", "TEST", 232, 254], ["Figura", "TEST", 255, 261], ["ventricular", "ANATOMY", 69, 80], ["la arteria", "ANATOMY", 149, 159]]], ["Observamos que Galicia y Murcia muestran una reducci\u00f3n de actividad inferior, coincidiendo con la menor afectaci\u00f3n de estas Comunidades Aut\u00f3nomas (CCAA) por el COVID-19.J o u r n a l P r e -p r o o fDurante estos dos meses de Estado de Alarma (Figura-2), las cirug\u00edas de cardiopat\u00edas cong\u00e9nitas se realizaron fundamentalmente en pacientes menores de un a\u00f1o (72%) siendo m\u00ednima la actividad en pacientes cong\u00e9nitos adultos (5%).J o u r n a l P r e -p r o o fEl manejo preoperatorio de los pacientes durante este periodo se debe mantener hasta el completo control de la pandemia, para prevenir contagios tanto de pacientes como de profesionales.", [["COVID", "TEST", 160, 165], ["fDurante", "PROBLEM", 198, 206], ["estos dos", "TEST", 207, 216], ["m\u00ednima la actividad en pacientes cong\u00e9nitos adultos", "TREATMENT", 370, 421]]], ["Todos los grupos coincidimos en la necesidad de detectar preoperatoriamente infecci\u00f3n por el coronavirus, y realizamos una PCR para SARS-CoV2 en las 24-48 horas previas a la cirug\u00eda, adem\u00e1s de haber descartado s\u00edntomas de COVID-19 en la entrevista previa telef\u00f3nica, y tambi\u00e9n en el momento del ingreso hospitalario.", [["el coronavirus", "PROBLEM", 90, 104], ["una PCR", "TEST", 119, 126], ["para SARS", "TEST", 127, 136]]], ["Si la PCR resulta positiva, tambi\u00e9n hay unanimidad entre los profesionales de posponer la cirug\u00eda, individualizando J o u r n a l P r e -p r o o f cada caso, y realizando una operaci\u00f3n que asocie el menor riesgo posible s\u00f3lo en casos de urgencia/emergencia.J o u r n a l P r e -p r o o fComo actividad extraordinaria durante este tiempo, 6 cirujanos de 4 unidades de CC han estado trabajando en la atenci\u00f3n de primera l\u00ednea de los adultos con COVID-19, que suponen un 15% del total de cirujanos cardiovasculares de CC del pa\u00eds.", [["Si la PCR", "TEST", 0, 9], ["cada caso", "TEST", 147, 156], ["actividad", "PROBLEM", 292, 301], ["COVID", "TEST", 443, 448]]], ["La cirug\u00eda de los pacientes con CC supone una sub-especializaci\u00f3n m\u00e1s para atender a un peque\u00f1o porcentaje de pacientes que abarcan todo peso y edad.", [["CC", "CHEMICAL", 32, 34], ["una sub", "TEST", 42, 49]]], ["Aqu\u00ed tambi\u00e9n colaboramos \u00edntimamente con pediatras y obstetras, ya que el grueso de nuestra actividad la hacemos en poblaci\u00f3n pedi\u00e1trica.", [["Aqu\u00ed tambi\u00e9n colaboramos", "TREATMENT", 0, 24]]], ["En nuestro pa\u00eds la cirug\u00eda de CC se localiza fundamentalmente en 13 centros p\u00fablicos que atienden adecuadamente a nuestra poblaci\u00f3n.DISCUSI\u00d3NDeterminados tipos de CC (por ejemplo la D-trasposici\u00f3n de grandes arterias con septo intacto) requieren cirug\u00eda en per\u00edodo neonatal para que el paciente pueda ser dado de alta, otras tienen un tiempo \u00f3ptimo para realizarse, en orden de obtener la mayor relaci\u00f3n beneficio/riesgo (por ejemplo la cirug\u00eda del canal aur\u00edculo-ventricular completo se debe realizar entre los 3-6 meses de vida para que no se desarrolle hipertensi\u00f3n pulmonar).", [["CC", "CHEMICAL", 30, 32], ["CC", "CHEMICAL", 163, 165], ["relaci\u00f3n beneficio/riesgo (por ejemplo la cirug\u00eda del canal aur\u00edculo-ventricular completo se debe realizar entre los 3-6 meses de vida para que no se desarrolle hipertensi\u00f3n pulmonar", "SPECIES", 395, 577], ["a nuestra poblaci\u00f3n", "TREATMENT", 112, 131], ["trasposici\u00f3n de grandes arterias", "TREATMENT", 184, 216], ["ventricular", "ANATOMY", 464, 475]]], ["A nivel profesional es muy enriquecedor compartir el conocimiento y experiencias vividas, e implementar maneras de cooperar para optimizar la atenci\u00f3n de nuestros pacientes con CC.DISCUSI\u00d3NEn resumen, hemos dado una respuesta r\u00e1pida y eficaz a las necesidades de nuestros pacientes y de nuestros compa\u00f1eros seg\u00fan la evoluci\u00f3n de la pandemia.", [["la pandemia", "OBSERVATION", 329, 340]]], ["Por las particularidades de nuestros pacientes se considera imprescindible su necesidad de acompa\u00f1amiento familiar, y adem\u00e1s del necesario tratamiento quir\u00fargico tambi\u00e9n se tienen J o u r n a l P r e -p r o o f en cuenta los factores emocionales para proporcionar apoyo psicol\u00f3gico a pacientes, familiares, o al personal implicado seg\u00fan sea necesario.CONCLUSIONESLa pandemia del SARS-CoV2 ha obligado a todos los servicios de CC del pa\u00eds a reestructurarse para apoyar a los compa\u00f1eros con tratamiento directo del COVID-19, sin mermar la atenci\u00f3n de nuestros propios pacientes cuya cirug\u00eda no pod\u00eda demorarse.", [["del SARS", "PROBLEM", 375, 383], ["COVID", "TEST", 513, 518]]]], "9e7a8a7cddeaff40a45a8a7d3965d34d52b8f617": [["IntroductionPorcine epidemic diarrhea virus (PEDV) is a positive-sense single-stranded RNA virus belonging to group 1 of the genus Alphacoronavirus, within the family Coronaviridae.", [["IntroductionPorcine epidemic diarrhea", "DISEASE", 0, 37], ["IntroductionPorcine epidemic diarrhea virus", "ORGANISM", 0, 43], ["Alphacoronavirus", "GENE_OR_GENE_PRODUCT", 131, 147], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 167, 180], ["epidemic diarrhea virus", "SPECIES", 20, 43], ["IntroductionPorcine epidemic diarrhea virus", "SPECIES", 0, 43], ["PEDV", "SPECIES", 45, 49], ["IntroductionPorcine epidemic diarrhea virus (PEDV", "PROBLEM", 0, 49], ["a positive-sense single-stranded RNA virus", "PROBLEM", 54, 96], ["genus Alphacoronavirus", "ANATOMY", 125, 147]]], ["The virus is the etiological agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric disease characterized by watery diarrhea, vomiting, dehydration, and high mortality in nursery piglets [1] .", [["porcine epidemic diarrhea", "DISEASE", 38, 63], ["PED", "DISEASE", 65, 68], ["enteric disease", "DISEASE", 102, 117], ["watery diarrhea", "DISEASE", 135, 150], ["vomiting", "DISEASE", 152, 160], ["dehydration", "DISEASE", 162, 173], ["porcine", "ORGANISM", 38, 45], ["piglets", "ORGANISM", 205, 212], ["porcine", "SPECIES", 38, 45], ["piglets", "SPECIES", 205, 212], ["porcine epidemic diarrhea (PED)", "SPECIES", 38, 69], ["The virus", "PROBLEM", 0, 9], ["porcine epidemic diarrhea", "PROBLEM", 38, 63], ["an acute and highly contagious enteric disease", "PROBLEM", 71, 117], ["watery diarrhea", "PROBLEM", 135, 150], ["vomiting", "PROBLEM", 152, 160], ["dehydration", "PROBLEM", 162, 173], ["virus", "OBSERVATION", 4, 9], ["porcine", "OBSERVATION_MODIFIER", 38, 45], ["epidemic", "OBSERVATION_MODIFIER", 46, 54], ["diarrhea", "OBSERVATION", 55, 63], ["acute", "OBSERVATION_MODIFIER", 74, 79], ["highly", "OBSERVATION_MODIFIER", 84, 90], ["contagious", "OBSERVATION_MODIFIER", 91, 101], ["watery", "OBSERVATION_MODIFIER", 135, 141], ["diarrhea", "OBSERVATION", 142, 150], ["high", "OBSERVATION_MODIFIER", 179, 183], ["mortality", "OBSERVATION_MODIFIER", 184, 193]]], ["PEDV was first recognized as the causative agent of PED in Belgium [2] and the United Kingdom in 1978 [3] .", [["PEDV", "CHEMICAL", 0, 4], ["PED", "DISEASE", 52, 55], ["PEDV", "SPECIES", 0, 4], ["PEDV", "PROBLEM", 0, 4]]], ["The presence of PED in China was confirmed, by immunofluorescence assays and serum neutralization tests, in 1984.", [["serum", "ANATOMY", 77, 82], ["serum", "ORGANISM_SUBSTANCE", 77, 82], ["immunofluorescence assays", "TEST", 47, 72], ["serum neutralization tests", "TEST", 77, 103]]], ["Bivalent killed or attenuated vaccines have been used to prevent transmissible gastroenteritis (TGE) and PED in China since then.", [["gastroenteritis", "DISEASE", 79, 94], ["TGE", "DISEASE", 96, 99], ["PED", "DISEASE", 105, 108], ["attenuated vaccines", "TREATMENT", 19, 38], ["transmissible gastroenteritis", "PROBLEM", 65, 94], ["gastroenteritis", "OBSERVATION", 79, 94]]], ["Clinical PED outbreaks have reemerged in the major pigproducing areas of China since December 2010, resulting in major losses of suckling piglets.", [["piglets", "ORGANISM", 138, 145], ["piglets", "SPECIES", 138, 145], ["Clinical PED outbreaks", "PROBLEM", 0, 22], ["suckling piglets", "PROBLEM", 129, 145], ["suckling piglets", "OBSERVATION", 129, 145]]], ["Morbidity rates between 90 and100 % have been observed, with mortalities of 70-100 % on affected pig farms [4] .IntroductionHeterogeneity of genomic sequences is believed to be responsible for the diversity in PEDV pathogenicity.", [["pig", "ORGANISM", 97, 100], ["PEDV", "GENE_OR_GENE_PRODUCT", 210, 214], ["genomic sequences", "DNA", 141, 158], ["pig", "SPECIES", 97, 100], ["pig", "SPECIES", 97, 100], ["PEDV", "SPECIES", 210, 214], ["Morbidity rates", "TEST", 0, 15], ["Heterogeneity of genomic sequences", "PROBLEM", 124, 158], ["PEDV pathogenicity", "PROBLEM", 210, 228], ["believed to be responsible for", "UNCERTAINTY", 162, 192], ["diversity", "OBSERVATION", 197, 206], ["PEDV pathogenicity", "OBSERVATION", 210, 228]]], ["A number of molecular investigations have been conducted, revealing different levels of variation in nucleotide sequences among PEDV isolates [5] [6] [7] .", [["nucleotide", "CHEMICAL", 101, 111], ["nucleotide", "CHEMICAL", 101, 111], ["molecular investigations", "TEST", 12, 36], ["different levels of variation in nucleotide sequences", "PROBLEM", 68, 121], ["PEDV isolates", "TEST", 128, 141]]], ["Because of incomplete genomic information, most molecular epidemiological analyses have targeted a single gene of PEDV.", [["PEDV", "CANCER", 114, 118], ["PEDV", "DNA", 114, 118], ["PEDV", "SPECIES", 114, 118], ["PEDV", "PROBLEM", 114, 118]]], ["To date, complete genome sequences of 18 PEDV strains, including 10 endemic Chinese isolates, have been submitted to the GenBank database [4, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .", [["PEDV strains", "ORGANISM", 41, 53], ["[8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19]", "SIMPLE_CHEMICAL", 142, 199], ["PEDV", "SPECIES", 41, 45], ["18 PEDV strains", "PROBLEM", 38, 53]]], ["To better understand the diversity, epidemiology and molecular characteristics of PEDV isolates in China, we sequenced the complete genome of a virulent PEDV strain from Henan Province, China.", [["PEDV isolates", "CELL", 82, 95], ["PEDV", "SPECIES", 82, 86], ["PEDV", "SPECIES", 153, 157], ["PEDV isolates", "PROBLEM", 82, 95], ["a virulent PEDV strain", "PROBLEM", 142, 164], ["virulent", "OBSERVATION_MODIFIER", 144, 152], ["PEDV", "OBSERVATION", 153, 157]]], ["This isolate was from a suckling piglet that exhibited severe diarrhea.", [["piglet", "ANATOMY", 33, 39], ["diarrhea", "DISEASE", 62, 70], ["piglet", "ORGANISM", 33, 39], ["piglet", "SPECIES", 33, 39], ["a suckling piglet", "PROBLEM", 22, 39], ["severe diarrhea", "PROBLEM", 55, 70], ["severe", "OBSERVATION_MODIFIER", 55, 61], ["diarrhea", "OBSERVATION", 62, 70]]], ["We compared its genomic sequence with those of other Chinese PEDV isolates and reference strains.Materials and methodsIsolation and identification of PEDV strain CH/ZMDZY/11 PEDV strain CH/ZMDZY/11 was isolated from 2-to 3-day-old suckling piglets suffering from watery diarrhea and dehydration.", [["watery diarrhea", "DISEASE", 263, 278], ["dehydration", "DISEASE", 283, 294], ["PEDV strain CH/ZMDZY/11", "ORGANISM", 150, 173], ["PEDV strain CH/ZMDZY/11", "ORGANISM", 174, 197], ["piglets", "ORGANISM", 240, 247], ["piglets", "SPECIES", 240, 247], ["PEDV strain CH/ZMDZY/11 PEDV strain CH/ZMDZY/11", "SPECIES", 150, 197], ["other Chinese PEDV isolates", "TREATMENT", 47, 74], ["methodsIsolation", "TREATMENT", 111, 127], ["PEDV strain CH", "PROBLEM", 150, 164], ["ZMDZY", "TREATMENT", 165, 170], ["PEDV strain CH/ZMDZY", "TREATMENT", 174, 194], ["watery diarrhea", "PROBLEM", 263, 278], ["dehydration", "PROBLEM", 283, 294], ["watery diarrhea", "OBSERVATION", 263, 278]]], ["These piglets were from a single farm in Henan Province, China, which contained 1500 breeding sows.", [["piglets", "ORGANISM", 6, 13], ["sows", "ORGANISM", 94, 98], ["piglets", "SPECIES", 6, 13]]], ["Cases were characterized by watery diarrhea, dehydration with milk curd vomitus, thin-walled intestines, 100 % morbidity and 90 % mortality.", [["intestines", "ANATOMY", 93, 103], ["watery diarrhea", "DISEASE", 28, 43], ["dehydration", "DISEASE", 45, 56], ["milk curd vomitus", "DISEASE", 62, 79], ["intestines", "ORGAN", 93, 103], ["watery diarrhea", "PROBLEM", 28, 43], ["dehydration", "PROBLEM", 45, 56], ["milk curd vomitus", "PROBLEM", 62, 79], ["thin-walled intestines", "PROBLEM", 81, 103], ["watery diarrhea", "OBSERVATION", 28, 43], ["walled", "ANATOMY_MODIFIER", 86, 92], ["intestines", "ANATOMY", 93, 103]]], ["Pigs of other ages were affected, exhibiting diarrhea and loss of appetite to different degrees, with severity of symptoms dependent on age.", [["diarrhea", "DISEASE", 45, 53], ["loss of appetite", "DISEASE", 58, 74], ["Pigs", "ORGANISM", 0, 4], ["Pigs", "SPECIES", 0, 4], ["diarrhea", "PROBLEM", 45, 53], ["loss of appetite", "PROBLEM", 58, 74], ["severity of symptoms", "PROBLEM", 102, 122], ["diarrhea", "OBSERVATION", 45, 53], ["appetite to different degrees", "OBSERVATION_MODIFIER", 66, 95]]], ["Affected sows were characterized by anorexia, depression and transient diarrhea, with most affected sows recovering within one week.", [["anorexia", "DISEASE", 36, 44], ["depression", "DISEASE", 46, 56], ["diarrhea", "DISEASE", 71, 79], ["sows", "ORGANISM", 9, 13], ["sows", "ORGANISM", 100, 104], ["sows", "SPECIES", 9, 13], ["Affected sows", "PROBLEM", 0, 13], ["anorexia", "PROBLEM", 36, 44], ["depression", "PROBLEM", 46, 56], ["transient diarrhea", "PROBLEM", 61, 79], ["anorexia", "OBSERVATION", 36, 44], ["depression", "OBSERVATION", 46, 56], ["transient", "OBSERVATION_MODIFIER", 61, 70], ["diarrhea", "OBSERVATION", 71, 79]]], ["Production records showed that breeding herds had been immunized with a killed CV777-based vaccine that had been produced in China.Materials and methodsVirus isolation was conducted using Vero E6 cells (American Type Culture Collection, VA, USA).", [["Vero E6 cells", "ANATOMY", 188, 201], ["CV777", "CHEMICAL", 79, 84], ["CV777", "SIMPLE_CHEMICAL", 79, 84], ["Virus", "ORGANISM", 152, 157], ["Vero E6 cells", "CELL", 188, 201], ["Vero E6 cells", "CELL_LINE", 188, 201], ["Vero E6", "SPECIES", 188, 195], ["a killed CV777-based vaccine", "TREATMENT", 70, 98], ["Virus isolation", "TREATMENT", 152, 167], ["Vero E6 cells", "TREATMENT", 188, 201]]], ["Samples from the small intestines of pigs that were positive for PEDV but negative for TGE virus (TGEV), porcine rotavirus (PRV), classical swine fever virus (CSFV), and porcine circovirus 2 (PCV2) were homogenized by adding phosphate-buffered saline (PBS) to achieve a 10 % (w/v) homogenate.", [["Samples", "ANATOMY", 0, 7], ["intestines", "ANATOMY", 23, 33], ["porcine rotavirus", "DISEASE", 105, 122], ["swine fever", "DISEASE", 140, 151], ["phosphate", "CHEMICAL", 225, 234], ["phosphate", "CHEMICAL", 225, 234], ["small intestines", "ORGAN", 17, 33], ["pigs", "ORGANISM", 37, 41], ["PEDV", "GENE_OR_GENE_PRODUCT", 65, 69], ["TGE virus", "ORGANISM", 87, 96], ["TGEV", "ORGANISM", 98, 102], ["porcine rotavirus", "ORGANISM", 105, 122], ["PRV", "ORGANISM", 124, 127], ["classical swine fever virus", "ORGANISM", 130, 157], ["CSFV", "ORGANISM", 159, 163], ["porcine circovirus 2", "ORGANISM", 170, 190], ["PCV2", "ORGANISM", 192, 196], ["phosphate-buffered saline", "SIMPLE_CHEMICAL", 225, 250], ["pigs", "SPECIES", 37, 41], ["TGEV", "SPECIES", 98, 102], ["porcine rotavirus", "SPECIES", 105, 122], ["swine fever virus", "SPECIES", 140, 157], ["CSFV", "SPECIES", 159, 163], ["porcine circovirus", "SPECIES", 170, 188], ["pigs", "SPECIES", 37, 41], ["PEDV", "SPECIES", 65, 69], ["TGE virus", "SPECIES", 87, 96], ["TGEV", "SPECIES", 98, 102], ["porcine rotavirus", "SPECIES", 105, 122], ["PRV", "SPECIES", 124, 127], ["classical swine fever virus", "SPECIES", 130, 157], ["CSFV", "SPECIES", 159, 163], ["porcine circovirus 2 (PCV2)", "SPECIES", 170, 197], ["Samples", "TEST", 0, 7], ["the small intestines of pigs", "TEST", 13, 41], ["PEDV", "PROBLEM", 65, 69], ["TGE virus", "PROBLEM", 87, 96], ["TGEV", "PROBLEM", 98, 102], ["porcine rotavirus (PRV", "PROBLEM", 105, 127], ["classical swine fever virus", "PROBLEM", 130, 157], ["CSFV", "PROBLEM", 159, 163], ["porcine circovirus", "PROBLEM", 170, 188], ["phosphate-buffered saline (PBS", "TREATMENT", 225, 255], ["small intestines", "ANATOMY", 17, 33], ["pigs", "ANATOMY", 37, 41]]], ["These were then centrifuged (10,0009g, 15 min, 4\u00b0C) in a Sorvall ST 16R microcentrifuge (Fisher Scientific, MA, USA) and filtered through a 0.22-lm filter (Millipore, MA, USA) for use as inocula.", [["a 0.22-lm filter (Millipore", "TREATMENT", 138, 165]]], ["Vero E6 cells were seeded onto 21-cm 2 tissue culture plates 24 h prior to infection.", [["Vero E6 cells", "ANATOMY", 0, 13], ["infection", "DISEASE", 75, 84], ["Vero E6 cells", "CELL", 0, 13], ["Vero E6 cells", "CELL_LINE", 0, 13], ["Vero E6", "SPECIES", 0, 7], ["Vero E6 cells", "TREATMENT", 0, 13], ["tissue culture plates", "TEST", 39, 60], ["infection", "PROBLEM", 75, 84], ["E6 cells", "OBSERVATION", 5, 13], ["infection", "OBSERVATION", 75, 84]]], ["The growth medium was Dulbecco's modified Eagle's medium (DMEM) (Life Technologies, NY, USA) supplemented with 10 % heat-inactivated fetal calf serum, 100 U/ml penicillin G, and 100 lg/ml streptomycin.", [["fetal calf serum", "ANATOMY", 133, 149], ["penicillin", "CHEMICAL", 160, 170], ["streptomycin", "CHEMICAL", 188, 200], ["penicillin G", "CHEMICAL", 160, 172], ["streptomycin", "CHEMICAL", 188, 200], ["calf", "ORGANISM", 139, 143], ["serum", "ORGANISM_SUBSTANCE", 144, 149], ["penicillin G", "SIMPLE_CHEMICAL", 160, 172], ["streptomycin", "SIMPLE_CHEMICAL", 188, 200], ["calf", "SPECIES", 139, 143], ["fetal calf serum", "TEST", 133, 149], ["penicillin G", "TREATMENT", 160, 172], ["streptomycin", "TREATMENT", 188, 200], ["growth", "OBSERVATION_MODIFIER", 4, 10], ["medium", "OBSERVATION_MODIFIER", 11, 17]]], ["When confluent, growth medium was removed, and cell monolayers were washed once with PBS and then with DMEM containing 0.3 % tryptose phosphate broth and 0.02 % yeast extract.", [["cell monolayers", "ANATOMY", 47, 62], ["extract", "ANATOMY", 167, 174], ["tryptose phosphate", "CHEMICAL", 125, 143], ["tryptose phosphate", "CHEMICAL", 125, 143], ["cell monolayers", "CELL", 47, 62], ["tryptose", "SIMPLE_CHEMICAL", 125, 133], ["yeast", "SPECIES", 161, 166], ["yeast", "SPECIES", 161, 166], ["cell monolayers", "TEST", 47, 62], ["PBS", "TREATMENT", 85, 88], ["DMEM", "TREATMENT", 103, 107], ["0.3 % tryptose phosphate broth", "TREATMENT", 119, 149], ["confluent", "OBSERVATION_MODIFIER", 5, 14], ["growth", "OBSERVATION_MODIFIER", 16, 22], ["medium", "OBSERVATION_MODIFIER", 23, 29]]], ["The washed cells were infected with the filtered intestinal preparation that had been resuspended in 'infection medium' (DMEM, 0.3 % tryptose phosphate broth, 0.02 % yeast extract, and 10 lg/ml trypsin).", [["cells", "ANATOMY", 11, 16], ["intestinal", "ANATOMY", 49, 59], ["extract", "ANATOMY", 172, 179], ["infection", "DISEASE", 102, 111], ["tryptose phosphate", "CHEMICAL", 133, 151], ["tryptose phosphate", "CHEMICAL", 133, 151], ["cells", "CELL", 11, 16], ["intestinal", "ORGAN", 49, 59], ["tryptose", "SIMPLE_CHEMICAL", 133, 141], ["trypsin", "GENE_OR_GENE_PRODUCT", 194, 201], ["washed cells", "CELL_LINE", 4, 16], ["trypsin", "PROTEIN", 194, 201], ["yeast", "SPECIES", 166, 171], ["yeast", "SPECIES", 166, 171], ["The washed cells", "TREATMENT", 0, 16], ["the filtered intestinal preparation", "TREATMENT", 36, 71], ["tryptose phosphate broth", "TREATMENT", 133, 157], ["washed cells", "OBSERVATION", 4, 16], ["intestinal", "ANATOMY", 49, 59]]], ["After adsorption at 37\u00b0C for 1 h, an equal volume of infection medium was added.", [["infection", "DISEASE", 53, 62], ["infection medium", "PROBLEM", 53, 69], ["infection", "OBSERVATION", 53, 62]]], ["Every 24 h, the culture supernatants were supplied with trypsin at 80 % of the initial concentration.", [["supernatants", "ANATOMY", 24, 36], ["trypsin", "GENE_OR_GENE_PRODUCT", 56, 63], ["trypsin", "PROTEIN", 56, 63], ["the culture supernatants", "TEST", 12, 36], ["trypsin", "TREATMENT", 56, 63]]], ["PEDV strain CH/ZMDZY/11 was identified by amplifying structural and non-structural genes of the virus using PEDV-specific primers in a reverse transcription polymerase chain reaction (RT-PCR).Materials and methodsOther Chinese PEDV isolates and reference strains Another 11 Chinese PEDV isolates from 3-to 10-day-old suckling piglets suffering from watery diarrhea, dehydration and vomiting were examined.", [["watery diarrhea", "DISEASE", 349, 364], ["dehydration", "DISEASE", 366, 377], ["vomiting", "DISEASE", 382, 390], ["PEDV strain CH/ZMDZY/11", "ORGANISM", 0, 23], ["PEDV", "ORGANISM", 282, 286], ["piglets", "ORGANISM", 326, 333], ["non-structural genes", "DNA", 68, 88], ["PEDV-specific primers", "DNA", 108, 129], ["piglets", "SPECIES", 326, 333], ["PEDV strain CH/ZMDZY/11", "SPECIES", 0, 23], ["PEDV", "SPECIES", 282, 286], ["PEDV strain CH", "PROBLEM", 0, 14], ["the virus", "PROBLEM", 92, 101], ["PEDV", "PROBLEM", 108, 112], ["specific primers", "TREATMENT", 113, 129], ["a reverse transcription polymerase chain reaction", "PROBLEM", 133, 182], ["RT-PCR", "TEST", 184, 190], ["Other Chinese PEDV isolates", "TREATMENT", 213, 240], ["reference strains", "PROBLEM", 245, 262], ["watery diarrhea", "PROBLEM", 349, 364], ["dehydration", "PROBLEM", 366, 377], ["vomiting", "PROBLEM", 382, 390], ["watery diarrhea", "OBSERVATION", 349, 364]]], ["For these isolates, from different farms across seven provinces within China, morbidity of affected piglets was 70-100 %, and mortality, 60-90 %.", [["piglets", "ORGANISM", 100, 107], ["piglets", "SPECIES", 100, 107], ["these isolates", "TEST", 4, 18], ["affected piglets", "PROBLEM", 91, 107], ["mortality", "TEST", 126, 135]]], ["Some of the breeding herds from these farms had been immunized with CV777-based vaccines.", [["CV777", "CHEMICAL", 68, 73], ["CV777", "SIMPLE_CHEMICAL", 68, 73], ["CV777-based vaccines", "TREATMENT", 68, 88]]], ["Information pertaining to the reference strains and 11 PEDV isolates we analyzed is summarized in Table 1 .Nucleotide sequence analysisNucleotide sequences were edited, aligned and analyzed with the MegAlign program, a part of the Lasergene sequence analysis software package.", [["Lasergene sequence", "DNA", 231, 249], ["PEDV", "SPECIES", 55, 59], ["the reference strains", "TEST", 26, 47], ["Nucleotide sequence analysis", "TEST", 107, 135], ["Nucleotide sequences", "TEST", 135, 155]]], ["Phylogenetic trees were constructed using Molecular Evolutionary Genetics Analysis (MEGA) software version 5.02, applying the neighbor-joining method, which was based on the nucleotide sequence of each gene.Virus isolation and identificationCytopathic effects, such as cell fusion and syncytia formation, typical of coronavirus infection, were observed after 11 passages in Vero-E6 cells.", [["cell", "ANATOMY", 269, 273], ["syncytia", "ANATOMY", 285, 293], ["Vero-E6 cells", "ANATOMY", 374, 387], ["coronavirus infection", "DISEASE", 316, 337], ["nucleotide", "CHEMICAL", 174, 184], ["Virus", "ORGANISM", 207, 212], ["cell", "CELL", 269, 273], ["syncytia", "CELLULAR_COMPONENT", 285, 293], ["coronavirus", "ORGANISM", 316, 327], ["Vero-E6 cells", "CELL", 374, 387], ["Vero-E6 cells", "CELL_LINE", 374, 387], ["Vero-E6", "SPECIES", 374, 381], ["Virus isolation", "TREATMENT", 207, 222], ["Cytopathic effects", "PROBLEM", 241, 259], ["cell fusion", "TREATMENT", 269, 280], ["syncytia formation", "PROBLEM", 285, 303], ["coronavirus infection", "PROBLEM", 316, 337], ["Vero-E6 cells", "TREATMENT", 374, 387], ["Cytopathic", "OBSERVATION_MODIFIER", 241, 251], ["cell fusion", "OBSERVATION", 269, 280], ["syncytia formation", "OBSERVATION", 285, 303], ["coronavirus", "OBSERVATION_MODIFIER", 316, 327], ["infection", "OBSERVATION", 328, 337], ["E6 cells", "OBSERVATION", 379, 387]]], ["Genes encoding the spike protein (S), envelope protein (E), membrane protein (M), and nucleoprotein (N), along with open reading frame 3 (ORF3), were successfully amplified by RT-PCR ( Fig. 1 ).Virus isolation and identificationOur sequencing results showed that the amplified fragments shared high homology to other reported PEDV strains.Genomic structures in PEDV isolatesThe genome of the CH/ZMDZY/11 strain comprises 28,038 nucleotides (nt), excluding the poly (A) tail.", [["nucleotides", "CHEMICAL", 428, 439], ["spike protein (S)", "GENE_OR_GENE_PRODUCT", 19, 36], ["envelope protein (E), membrane protein", "GENE_OR_GENE_PRODUCT", 38, 76], ["M", "GENE_OR_GENE_PRODUCT", 78, 79], ["nucleoprotein (N)", "GENE_OR_GENE_PRODUCT", 86, 103], ["open reading frame 3", "GENE_OR_GENE_PRODUCT", 116, 136], ["ORF3", "GENE_OR_GENE_PRODUCT", 138, 142], ["Virus", "ORGANISM", 194, 199], ["PEDV", "GENE_OR_GENE_PRODUCT", 326, 330], ["CH/ZMDZY/11 strain", "ORGANISM", 392, 410], ["poly (A) tail", "GENE_OR_GENE_PRODUCT", 460, 473], ["spike protein", "PROTEIN", 19, 32], ["S", "PROTEIN", 34, 35], ["envelope protein", "PROTEIN", 38, 54], ["E", "PROTEIN", 56, 57], ["membrane protein", "PROTEIN", 60, 76], ["M", "PROTEIN", 78, 79], ["nucleoprotein", "PROTEIN", 86, 99], ["N", "PROTEIN", 101, 102], ["open reading frame 3", "DNA", 116, 136], ["ORF3", "DNA", 138, 142], ["amplified fragments", "DNA", 267, 286], ["28,038 nucleotides", "DNA", 421, 439], ["poly (A) tail", "DNA", 460, 473], ["PEDV", "SPECIES", 361, 365], ["CH/ZMDZY/11 strain", "SPECIES", 392, 410], ["the spike protein (S", "TEST", 15, 35], ["envelope protein (E", "TEST", 38, 57], ["membrane protein", "TEST", 60, 76], ["PCR", "TEST", 179, 182], ["Virus isolation", "TREATMENT", 194, 209], ["identificationOur sequencing", "TEST", 214, 242], ["the amplified fragments", "PROBLEM", 263, 286], ["PEDV strains", "PROBLEM", 326, 338], ["Genomic structures in PEDV isolates", "PROBLEM", 339, 374], ["the CH/ZMDZY", "TEST", 388, 400], ["PEDV strains", "OBSERVATION", 326, 338], ["PEDV isolates", "OBSERVATION", 361, 374], ["tail", "ANATOMY", 469, 473]]], ["The organization of genes is similar to that for other reported PEDVs (5 0 -ORF1a/1b-S-ORF3-E-M-N-3 0 ), with seven coding regions identified [1, 20] .", [["PEDVs", "GENE_OR_GENE_PRODUCT", 64, 69], ["PEDVs", "DNA", 64, 69], ["ORF1a", "DNA", 76, 81], ["S-ORF3", "DNA", 85, 91], ["E", "DNA", 92, 93], ["N", "DNA", 96, 97], ["PEDVs", "TEST", 64, 69], ["ORF1a", "TEST", 76, 81], ["1b", "TEST", 82, 84], ["ORF3", "TEST", 87, 91]]], ["The 5 0 and 3 0 ends of the genome contain untranslated regions (UTRs) of 292 and 334 nt, respectively.", [["5 0 and 3 0 ends", "DNA", 4, 20], ["untranslated regions", "DNA", 43, 63], ["UTRs", "DNA", 65, 69], ["UTRs", "TEST", 65, 69], ["untranslated", "OBSERVATION", 43, 55], ["regions", "ANATOMY_MODIFIER", 56, 63]]], ["ORF1a/1b encodes two large nonstructural precursor polyproteins, replicases 1a and 1b.", [["ORF1a/1b", "GENE_OR_GENE_PRODUCT", 0, 8], ["replicases 1a", "GENE_OR_GENE_PRODUCT", 65, 78], ["1b", "GENE_OR_GENE_PRODUCT", 83, 85], ["ORF1a", "PROTEIN", 0, 5], ["nonstructural precursor polyproteins", "PROTEIN", 27, 63], ["replicases 1a and 1b", "PROTEIN", 65, 85], ["two large nonstructural precursor polyproteins", "PROBLEM", 17, 63], ["large", "OBSERVATION_MODIFIER", 21, 26], ["nonstructural precursor polyproteins", "OBSERVATION", 27, 63]]], ["The S gene encodes the S protein (150-220 kDa), E encodes the E protein (7 kDa), M encodes the M protein (20-30 kDa), and the N gene encodes N (58 kDa).", [["E", "GENE_OR_GENE_PRODUCT", 48, 49], ["E", "GENE_OR_GENE_PRODUCT", 62, 63], ["N (58 kDa", "GENE_OR_GENE_PRODUCT", 141, 150], ["S gene", "DNA", 4, 10], ["S protein", "PROTEIN", 23, 32], ["E", "PROTEIN", 48, 49], ["E protein", "PROTEIN", 62, 71], ["M", "PROTEIN", 81, 82], ["M protein", "PROTEIN", 95, 104], ["N gene", "DNA", 126, 132], ["N (58 kDa", "PROTEIN", 141, 150], ["the S protein", "TEST", 19, 32], ["the E protein", "TEST", 58, 71], ["the M protein", "TEST", 91, 104]]], ["ORF3, between the S and E genes, encodes a non-structural protein.Sequence homology and genetic characterizationThe nucleotide and deduced amino acid (aa) sequences of certain reference strains and 11 Chinese PEDV isolates were examined and compared with that for the CH/ ZMDZY/11 strain (Table 1) .", [["nucleotide", "CHEMICAL", 116, 126], ["amino acid", "CHEMICAL", 139, 149], ["nucleotide", "CHEMICAL", 116, 126], ["amino acid", "CHEMICAL", 139, 149], ["ORF3", "GENE_OR_GENE_PRODUCT", 0, 4], ["E", "GENE_OR_GENE_PRODUCT", 24, 25], ["amino acid", "AMINO_ACID", 139, 149], ["ORF3", "DNA", 0, 4], ["S and E genes", "DNA", 18, 31], ["non-structural protein", "PROTEIN", 43, 65], ["PEDV", "SPECIES", 209, 213], ["CH/ ZMDZY/11 strain", "SPECIES", 268, 287], ["ORF3", "PROBLEM", 0, 4], ["a non-structural protein", "PROBLEM", 41, 65], ["Sequence homology", "TEST", 66, 83], ["genetic characterization", "TEST", 88, 112], ["The nucleotide and deduced amino acid (aa) sequences", "TEST", 112, 164], ["certain reference strains", "PROBLEM", 168, 193], ["Chinese PEDV isolates", "TEST", 201, 222], ["the CH/ ZMDZY/11 strain", "TREATMENT", 264, 287], ["non-structural protein", "OBSERVATION", 43, 65]]], ["Of these isolates, 10 were identified after 2010 from PEDV-affected swine farms of major swine-breeding provinces in China.", [["PEDV", "CHEMICAL", 54, 58], ["swine", "SPECIES", 68, 73], ["swine", "SPECIES", 89, 94], ["swine", "SPECIES", 68, 73], ["these isolates", "TEST", 3, 17], ["PEDV", "PROBLEM", 54, 58]]], ["The remaining two isolates, CH-S and LZC, were isolated in 1986 and 2006, respectively [4] .ORF1a and 1bThe length of ORF1a/1b for the 10 Phylogenetic analysis of the nucleotide and amino acid sequences of ORF1a/1b confirmed that all field strains belonged to three groups (Fig. 3a) .", [["nucleotide", "CHEMICAL", 167, 177], ["amino acid", "CHEMICAL", 182, 192], ["nucleotide", "CHEMICAL", 167, 177], ["amino acid", "CHEMICAL", 182, 192], ["LZC", "CELL", 37, 40], ["ORF1a", "GENE_OR_GENE_PRODUCT", 92, 97], ["ORF1a/1b", "GENE_OR_GENE_PRODUCT", 118, 126], ["amino acid", "AMINO_ACID", 182, 192], ["ORF1a/1b", "GENE_OR_GENE_PRODUCT", 206, 214], ["ORF1a", "DNA", 92, 97], ["ORF1a", "DNA", 118, 123], ["ORF1a", "PROTEIN", 206, 211], ["LZC", "TEST", 37, 40], ["the nucleotide", "TEST", 163, 177], ["amino acid sequences", "TEST", 182, 202], ["ORF1a", "TEST", 206, 211], ["all field strains", "PROBLEM", 230, 247], ["LZC", "ANATOMY", 37, 40]]], ["Group 1 comprised CV777 (Europe), LZC and SM98 (South Korea).", [["LZC", "TEST", 34, 37]]], ["Group 2 only contained attenuated DR13 (South Korea).", [["attenuated", "OBSERVATION_MODIFIER", 23, 33]]], ["The 10 Chinese PEDV strains isolated after 2010 were grouped together with virulent DR13 and CH-S (China) in group 3.S genePairwise alignment and comparison of the S gene from the 10 post-2010 Chinese PEDV isolates showed high levels of nucleotide sequence identity (97.4-100 %).", [["nucleotide", "CHEMICAL", 237, 247], ["nucleotide", "CHEMICAL", 237, 247], ["S gene", "DNA", 164, 170], ["The 10 Chinese PEDV strains", "TREATMENT", 0, 27], ["the S gene", "TEST", 160, 170], ["Chinese PEDV isolates", "TEST", 193, 214], ["nucleotide sequence identity", "TEST", 237, 265]]], ["When the S gene sequence for these isolates was compared with the European prototype CV777, we found 92.9-94.6 % nucleotide sequence identity; when they were compared against SM98, attenuated and virulent DR13 strains, nucleotide sequence identities of 92.9-94.6 % were seen.S geneThe homology of the S gene of CH-S to CV777, SM98, attenuated and virulent DR13 was 95.2-97 %, while that of LZC to CV777, SM98, attenuated and virulent DR13 was 95.2-99.1 %.S geneAmino acid sequence analysis of the S glycoprotein gene revealed that the 10 post-2010 PEDV isolates displayed sequence homology ranging from 97 to 100 % when compared with each other.", [["nucleotide", "CHEMICAL", 113, 123], ["nucleotide", "CHEMICAL", 219, 229], ["nucleotide", "CHEMICAL", 113, 123], ["DR13 strains", "ORGANISM", 205, 217], ["DR13", "CANCER", 434, 438], ["S glycoprotein", "GENE_OR_GENE_PRODUCT", 497, 511], ["S gene sequence", "DNA", 9, 24], ["S gene", "DNA", 275, 281], ["S gene", "DNA", 301, 307], ["S glycoprotein gene", "DNA", 497, 516], ["European prototype CV777", "SPECIES", 66, 90], ["DR13", "SPECIES", 205, 209], ["SM98", "TEST", 175, 179], ["attenuated and virulent DR13 strains", "PROBLEM", 181, 217], ["nucleotide sequence identities", "TEST", 219, 249], ["virulent DR13", "TEST", 347, 360], ["LZC", "TEST", 390, 393], ["virulent DR13", "TEST", 425, 438], ["S geneAmino acid sequence analysis", "TEST", 455, 489], ["the S glycoprotein gene", "TEST", 493, 516], ["PEDV isolates", "TEST", 548, 561], ["sequence homology", "TEST", 572, 589]]], ["These isolates shared relative low levels of identity with earlier Chinese isolates and those from Europe and South Korea, at 92.", [["These isolates", "TEST", 0, 14], ["earlier Chinese isolates", "TREATMENT", 59, 83], ["low levels", "OBSERVATION_MODIFIER", 31, 41]]], ["6 Phylogenetic analysis of the S gene and protein confirmed that all field strains could be classified into three and D?N at 168.", [["S gene", "DNA", 31, 37], ["Phylogenetic analysis", "TEST", 2, 23], ["the S gene and protein", "TEST", 27, 49], ["all field strains", "PROBLEM", 65, 82]]], ["There was a continuous 17-aa deletion in ORF3 of attenuated DR13 (82YCPLLYYCGALLD-ATII98); however, such a deletion did not exist in CH-ZMDZY-11 and other Chinese PEDV strains.", [["17-aa deletion", "DNA", 23, 37], ["ORF3", "DNA", 41, 45], ["DR13", "DNA", 60, 64], ["82YCPLLYYCGALLD", "DNA", 66, 81], ["ATII98", "DNA", 82, 88], ["a deletion", "PROBLEM", 105, 115], ["ZMDZY", "TEST", 136, 141]]], ["Phylogenetic analysis based on ORF3 nucleotide and amino acid sequences showed that PEDV Chinese field strains clustered into three groups (Fig. 3c) Table 1 Porcine epidemic diarrhea virus strains in China 2491 identity and 94.3-100 % amino acid similarity) when the E sequences from post-2010 isolates were compared with earlier Chinese strains and reference strains.", [["nucleotide", "CHEMICAL", 36, 46], ["amino acid", "CHEMICAL", 51, 61], ["diarrhea", "DISEASE", 174, 182], ["amino acid", "CHEMICAL", 235, 245], ["nucleotide", "CHEMICAL", 36, 46], ["amino acid", "CHEMICAL", 51, 61], ["amino acid", "CHEMICAL", 235, 245], ["ORF3", "GENE_OR_GENE_PRODUCT", 31, 35], ["amino acid", "AMINO_ACID", 51, 61], ["Porcine epidemic diarrhea virus", "ORGANISM", 157, 188], ["amino acid", "AMINO_ACID", 235, 245], ["ORF3 nucleotide", "DNA", 31, 46], ["E sequences", "DNA", 267, 278], ["Porcine epidemic diarrhea virus", "SPECIES", 157, 188], ["Porcine epidemic diarrhea virus", "SPECIES", 157, 188], ["Phylogenetic analysis", "TEST", 0, 21], ["ORF3 nucleotide", "TEST", 31, 46], ["amino acid sequences", "TEST", 51, 71], ["PEDV Chinese field strains", "PROBLEM", 84, 110], ["Porcine epidemic diarrhea virus strains", "PROBLEM", 157, 196], ["identity", "TEST", 211, 219], ["amino acid similarity", "TEST", 235, 256], ["the E sequences", "TEST", 263, 278]]], ["The following nucleotide changes in post-2010 PEDV strains and virulent DR13 were observed at the following nucleotide positions: C?T at 90, 165, and 166, and G?A at 194.", [["nucleotide", "CHEMICAL", 14, 24], ["nucleotide", "CHEMICAL", 14, 24], ["nucleotide", "CHEMICAL", 108, 118], ["DR13", "GENE_OR_GENE_PRODUCT", 72, 76], ["virulent DR13", "DNA", 63, 76], ["nucleotide changes", "PROBLEM", 14, 32], ["PEDV strains", "PROBLEM", 46, 58], ["virulent DR13", "PROBLEM", 63, 76], ["C", "TEST", 130, 131], ["T", "TEST", 132, 133]]], ["The change at 194 resulted in an altered amino acid at residue 65 (R?Q).", [["amino acid", "CHEMICAL", 41, 51], ["amino acid", "CHEMICAL", 41, 51], ["amino acid", "AMINO_ACID", 41, 51], ["an altered amino acid at residue", "PROBLEM", 30, 62], ["amino acid", "OBSERVATION", 41, 51]]], ["Attenuated DR13 has a 21-nt deletion from 67-87, which corresponds to a 7-aa deletion.", [["DR13", "CHEMICAL", 11, 15], ["DR13", "GENE_OR_GENE_PRODUCT", 11, 15], ["DR13", "DNA", 11, 15], ["21-nt deletion", "DNA", 22, 36], ["7-aa deletion", "DNA", 72, 85], ["a 21-nt deletion", "PROBLEM", 20, 36], ["a 7-aa deletion", "PROBLEM", 70, 85]]], ["Phylogenetic analysis showed that Chinese field isolates belonged to three groups (Fig. 3d) .", [["Phylogenetic analysis", "TEST", 0, 21], ["Chinese field isolates", "PROBLEM", 34, 56]]], ["Group Phylogenetic analysis of the N gene confirmed that all field strains could be classified into three groups (Fig. 3f) .", [["N gene", "DNA", 35, 41], ["Group Phylogenetic analysis", "TEST", 0, 27], ["all field strains", "PROBLEM", 57, 74]]], ["Group 2 comprised CH-S (China) and attenuated DR13 (South Korea), and group3 contained the 10 post-2010 Chinese PEDV strains and virulent DR13 (South Korea).DiscussionIn the present study, a virulent PEDV strain was isolated from a suckling piglet, and its genome was sequenced and compared with those of other PEDV strains.", [["piglet", "ANATOMY", 241, 247], ["PEDV", "CHEMICAL", 200, 204], ["PEDV", "ORGANISM", 200, 204], ["piglet", "ORGANISM", 241, 247], ["piglet", "SPECIES", 241, 247], ["PEDV", "SPECIES", 200, 204], ["PEDV", "SPECIES", 311, 315], ["group3", "TEST", 70, 76], ["Chinese PEDV strains", "PROBLEM", 104, 124], ["the present study", "TEST", 170, 187], ["a virulent PEDV strain", "PROBLEM", 189, 211], ["other PEDV strains", "PROBLEM", 305, 323]]], ["To the best of our knowledge, we are the first to report the genetic characteristics of viruses causing PED outbreaks in China.", [["PED", "DISEASE", 104, 107], ["viruses", "PROBLEM", 88, 95], ["viruses", "OBSERVATION", 88, 95]]], ["Comparative analysis of the whole genome sequence indicated that CH/ZMDZY11 shared high nucleotide sequence identity and amino acid sequence similarity with PEDV strains isolated between 2010 and 2012.", [["nucleotide", "CHEMICAL", 88, 98], ["amino acid", "CHEMICAL", 121, 131], ["nucleotide", "CHEMICAL", 88, 98], ["amino acid", "CHEMICAL", 121, 131], ["amino acid", "AMINO_ACID", 121, 131], ["whole genome sequence", "DNA", 28, 49], ["ZMDZY11", "DNA", 68, 75], ["Comparative analysis", "TEST", 0, 20], ["the whole genome sequence", "TEST", 24, 49], ["CH/ZMDZY11", "PROBLEM", 65, 75], ["high nucleotide sequence identity", "PROBLEM", 83, 116], ["amino acid sequence", "TEST", 121, 140], ["PEDV strains", "PROBLEM", 157, 169]]], ["The PEDV strain prevailing in China has developed several mutations in its genome.", [["PEDV strain", "ORGANISM", 4, 15], ["The PEDV strain", "PROBLEM", 0, 15], ["several mutations", "PROBLEM", 50, 67], ["PEDV strain", "OBSERVATION", 4, 15], ["several", "OBSERVATION_MODIFIER", 50, 57], ["mutations", "OBSERVATION", 58, 67]]], ["The majority of the 10 post-2010 Chinese PEDV strains were isolated from farms where breeding herds were immunized with inactivated or attenuated PEDV vaccines.", [["PEDV", "CHEMICAL", 146, 150], ["PEDV", "ORGANISM", 41, 45], ["PEDV", "SPECIES", 41, 45], ["PEDV", "SPECIES", 146, 150], ["Chinese PEDV strains", "PROBLEM", 33, 53], ["breeding herds", "TREATMENT", 85, 99], ["attenuated PEDV vaccines", "TREATMENT", 135, 159]]], ["These were manufactured with the CV777 vaccine strain; however, the morbidity and mortality of suckling piglets suffering from PED remains high, indicating low efficacy of the current vaccine in use.DiscussionThe polymerase gene comprises two large ORFs, 1a and 1b, which encode two replicases that determine the replication efficacy of the virus.", [["PED", "DISEASE", 127, 130], ["piglets", "ORGANISM", 104, 111], ["1a", "GENE_OR_GENE_PRODUCT", 255, 257], ["1b", "GENE_OR_GENE_PRODUCT", 262, 264], ["polymerase gene", "DNA", 213, 228], ["ORFs", "DNA", 249, 253], ["1a and 1b", "DNA", 255, 264], ["piglets", "SPECIES", 104, 111], ["the CV777 vaccine strain", "TREATMENT", 29, 53], ["the morbidity", "PROBLEM", 64, 77], ["suckling piglets", "PROBLEM", 95, 111], ["PED", "PROBLEM", 127, 130], ["the current vaccine", "TREATMENT", 172, 191], ["the virus", "PROBLEM", 337, 346], ["low efficacy", "OBSERVATION_MODIFIER", 156, 168], ["large", "OBSERVATION_MODIFIER", 243, 248], ["ORFs", "OBSERVATION", 249, 253], ["virus", "OBSERVATION", 341, 346]]], ["Sequence analysis of these ORFs showed that the post-2010 Chinese PEDV isolates and virulent DR13 shared multiple mutations at the same location and were clustered in one group.", [["DR13", "GENE_OR_GENE_PRODUCT", 93, 97], ["ORFs", "DNA", 27, 31], ["Chinese PEDV", "SPECIES", 58, 70], ["Sequence analysis", "TEST", 0, 17], ["these ORFs", "TEST", 21, 31], ["Chinese PEDV isolates", "TEST", 58, 79], ["virulent DR13", "PROBLEM", 84, 97], ["multiple mutations", "PROBLEM", 105, 123], ["multiple", "OBSERVATION_MODIFIER", 105, 113], ["mutations", "OBSERVATION", 114, 123]]], ["The 10 post-2010 PEDV strains appear to be related with the earlier prevailing Chinese strain, CH-S.DiscussionThe S protein is an antigen on the surface of the virion that plays a pivotal role in regulating interactions with specific host-cell receptor glycoproteins to mediate viral entry.", [["surface", "ANATOMY", 145, 152], ["cell", "ANATOMY", 239, 243], ["surface", "CELLULAR_COMPONENT", 145, 152], ["virion", "CELLULAR_COMPONENT", 160, 166], ["cell", "CELL", 239, 243], ["S protein", "PROTEIN", 114, 123], ["host-cell receptor glycoproteins", "PROTEIN", 234, 266], ["PEDV strains", "PROBLEM", 17, 29], ["specific host-cell receptor glycoproteins", "TREATMENT", 225, 266]]], ["This stimulates induction of neutralizing antibodies in the natural host [21, 22] .", [["neutralizing antibodies", "PROTEIN", 29, 52], ["neutralizing antibodies", "PROBLEM", 29, 52]]], ["It is also associated with growth adaptation in vitro and attenuation of virulence in vivo [23, 24] .", [["growth adaptation", "PROBLEM", 27, 44], ["also associated with", "UNCERTAINTY", 6, 26], ["growth adaptation", "OBSERVATION", 27, 44], ["attenuation", "OBSERVATION_MODIFIER", 58, 69]]], ["The S genes of the 10 post-2010 Chinese PEDV isolates were highly homologous.", [["PEDV", "ORGANISM", 40, 44], ["S genes", "DNA", 4, 11], ["PEDV", "SPECIES", 40, 44], ["The S genes", "TEST", 0, 11], ["Chinese PEDV isolates", "TEST", 32, 53]]], ["The S genes in all 10 isolates contained some altered amino acids, with a discontinuous 5-aa insertion and a 2-aa deletion at the same sites of the N-terminal region.", [["amino acids", "CHEMICAL", 54, 65], ["amino acids", "CHEMICAL", 54, 65], ["N-", "CHEMICAL", 148, 150], ["amino acids", "AMINO_ACID", 54, 65], ["S genes", "DNA", 4, 11], ["discontinuous 5-aa insertion", "DNA", 74, 102], ["2-aa deletion", "DNA", 109, 122], ["N-terminal region", "PROTEIN", 148, 165], ["some altered amino acids", "PROBLEM", 41, 65], ["a discontinuous 5-aa insertion", "TREATMENT", 72, 102], ["a 2-aa deletion", "TREATMENT", 107, 122], ["amino acids", "OBSERVATION", 54, 65], ["N-", "ANATOMY", 148, 150], ["terminal", "ANATOMY_MODIFIER", 150, 158], ["region", "ANATOMY_MODIFIER", 159, 165]]], ["The S gene has been considered a target gene for analyzing genetic variation of PEDV strains in the field [4, 6] .", [["PEDV", "GENE_OR_GENE_PRODUCT", 80, 84], ["S gene", "DNA", 4, 10], ["target gene", "DNA", 33, 44], ["PEDV", "SPECIES", 80, 84], ["PEDV strains", "PROBLEM", 80, 92]]], ["Our findings indicate that the current PEDV isolate prevailing in China is a novel strain with a variant S gene that is distinct from previous Chinese and reference strains.", [["PEDV", "CHEMICAL", 39, 43], ["PEDV", "ORGANISM", 39, 43], ["S gene", "DNA", 105, 111], ["a novel strain", "PROBLEM", 75, 89]]], ["This could explain the lesseffective immunological protection against PEDV strains induced by the current vaccine in China, and the effectiveness of feeding sows feces or intestinal contents of infected piglets.", [["feces", "ANATOMY", 162, 167], ["intestinal", "ANATOMY", 171, 181], ["PEDV", "CHEMICAL", 70, 74], ["PEDV strains", "ORGANISM", 70, 82], ["sows", "ORGANISM", 157, 161], ["feces", "ORGANISM_SUBDIVISION", 162, 167], ["intestinal", "ORGAN", 171, 181], ["piglets", "ORGANISM", 203, 210], ["piglets", "SPECIES", 203, 210], ["PEDV", "SPECIES", 70, 74], ["the lesseffective immunological protection", "TREATMENT", 19, 61], ["PEDV strains", "PROBLEM", 70, 82], ["the current vaccine", "TREATMENT", 94, 113], ["feeding sows feces", "PROBLEM", 149, 167], ["intestinal contents of infected piglets", "PROBLEM", 171, 210], ["intestinal", "ANATOMY", 171, 181], ["infected piglets", "OBSERVATION", 194, 210]]], ["Further investigation of the antigenic differences among current isolates and the vaccine strain used in China is necessary for the development of an effective vaccine against PED in China.DiscussionORF3 is an accessory gene, located between the S and E genes, and its function has rarely been examined.", [["PED", "DISEASE", 176, 179], ["DiscussionORF3", "GENE_OR_GENE_PRODUCT", 189, 203], ["E", "GENE_OR_GENE_PRODUCT", 252, 253], ["DiscussionORF3", "DNA", 189, 203], ["accessory gene", "DNA", 210, 224], ["S and E genes", "DNA", 246, 259], ["Further investigation", "TEST", 0, 21], ["the antigenic differences", "PROBLEM", 25, 50], ["current isolates", "TREATMENT", 57, 73], ["the vaccine strain", "TREATMENT", 78, 96], ["an effective vaccine", "TREATMENT", 147, 167], ["accessory gene", "OBSERVATION", 210, 224]]], ["Sequence analysis revealed a continuous 17-aa deletion in ORF3 of attenuated DR13 and the CV777 vaccine strain.", [["ORF3", "GENE_OR_GENE_PRODUCT", 58, 62], ["DR13", "GENE_OR_GENE_PRODUCT", 77, 81], ["continuous 17-aa deletion", "DNA", 29, 54], ["ORF3", "DNA", 58, 62], ["DR13", "DNA", 77, 81], ["Sequence analysis", "TEST", 0, 17], ["a continuous 17-aa deletion", "PROBLEM", 27, 54], ["attenuated DR13", "PROBLEM", 66, 81], ["the CV777 vaccine strain", "TREATMENT", 86, 110]]], ["However, this deletion does not exist in current Chinese PEDV strains isolated after 2010.", [["PEDV strains", "ORGANISM", 57, 69], ["this deletion", "PROBLEM", 9, 22]]], ["Differences in ORF3 sequences between cell-adapted and field viruses could be a marker of their adaptation to environmental conditions.", [["cell", "ANATOMY", 38, 42], ["ORF3", "GENE_OR_GENE_PRODUCT", 15, 19], ["cell", "CELL", 38, 42], ["ORF3 sequences", "DNA", 15, 29], ["ORF3 sequences", "TEST", 15, 29]]], ["A recently study suggested that PEDV ORF3 is related to viral infectivity and pathogenicity and encodes an ion channel protein that regulates virus production [25] .", [["PEDV ORF3", "GENE_OR_GENE_PRODUCT", 32, 41], ["PEDV ORF3", "DNA", 32, 41], ["ion channel protein", "PROTEIN", 107, 126], ["PEDV", "SPECIES", 32, 36], ["A recently study", "TEST", 0, 16], ["PEDV ORF3", "PROBLEM", 32, 41], ["viral infectivity", "PROBLEM", 56, 73], ["pathogenicity", "PROBLEM", 78, 91], ["an ion channel protein", "TREATMENT", 104, 126], ["related to", "UNCERTAINTY", 45, 55], ["viral infectivity", "OBSERVATION", 56, 73]]], ["The post-2010 isolates were clustered together with virulent DR13, implying that current Chinese PEDV strains retain high infectivity and pathogenicity.", [["DR13", "GENE_OR_GENE_PRODUCT", 61, 65], ["PEDV strains", "ORGANISM", 97, 109], ["PEDV", "SPECIES", 97, 101], ["virulent DR13", "TREATMENT", 52, 65], ["Chinese PEDV strains", "PROBLEM", 89, 109], ["high infectivity", "PROBLEM", 117, 133], ["pathogenicity", "PROBLEM", 138, 151], ["high infectivity", "OBSERVATION", 117, 133]]], ["The effects of this deletion on virulence and other properties requires further investigation.DiscussionThe E protein plays an important role during coronavirus budding.", [["E", "GENE_OR_GENE_PRODUCT", 108, 109], ["coronavirus", "ORGANISM", 149, 160], ["E protein", "PROTEIN", 108, 117], ["this deletion on virulence", "PROBLEM", 15, 41], ["further investigation", "TEST", 72, 93], ["coronavirus budding", "PROBLEM", 149, 168]]], ["It transiently resides in a pre-Golgi compartment before progressing to the Golgi apparatus [26] .", [["pre-Golgi compartment", "ANATOMY", 28, 49], ["Golgi apparatus", "ANATOMY", 76, 91], ["Golgi", "CELLULAR_COMPONENT", 76, 81], ["the Golgi apparatus", "TEST", 72, 91]]], ["Recently, many studies have focused on the genetic and phylogenetic analysis of PEDV S, M and ORF3 genes, whereas a comparison of E genes has rarely been conducted.", [["PEDV S", "GENE_OR_GENE_PRODUCT", 80, 86], ["ORF3", "GENE_OR_GENE_PRODUCT", 94, 98], ["E", "GENE_OR_GENE_PRODUCT", 130, 131], ["PEDV S, M and ORF3 genes", "DNA", 80, 104], ["E genes", "DNA", 130, 137], ["PEDV", "SPECIES", 80, 84], ["many studies", "TEST", 10, 22], ["phylogenetic analysis", "TEST", 55, 76], ["PEDV S", "PROBLEM", 80, 86]]], ["Our results show a 21-nt deletion in the E gene of attenuated DR13, which does not exist in post-2010 Chinese PEDV isolates and virulent DR13.", [["DR13", "GENE_OR_GENE_PRODUCT", 62, 66], ["21-nt deletion", "DNA", 19, 33], ["E gene", "DNA", 41, 47], ["DR13", "DNA", 62, 66], ["a 21-nt deletion", "PROBLEM", 17, 33], ["attenuated DR13", "PROBLEM", 51, 66]]], ["All post-2010 Chinese PEDV strains exhibited a close relationship to the South Korean virulent DR13 and its derivative.DiscussionThe M protein plays an important role in the viral assembly process and also induces antibodies that neutralize the virus [27, 28] .", [["DR13", "CHEMICAL", 95, 99], ["DR13", "GENE_OR_GENE_PRODUCT", 95, 99], ["M protein", "PROTEIN", 133, 142], ["antibodies", "PROTEIN", 214, 224], ["South Korean virulent DR13", "SPECIES", 73, 99], ["Chinese PEDV strains", "PROBLEM", 14, 34], ["its derivative", "TREATMENT", 104, 118], ["the viral assembly process", "PROBLEM", 170, 196], ["the virus", "PROBLEM", 241, 250]]], ["Heterogeneity of the M gene sequence is known to confer diverse PEDV pathogenicities [5] .", [["M gene sequence", "DNA", 21, 36], ["PEDV", "SPECIES", 64, 68], ["Heterogeneity of the M gene sequence", "PROBLEM", 0, 36], ["diverse PEDV pathogenicities", "PROBLEM", 56, 84], ["diverse", "OBSERVATION_MODIFIER", 56, 63], ["PEDV", "OBSERVATION", 64, 68]]], ["Sequence comparisons indicate that the 10 post-2010 Chinese PEDV strains contain an amino acid change (V46A) compared with earlier Chinese isolates and other reference strains.", [["amino acid", "CHEMICAL", 84, 94], ["amino acid", "CHEMICAL", 84, 94], ["PEDV strains", "ORGANISM", 60, 72], ["amino acid", "AMINO_ACID", 84, 94], ["Sequence comparisons", "TEST", 0, 20], ["Chinese PEDV strains", "PROBLEM", 52, 72], ["an amino acid change", "PROBLEM", 81, 101], ["amino acid", "OBSERVATION", 84, 94]]], ["The post-2010 isolates were clustered together with virulent DR13.", [["DR13", "DNA", 61, 65], ["virulent DR13", "TREATMENT", 52, 65]]], ["The N protein, which binds to virion RNA and provides a structural basis for the helical nucleocapsid, is a basic phosphoprotein associated with the genome [29] .", [["N protein", "PROTEIN", 4, 13], ["virion RNA", "RNA", 30, 40], ["helical nucleocapsid", "PROTEIN", 81, 101], ["basic phosphoprotein", "PROTEIN", 108, 128], ["The N protein", "TREATMENT", 0, 13], ["the helical nucleocapsid", "PROBLEM", 77, 101], ["a basic phosphoprotein", "PROBLEM", 106, 128]]], ["Alignment with reference strains indicated that the N gene is highly conserved, with the exception of some point mutations.", [["N gene", "DNA", 52, 58], ["reference strains", "PROBLEM", 15, 32], ["some point mutations", "PROBLEM", 102, 122]]], ["Phylogenetic analysis confirmed that all 10 post-2010 Chinese PEDV isolates were grouped with virulent DR13.DiscussionTaken together, our results show that a novel PEDV strain is the etiological agent contributing to the re-emergence of PED in China.", [["PEDV", "CHEMICAL", 164, 168], ["PED", "DISEASE", 237, 240], ["PEDV", "ORGANISM", 62, 66], ["PEDV strain", "ORGANISM", 164, 175], ["DR13", "DNA", 103, 107], ["PEDV", "SPECIES", 62, 66], ["PEDV", "SPECIES", 164, 168], ["Phylogenetic analysis", "TEST", 0, 21], ["Chinese PEDV isolates", "TREATMENT", 54, 75], ["a novel PEDV strain", "PROBLEM", 156, 175]]], ["Prevailing PEDV field isolates share common molecular characteristics in their S, E, and M genes.", [["E", "GENE_OR_GENE_PRODUCT", 82, 83], ["S, E, and M genes", "DNA", 79, 96]]], ["Phylogenetic analyses of ORF1a/b, ORF3, E, M, and N genes confirmed that the 10 post-2010 Chinese PEDV isolates have a close relationship to a virulent DR13 strain from South Korea.", [["ORF1a/b", "GENE_OR_GENE_PRODUCT", 25, 32], ["ORF3", "GENE_OR_GENE_PRODUCT", 34, 38], ["E", "GENE_OR_GENE_PRODUCT", 40, 41], ["PEDV isolates", "ORGANISM", 98, 111], ["DR13 strain", "ORGANISM", 152, 163], ["ORF1a/b, ORF3, E, M, and N genes", "DNA", 25, 57], ["Phylogenetic analyses", "TEST", 0, 21], ["ORF1a", "TEST", 25, 30], ["ORF3", "TEST", 34, 38], ["Chinese PEDV isolates", "PROBLEM", 90, 111]]], ["The differences between the current isolates and the vaccine strain must be defined to develop an effective vaccine that better prevents and controls PED epidemics.", [["the current isolates", "TREATMENT", 24, 44], ["the vaccine strain", "TREATMENT", 49, 67], ["an effective vaccine", "TREATMENT", 95, 115], ["PED epidemics", "PROBLEM", 150, 163]]]]}